Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NC_012920.1(MT-CYB):m.235A>G			Mitochondrial inheritance	Uncertain significance	no assertion criteria provided	VCV001344497	MT	235	MT	235	1344497	1336200		NC_012920.1:234:A:G
NC_012920.1(MT-CYB):m.263A>G			not provided	not provided	no assertion provided	VCV000441147	MT	263	MT	263	441147	434777	rs2853515	NC_012920.1:262:A:G
NC_012920.1(MT-CYB):m.578T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689805	MT	578	MT	578	689805	677824	rs1603218446	NC_012920.1:577:T:C
NC_012920.1(MT-CYB):m.579T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689806	MT	579	MT	579	689806	677830	rs1603218447	NC_012920.1:578:T:C
m.583G>A	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009573	MT	583	MT	583	9573	24612	rs118203885	NC_012920.1:582:G:A
m.586G>A	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial encephalopathy	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000030005	MT	586	MT	586	30005	38960	rs387906734	NC_012920.1:585:G:A
NC_012920.1(MT-CYB):m.588T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689807	MT	588	MT	588	689807	677863	rs1603218449	NC_012920.1:587:T:C
NC_012920.1(MT-CYB):m.590A>G	MT-TF		Mitochondrial disease	Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000870573	MT	590	MT	590	870573	858735	rs2068676854	NC_012920.1:589:A:G
NC_012920.1(MT-CYB):m.591C>T	MT-TF		Hypokalemia|Hypomagnesemia	Pathogenic(Last reviewed: Jul 2, 2021)	criteria provided, single submitter	VCV001177637	MT	591	MT	591	1177637	1167121		NC_012920.1:590:C:T
NC_012920.1(MT-CYB):m.592C>T	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689808	MT	592	MT	592	689808	677866	rs1603218450	NC_012920.1:591:C:T
NC_012920.1(MT-CYB):m.593T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689809	MT	593	MT	593	689809	677867	rs879123694	NC_012920.1:592:T:C
NC_012920.1(MT-CYB):m.595C>T	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689812	MT	595	MT	595	689812	677870	rs1603218452	NC_012920.1:594:C:T
NC_012920.1(MT-CYB):m.595C>A	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689811	MT	595	MT	595	689811	677869	rs1603218452	NC_012920.1:594:C:A
NC_012920.1(MT-CYB):m.596T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689813	MT	596	MT	596	689813	677871	rs1556422474	NC_012920.1:595:T:C
NC_012920.1(MT-CYB):m.597C>T	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689814	MT	597	MT	597	689814	677872	rs1603218453	NC_012920.1:596:C:T
NC_012920.1(MT-CYB):m.603A>G	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689816	MT	603	MT	603	689816	677874	rs1603218456	NC_012920.1:602:A:G
NC_012920.1(MT-CYB):m.606A>G	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689817	MT	606	MT	606	689817	677875	rs200056066	NC_012920.1:605:A:G
m.608A>G	MT-TF		Interstitial nephritis	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000030006	MT	608	MT	608	30006	38961	rs387906735	NC_012920.1:607:A:G
m.611G>A	MT-TF		MERRF syndrome	Pathogenic(Last reviewed: Jan 29, 2015)	no assertion criteria provided	VCV000009574	MT	611	MT	611	9574	24613	rs118203886	NC_012920.1:610:G:A
m.616T>G	MT-TF		Epilepsy, mitochondrial	Pathogenic(Last reviewed: Feb 9, 2010)	no assertion criteria provided	VCV000009577	MT	616	MT	616	9577	24616	rs387906420	NC_012920.1:615:T:G
m.616T>C	MT-TF		Interstitial nephritis|Epilepsy, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009576	MT	616	MT	616	9576	24615	rs387906420	NC_012920.1:615:T:C
NC_012920.1(MT-CYB):m.618T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689818	MT	618	MT	618	689818	677876	rs1603218460	NC_012920.1:617:T:C
NC_012920.1(MT-CYB):m.619T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689819	MT	619	MT	619	689819	677877	rs1603218462	NC_012920.1:618:T:C
NC_012920.1(MT-CYB):m.621A>G	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689820	MT	621	MT	621	689820	677878	rs1603218463	NC_012920.1:620:A:G
m.622G>A	MT-TF		Myopathy, mitochondrial, late-onset	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000009575	MT	622	MT	622	9575	24614	rs118203887	NC_012920.1:621:G:A
NC_012920.1(MT-CYB):m.624C>T	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689821	MT	624	MT	624	689821	677879	rs1603218465	NC_012920.1:623:C:T
NC_012920.1(MT-CYB):m.628C>T	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689822	MT	628	MT	628	689822	677880	rs1603218467	NC_012920.1:627:C:T
NC_012920.1(MT-CYB):m.629T>A	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689824	MT	629	MT	629	689824	677881	rs201031012	NC_012920.1:628:T:A
NC_012920.1(MT-CYB):m.629T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689823	MT	629	MT	629	689823	677882	rs201031012	NC_012920.1:628:T:C
NC_012920.1(MT-CYB):m.630C>T	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689825	MT	630	MT	630	689825	677883	rs1603218468	NC_012920.1:629:C:T
NC_012920.1(MT-CYB):m.633A>G	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689826	MT	633	MT	633	689826	677884	rs1603218469	NC_012920.1:632:A:G
NC_012920.1(MT-CYB):m.634T>C	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689828	MT	634	MT	634	689828	677886	rs1603218470	NC_012920.1:633:T:C
NC_012920.1(MT-CYB):m.634T>A	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689827	MT	634	MT	634	689827	677885	rs1603218470	NC_012920.1:633:T:A
NC_012920.1(MT-CYB):m.635C>T	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689829	MT	635	MT	635	689829	677887	rs1603218471	NC_012920.1:634:C:T
NC_012920.1(MT-CYB):m.643A>G	MT-TF		Hypokalemia|Hypomagnesemia|Chronic kidney disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000689830	MT	643	MT	643	689830	677888	rs1603218472	NC_012920.1:642:A:G
NC_012920.1(MT-CYB):m.644A>G	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689831	MT	644	MT	644	689831	677889	rs1556422475	NC_012920.1:643:A:G
NC_012920.1(MT-CYB):m.647A>G	MT-TF		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689832	MT	647	MT	647	689832	677890	rs1569483788	NC_012920.1:646:A:G
NC_012920.1(MT-ND6):m.663A>G	MT-RNR1		not provided	Benign(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000805059	MT	663	MT	663	805059	793917	rs56489998	NC_012920.1:662:A:G
NC_012920.1(MT-CYB):m.721T>C	MT-RNR1		not provided	Likely benign(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV000994690	MT	721	MT	721	994690	983281	rs1556422479	NC_012920.1:720:T:C
NC_012920.1(MT-CYB):m.750A>G	MT-RNR1		not provided	not provided	no assertion provided	VCV000441148	MT	750	MT	750	441148	434781	rs2853518	NC_012920.1:749:A:G
NC_012920.1(MT-CYB):m.813A>G	MT-RNR1		not provided	Benign(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000805060	MT	813	MT	813	805060	793932	rs878985110	NC_012920.1:812:A:G
NC_012920.1:m.827A>G	MT-RNR1		Mitochondrial non-syndromic sensorineural hearing loss|Gentamicin response|Aminoglycoside-induced deafness	drug response(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000009634	MT	827	MT	827	9634	24673	rs28358569	NC_012920.1:826:A:G
NC_012920.1(MT-CYB):m.869C>T	MT-RNR1		not provided	Likely benign(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000235207	MT	869	MT	869	235207	236896	rs386828880	NC_012920.1:868:C:T
NC_012920.1(MT-ATP8):m.930G>A	MT-RNR1		not provided	Benign(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000805061	MT	930	MT	930	805061	793935	rs41352944	NC_012920.1:929:G:A
m.951G>A	MT-RNR1		not specified	Likely benign(Last reviewed: Aug 28, 2013)	criteria provided, single submitter	VCV000042231	MT	951	MT	951	42231	51401	rs200887992	NC_012920.1:950:G:A
NC_012920.1(MT-CYB):m.953T>C	MT-RNR1		not specified	Likely benign(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000517299	MT	953	MT	953	517299	497360	rs1556422495	NC_012920.1:952:T:C
NC_012920.1(MT-CYB):m.954C>T	MT-RNR1		not specified	Benign(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000517632	MT	954	MT	954	517632	497361	rs1556422496	NC_012920.1:953:C:T
m.956C>T	MT-RNR1		not specified	Uncertain significance(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	VCV000042232	MT	956	MT	956	42232	51402	rs397515729	NC_012920.1:955:C:T
m.961T>C	MT-RNR1		not specified	Benign(Last reviewed: Dec 12, 2011)	criteria provided, single submitter	VCV000042236	MT	961	MT	961	42236	51406	rs3888511	NC_012920.1:960:T:C
m.961T>G	MT-RNR1		Mitochondrial non-syndromic sensorineural hearing loss|not specified	Likely benign(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	VCV000009633	MT	961	MT	961	9633	24672	rs3888511	NC_012920.1:960:T:G
NC_012920.1(MT-CYB):m.962C>T	MT-RNR1		not specified	Uncertain significance(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000505138	MT	962	MT	962	505138	497553	rs1556422500	NC_012920.1:961:C:T
NC_012920.1(MT-CYB):m.979C>T	MT-RNR1		not specified	Likely benign(Last reviewed: Jan 14, 2015)	criteria provided, single submitter	VCV000227551	MT	979	MT	979	227551	231302	rs876657507	NC_012920.1:978:C:T
m.980T>C	MT-RNR1		not specified	Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000042237	MT	980	MT	980	42237	51407	rs397515731	NC_012920.1:979:T:C
NC_012920.1(MT-CYB):m.990T>C	MT-RNR1		not specified	Likely benign(Last reviewed: Dec 13, 2013)	criteria provided, single submitter	VCV000163989	MT	990	MT	990	163989	176337	rs727503165	NC_012920.1:989:T:C
m.1005T>C	MT-RNR1		not specified	Benign(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	VCV000042201	MT	1005	MT	1005	42201	51371	rs111033179	NC_012920.1:1004:T:C
m.1007G>A	MT-RNR1		not specified	Benign(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	VCV000042202	MT	1007	MT	1007	42202	51372	rs111033213	NC_012920.1:1006:G:A
NC_012920.1(MT-CYB):m.1008A>G	MT-RNR1		not specified	Likely benign(Last reviewed: May 15, 2013)	criteria provided, single submitter	VCV000178871	MT	1008	MT	1008	178871	176333	rs727504505	NC_012920.1:1007:A:G
m.1018G>A	MT-RNR1		not specified|not provided	Benign(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042203	MT	1018	MT	1018	42203	51373	rs2856982	NC_012920.1:1017:G:A
NC_012920.1(MT-CYB):m.1027A>G	MT-RNR1		Rare genetic deafness	Likely pathogenic(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	VCV000178943	MT	1027	MT	1027	178943	176456	rs727504555	NC_012920.1:1026:A:G
NC_012920.1(MT-CYB):m.1040T>C	MT-RNR1		not specified	Likely benign(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000163983	MT	1040	MT	1040	163983	176334	rs727503163	NC_012920.1:1039:T:C
NC_012920.1(MT-CYB):m.1041A>G	MT-RNR1		not specified	Likely benign(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000505132	MT	1041	MT	1041	505132	497356	rs58327546	NC_012920.1:1040:A:G
NC_012920.1(MT-CYB):m.1047A>G	MT-RNR1		not specified	Likely benign(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000517649	MT	1047	MT	1047	517649	497774	rs1556422506	NC_012920.1:1046:A:G
m.1048C>T	MT-RNR1		not specified	Benign(Last reviewed: Oct 5, 2013)	criteria provided, single submitter	VCV000042204	MT	1048	MT	1048	42204	51374	rs2000974	NC_012920.1:1047:C:T
m.1095T>C	MT-RNR1		not specified|Auditory neuropathy|Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness|aminoglycoside antibacterials response - Toxicity|kanamycin response - Toxicity|streptomycin response - Toxicity|gentamicin response - Toxicity	drug response(Last reviewed: Jun 15, 2021)	reviewed by expert panel	VCV000009631	MT	1095	MT	1095	9631	24670	rs267606618	NC_012920.1:1094:T:C
NC_012920.1(MT-CYB):m.1106C>T	MT-RNR1		not specified	Uncertain significance(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000667034	MT	1106	MT	1106	667034	654970	rs1603218523	NC_012920.1:1105:C:T
m.1107T>C	MT-RNR1		not specified	Benign(Last reviewed: Jun 8, 2012)	criteria provided, single submitter	VCV000042207	MT	1107	MT	1107	42207	51377	rs111033323	NC_012920.1:1106:T:C
m.1116A>G	MT-RNR1		not specified	Benign(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000042208	MT	1116	MT	1116	42208	51378	rs111033208	NC_012920.1:1115:A:G
NC_012920.1(MT-CYB):m.1117A>G	MT-RNR1		not specified	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000929973	MT	1117	MT	1117	929973	918480	rs2068677687	NC_012920.1:1116:A:G
m.1119T>C	MT-RNR1		not specified	Benign(Last reviewed: Apr 27, 2012)	criteria provided, single submitter	VCV000042209	MT	1119	MT	1119	42209	51379	rs397515724	NC_012920.1:1118:T:C
NC_012920.1(MT-CYB):m.1120C>T	MT-RNR1		not specified	Likely benign(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000179852	MT	1120	MT	1120	179852	176457	rs727505171	NC_012920.1:1119:C:T
NC_012920.1(MT-CYB):m.1183T>C	MT-RNR1		not specified	Uncertain significance(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000505289	MT	1183	MT	1183	505289	497552	rs1556422511	NC_012920.1:1182:T:C
m.1187T>C	MT-RNR1		not specified	Uncertain significance(Last reviewed: Feb 28, 2007)	no assertion criteria provided	VCV000042210	MT	1187	MT	1187	42210	51380	rs111033320	NC_012920.1:1186:T:C
m.1189T>C	MT-RNR1		not specified	Benign(Last reviewed: May 1, 2014)	criteria provided, single submitter	VCV000042205	MT	1189	MT	1189	42205	51375	rs28358571	NC_012920.1:1188:T:C
m.1193T>C	MT-RNR1		not specified|not provided	Benign/Likely benign(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042206	MT	1193	MT	1193	42206	51376	rs111033321	NC_012920.1:1192:T:C
m.1211G>A	MT-RNR1		not specified	Likely benign(Last reviewed: Jun 4, 2016)	criteria provided, single submitter	VCV000042211	MT	1211	MT	1211	42211	51381	rs397515725	NC_012920.1:1210:G:A
m.1243T>C	MT-RNR1		not provided|not specified	Benign(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042212	MT	1243	MT	1243	42212	51382	rs28358572	NC_012920.1:1242:T:C
NC_012920.1(MT-CYB):m.1257T>C	MT-RNR1		not provided	Uncertain significance(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000805058	MT	1257	MT	1257	805058	793901	rs1603218535	NC_012920.1:1256:T:C
NC_012920.1(MT-CYB):m.1282G>A	MT-RNR1		not provided	Uncertain significance(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618730	MT	1282	MT	1282	618730	610265	rs1569483805	NC_012920.1:1281:G:A
NC_012920.1(MT-CYB):m.1284T>C	MT-RNR1		not specified	Benign(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000505294	MT	1284	MT	1284	505294	497808	rs1556422516	NC_012920.1:1283:T:C
NC_012920.1(MT-CYB):m.1290C>T	MT-RNR1		not specified	Likely benign(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000505197	MT	1290	MT	1290	505197	497775	rs1556422517	NC_012920.1:1289:C:T
m.1291T>C	MT-RNR1		Mitochondrial non-syndromic sensorineural hearing loss|not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000009630	MT	1291	MT	1291	9630	24669	rs267606620	NC_012920.1:1290:T:C
NC_012920.1(MT-CYB):m.1299A>G	MT-RNR1		not specified	Likely benign(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000517363	MT	1299	MT	1299	517363	497357	rs1556422518	NC_012920.1:1298:A:G
NC_012920.1(MT-CYB):m.1303G>A	MT-RNR1		not specified	Benign(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000667050	MT	1303	MT	1303	667050	654971	rs879036775	NC_012920.1:1302:G:A
m.1310C>T	MT-RNR1		not specified	Likely benign(Last reviewed: Aug 14, 2009)	no assertion criteria provided	VCV000042213	MT	1310	MT	1310	42213	51383	rs111033354	NC_012920.1:1309:C:T
NC_012920.1(MT-ND1):m.1313A>G	MT-RNR1		not specified	Likely benign(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000666715	MT	1313	MT	1313	666715	654972	rs1603218542	NC_012920.1:1312:A:G
NC_012920.1:m.1341C>T	MT-RNR1		not specified	Likely benign(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000505200	MT	1341	MT	1341	505200	497809	rs1556422519	NC_012920.1:1340:C:T
NC_012920.1:m.1375C>T	MT-RNR1		not specified	Uncertain significance(Last reviewed: Oct 5, 2013)	criteria provided, single submitter	VCV000179340	MT	1375	MT	1375	179340	176335	rs727504803	NC_012920.1:1374:C:T
NC_012920.1(MT-ND1):m.1377C>A	MT-RNR1		not specified	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000667265	MT	1377	MT	1377	667265	654973	rs1603218549	NC_012920.1:1376:C:A
m.1382A>C	MT-RNR1		not specified	Benign(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	VCV000042214	MT	1382	MT	1382	42214	51384	rs111033358	NC_012920.1:1381:A:C
m.1385C>T	MT-RNR1		not specified	Uncertain significance(Last reviewed: Aug 14, 2009)	no assertion criteria provided	VCV000042215	MT	1385	MT	1385	42215	51385	rs111033442	NC_012920.1:1384:C:T
m.1391T>C	MT-RNR1		not specified	Benign(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000042216	MT	1391	MT	1391	42216	51386	rs111033357	NC_012920.1:1390:T:C
m.1393G>A	MT-RNR1		not specified|not provided	Benign/Likely benign(Last reviewed: Dec 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000042217	MT	1393	MT	1393	42217	51387	rs111033325	NC_012920.1:1392:G:A
m.1406T>C	MT-RNR1		not specified	Benign(Last reviewed: Aug 18, 2010)	criteria provided, single submitter	VCV000042218	MT	1406	MT	1406	42218	51388	rs111033322	NC_012920.1:1405:T:C
NC_012920.1:m.1415G>A	MT-RNR1		not specified	Likely benign(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000227549	MT	1415	MT	1415	227549	231299	rs876657505	NC_012920.1:1414:G:A
m.1420T>C	MT-RNR1		not specified|not provided	Benign(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042219	MT	1420	MT	1420	42219	51389	rs111033356	NC_012920.1:1419:T:C
NC_012920.1(MT-CYB):m.1438=	MT-RNR1		not specified	Benign(Last reviewed: Feb 2, 2012)	criteria provided, single submitter	VCV000177708	MT	1438	MT	1438	177708	176458	rs2001030	NC_012920.1:1437:A:A
m.1438A>G	MT-RNR1		not provided|not specified	Benign(Last reviewed: Mar 8, 2012)	criteria provided, single submitter	VCV000042220	MT	1438	MT	1438	42220	51390	rs2001030	NC_012920.1:1437:A:G
m.1442G>A	MT-RNR1		not specified|not provided	Benign/Likely benign(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042221	MT	1442	MT	1442	42221	51391	rs28358573	NC_012920.1:1441:G:A
NC_012920.1(MT-CYB):m.1452T>C	MT-RNR1		not provided	Likely benign(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000445831	MT	1452	MT	1452	445831	439103	rs1556422531	NC_012920.1:1451:T:C
NC_012920.1:m.1461A>G	MT-RNR1		not specified	Likely benign(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000504960	MT	1461	MT	1461	504960	497358	rs1556422534	NC_012920.1:1460:A:G
m.1462G>A	MT-RNR1		not specified|not provided	Benign(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000042222	MT	1462	MT	1462	42222	51392	rs111033326	NC_012920.1:1461:G:A
NC_012920.1:m.1473C>T	MT-RNR1		not specified	Likely benign(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000505288	MT	1473	MT	1473	505288	497776	rs1556422538	NC_012920.1:1472:C:T
NC_012920.1:m.1494C>T	MT-RNR1|MT-TS1		Rare genetic deafness|Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness|Gentamicin response|streptomycin response - Toxicity|tobramycin response - Toxicity|kanamycin response - Toxicity|gentamicin response - Toxicity|aminoglycoside antibacterials response - Toxicity	drug response(Last reviewed: Jun 15, 2021)	reviewed by expert panel	VCV000009632	MT	1494	MT	1494	9632	24671	rs267606619	NC_012920.1:1493:C:T
NC_012920.1:m.1503G>A	MT-RNR1		not specified	Benign(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	VCV000163987	MT	1503	MT	1503	163987	176336	rs727503164	NC_012920.1:1502:G:A
NC_012920.1:m.1508C>T	MT-RNR1		not specified	Likely benign(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000163988	MT	1508	MT	1508	163988	176459	rs386828884	NC_012920.1:1507:C:T
NC_012920.1:m.1536A>G	MT-RNR1		not specified	Likely benign(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000227550	MT	1536	MT	1536	227550	231300	rs876657506	NC_012920.1:1535:A:G
NC_012920.1:m.1555A>G	MT-ND1|MT-RNR1		Rare genetic deafness|not provided|Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness|Restrictive cardiomyopathy|Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness|Gentamicin response|tobramycin response - Toxicity|kanamycin response - Toxicity|streptomycin response - Toxicity|gentamicin response - Toxicity|amikacin response - Toxicity|aminoglycoside antibacterials response - Toxicity	drug response(Last reviewed: Jun 15, 2021)	reviewed by expert panel	VCV000009628	MT	1555	MT	1555	9628	24667	rs267606617	NC_012920.1:1554:A:G
m.1598G>A	MT-RNR1		not provided|not specified	Benign(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042223	MT	1598	MT	1598	42223	51393	rs3135027	NC_012920.1:1597:G:A
m.1606G>A	MT-TV		Ataxia, progressive seizures, mental deterioration, and hearing loss|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009548	MT	1606	MT	1606	9548	24587	rs199476143	NC_012920.1:1605:G:A
NC_012920.1(MT-CYB):m.1607T>C	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689833	MT	1607	MT	1607	689833	677670	rs1603218581	NC_012920.1:1606:T:C
NC_012920.1(MT-CYB):m.1608G>A	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689834	MT	1608	MT	1608	689834	677671	rs1603218582	NC_012920.1:1607:G:A
NC_012920.1(MT-ND1):m.1616A>G	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Nov 19, 2021)	criteria provided, single submitter	VCV001325837	MT	1616	MT	1616	1325837	1316098		NC_012920.1:1615:A:G
NC_012920.1(MT-CYB):m.1617C>T	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689835	MT	1617	MT	1617	689835	677672	rs1603218583	NC_012920.1:1616:C:T
NC_012920.1(MT-CYB):m.1618A>G	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689836	MT	1618	MT	1618	689836	677673	rs1603218584	NC_012920.1:1617:A:G
NC_012920.1(MT-CYB):m.1619C>T	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000618222	MT	1619	MT	1619	618222	610271	rs1569483811	NC_012920.1:1618:C:T
m.1624C>T	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Neonatal death|Leigh syndrome	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009549	MT	1624	MT	1624	9549	24588	rs199476144	NC_012920.1:1623:C:T
NC_012920.1(MT-CYB):m.1628C>T	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689838	MT	1628	MT	1628	689838	677675	rs1603218586	NC_012920.1:1627:C:T
NC_012920.1(MT-CYB):m.1629A>G	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689839	MT	1629	MT	1629	689839	677676	rs1603218587	NC_012920.1:1628:A:G
NC_012920.1(MT-CYB):m.1630A>G	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689840	MT	1630	MT	1630	689840	677677	rs1603218588	NC_012920.1:1629:A:G
NC_012920.1(MT-CYB):m.1631C>T	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689841	MT	1631	MT	1631	689841	677678	rs1603218590	NC_012920.1:1630:C:T
NC_012920.1(MT-CYB):m.1636A>G	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689842	MT	1636	MT	1636	689842	677679	rs1603218591	NC_012920.1:1635:A:G
NC_012920.1(MT-CYB):m.1638T>C	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689843	MT	1638	MT	1638	689843	677680	rs1603218592	NC_012920.1:1637:T:C
NC_012920.1(MT-CYB):m.1640A>G	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689844	MT	1640	MT	1640	689844	677681	rs1603218594	NC_012920.1:1639:A:G
NC_012920.1(MT-CYB):m.1641G>A	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689845	MT	1641	MT	1641	689845	677682	rs28416113	NC_012920.1:1640:G:A
NC_012920.1(MT-CYB):m.1643A>G	MT-TV		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000684496	MT	1643	MT	1643	684496	672123	rs1603218595	NC_012920.1:1642:A:G
NC_012920.1(MT-CYB):m.1644G>A	MT-TV		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV000689846	MT	1644	MT	1644	689846	677683	rs587776441	NC_012920.1:1643:G:A
NC_012920.1:m.1644G>T	MT-TV		Leigh syndrome	Pathogenic(Last reviewed: Dec 2, 2021)	no assertion criteria provided	VCV000155890	MT	1644	MT	1644	155890	165639	rs587776441	NC_012920.1:1643:G:T
NC_012920.1(MT-CYB):m.1646T>C	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689847	MT	1646	MT	1646	689847	677684	rs1603218598	NC_012920.1:1645:T:C
NC_012920.1(MT-CYB):m.1654T>C	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689848	MT	1654	MT	1654	689848	677685	rs1603218602	NC_012920.1:1653:T:C
NC_012920.1:m.1655A>G	MT-TV		Epilepsy|Muscular hypotonia of the trunk|Developmental delay|Hyperlactaemia	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370044	MT	1655	MT	1655	370044	354296	rs1057516056	NC_012920.1:1654:A:G
NC_012920.1(MT-CYB):m.1657C>T	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689850	MT	1657	MT	1657	689850	677687	rs1603218606	NC_012920.1:1656:C:T
NC_012920.1(MT-CYB):m.1658T>C	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689851	MT	1658	MT	1658	689851	677688	rs1603218607	NC_012920.1:1657:T:C
NC_012920.1(MT-CYB):m.1659T>C	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689852	MT	1659	MT	1659	689852	677689	rs1603218609	NC_012920.1:1658:T:C
NC_012920.1:m.1661A>G	MT-TV		Epilepsy|Muscular hypotonia of the trunk|Developmental delay|Hyperlactaemia|Charcot-Marie-Tooth disease, axonal, mitochondrial form, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2021)	no assertion criteria provided	VCV000370043	MT	1661	MT	1661	370043	354297	rs1057516055	NC_012920.1:1660:A:G
NC_012920.1(MT-CYB):m.1664G>A	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689853	MT	1664	MT	1664	689853	677690	rs200807305	NC_012920.1:1663:G:A
NC_012920.1(MT-CYB):m.1670A>T	MT-TV		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689854	MT	1670	MT	1670	689854	677691	rs1603218611	NC_012920.1:1669:A:T
NC_012920.1(MT-ND1):m.1736A>G	MT-RNR2		Mitochondrial inheritance	Uncertain significance	no assertion criteria provided	VCV001344551	MT	1736	MT	1736	1344551	1336255		NC_012920.1:1735:A:G
NC_012920.1(MT-CYB):m.1836A>G	MT-RNR2		not provided	Uncertain significance(Last reviewed: Oct 29, 2014)	criteria provided, single submitter	VCV000235585	MT	1836	MT	1836	235585	237266	rs878853073	NC_012920.1:1835:A:G
NC_012920.1:m.2483T>C	MT-RNR2		not provided	Uncertain significance(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000235652	MT	2483	MT	2483	235652	237333	rs28445203	NC_012920.1:2482:T:C
NC_012920.1:m.2550A>T	MT-RNR2		See cases	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000931582	MT	2550	MT	2550	931582	920077	rs2068680580	NC_012920.1:2549:A:T
m.2939C>A	MT-RNR2		Chloramphenicol resistance	Pathogenic(Last reviewed: Nov 11, 1981)	no assertion criteria provided	VCV000009627	MT	2939	MT	2939	9627	24666	rs199474824	NC_012920.1:2938:C:A
m.2991T>C	MT-RNR2		Chloramphenicol resistance	Pathogenic(Last reviewed: Nov 11, 1981)	no assertion criteria provided	VCV000009626	MT	2991	MT	2991	9626	24665	rs199474823	NC_012920.1:2990:T:C
NC_012920.1:m.3010G>A	MT-RNR2		not provided	not provided	no assertion provided	VCV000441149	MT	3010	MT	3010	441149	434778	rs3928306	NC_012920.1:3009:G:A
NC_012920.1:m.3169C>T	MT-RNR2		not provided	Uncertain significance(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000377249	MT	3169	MT	3169	377249	364127	rs1057520173	NC_012920.1:3168:C:T
NC_012920.1(MT-CYB):m.3236A>G	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689855	MT	3236	MT	3236	689855	677692	rs1603218849	NC_012920.1:3235:A:G
m.3242G>A	MT-TL1		Myelodysplastic syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009600	MT	3242	MT	3242	9600	24639	rs193303018	NC_012920.1:3241:G:A
NC_012920.1(MT-CYB):m.3243A>T	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689856	MT	3243	MT	3243	689856	677693	rs199474657	NC_012920.1:3242:A:T
NC_012920.1:m.3243A>G	MT-TL1		Glucose intolerance|Stroke|Sensorineural hearing loss disorder|Short stature|not provided|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial disease|Cyclical vomiting syndrome|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age related macular degeneration 2|MERRF/MELAS overlap syndrome|3-methylglutaconic aciduria type 1|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome|Cytochrome-c oxidase deficiency disease|Cerebral palsy	Pathogenic(Last reviewed: Nov 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G
NC_012920.1(MT-CYB):m.3248G>A	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689857	MT	3248	MT	3248	689857	677694	rs879110136	NC_012920.1:3247:G:A
m.3249G>A	MT-TL1		Kearns-Sayre syndrome	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000009599	MT	3249	MT	3249	9599	24638	rs199474667	NC_012920.1:3248:G:A
m.3250T>C	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Skeletal myopathy, responsive to riboflavin	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009593	MT	3250	MT	3250	9593	24632	rs199474664	NC_012920.1:3249:T:C
m.3251A>G	MT-TL1		Progressive external ophthalmoplegia, proximal myopathy, and sudden death|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009595	MT	3251	MT	3251	9595	24634	rs199474662	NC_012920.1:3250:A:G
NC_012920.1(MT-CYB):m.3252A>T	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689858	MT	3252	MT	3252	689858	677695	rs199474661	NC_012920.1:3251:A:T
m.3252A>G	MT-TL1		Mitochondrial encephalomyopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009594	MT	3252	MT	3252	9594	24633	rs199474661	NC_012920.1:3251:A:G
NC_012920.1(MT-CYB):m.3254C>A	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689860	MT	3254	MT	3254	689860	677696	rs1603218855	NC_012920.1:3253:C:A
NC_012920.1(MT-CYB):m.3254C>T	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689859	MT	3254	MT	3254	689859	677697	rs1603218855	NC_012920.1:3253:C:T
NC_012920.1(MT-CYB):m.3255G>A	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689861	MT	3255	MT	3255	689861	677698	rs1603218856	NC_012920.1:3254:G:A
m.3256C>T	MT-TL1		Diabetes mellitus, noninsulin-dependent, maternally transmitted|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009591	MT	3256	MT	3256	9591	24630	rs199474659	NC_012920.1:3255:C:T
m.3260A>G	MT-TL1		Cardiomyopathy with or without skeletal myopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009596	MT	3260	MT	3260	9596	24635	rs199474663	NC_012920.1:3259:A:G
NC_012920.1(MT-CYB):m.3261A>G	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689862	MT	3261	MT	3261	689862	677699	rs1603218859	NC_012920.1:3260:A:G
NC_012920.1(MT-CYB):m.3263C>T	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689863	MT	3263	MT	3263	689863	677700	rs1603218860	NC_012920.1:3262:C:T
NC_012920.1(MT-CYB):m.3269A>G	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689864	MT	3269	MT	3269	689864	677701	rs1603218862	NC_012920.1:3268:A:G
m.3271T>C	MT-TL1		not specified|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009590	MT	3271	MT	3271	9590	24629	rs199474658	NC_012920.1:3270:T:C
NC_012920.1(MT-CYB):m.3272T>C	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689865	MT	3272	MT	3272	689865	677702	rs1603218865	NC_012920.1:3271:T:C
m.3274A>G	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Neuropsychiatric disorder and early-onset cataract	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009598	MT	3274	MT	3274	9598	24637	rs199474666	NC_012920.1:3273:A:G
NC_012920.1(MT-CYB):m.3275C>A	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689867	MT	3275	MT	3275	689867	677703	rs1057516057	NC_012920.1:3274:C:A
NC_012920.1(MT-CYB):m.3275C>G	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689866	MT	3275	MT	3275	689866	677704	rs1057516057	NC_012920.1:3274:C:G
NC_012920.1:m.3275C>T	MT-TL1		Neuromuscular disease|Developmental delay|Myopia|Hepatic steatosis|Hepatitis|Fibrosis|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leber optic atrophy|Developmental delay	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000370045	MT	3275	MT	3275	370045	354298	rs1057516057	NC_012920.1:3274:C:T
NC_012920.1:m.3276A>G	MT-TL1		not specified	Uncertain significance(Last reviewed: Dec 19, 2012)	no assertion criteria provided	VCV000235016	MT	3276	MT	3276	235016	236825	rs876661362	NC_012920.1:3275:A:G
NC_012920.1(MT-CYB):m.3277G>A	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689868	MT	3277	MT	3277	689868	677705	rs386828902	NC_012920.1:3276:G:A
NC_012920.1(MT-CYB):m.3278T>C	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689869	MT	3278	MT	3278	689869	677706	rs1603218868	NC_012920.1:3277:T:C
NC_012920.1(MT-CYB):m.3288A>G	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689870	MT	3288	MT	3288	689870	677707	rs1603218872	NC_012920.1:3287:A:G
NC_012920.1:m.3290T>A	MT-TL1		See cases	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000930602	MT	3290	MT	3290	930602	920078	rs199474665	NC_012920.1:3289:T:A
m.3290T>C	MT-TL1		SUDDEN INFANT DEATH SYNDROME|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009597	MT	3290	MT	3290	9597	24636	rs199474665	NC_012920.1:3289:T:C
NC_012920.1:m.3291T>C	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000223247	MT	3291	MT	3291	223247	224979	rs869312463	NC_012920.1:3290:T:C
NC_012920.1(MT-CYB):m.3302A>G	MT-TL1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689871	MT	3302	MT	3302	689871	677708	rs1603218878	NC_012920.1:3301:A:G
m.3303C>T	MT-TL1		Cardiomyopathy with or without skeletal myopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009592	MT	3303	MT	3303	9592	24631	rs199474660	NC_012920.1:3302:C:T
NC_012920.1:m.3307A>T	MT-ND1	M1L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692328	MT	3307	MT	3307	692328	680864	rs1603218882	NC_012920.1:3306:A:T
m.3308T>G	MT-ND1	M1*	Leigh syndrome|SUDDEN INFANT DEATH SYNDROME	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009729	MT	3308	MT	3308	9729	24768	rs28358582	NC_012920.1:3307:T:G
m.3308T>C	MT-ND1	M1T	Carcinoma of colon|SUDDEN INFANT DEATH SYNDROME|Leigh syndrome|not specified	Benign/Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009728	MT	3308	MT	3308	9728	24767	rs28358582	NC_012920.1:3307:T:C
NC_012920.1:m.3310C>T	MT-ND1	P2S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692330	MT	3310	MT	3310	692330	680866	rs1603218889	NC_012920.1:3309:C:T
NC_012920.1:m.3313A>G	MT-ND1	M3V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692331	MT	3313	MT	3313	692331	680867	rs1603218891	NC_012920.1:3312:A:G
NC_012920.1:m.3316G>A	MT-ND1	A4T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692333	MT	3316	MT	3316	692333	680868	rs2853516	NC_012920.1:3315:G:A
NC_012920.1:m.3316G>C	MT-ND1	A4P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692332	MT	3316	MT	3316	692332	680869	rs2853516	NC_012920.1:3315:G:C
NC_012920.1:m.3320A>G	MT-ND1	N5S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692334	MT	3320	MT	3320	692334	680870	rs1603218896	NC_012920.1:3319:A:G
NC_012920.1:m.3328C>T	MT-ND1	L8F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692335	MT	3328	MT	3328	692335	680871	rs1603218901	NC_012920.1:3327:C:T
NC_012920.1:m.3335T>C	MT-ND1	I10T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692336	MT	3335	MT	3335	692336	680872	rs879173824	NC_012920.1:3334:T:C
NC_012920.1:m.3337G>A	MT-ND1	V11M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692337	MT	3337	MT	3337	692337	680873	rs1556422709	NC_012920.1:3336:G:A
NC_012920.1:m.3338T>C	MT-ND1	V11A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692338	MT	3338	MT	3338	692338	680874	rs201969351	NC_012920.1:3337:T:C
NC_012920.1:m.3340C>T	MT-ND1	P12S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692339	MT	3340	MT	3340	692339	680875	rs1603218910	NC_012920.1:3339:C:T
NC_012920.1:m.3344T>C	MT-ND1	I13T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692340	MT	3344	MT	3344	692340	680876	rs1603218912	NC_012920.1:3343:T:C
NC_012920.1:m.3349A>G	MT-ND1	I15V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692341	MT	3349	MT	3349	692341	680877	rs879193727	NC_012920.1:3348:A:G
NC_012920.1:m.3350T>C	MT-ND1	I15T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692342	MT	3350	MT	3350	692342	680878	rs1603218915	NC_012920.1:3349:T:C
NC_012920.1:m.3357G>C	MT-ND1	M17I	Mitochondrial disease|Leigh syndrome|not provided	Uncertain significance(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV000692343	MT	3357	MT	3357	692343	680879	rs1556422714	NC_012920.1:3356:G:C
NC_012920.1:m.3358G>A	MT-ND1	A18T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692344	MT	3358	MT	3358	692344	680880	rs1556422715	NC_012920.1:3357:G:A
NC_012920.1:m.3368T>C	MT-ND1	M21T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692345	MT	3368	MT	3368	692345	680881	rs1603218920	NC_012920.1:3367:T:C
m.3376G>A	MT-ND1	E24K	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000065921	MT	3376	MT	3376	65921	76829	rs397515612	NC_012920.1:3375:G:A
NC_012920.1:m.3380G>A	MT-ND1	R25Q	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692346	MT	3380	MT	3380	692346	680882	rs1603218926	NC_012920.1:3379:G:A
NC_012920.1:m.3385A>G	MT-ND1	I27V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692347	MT	3385	MT	3385	692347	680883	rs879050714	NC_012920.1:3384:A:G
m.3388C>A	MT-ND1	L28M	Mitochondrial non-syndromic sensorineural hearing loss|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000029998	MT	3388	MT	3388	29998	38953	rs387906730	NC_012920.1:3387:C:A
NC_012920.1:m.3391G>A	MT-ND1	G29S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692348	MT	3391	MT	3391	692348	680884	rs1603218931	NC_012920.1:3390:G:A
m.3394T>C	MT-ND1	Y30H	not provided|Leber optic atrophy|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000009725	MT	3394	MT	3394	9725	24764	rs41460449	NC_012920.1:3393:T:C
NC_012920.1:m.3395A>G	MT-ND1	Y30C	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692350	MT	3395	MT	3395	692350	680886	rs1556422722	NC_012920.1:3394:A:G
NC_012920.1:m.3395A>C	MT-ND1	Y30S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692349	MT	3395	MT	3395	692349	680885	rs1556422722	NC_012920.1:3394:A:C
NC_012920.1:m.3396T>C	MT-ND1		not provided	Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000235394	MT	3396	MT	3396	235394	237079	rs374875201	NC_012920.1:3395:T:C
m.3397A>G	MT-ND1	M31V	Alzheimer disease|Parkinson disease, late-onset|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009726	MT	3397	MT	3397	9726	24765	rs199476120	NC_012920.1:3396:A:G
NC_012920.1:m.3398T>C	MT-ND1	M31T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692351	MT	3398	MT	3398	692351	680887	rs201212638	NC_012920.1:3397:T:C
NC_012920.1:m.3399A>T	MT-ND1	M31I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692352	MT	3399	MT	3399	692352	680888	rs386828905	NC_012920.1:3398:A:T
NC_012920.1:m.3419A>G	MT-ND1	N38S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692353	MT	3419	MT	3419	692353	680889	rs1603218949	NC_012920.1:3418:A:G
NC_012920.1:m.3421G>A	MT-ND1	V39I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692354	MT	3421	MT	3421	692354	680890	rs1603218954	NC_012920.1:3420:G:A
NC_012920.1:m.3427G>A	MT-ND1	G41S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692355	MT	3427	MT	3427	692355	680891	rs1603218960	NC_012920.1:3426:G:A
NC_012920.1:m.3434A>G	MT-ND1	Y43C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692356	MT	3434	MT	3434	692356	680892	rs202123618	NC_012920.1:3433:A:G
NC_012920.1(MT-ND1):m.3447A>G	MT-ND1		not provided	Benign(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235591	MT	3447	MT	3447	235591	237272	rs878853074	NC_012920.1:3446:A:G
NC_012920.1:m.3460G>A	MT-ND1	A52T	MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3|not provided|Leber optic atrophy|Leigh syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009722	MT	3460	MT	3460	9722	24761	rs199476118	NC_012920.1:3459:G:A
NC_012920.1:m.3481G>A	MT-ND1	E59K	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000155880	MT	3481	MT	3481	155880	165629	rs587776433	NC_012920.1:3480:G:A
NC_012920.1:m.3488T>C	MT-ND1	L61P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692357	MT	3488	MT	3488	692357	680893	rs1603218982	NC_012920.1:3487:T:C
NC_012920.1:m.3492A>C	MT-ND1	K62N	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692358	MT	3492	MT	3492	692358	680894	rs878950749	NC_012920.1:3491:A:C
NC_012920.1:m.3496G>A	MT-ND1	A64T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692359	MT	3496	MT	3496	692359	680895	rs1603218984	NC_012920.1:3495:G:A
NC_012920.1:m.3497C>T	MT-ND1	A64V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692360	MT	3497	MT	3497	692360	680896	rs200319905	NC_012920.1:3496:C:T
NC_012920.1:m.3498C>T	MT-ND1		not provided	Likely benign(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000377309	MT	3498	MT	3498	377309	364187	rs878982719	NC_012920.1:3497:C:T
NC_012920.1:m.3502T>C	MT-ND1	S66P	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692361	MT	3502	MT	3502	692361	680897	rs1603218987	NC_012920.1:3501:T:C
NC_012920.1:m.3504T>C	MT-ND1		not provided	Likely benign(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV000994648	MT	3504	MT	3504	994648	983276	rs1603218988	NC_012920.1:3503:T:C
NC_012920.1:m.3505A>G	MT-ND1	T67A	not specified|not provided|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252456	MT	3505	MT	3505	252456	247211	rs28358585	NC_012920.1:3504:A:G
NC_012920.1:m.3508A>G	MT-ND1	I68V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692362	MT	3508	MT	3508	692362	680898	rs1603218990	NC_012920.1:3507:A:G
NC_012920.1:m.3509T>C	MT-ND1	I68T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692363	MT	3509	MT	3509	692363	680899	rs1603218992	NC_012920.1:3508:T:C
NC_012920.1:m.3511A>G	MT-ND1	T69A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692364	MT	3511	MT	3511	692364	680900	rs386828909	NC_012920.1:3510:A:G
NC_012920.1:m.3513C>T	MT-ND1		not provided	Benign(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000805044	MT	3513	MT	3513	805044	793902	rs28369556	NC_012920.1:3512:C:T
NC_012920.1:m.3520A>G	MT-ND1	I72V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692365	MT	3520	MT	3520	692365	680901	rs1603218996	NC_012920.1:3519:A:G
NC_012920.1:m.3523A>G	MT-ND1	T73A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692366	MT	3523	MT	3523	692366	680902	rs878982767	NC_012920.1:3522:A:G
NC_012920.1:m.3526G>A	MT-ND1	A74T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692367	MT	3526	MT	3526	692367	680903	rs1603218998	NC_012920.1:3525:G:A
NC_012920.1:m.3533C>T	MT-ND1	T76I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692368	MT	3533	MT	3533	692368	680904	rs377091327	NC_012920.1:3532:C:T
NC_012920.1:m.3535T>C	MT-ND1		not provided	Benign(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000805045	MT	3535	MT	3535	805045	793903	rs1603219004	NC_012920.1:3534:T:C
NC_012920.1:m.3535T>A	MT-ND1	L77M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692369	MT	3535	MT	3535	692369	680905	rs1603219004	NC_012920.1:3534:T:A
NC_012920.1:m.3547A>G	MT-ND1	I81V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692370	MT	3547	MT	3547	692370	680906	rs28358586	NC_012920.1:3546:A:G
NC_012920.1:m.3548T>C	MT-ND1	I81T	Leigh syndrome|not specified	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000235006	MT	3548	MT	3548	235006	236826	rs876661353	NC_012920.1:3547:T:C
NC_012920.1:m.3552T>A	MT-ND1		not provided	Benign(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000805046	MT	3552	MT	3552	805046	793904	rs28358587	NC_012920.1:3551:T:A
NC_012920.1:m.3555T>C	MT-ND1		not provided	Likely benign(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000805047	MT	3555	MT	3555	805047	793905	rs1603219017	NC_012920.1:3554:T:C
NC_012920.1:m.3565A>G	MT-ND1	T87A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692371	MT	3565	MT	3565	692371	680907	rs2854133	NC_012920.1:3564:A:G
NC_012920.1:m.3569C>T	MT-ND1	P88L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692372	MT	3569	MT	3569	692372	680909	rs1603219022	NC_012920.1:3568:C:T
NC_012920.1:m.3571C>T	MT-ND1	L89F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692373	MT	3571	MT	3571	692373	680910	rs200453691	NC_012920.1:3570:C:T
NC_012920.1:m.3582C>T	MT-ND1		not provided	Uncertain significance(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000235531	MT	3582	MT	3582	235531	237212	rs878853059	NC_012920.1:3581:C:T
NC_012920.1:m.3592G>A	MT-ND1	V96I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692375	MT	3592	MT	3592	692375	680911	rs1603219036	NC_012920.1:3591:G:A
NC_012920.1:m.3593T>C	MT-ND1	V96A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692376	MT	3593	MT	3593	692376	680912	rs2854134	NC_012920.1:3592:T:C
NC_012920.1:m.3607G>A	MT-ND1	G101S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692377	MT	3607	MT	3607	692377	680913	rs1556422761	NC_012920.1:3606:G:A
NC_012920.1:m.3622C>A	MT-ND1	L106M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692378	MT	3622	MT	3622	692378	680914	rs1603219048	NC_012920.1:3621:C:A
NC_012920.1:m.3624A>G	MT-ND1		Global developmental delay|Generalized hypotonia	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370046	MT	3624	MT	3624	370046	354299	rs1057516058	NC_012920.1:3623:A:G
NC_012920.1:m.3628A>T	MT-ND1	T108S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692379	MT	3628	MT	3628	692379	680915	rs1603219051	NC_012920.1:3627:A:T
m.3635G>A	MT-ND1	S110N	Leber optic atrophy	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065518	MT	3635	MT	3635	65518	76426	rs397515507	NC_012920.1:3634:G:A
NC_012920.1:m.3640G>A	MT-ND1	A112T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692380	MT	3640	MT	3640	692380	680916	rs1603219059	NC_012920.1:3639:G:A
NC_012920.1:m.3643G>A	MT-ND1	V113I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692381	MT	3643	MT	3643	692381	680917	rs1603219061	NC_012920.1:3642:G:A
NC_012920.1:m.3644T>C	MT-ND1	V113A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692382	MT	3644	MT	3644	692382	680918	rs878991470	NC_012920.1:3643:T:C
NC_012920.1:m.3652A>G	MT-ND1	I116V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692383	MT	3652	MT	3652	692383	680919	rs1603219066	NC_012920.1:3651:A:G
NC_012920.1:m.3653T>C	MT-ND1	I116T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692384	MT	3653	MT	3653	692384	680920	rs1603219067	NC_012920.1:3652:T:C
NC_012920.1:m.3661T>G	MT-ND1	S119A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692385	MT	3661	MT	3661	692385	680921	rs1603219070	NC_012920.1:3660:T:G
NC_012920.1:m.3669A>G	MT-ND1		not specified	Likely benign(Last reviewed: Feb 25, 2021)	criteria provided, single submitter	VCV001256442	MT	3669	MT	3669	1256442	1246371		NC_012920.1:3668:A:G
NC_012920.1:m.3670G>A	MT-ND1	A122T	Ptosis|Abnormal CSF lactate level|Gait disturbance|Dysarthria|Abnormality of eye movement|Increased serum lactate|Leigh syndrome	Uncertain significance(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000692386	MT	3670	MT	3670	692386	680922	rs1603219074	NC_012920.1:3669:G:A
NC_012920.1:m.3685T>C	MT-ND1	Y127H	Leigh syndrome	Likely pathogenic(Last reviewed: Dec 21, 2021)	no assertion criteria provided	VCV001328561	MT	3685	MT	3685	1328561	1319226		NC_012920.1:3684:T:C
NC_012920.1:m.3693G>A	MT-ND1		not specified	Benign(Last reviewed: May 24, 2021)	criteria provided, single submitter	VCV001256467	MT	3693	MT	3693	1256467	1246396		NC_012920.1:3692:G:A
m.3697G>A	MT-ND1	G131S	Mitochondrial disease|Leber optic atrophy|Leber optic atrophy and dystonia|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000009733	MT	3697	MT	3697	9733	24772	rs199476122	NC_012920.1:3696:G:A
m.3700G>A	MT-ND1	A132T	Leber optic atrophy|Abnormal electroretinogram|Optic neuropathy|Visual loss|Mitochondrial disease	Uncertain significance(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000065519	MT	3700	MT	3700	65519	76427	rs397515508	NC_012920.1:3699:G:A
NC_012920.1:m.3701C>T	MT-ND1	A132V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692387	MT	3701	MT	3701	692387	680923	rs1603219086	NC_012920.1:3700:C:T
NC_012920.1:m.3709G>A	MT-ND1	A135T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692388	MT	3709	MT	3709	692388	680924	rs1603219090	NC_012920.1:3708:G:A
NC_012920.1:m.3710C>T	MT-ND1	A135V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692389	MT	3710	MT	3710	692389	680925	rs1603219093	NC_012920.1:3709:C:T
NC_012920.1:m.3712G>A	MT-ND1	V136M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692390	MT	3712	MT	3712	692390	680926	rs1603219095	NC_012920.1:3711:G:A
NC_012920.1:m.3713T>C	MT-ND1	V136A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692391	MT	3713	MT	3713	692391	680927	rs1603219096	NC_012920.1:3712:T:C
NC_012920.1:m.3715G>A	MT-ND1	A137T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692392	MT	3715	MT	3715	692392	680928	rs1603219097	NC_012920.1:3714:G:A
m.3733G>A	MT-ND1	E143K	Mitochondrial disease|Leber optic atrophy	Uncertain significance(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000009736	MT	3733	MT	3733	9736	24775	rs199476125	NC_012920.1:3732:G:A
NC_012920.1:m.3736G>A	MT-ND1	V144I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692393	MT	3736	MT	3736	692393	680929	rs201513497	NC_012920.1:3735:G:A
NC_012920.1:m.3745G>A	MT-ND1	A147T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692394	MT	3745	MT	3745	692394	680930	rs1556422777	NC_012920.1:3744:G:A
NC_012920.1:m.3746C>T	MT-ND1	A147V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692395	MT	3746	MT	3746	692395	680931	rs199684756	NC_012920.1:3745:C:T
NC_012920.1:m.3749T>C	MT-ND1	I148T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692396	MT	3749	MT	3749	692396	680932	rs1603219116	NC_012920.1:3748:T:C
NC_012920.1:m.3751A>G	MT-ND1	I149V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692397	MT	3751	MT	3751	692397	680933	rs1603219119	NC_012920.1:3750:A:G
NC_012920.1:m.3761C>A	MT-ND1	S152*	Mitochondrial disease	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000800504	MT	3761	MT	3761	800504	789103	rs1603219126	NC_012920.1:3760:C:A
NC_012920.1:m.3764C>T	MT-ND1	T153M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692398	MT	3764	MT	3764	692398	680934	rs1603219127	NC_012920.1:3763:C:T
NC_012920.1:m.3772A>G	MT-ND1	M156V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692399	MT	3772	MT	3772	692399	680935	rs1603219135	NC_012920.1:3771:A:G
NC_012920.1:m.3775A>T	MT-ND1	S157C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692400	MT	3775	MT	3775	692400	680936	rs1603219137	NC_012920.1:3774:A:T
NC_012920.1:m.3793T>C	MT-ND1	S163P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692401	MT	3793	MT	3793	692401	680937	rs1603219148	NC_012920.1:3792:T:C
NC_012920.1(MT-ND1):m.3796A>T	MT-ND1	T164S	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235654	MT	3796	MT	3796	235654	237334	rs28357970	NC_012920.1:3795:A:T
m.3796A>G	MT-ND1	T164A	Dystonia, adult-onset|Leigh syndrome|not provided	Benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009730	MT	3796	MT	3796	9730	24769	rs28357970	NC_012920.1:3795:A:G
NC_012920.1:m.3808A>G	MT-ND1	T168A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692402	MT	3808	MT	3808	692402	680938	rs2854135	NC_012920.1:3807:A:G
NC_012920.1:m.3843A>G	MT-ND1		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235228	MT	3843	MT	3843	235228	236916	rs28357971	NC_012920.1:3842:A:G
NC_012920.1(MT-ND1):m.3849G>A	MT-ND1		not provided	Benign/Likely benign(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235619	MT	3849	MT	3849	235619	237300	rs878853081	NC_012920.1:3848:G:A
NC_012920.1:m.3865A>G	MT-ND1	I187V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692403	MT	3865	MT	3865	692403	680939	rs878989562	NC_012920.1:3864:A:G
NC_012920.1:m.3866T>C	MT-ND1	I187T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692404	MT	3866	MT	3866	692404	680940	rs200479541	NC_012920.1:3865:T:C
NC_012920.1:m.3887A>G	MT-ND1	N194S	Leigh syndrome|See cases	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000692405	MT	3887	MT	3887	692405	680941	rs1603219185	NC_012920.1:3886:A:G
NC_012920.1:m.3890G>A	MT-ND1	R195Q	Leigh syndrome	Pathogenic(Last reviewed: Dec 2, 2021)	no assertion criteria provided	VCV000155881	MT	3890	MT	3890	155881	165630	rs587776434	NC_012920.1:3889:G:A
NC_012920.1:m.3892A>G	MT-ND1	T196A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692406	MT	3892	MT	3892	692406	680942	rs879131781	NC_012920.1:3891:A:G
NC_012920.1:m.3907G>A	MT-ND1	A201T	not specified	Uncertain significance(Last reviewed: Jun 10, 2015)	no assertion criteria provided	VCV000235007	MT	3907	MT	3907	235007	236827	rs876661354	NC_012920.1:3906:G:A
NC_012920.1:m.3910G>A	MT-ND1	E202K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692407	MT	3910	MT	3910	692407	680943	rs1603219195	NC_012920.1:3909:G:A
NC_012920.1:m.3915G>A	MT-ND1		not provided	Benign(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000805048	MT	3915	MT	3915	805048	793906	rs41524046	NC_012920.1:3914:G:A
NC_012920.1:m.3918G>C	MT-ND1	E204D	not specified	Uncertain significance(Last reviewed: Jul 15, 2013)	no assertion criteria provided	VCV000235008	MT	3918	MT	3918	235008	236828	rs28357972	NC_012920.1:3917:G:C
NC_012920.1:m.3921C>A	MT-ND1		not provided	Benign(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000805049	MT	3921	MT	3921	805049	793907	rs878999809	NC_012920.1:3920:C:A
NC_012920.1:m.3928G>C	MT-ND1	V208L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000155891	MT	3928	MT	3928	155891	165640	rs587776442	NC_012920.1:3927:G:C
NC_012920.1:m.3937T>C	MT-ND1	F211L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692408	MT	3937	MT	3937	692408	680944	rs1603219204	NC_012920.1:3936:T:C
NC_012920.1:m.3943A>G	MT-ND1	I213V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692409	MT	3943	MT	3943	692409	680945	rs879176055	NC_012920.1:3942:A:G
m.3946G>A	MT-ND1	E214K	Leber optic atrophy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000009734	MT	3946	MT	3946	9734	24773	rs199476123	NC_012920.1:3945:G:A
m.3949T>C	MT-ND1	Y215H	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000009735	MT	3949	MT	3949	9735	24774	rs199476124	NC_012920.1:3948:T:C
NC_012920.1(MT-ND1):m.3990C>T	MT-ND1		not provided	Benign(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235299	MT	3990	MT	3990	235299	236986	rs878853005	NC_012920.1:3989:C:T
NC_012920.1:m.3991A>G	MT-ND1	T229A	not provided	Uncertain significance(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000618726	MT	3991	MT	3991	618726	610272	rs1569483910	NC_012920.1:3990:A:G
NC_012920.1:m.3992C>T	MT-ND1	T229M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692410	MT	3992	MT	3992	692410	680946	rs879051705	NC_012920.1:3991:C:T
NC_012920.1:m.4012A>G	MT-ND1	T236A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692411	MT	4012	MT	4012	692411	680947	rs201610884	NC_012920.1:4011:A:G
NC_012920.1:m.4013C>T	MT-ND1	T236I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692412	MT	4013	MT	4013	692412	680948	rs1603219257	NC_012920.1:4012:C:T
NC_012920.1:m.4021A>G	MT-ND1	T239A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692413	MT	4021	MT	4021	692413	680949	rs199771084	NC_012920.1:4020:A:G
NC_012920.1:m.4023T>C	MT-ND1		not provided	Likely benign(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000235434	MT	4023	MT	4023	235434	237118	rs878853034	NC_012920.1:4022:T:C
NC_012920.1:m.4024A>G	MT-ND1	T240A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692414	MT	4024	MT	4024	692414	680950	rs41504646	NC_012920.1:4023:A:G
m.4025C>T	MT-ND1	T240M	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065520	MT	4025	MT	4025	65520	76428	rs397515509	NC_012920.1:4024:C:T
NC_012920.1:m.4029C>A	MT-ND1	I241M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692415	MT	4029	MT	4029	692415	680951	rs1603219264	NC_012920.1:4028:C:A
NC_012920.1:m.4048G>A	MT-ND1	D248N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692416	MT	4048	MT	4048	692416	680952	rs201629275	NC_012920.1:4047:G:A
NC_012920.1:m.4055T>C	MT-ND1	L250P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692417	MT	4055	MT	4055	692417	680953	rs1603219279	NC_012920.1:4054:T:C
NC_012920.1:m.4058C>T	MT-ND1	S251F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692418	MT	4058	MT	4058	692418	680954	rs1603219282	NC_012920.1:4057:C:T
NC_012920.1:m.4079A>G	MT-ND1	Y258C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692419	MT	4079	MT	4079	692419	680955	rs1603219286	NC_012920.1:4078:A:G
NC_012920.1:m.4082T>C	MT-ND1	F259S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692420	MT	4082	MT	4082	692420	680956	rs1603219291	NC_012920.1:4081:T:C
NC_012920.1:m.4084G>A	MT-ND1	V260I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692421	MT	4084	MT	4084	692421	680957	rs1603219293	NC_012920.1:4083:G:A
NC_012920.1:m.4093A>G	MT-ND1	T263A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692422	MT	4093	MT	4093	692422	680958	rs200180511	NC_012920.1:4092:A:G
NC_012920.1:m.4094C>T	MT-ND1	T263I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692423	MT	4094	MT	4094	692423	680959	rs1603219299	NC_012920.1:4093:C:T
NC_012920.1:m.4105A>G	MT-ND1	T267A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692424	MT	4105	MT	4105	692424	680960	rs1603219306	NC_012920.1:4104:A:G
NC_012920.1:m.4123A>G	MT-ND1	I273V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692425	MT	4123	MT	4123	692425	680961	rs200764459	NC_012920.1:4122:A:G
NC_012920.1:m.4129A>G	MT-ND1	T275A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692426	MT	4129	MT	4129	692426	680962	rs201832206	NC_012920.1:4128:A:G
NC_012920.1(MT-ND1):m.4132G>A	MT-ND1	A276T	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000377340	MT	4132	MT	4132	377340	364218	rs1057520201	NC_012920.1:4131:G:A
NC_012920.1:m.4135T>C	MT-ND1	Y277H	Leigh syndrome|not specified	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000235009	MT	4135	MT	4135	235009	236829	rs876661355	NC_012920.1:4134:T:C
m.4136A>G	MT-ND1	Y277C	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009727	MT	4136	MT	4136	9727	24766	rs199476121	NC_012920.1:4135:A:G
NC_012920.1:m.4137C>T	MT-ND1		not provided	Likely benign(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000445420	MT	4137	MT	4137	445420	438692	rs368539747	NC_012920.1:4136:C:T
NC_012920.1:m.4142G>A	MT-ND1	R279Q	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692427	MT	4142	MT	4142	692427	680963	rs1603219317	NC_012920.1:4141:G:A
NC_012920.1:m.4148G>A	MT-ND1	R281H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692428	MT	4148	MT	4148	692428	680964	rs1603219323	NC_012920.1:4147:G:A
NC_012920.1:m.4153G>A	MT-ND1	D283N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692429	MT	4153	MT	4153	692429	680965	rs28566134	NC_012920.1:4152:G:A
NC_012920.1:m.4158A>G	MT-ND1		not provided	Benign(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000805050	MT	4158	MT	4158	805050	793908	rs1603219327	NC_012920.1:4157:A:G
m.4160T>C	MT-ND1	L285P	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009723	MT	4160	MT	4160	9723	24762	rs199476119	NC_012920.1:4159:T:C
NC_012920.1:m.4165C>G	MT-ND1	H287D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692430	MT	4165	MT	4165	692430	680966	rs1603219331	NC_012920.1:4164:C:G
NC_012920.1:m.4167C>T	MT-ND1		not provided	Likely benign(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000805051	MT	4167	MT	4167	805051	793909	rs1603219333	NC_012920.1:4166:C:T
m.4171C>A	MT-ND1	L289M	Leber optic atrophy	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009732	MT	4171	MT	4171	9732	24771	rs28616230	NC_012920.1:4170:C:A
NC_012920.1:m.4172T>A	MT-ND1	L289Q	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692431	MT	4172	MT	4172	692431	680967	rs1603219337	NC_012920.1:4171:T:A
NC_012920.1:m.4180A>G	MT-ND1	N292D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692432	MT	4180	MT	4180	692432	680968	rs1603219342	NC_012920.1:4179:A:G
NC_012920.1:m.4193T>C	MT-ND1	L296P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692433	MT	4193	MT	4193	692433	680969	rs1603219346	NC_012920.1:4192:T:C
NC_012920.1:m.4205T>C	MT-ND1	L300S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692434	MT	4205	MT	4205	692434	680970	rs1603219353	NC_012920.1:4204:T:C
NC_012920.1:m.4211T>C	MT-ND1	M302T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692435	MT	4211	MT	4211	692435	680971	rs1603219356	NC_012920.1:4210:T:C
m.4216T>C	MT-ND1	Y304H	not provided|Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009724	MT	4216	MT	4216	9724	24763	rs1599988	NC_012920.1:4215:T:C
NC_012920.1:m.4218T>C	MT-ND1		not provided	Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000235539	MT	4218	MT	4218	235539	237220	rs878853061	NC_012920.1:4217:T:C
NC_012920.1(MT-ND1):m.4219G>A	MT-ND1	V305I	Leigh syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235315	MT	4219	MT	4219	235315	237002	rs878853008	NC_012920.1:4218:G:A
NC_012920.1:m.4225A>G	MT-ND1	M307V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692436	MT	4225	MT	4225	692436	680972	rs1603219364	NC_012920.1:4224:A:G
NC_012920.1:m.4226T>C	MT-ND1	M307T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692437	MT	4226	MT	4226	692437	680973	rs1603219365	NC_012920.1:4225:T:C
NC_012920.1:m.4231A>G	MT-ND1	I309V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692438	MT	4231	MT	4231	692438	680974	rs878929819	NC_012920.1:4230:A:G
NC_012920.1:m.4232T>C	MT-ND1	I309T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692439	MT	4232	MT	4232	692439	680975	rs1556422834	NC_012920.1:4231:T:C
NC_012920.1:m.4234A>G	MT-ND1	T310A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692440	MT	4234	MT	4234	692440	680976	rs1603219368	NC_012920.1:4233:A:G
NC_012920.1:m.4238T>C	MT-ND1	I311T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692441	MT	4238	MT	4238	692441	680977	rs1603219369	NC_012920.1:4237:T:C
NC_012920.1:m.4242C>T	MT-ND1		not provided	Likely benign(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000805052	MT	4242	MT	4242	805052	793910	rs1603219372	NC_012920.1:4241:C:T
NC_012920.1:m.4243A>G	MT-ND1	S313G	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692442	MT	4243	MT	4243	692442	680978	rs1603219373	NC_012920.1:4242:A:G
NC_012920.1:m.4247T>C	MT-ND1	I314T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692443	MT	4247	MT	4247	692443	680979	rs1603219376	NC_012920.1:4246:T:C
NC_012920.1:m.4248T>C	MT-ND1		not provided	Benign(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000805053	MT	4248	MT	4248	805053	793911	rs9326618	NC_012920.1:4247:T:C
NC_012920.1:m.4258A>G	MT-ND1	T318A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692444	MT	4258	MT	4258	692444	680980	rs1603219383	NC_012920.1:4257:A:G
NC_012920.1(MT-CYB):m.4264G>A	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689872	MT	4264	MT	4264	689872	677709	rs1603219385	NC_012920.1:4263:G:A
m.4269A>G	MT-TI		Cardiomyopathy, fatal	Pathogenic(Last reviewed: Jul 15, 1992)	no assertion criteria provided	VCV000009602	MT	4269	MT	4269	9602	24641	rs121434466	NC_012920.1:4268:A:G
NC_012920.1:m.4277T>C	MT-TI		not specified|not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000235012	MT	4277	MT	4277	235012	236830	rs876661358	NC_012920.1:4276:T:C
m.4284G>A	MT-TI		not provided|Multisystem disorder|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2021)	criteria provided, conflicting interpretations	VCV000009604	MT	4284	MT	4284	9604	24643	rs121434468	NC_012920.1:4283:G:A
m.4290T>C	MT-TI		Encephalopathy, familial progressive necrotizing|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009605	MT	4290	MT	4290	9605	24644	rs121434469	NC_012920.1:4289:T:C
m.4291T>C	MT-TI		Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial	Pathogenic(Last reviewed: Jul 7, 2021)	criteria provided, single submitter	VCV000009607	MT	4291	MT	4291	9607	24646	rs121434471	NC_012920.1:4290:T:C
m.4295A>G	MT-TI		Primary familial hypertrophic cardiomyopathy|Mitochondrial non-syndromic sensorineural hearing loss|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000009603	MT	4295	MT	4295	9603	24642	rs121434467	NC_012920.1:4294:A:G
NC_012920.1(MT-CYB):m.4296G>A	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689873	MT	4296	MT	4296	689873	677710	rs1603219393	NC_012920.1:4295:G:A
NC_012920.1(MT-CYB):m.4298G>A	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689874	MT	4298	MT	4298	689874	677711	rs1603219395	NC_012920.1:4297:G:A
m.4300A>G	MT-TI		Primary dilated cardiomyopathy|Asymmetric septal hypertrophy|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000009606	MT	4300	MT	4300	9606	24645	rs121434470	NC_012920.1:4299:A:G
NC_012920.1:m.4305A>G	MT-TI		not provided	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000618731	MT	4305	MT	4305	618731	610273	rs1569483932	NC_012920.1:4304:A:G
NC_012920.1(MT-CYB):m.4308G>A	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689875	MT	4308	MT	4308	689875	677712	rs1603219396	NC_012920.1:4307:G:A
NC_012920.1(MT-CYB):m.4310A>G	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689876	MT	4310	MT	4310	689876	677713	rs1556422841	NC_012920.1:4309:A:G
NC_012920.1(MT-CYB):m.4312C>T	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689877	MT	4312	MT	4312	689877	677714	rs193303033	NC_012920.1:4311:C:T
NC_012920.1(MT-CYB):m.4313T>C	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689878	MT	4313	MT	4313	689878	677715	rs1603219398	NC_012920.1:4312:T:C
NC_012920.1(MT-CYB):m.4314T>A	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689880	MT	4314	MT	4314	689880	677717	rs1603219401	NC_012920.1:4313:T:A
NC_012920.1(MT-CYB):m.4314T>C	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689879	MT	4314	MT	4314	689879	677718	rs1603219401	NC_012920.1:4313:T:C
NC_012920.1:m.4315A>G	MT-TI		not provided|not specified	Uncertain significance(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000235013	MT	4315	MT	4315	235013	236831	rs876661359	NC_012920.1:4314:A:G
NC_012920.1:m.4316A>G	MT-TI		not specified|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000235014	MT	4316	MT	4316	235014	236832	rs876661360	NC_012920.1:4315:A:G
m.4317A>G	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Cardiomyopathy, fatal infantile	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009601	MT	4317	MT	4317	9601	24640	rs121434465	NC_012920.1:4316:A:G
NC_012920.1(MT-CYB):m.4318C>T	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689882	MT	4318	MT	4318	689882	677719	rs1603219405	NC_012920.1:4317:C:T
NC_012920.1(MT-CYB):m.4320C>A	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689884	MT	4320	MT	4320	689884	677720	rs1603219406	NC_012920.1:4319:C:A
NC_012920.1(MT-CYB):m.4320C>T	MT-TI		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689883	MT	4320	MT	4320	689883	677721	rs1603219406	NC_012920.1:4319:C:T
NC_012920.1(MT-CYB):m.4327T>C	MT-TI		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689885	MT	4327	MT	4327	689885	677722	rs1603219411	NC_012920.1:4326:T:C
m.4332G>A	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Feb 13, 2001)	no assertion criteria provided	VCV000009616	MT	4332	MT	4332	9616	24655	rs199476141	NC_012920.1:4331:G:A
NC_012920.1(MT-CYB):m.4335C>T	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689886	MT	4335	MT	4335	689886	677723	rs878959563	NC_012920.1:4334:C:T
m.4336T>C	MT-TQ		not specified|Sensorineural deafness and migraine|not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2020)	criteria provided, conflicting interpretations	VCV000009615	MT	4336	MT	4336	9615	24654	rs41456348	NC_012920.1:4335:T:C
NC_012920.1(MT-CYB):m.4339G>A	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689887	MT	4339	MT	4339	689887	677724	rs1603219415	NC_012920.1:4338:G:A
NC_012920.1(MT-CYB):m.4340A>G	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689888	MT	4340	MT	4340	689888	677725	rs1603219416	NC_012920.1:4339:A:G
NC_012920.1(MT-CYB):m.4343A>G	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689889	MT	4343	MT	4343	689889	677726	rs386828939	NC_012920.1:4342:A:G
NC_012920.1(MT-CYB):m.4350C>T	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689890	MT	4350	MT	4350	689890	677727	rs1603219418	NC_012920.1:4349:C:T
NC_012920.1(MT-CYB):m.4353T>C	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689891	MT	4353	MT	4353	689891	677728	rs1603219419	NC_012920.1:4352:T:C
NC_012920.1(MT-CYB):m.4360G>A	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689892	MT	4360	MT	4360	689892	677729	rs1603219422	NC_012920.1:4359:G:A
NC_012920.1:m.4363T>C	MT-TQ		not specified|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000235017	MT	4363	MT	4363	235017	236834	rs200009705	NC_012920.1:4362:T:C
NC_012920.1(MT-CYB):m.4370T>C	MT-TQ		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689893	MT	4370	MT	4370	689893	677730	rs1603219427	NC_012920.1:4369:T:C
NC_012920.1(MT-CYB):m.4371T>C	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689894	MT	4371	MT	4371	689894	677731	rs1603219428	NC_012920.1:4370:T:C
NC_012920.1(MT-CYB):m.4372C>T	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689895	MT	4372	MT	4372	689895	677732	rs1603219429	NC_012920.1:4371:C:T
NC_012920.1(MT-CYB):m.4373T>C	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689896	MT	4373	MT	4373	689896	677733	rs1603219432	NC_012920.1:4372:T:C
NC_012920.1(MT-CYB):m.4375C>T	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689897	MT	4375	MT	4375	689897	677734	rs1603219433	NC_012920.1:4374:C:T
NC_012920.1(MT-CYB):m.4381A>G	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689898	MT	4381	MT	4381	689898	677735	rs1603219434	NC_012920.1:4380:A:G
NC_012920.1(MT-CYB):m.4384T>A	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689900	MT	4384	MT	4384	689900	677736	rs1603219436	NC_012920.1:4383:T:A
NC_012920.1(MT-CYB):m.4384T>C	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689899	MT	4384	MT	4384	689899	677737	rs1603219436	NC_012920.1:4383:T:C
NC_012920.1(MT-CYB):m.4385A>G	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689902	MT	4385	MT	4385	689902	677738	rs386828941	NC_012920.1:4384:A:G
NC_012920.1(MT-CYB):m.4385A>T	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689901	MT	4385	MT	4385	689901	677739	rs386828941	NC_012920.1:4384:A:T
NC_012920.1(MT-CYB):m.4386T>C	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689903	MT	4386	MT	4386	689903	677740	rs1569483940	NC_012920.1:4385:T:C
NC_012920.1(MT-CYB):m.4387C>T	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689904	MT	4387	MT	4387	689904	677741	rs1556422854	NC_012920.1:4386:C:T
Single allele	MT-TQ		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000235438	MT	4388	MT	4388	235438	237121	rs375986475	NC_012920.1:4387:A:G
NC_012920.1(MT-CYB):m.4394C>A	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689905	MT	4394	MT	4394	689905	677742	rs1603219441	NC_012920.1:4393:C:A
NC_012920.1(MT-CYB):m.4395A>G	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689906	MT	4395	MT	4395	689906	677743	rs1603219443	NC_012920.1:4394:A:G
NC_012920.1(MT-CYB):m.4399T>C	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689907	MT	4399	MT	4399	689907	677744	rs1603219445	NC_012920.1:4398:T:C
NC_012920.1(MT-CYB):m.4400A>G	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689908	MT	4400	MT	4400	689908	677745	rs1603219449	NC_012920.1:4399:A:G
m.4409T>C	MT-TM		Inborn mitochondrial myopathy	Pathogenic(Last reviewed: Dec 5, 2008)	no assertion criteria provided	VCV000009578	MT	4409	MT	4409	9578	24617	rs118203884	NC_012920.1:4408:T:C
NC_012920.1(MT-CYB):m.4417A>G	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689909	MT	4417	MT	4417	689909	677746	rs1603219452	NC_012920.1:4416:A:G
NC_012920.1(MT-CYB):m.4418T>C	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689910	MT	4418	MT	4418	689910	677747	rs1556422856	NC_012920.1:4417:T:C
NC_012920.1(MT-CYB):m.4429G>A	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689911	MT	4429	MT	4429	689911	677748	rs1603219456	NC_012920.1:4428:G:A
NC_012920.1(MT-CYB):m.4435A>G	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689912	MT	4435	MT	4435	689912	677749	rs878930498	NC_012920.1:4434:A:G
NC_012920.1(MT-CYB):m.4437C>T	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689913	MT	4437	MT	4437	689913	677750	rs1603219459	NC_012920.1:4436:C:T
NC_012920.1(MT-CYB):m.4451T>G	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689914	MT	4451	MT	4451	689914	677751	rs1603219461	NC_012920.1:4450:T:G
NC_012920.1(MT-CYB):m.4452T>C	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689915	MT	4452	MT	4452	689915	677752	rs377043134	NC_012920.1:4451:T:C
NC_012920.1(MT-CYB):m.4454T>A	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689917	MT	4454	MT	4454	689917	677753	rs11510098	NC_012920.1:4453:T:A
NC_012920.1(MT-CYB):m.4454T>C	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689916	MT	4454	MT	4454	689916	677754	rs11510098	NC_012920.1:4453:T:C
NC_012920.1(MT-CYB):m.4455A>G	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689918	MT	4455	MT	4455	689918	677755	rs878986264	NC_012920.1:4454:A:G
NC_012920.1(MT-CYB):m.4456C>T	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689919	MT	4456	MT	4456	689919	677756	rs1603219465	NC_012920.1:4455:C:T
NC_012920.1(MT-CYB):m.4464G>A	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689920	MT	4464	MT	4464	689920	677757	rs1603219466	NC_012920.1:4463:G:A
NC_012920.1(MT-CYB):m.4466A>G	MT-TM		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689921	MT	4466	MT	4466	689921	677758	rs1603219467	NC_012920.1:4465:A:G
NC_012920.1:m.4472T>C	MT-ND2		not provided	Uncertain significance(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	VCV000376834	MT	4472	MT	4472	376834	363712	rs1057520067	NC_012920.1:4471:T:C
NC_012920.1:m.4480T>C	MT-ND2	L4P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692445	MT	4480	MT	4480	692445	680981	rs1603219468	NC_012920.1:4479:T:C
NC_012920.1:m.4482G>A	MT-ND2	A5T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692446	MT	4482	MT	4482	692446	680982	rs1603219472	NC_012920.1:4481:G:A
NC_012920.1:m.4488C>T	MT-ND2	P7S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692447	MT	4488	MT	4488	692447	680983	rs1603219476	NC_012920.1:4487:C:T
NC_012920.1:m.4491G>A	MT-ND2	V8I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692448	MT	4491	MT	4491	692448	680984	rs201172504	NC_012920.1:4490:G:A
NC_012920.1:m.4494A>G	MT-ND2	I9V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692449	MT	4494	MT	4494	692449	680985	rs1603219477	NC_012920.1:4493:A:G
NC_012920.1:m.4495T>C	MT-ND2	I9T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692450	MT	4495	MT	4495	692450	680986	rs1603219480	NC_012920.1:4494:T:C
NC_012920.1:m.4497T>C	MT-ND2	Y10H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692451	MT	4497	MT	4497	692451	680987	rs1603219482	NC_012920.1:4496:T:C
NC_012920.1:m.4500T>C	MT-ND2	S11P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692452	MT	4500	MT	4500	692452	680988	rs879007369	NC_012920.1:4499:T:C
NC_012920.1:m.4501C>T	MT-ND2	S11F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692453	MT	4501	MT	4501	692453	680989	rs1603219484	NC_012920.1:4500:C:T
NC_012920.1:m.4503A>T	MT-ND2	T12S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692454	MT	4503	MT	4503	692454	680990	rs1603219486	NC_012920.1:4502:A:T
NC_012920.1:m.4506A>G	MT-ND2	I13V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692455	MT	4506	MT	4506	692455	680991	rs11510099	NC_012920.1:4505:A:G
NC_012920.1:m.4509T>C	MT-ND2	F14L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692456	MT	4509	MT	4509	692456	680992	rs1603219488	NC_012920.1:4508:T:C
NC_012920.1:m.4512G>A	MT-ND2	A15T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692457	MT	4512	MT	4512	692457	680993	rs1603219492	NC_012920.1:4511:G:A
NC_012920.1:m.4513C>T	MT-ND2	A15V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692458	MT	4513	MT	4513	692458	680994	rs1603219494	NC_012920.1:4512:C:T
NC_012920.1:m.4531C>T	MT-ND2	A21V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692459	MT	4531	MT	4531	692459	680995	rs1603219496	NC_012920.1:4530:C:T
NC_012920.1:m.4548T>C	MT-ND2	F27L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692460	MT	4548	MT	4548	692460	680996	rs1603219503	NC_012920.1:4547:T:C
NC_012920.1:m.4554A>G	MT-ND2	T29A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692461	MT	4554	MT	4554	692461	680997	rs1603219508	NC_012920.1:4553:A:G
NC_012920.1:m.4560G>A	MT-ND2	V31M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692462	MT	4560	MT	4560	692462	680998	rs1603219511	NC_012920.1:4559:G:A
NC_012920.1:m.4561T>C	MT-ND2	V31A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692463	MT	4561	MT	4561	692463	680999	rs41376350	NC_012920.1:4560:T:C
NC_012920.1:m.4579T>C	MT-ND2	M37T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692464	MT	4579	MT	4579	692464	681000	rs1603219517	NC_012920.1:4578:T:C
NC_012920.1:m.4596G>A	MT-ND2	V43I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692465	MT	4596	MT	4596	692465	681001	rs1117207	NC_012920.1:4595:G:A
NC_012920.1:m.4597T>C	MT-ND2	V43A	not provided	Uncertain significance(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000618727	MT	4597	MT	4597	618727	610274	rs1569483945	NC_012920.1:4596:T:C
NC_012920.1:m.4612T>C	MT-ND2	M48T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692467	MT	4612	MT	4612	692467	681003	rs1603219525	NC_012920.1:4611:T:C
NC_012920.1:m.4615A>G	MT-ND2	N49S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692468	MT	4615	MT	4615	692468	681004	rs386828946	NC_012920.1:4614:A:G
NC_012920.1:m.4632G>A	MT-ND2	A55T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692469	MT	4632	MT	4632	692469	681005	rs1603219530	NC_012920.1:4631:G:A
NC_012920.1:m.4638A>G	MT-ND2	I57V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692470	MT	4638	MT	4638	692470	681006	rs878960801	NC_012920.1:4637:A:G
NC_012920.1:m.4639T>C	MT-ND2	I57T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692471	MT	4639	MT	4639	692471	681007	rs41510547	NC_012920.1:4638:T:C
m.4640C>A	MT-ND2	I57M	Leigh syndrome|Leber optic atrophy	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009718	MT	4640	MT	4640	9718	24757	rs387906426	NC_012920.1:4639:C:A
NC_012920.1:m.4654C>T	MT-ND2	T62M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692472	MT	4654	MT	4654	692472	681008	rs1603219538	NC_012920.1:4653:C:T
NC_012920.1:m.4659G>T	MT-ND2	A64S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692474	MT	4659	MT	4659	692474	681010	rs1556422882	NC_012920.1:4658:G:T
NC_012920.1:m.4659G>A	MT-ND2	A64T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692473	MT	4659	MT	4659	692473	681009	rs1556422882	NC_012920.1:4658:G:A
NC_012920.1:m.4664C>T	MT-ND2		Epilepsy|Developmental delay	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370047	MT	4664	MT	4664	370047	354300	rs1057516059	NC_012920.1:4663:C:T
NC_012920.1:m.4665G>A	MT-ND2	A66T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692475	MT	4665	MT	4665	692475	681011	rs1603219544	NC_012920.1:4664:G:A
NC_012920.1:m.4674A>G	MT-ND2	I69V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692476	MT	4674	MT	4674	692476	681012	rs1556422884	NC_012920.1:4673:A:G
NC_012920.1:m.4676C>A	MT-ND2	I69M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692477	MT	4676	MT	4676	692477	681013	rs1603219551	NC_012920.1:4675:C:A
NC_012920.1:m.4680C>A	MT-ND2	L71M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692478	MT	4680	MT	4680	692478	681014	rs1603219554	NC_012920.1:4679:C:A
m.4681T>C	MT-ND2	L71P	Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome	Pathogenic(Last reviewed: Dec 2, 2021)	no assertion criteria provided	VCV000009721	MT	4681	MT	4681	9721	24760	rs267606889	NC_012920.1:4680:T:C
NC_012920.1:m.4688T>C	MT-ND2		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235516	MT	4688	MT	4688	235516	237197	rs878853056	NC_012920.1:4687:T:C
NC_012920.1:m.4689A>G	MT-ND2	I74V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692479	MT	4689	MT	4689	692479	681015	rs1603219555	NC_012920.1:4688:A:G
NC_012920.1:m.4690T>C	MT-ND2	I74T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692480	MT	4690	MT	4690	692480	681016	rs1603219557	NC_012920.1:4689:T:C
NC_012920.1:m.4695T>C	MT-ND2	F76L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692481	MT	4695	MT	4695	692481	681017	rs1556422885	NC_012920.1:4694:T:C
NC_012920.1:m.4696T>C	MT-ND2	F76S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692482	MT	4696	MT	4696	692482	681018	rs1603219566	NC_012920.1:4695:T:C
NC_012920.1:m.4702A>G	MT-ND2	N78S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692483	MT	4702	MT	4702	692483	681019	rs1603219570	NC_012920.1:4701:A:G
NC_012920.1:m.4705T>C	MT-ND2	M79T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692484	MT	4705	MT	4705	692484	681020	rs1603219572	NC_012920.1:4704:T:C
NC_012920.1:m.4707C>T	MT-ND2	L80F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692485	MT	4707	MT	4707	692485	681021	rs1603219574	NC_012920.1:4706:C:T
NC_012920.1:m.4717A>T	MT-ND2	Q83L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692486	MT	4717	MT	4717	692486	681022	rs1603219578	NC_012920.1:4716:A:T
NC_012920.1:m.4722A>G	MT-ND2	T85A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692487	MT	4722	MT	4722	692487	681023	rs1569483952	NC_012920.1:4721:A:G
NC_012920.1:m.4725A>C	MT-ND2	M86L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692489	MT	4725	MT	4725	692489	681024	rs1603219581	NC_012920.1:4724:A:C
NC_012920.1:m.4725A>T	MT-ND2	M86L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692488	MT	4725	MT	4725	692488	681025	rs1603219581	NC_012920.1:4724:A:T
NC_012920.1:m.4728A>G	MT-ND2	T87A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692490	MT	4728	MT	4728	692490	681026	rs1556422892	NC_012920.1:4727:A:G
NC_012920.1:m.4732A>G	MT-ND2	N88S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692491	MT	4732	MT	4732	692491	681027	rs201854167	NC_012920.1:4731:A:G
NC_012920.1:m.4733T>C	MT-ND2		not provided	Likely benign(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000235579	MT	4733	MT	4733	235579	237260	rs878853072	NC_012920.1:4732:T:C
NC_012920.1:m.4734A>G	MT-ND2	T89A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692492	MT	4734	MT	4734	692492	681028	rs1603219588	NC_012920.1:4733:A:G
T89S	MT-ND2	T89S	Mitochondrial disease	Uncertain significance(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV001328512	MT	4735	MT	4735	1328512	1319161		NC_012920.1:4734:C:G
NC_012920.1:m.4735C>A	MT-ND2	T89N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692493	MT	4735	MT	4735	692493	681029	rs1603219589	NC_012920.1:4734:C:A
NC_012920.1:m.4745A>T	MT-ND2	Q92H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692494	MT	4745	MT	4745	692494	681030	rs1556422896	NC_012920.1:4744:A:T
NC_012920.1:m.4746T>C	MT-ND2	Y93H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692495	MT	4746	MT	4746	692495	681031	rs1603219594	NC_012920.1:4745:T:C
NC_012920.1:m.4749T>C	MT-ND2	S94P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692496	MT	4749	MT	4749	692496	681032	rs1603219596	NC_012920.1:4748:T:C
NC_012920.1:m.4759T>C	MT-ND2	M97T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692497	MT	4759	MT	4759	692497	681033	rs1603219604	NC_012920.1:4758:T:C
NC_012920.1:m.4762T>C	MT-ND2	I98T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692498	MT	4762	MT	4762	692498	681034	rs1603219605	NC_012920.1:4761:T:C
NC_012920.1:m.4763C>A	MT-ND2	I98M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692499	MT	4763	MT	4763	692499	681035	rs1603219607	NC_012920.1:4762:C:A
NC_012920.1:m.4764A>G	MT-ND2	M99V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692500	MT	4764	MT	4764	692500	681036	rs1603219609	NC_012920.1:4763:A:G
NC_012920.1:m.4765T>C	MT-ND2	M99T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692501	MT	4765	MT	4765	692501	681037	rs1603219611	NC_012920.1:4764:T:C
NC_012920.1:m.4767A>G	MT-ND2	M100V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692502	MT	4767	MT	4767	692502	681038	rs1569483957	NC_012920.1:4766:A:G
NC_012920.1:m.4768T>C	MT-ND2	M100T	not provided	Uncertain significance(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000235413	MT	4768	MT	4768	235413	237098	rs878853032	NC_012920.1:4767:T:C
NC_012920.1:m.4769A>G	MT-ND2		not provided|Mitochondrial disease	Benign(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000441150	MT	4769	MT	4769	441150	434779	rs3021086	NC_012920.1:4768:A:G
NC_012920.1:m.4770G>A	MT-ND2	A101T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692504	MT	4770	MT	4770	692504	681040	rs1603219619	NC_012920.1:4769:G:A
NC_012920.1:m.4776G>A	MT-ND2	A103T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692505	MT	4776	MT	4776	692505	681041	rs1603219623	NC_012920.1:4775:G:A
NC_012920.1:m.4788G>A	MT-ND2	G107*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692506	MT	4788	MT	4788	692506	681042	rs1603219627	NC_012920.1:4787:G:A
NC_012920.1:m.4789G>A	MT-ND2	G107E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692507	MT	4789	MT	4789	692507	681043	rs1603219628	NC_012920.1:4788:G:A
m.4810G>A	MT-ND2	W114*	Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Mar 22, 2005)	no assertion criteria provided	VCV000009720	MT	4810	MT	4810	9720	24759	rs267606888	NC_012920.1:4809:G:A
NC_012920.1:m.4812G>A	MT-ND2	V115I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692509	MT	4812	MT	4812	692509	681044	rs1603219637	NC_012920.1:4811:G:A
NC_012920.1:m.4812G>C	MT-ND2	V115L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692508	MT	4812	MT	4812	692508	681045	rs1603219637	NC_012920.1:4811:G:C
NC_012920.1:m.4823T>C	MT-ND2		not provided	Likely benign(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000235544	MT	4823	MT	4823	235544	237225	rs878853062	NC_012920.1:4822:T:C
NC_012920.1:m.4824A>G	MT-ND2	T119A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692510	MT	4824	MT	4824	692510	681046	rs1556422903	NC_012920.1:4823:A:G
NC_012920.1:m.4833A>G	MT-ND2	T122A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692511	MT	4833	MT	4833	692511	681047	rs386419995	NC_012920.1:4832:A:G
NC_012920.1:m.4842A>G	MT-ND2	T125A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692512	MT	4842	MT	4842	692512	681048	rs1603219643	NC_012920.1:4841:A:G
NC_012920.1:m.4843C>T	MT-ND2	T125M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692513	MT	4843	MT	4843	692513	681049	rs1556422913	NC_012920.1:4842:C:T
NC_012920.1:m.4894T>C	MT-ND2	M142T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692514	MT	4894	MT	4894	692514	681050	rs1603219656	NC_012920.1:4893:T:C
NC_012920.1:m.4902A>G	MT-ND2	I145V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692515	MT	4902	MT	4902	692515	681051	rs1603219664	NC_012920.1:4901:A:G
NC_012920.1:m.4908C>T	MT-ND2	P147S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692516	MT	4908	MT	4908	692516	681052	rs1603219668	NC_012920.1:4907:C:T
NC_012920.1:m.4911T>G	MT-ND2	S148A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692517	MT	4911	MT	4911	692517	681053	rs1603219671	NC_012920.1:4910:T:G
m.4917A>G	MT-ND2	N150D	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009716	MT	4917	MT	4917	9716	24755	rs28357980	NC_012920.1:4916:A:G
NC_012920.1:m.4923A>T	MT-ND2	S152C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692518	MT	4923	MT	4923	692518	681054	rs1603219674	NC_012920.1:4922:A:T
NC_012920.1:m.4924G>A	MT-ND2	S152N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692520	MT	4924	MT	4924	692520	681055	rs386828956	NC_012920.1:4923:G:A
NC_012920.1:m.4924G>C	MT-ND2	S152T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692519	MT	4924	MT	4924	692519	681056	rs386828956	NC_012920.1:4923:G:C
NC_012920.1:m.4929C>T	MT-ND2	L154F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692521	MT	4929	MT	4929	692521	681057	rs1603219676	NC_012920.1:4928:C:T
NC_012920.1:m.4935A>G	MT-ND2	T156A	Mitochondrial disease|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692523	MT	4935	MT	4935	692523	681059	rs1603219678	NC_012920.1:4934:A:G
NC_012920.1:m.4935A>C	MT-ND2	T156P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692522	MT	4935	MT	4935	692522	681058	rs1603219678	NC_012920.1:4934:A:C
NC_012920.1:m.4936C>T	MT-ND2	T156I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692524	MT	4936	MT	4936	692524	681060	rs1603219679	NC_012920.1:4935:C:T
NC_012920.1:m.4944A>G	MT-ND2	I159V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692525	MT	4944	MT	4944	692525	681061	rs878971699	NC_012920.1:4943:A:G
NC_012920.1:m.4948T>C	MT-ND2	L160S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692526	MT	4948	MT	4948	692526	681062	rs1603219686	NC_012920.1:4947:T:C
NC_012920.1:m.4953A>G	MT-ND2	I162V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692527	MT	4953	MT	4953	692527	681063	rs1603219688	NC_012920.1:4952:A:G
NC_012920.1:m.4954T>C	MT-ND2	I162T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692528	MT	4954	MT	4954	692528	681064	rs1603219689	NC_012920.1:4953:T:C
NC_012920.1:m.4959G>A	MT-ND2	A164T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692529	MT	4959	MT	4959	692529	681065	rs1603219694	NC_012920.1:4958:G:A
NC_012920.1:m.4960C>T	MT-ND2	A164V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692530	MT	4960	MT	4960	692530	681066	rs1603219696	NC_012920.1:4959:C:T
NC_012920.1:m.4965A>G	MT-ND2	S166G	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692531	MT	4965	MT	4965	692531	681067	rs879150535	NC_012920.1:4964:A:G
NC_012920.1:m.4974G>A	MT-ND2	G169*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692532	MT	4974	MT	4974	692532	681068	rs1603219704	NC_012920.1:4973:G:A
NC_012920.1:m.4983C>T	MT-ND2	Q172*	not provided	Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000439962	MT	4983	MT	4983	439962	433752	rs1556422937	NC_012920.1:4982:C:T
NC_012920.1:m.5010T>C	MT-ND2	Y181H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692534	MT	5010	MT	5010	692534	681070	rs1603219718	NC_012920.1:5009:T:C
NC_012920.1:m.5033A>G	MT-ND2		not provided	Likely benign(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000235462	MT	5033	MT	5033	235462	237145	rs878853043	NC_012920.1:5032:A:G
NC_012920.1:m.5038T>C	MT-ND2	M190T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692535	MT	5038	MT	5038	692535	681071	rs1556422943	NC_012920.1:5037:T:C
NC_012920.1:m.5046G>A	MT-ND2	V193I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692536	MT	5046	MT	5046	692536	681072	rs878927053	NC_012920.1:5045:G:A
NC_012920.1:m.5047T>C	MT-ND2	V193A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692537	MT	5047	MT	5047	692537	681073	rs1603219746	NC_012920.1:5046:T:C
NC_012920.1:m.5067A>G	MT-ND2	M200V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692538	MT	5067	MT	5067	692538	681074	rs1603219758	NC_012920.1:5066:A:G
NC_012920.1:m.5069A>T	MT-ND2	M200I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692539	MT	5069	MT	5069	692539	681075	rs1603219761	NC_012920.1:5068:A:T
NC_012920.1:m.5073A>G	MT-ND2	I202V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692540	MT	5073	MT	5073	692540	681076	rs1603219765	NC_012920.1:5072:A:G
NC_012920.1:m.5074T>C	MT-ND2	I202T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692541	MT	5074	MT	5074	692541	681077	rs1556422946	NC_012920.1:5073:T:C
NC_012920.1:m.5076C>T	MT-ND2	L203F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692542	MT	5076	MT	5076	692542	681078	rs386828960	NC_012920.1:5075:C:T
NC_012920.1:m.5080A>G	MT-ND2	N204S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692543	MT	5080	MT	5080	692543	681079	rs1603219771	NC_012920.1:5079:A:G
NC_012920.1:m.5086C>T	MT-ND2	T206I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692544	MT	5086	MT	5086	692544	681080	rs1603219776	NC_012920.1:5085:C:T
NC_012920.1:m.5094A>G	MT-ND2	I209V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692545	MT	5094	MT	5094	692545	681081	rs1603219783	NC_012920.1:5093:A:G
NC_012920.1:m.5095T>C	MT-ND2	I209T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692546	MT	5095	MT	5095	692546	681082	rs1556422950	NC_012920.1:5094:T:C
NC_012920.1:m.5105T>C	MT-ND2		not provided	Uncertain significance(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000376792	MT	5105	MT	5105	376792	363670	rs1057520057	NC_012920.1:5104:T:C
NC_012920.1:m.5127A>G	MT-ND2	N220D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692547	MT	5127	MT	5127	692547	681083	rs1603219795	NC_012920.1:5126:A:G
NC_012920.1:m.5128A>G	MT-ND2	N220S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692548	MT	5128	MT	5128	692548	681084	rs1603219796	NC_012920.1:5127:A:G
NC_012920.1:m.5149C>T	MT-ND2	T227I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692549	MT	5149	MT	5149	692549	681085	rs1603219806	NC_012920.1:5148:C:T
NC_012920.1:m.5166A>G	MT-ND2	T233A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692550	MT	5166	MT	5166	692550	681086	rs1603219809	NC_012920.1:5165:A:G
NC_012920.1:m.5177G>A	MT-ND2		not provided	Likely benign(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000445705	MT	5177	MT	5177	445705	438977	rs1556422960	NC_012920.1:5176:G:A
NC_012920.1:m.5178C>A	MT-ND2	L237M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692551	MT	5178	MT	5178	692551	681087	rs28357984	NC_012920.1:5177:C:A
NC_012920.1:m.5186A>T	MT-ND2	W239C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692552	MT	5186	MT	5186	692552	681088	rs878939965	NC_012920.1:5185:A:T
NC_012920.1:m.5190A>G	MT-ND2	T241A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692553	MT	5190	MT	5190	692553	681089	rs1603219819	NC_012920.1:5189:A:G
NC_012920.1:m.5191C>T	MT-ND2	T241M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692554	MT	5191	MT	5191	692554	681090	rs1603219822	NC_012920.1:5190:C:T
NC_012920.1:m.5194C>T	MT-ND2	P242L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692555	MT	5194	MT	5194	692555	681091	rs1603219824	NC_012920.1:5193:C:T
NC_012920.1:m.5205T>C	MT-ND2	S246P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692556	MT	5205	MT	5205	692556	681092	rs1603219831	NC_012920.1:5204:T:C
NC_012920.1:m.5206C>T	MT-ND2	S246F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692557	MT	5206	MT	5206	692557	681093	rs1556422963	NC_012920.1:5205:C:T
NC_012920.1:m.5211C>T	MT-ND2	L248F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692558	MT	5211	MT	5211	692558	681094	rs1603219834	NC_012920.1:5210:C:T
m.5244G>A	MT-ND2	G259S	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009717	MT	5244	MT	5244	9717	24756	rs199476115	NC_012920.1:5243:G:A
NC_012920.1:m.5262G>A	MT-ND2	A265T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692559	MT	5262	MT	5262	692559	681095	rs1603219855	NC_012920.1:5261:G:A
NC_012920.1:m.5263C>T	MT-ND2	A265V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692560	MT	5263	MT	5263	692560	681096	rs41320049	NC_012920.1:5262:C:T
NC_012920.1:m.5265A>G	MT-ND2	I266V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692561	MT	5265	MT	5265	692561	681097	rs1603219856	NC_012920.1:5264:A:G
NC_012920.1:m.5266T>C	MT-ND2	I266T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692562	MT	5266	MT	5266	692562	681098	rs1603219857	NC_012920.1:5265:T:C
NC_012920.1:m.5268A>G	MT-ND2	I267V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692563	MT	5268	MT	5268	692563	681099	rs1603219860	NC_012920.1:5267:A:G
NC_012920.1:m.5273A>T	MT-ND2	E268D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692564	MT	5273	MT	5273	692564	681100	rs1603219868	NC_012920.1:5272:A:T
NC_012920.1:m.5277T>C	MT-ND2	F270L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692565	MT	5277	MT	5277	692565	681101	rs1556422968	NC_012920.1:5276:T:C
NC_012920.1:m.5289A>G	MT-ND2	N274D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692566	MT	5289	MT	5289	692566	681102	rs1603219875	NC_012920.1:5288:A:G
NC_012920.1:m.5293G>A	MT-ND2	S275N	Mitochondrial disease|Leigh syndrome	Likely benign(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000692567	MT	5293	MT	5293	692567	681103	rs28690990	NC_012920.1:5292:G:A
NC_012920.1:m.5295C>A	MT-ND2	L276I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692569	MT	5295	MT	5295	692569	681104	rs1556422970	NC_012920.1:5294:C:A
NC_012920.1:m.5295C>T	MT-ND2	L276F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692568	MT	5295	MT	5295	692568	681105	rs1556422970	NC_012920.1:5294:C:T
NC_012920.1:m.5296T>C	MT-ND2	L276P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692570	MT	5296	MT	5296	692570	681106	rs1603219883	NC_012920.1:5295:T:C
NC_012920.1:m.5298A>G	MT-ND2	I277V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692571	MT	5298	MT	5298	692571	681107	rs1603219886	NC_012920.1:5297:A:G
NC_012920.1:m.5301A>C	MT-ND2	I278L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692573	MT	5301	MT	5301	692573	681108	rs199794187	NC_012920.1:5300:A:C
NC_012920.1:m.5301A>G	MT-ND2	I278V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692572	MT	5301	MT	5301	692572	681109	rs199794187	NC_012920.1:5300:A:G
NC_012920.1:m.5302T>C	MT-ND2	I278T	not provided|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235811	MT	5302	MT	5302	235811	237470	rs878853115	NC_012920.1:5301:T:C
NC_012920.1:m.5310A>G	MT-ND2	I281V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692574	MT	5310	MT	5310	692574	681110	rs1603219891	NC_012920.1:5309:A:G
NC_012920.1:m.5311T>C	MT-ND2	I281T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692575	MT	5311	MT	5311	692575	681111	rs1603219892	NC_012920.1:5310:T:C
NC_012920.1:m.5316G>A	MT-ND2	A283T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692576	MT	5316	MT	5316	692576	681112	rs1603219895	NC_012920.1:5315:G:A
NC_012920.1:m.5319A>T	MT-ND2	T284S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692578	MT	5319	MT	5319	692578	681114	rs28456039	NC_012920.1:5318:A:T
NC_012920.1:m.5319A>G	MT-ND2	T284A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692577	MT	5319	MT	5319	692577	681113	rs28456039	NC_012920.1:5318:A:G
NC_012920.1:m.5320C>T	MT-ND2	T284I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692580	MT	5320	MT	5320	692580	681116	rs1603219899	NC_012920.1:5319:C:T
NC_012920.1:m.5320C>G	MT-ND2	T284S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692579	MT	5320	MT	5320	692579	681115	rs1603219899	NC_012920.1:5319:C:G
NC_012920.1:m.5325A>T	MT-ND2	T286S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692582	MT	5325	MT	5325	692582	681118	rs1603219901	NC_012920.1:5324:A:T
NC_012920.1:m.5325A>G	MT-ND2	T286A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692581	MT	5325	MT	5325	692581	681117	rs1603219901	NC_012920.1:5324:A:G
NC_012920.1:m.5331C>G	MT-ND2	L288V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692584	MT	5331	MT	5331	692584	681120	rs200778062	NC_012920.1:5330:C:G
NC_012920.1:m.5331C>A	MT-ND2	L288I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692583	MT	5331	MT	5331	692583	681119	rs200778062	NC_012920.1:5330:C:A
NC_012920.1:m.5437C>T	MT-ND2	T323I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692586	MT	5437	MT	5437	692586	681122	rs1603219948	NC_012920.1:5436:C:T
NC_012920.1:m.5442T>C	MT-ND2	F325L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692587	MT	5442	MT	5442	692587	681123	rs3020601	NC_012920.1:5441:T:C
NC_012920.1:m.5444C>A	MT-ND2	F325L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692588	MT	5444	MT	5444	692588	681124	rs1603219956	NC_012920.1:5443:C:A
NC_012920.1:m.5451A>G	MT-ND2	T328A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692589	MT	5451	MT	5451	692589	681125	rs1603219965	NC_012920.1:5450:A:G
NC_012920.1:m.5452C>T	MT-ND2	T328M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692590	MT	5452	MT	5452	692590	681126	rs1556422991	NC_012920.1:5451:C:T
NC_012920.1:m.5460G>A	MT-ND2	A331T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692591	MT	5460	MT	5460	692591	681127	rs3021088	NC_012920.1:5459:G:A
NC_012920.1:m.5463C>T	MT-ND2	L332F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692592	MT	5463	MT	5463	692592	681128	rs1556422993	NC_012920.1:5462:C:T
NC_012920.1:m.5465T>C	MT-ND2		not provided	Benign(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000235745	MT	5465	MT	5465	235745	237425	rs3902405	NC_012920.1:5464:T:C
NC_012920.1:m.5466A>G	MT-ND2	T333A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692593	MT	5466	MT	5466	692593	681129	rs1603219973	NC_012920.1:5465:A:G
NC_012920.1:m.5484A>G	MT-ND2	I339V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692594	MT	5484	MT	5484	692594	681130	rs1603219979	NC_012920.1:5483:A:G
NC_012920.1:m.5493T>C	MT-ND2	F342L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692595	MT	5493	MT	5493	692595	681131	rs1603219983	NC_012920.1:5492:T:C
NC_012920.1:m.5494T>G	MT-ND2	F342C	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692596	MT	5494	MT	5494	692596	681132	rs1556423001	NC_012920.1:5493:T:G
NC_012920.1:m.5496A>G	MT-ND2	M343V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692597	MT	5496	MT	5496	692597	681133	rs879099820	NC_012920.1:5495:A:G
NC_012920.1:m.5505A>G	MT-ND2	I346V	not provided|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000585066	MT	5505	MT	5505	585066	576198	rs1569484003	NC_012920.1:5504:A:G
NC_012920.1(MT-CYB):m.5514A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689922	MT	5514	MT	5514	689922	677759	rs1603219997	NC_012920.1:5513:A:G
NC_012920.1(MT-CYB):m.5515A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689923	MT	5515	MT	5515	689923	677760	rs1603220000	NC_012920.1:5514:A:G
NC_012920.1(MT-CYB):m.5516A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689924	MT	5516	MT	5516	689924	677761	rs1603220001	NC_012920.1:5515:A:G
m.5521G>A	MT-TW		Inborn mitochondrial myopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009556	MT	5521	MT	5521	9556	24595	rs199474673	NC_012920.1:5520:G:A
NC_012920.1:m.5523T>G	MT-TW		Leigh syndrome	Pathogenic(Last reviewed: Dec 2, 2021)	no assertion criteria provided	VCV000155882	MT	5523	MT	5523	155882	165631	rs587776435	NC_012920.1:5522:T:G
NC_012920.1(MT-CYB):m.5524T>C	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689925	MT	5524	MT	5524	689925	677762	rs1603220004	NC_012920.1:5523:T:C
NC_012920.1(MT-CYB):m.5527A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689926	MT	5527	MT	5527	689926	677763	rs1603220005	NC_012920.1:5526:A:G
NC_012920.1(MT-CYB):m.5528T>C	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689927	MT	5528	MT	5528	689927	677764	rs1556423004	NC_012920.1:5527:T:C
NC_012920.1(MT-CYB):m.5530C>T	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689928	MT	5530	MT	5530	689928	677765	rs1603220009	NC_012920.1:5529:C:T
m.5532G>A	MT-TW		Neurogastrointestinal syndrome, mitochondrial	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000009557	MT	5532	MT	5532	9557	24596	rs199474674	NC_012920.1:5531:G:A
NC_012920.1(MT-CYB):m.5538G>A	MT-TW		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Oct 26, 2021)	reviewed by expert panel	VCV000689930	MT	5538	MT	5538	689930	677767	rs1603220012	NC_012920.1:5537:G:A
NC_012920.1(MT-CYB):m.5539A>T	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689932	MT	5539	MT	5539	689932	677769	rs1603220013	NC_012920.1:5538:A:T
NC_012920.1(MT-CYB):m.5539A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689931	MT	5539	MT	5539	689931	677768	rs1603220013	NC_012920.1:5538:A:G
NC_012920.1(MT-CYB):m.5540G>A	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689933	MT	5540	MT	5540	689933	677770	rs1603220014	NC_012920.1:5539:G:A
NC_012920.1(MT-CYB):m.5542C>T	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689934	MT	5542	MT	5542	689934	677771	rs1603220015	NC_012920.1:5541:C:T
NC_012920.1(MT-CYB):m.5543T>C	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689935	MT	5543	MT	5543	689935	677772	rs1603220016	NC_012920.1:5542:T:C
NC_012920.1(MT-CYB):m.5544T>C	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689936	MT	5544	MT	5544	689936	677773	rs1603220018	NC_012920.1:5543:T:C
m.5545C>T	MT-TW		Encephalocardiomyopathy, mitochondrial	Pathogenic(Last reviewed: Jun 15, 2008)	no assertion criteria provided	VCV000009558	MT	5545	MT	5545	9558	24597	rs387906418	NC_012920.1:5544:C:T
m.5549G>A	MT-TW		Mitochondrial encephalopathy	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000009554	MT	5549	MT	5549	9554	24593	rs199474671	NC_012920.1:5548:G:A
NC_012920.1(MT-CYB):m.5550C>T	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689937	MT	5550	MT	5550	689937	677774	rs1603220019	NC_012920.1:5549:C:T
NC_012920.1(MT-CYB):m.5553T>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689938	MT	5553	MT	5553	689938	677775	rs878853053	NC_012920.1:5552:T:G
NC_012920.1(MT-CYB):m.5553T>C	MT-TW		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign/Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235498	MT	5553	MT	5553	235498	237180	rs878853053	NC_012920.1:5552:T:C
NC_012920.1(MT-CYB):m.5554C>A	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689939	MT	5554	MT	5554	689939	677776	rs1603220020	NC_012920.1:5553:C:A
m.5556G>A	MT-TW		Mitochondrial encephalomyopathy	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000030007	MT	5556	MT	5556	30007	38962	rs387906736	NC_012920.1:5555:G:A
NC_012920.1(MT-CYB):m.5557T>C	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689940	MT	5557	MT	5557	689940	677777	rs1603220022	NC_012920.1:5556:T:C
NC_012920.1(MT-CYB):m.5558A>G	MT-TW		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV000689941	MT	5558	MT	5558	689941	677778	rs370471013	NC_012920.1:5557:A:G
NC_012920.1:m.5559A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000155884	MT	5559	MT	5559	155884	165633	rs1556423008	NC_012920.1:5558:A:G
NC_012920.1(MT-CYB):m.5560G>A	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689942	MT	5560	MT	5560	689942	677779	rs1603220026	NC_012920.1:5559:G:A
NC_012920.1:m.5561T>C	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not provided	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000441156	MT	5561	MT	5561	441156	434780	rs1556423009	NC_012920.1:5560:T:C
NC_012920.1(MT-CYB):m.5563G>A	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689943	MT	5563	MT	5563	689943	677780	rs1603220027	NC_012920.1:5562:G:A
NC_012920.1(MT-CYB):m.5566A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689944	MT	5566	MT	5566	689944	677781	rs1603220029	NC_012920.1:5565:A:G
NC_012920.1(MT-CYB):m.5567T>C	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689945	MT	5567	MT	5567	689945	677782	rs1603220030	NC_012920.1:5566:T:C
NC_012920.1(MT-CYB):m.5568A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689946	MT	5568	MT	5568	689946	677783	rs200719361	NC_012920.1:5567:A:G
NC_012920.1(MT-CYB):m.5573A>G	MT-TW		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689947	MT	5573	MT	5573	689947	677784	rs1603220033	NC_012920.1:5572:A:G
NC_012920.1(MT-CYB):m.5575T>C	MT-TW		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689948	MT	5575	MT	5575	689948	677785	rs1603220034	NC_012920.1:5574:T:C
NC_012920.1(MT-CYB):m.5590G>A	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689949	MT	5590	MT	5590	689949	677786	rs28619345	NC_012920.1:5589:G:A
m.5591G>A	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Inborn mitochondrial myopathy	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009625	MT	5591	MT	5591	9625	24664	rs121434458	NC_012920.1:5590:G:A
NC_012920.1(MT-CYB):m.5592A>G	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689950	MT	5592	MT	5592	689950	677787	rs1603220042	NC_012920.1:5591:A:G
NC_012920.1(MT-CYB):m.5600A>G	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689951	MT	5600	MT	5600	689951	677788	rs1603220045	NC_012920.1:5599:A:G
NC_012920.1(MT-CYB):m.5601C>T	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689952	MT	5601	MT	5601	689952	677789	rs376884056	NC_012920.1:5600:C:T
NC_012920.1(MT-CYB):m.5603C>T	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689953	MT	5603	MT	5603	689953	677790	rs369496446	NC_012920.1:5602:C:T
NC_012920.1(MT-CYB):m.5604C>T	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689954	MT	5604	MT	5604	689954	677791	rs1603220053	NC_012920.1:5603:C:T
NC_012920.1(MT-CYB):m.5605A>G	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689955	MT	5605	MT	5605	689955	677792	rs878963919	NC_012920.1:5604:A:G
NC_012920.1(MT-CYB):m.5607T>C	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689956	MT	5607	MT	5607	689956	677793	rs1603220054	NC_012920.1:5606:T:C
NC_012920.1(MT-CYB):m.5608C>T	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689957	MT	5608	MT	5608	689957	677794	rs1603220057	NC_012920.1:5607:C:T
NC_012920.1(MT-CYB):m.5609T>C	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689958	MT	5609	MT	5609	689958	677795	rs1603220058	NC_012920.1:5608:T:C
NC_012920.1:m.5610G>A	MT-TA		Inborn mitochondrial myopathy	Pathogenic(Last reviewed: Dec 15, 2014)	no assertion criteria provided	VCV000162370	MT	5610	MT	5610	162370	172075	rs786200951	NC_012920.1:5609:G:A
NC_012920.1(MT-CYB):m.5618T>C	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689959	MT	5618	MT	5618	689959	677796	rs1603220060	NC_012920.1:5617:T:C
NC_012920.1(MT-CYB):m.5619G>A	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689960	MT	5619	MT	5619	689960	677797	rs1603220062	NC_012920.1:5618:G:A
NC_012920.1(MT-CYB):m.5628T>C	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689961	MT	5628	MT	5628	689961	677798	rs1556423015	NC_012920.1:5627:T:C
NC_012920.1:m.5631G>A	MT-TA		Inborn mitochondrial myopathy	Pathogenic(Last reviewed: Dec 15, 2014)	no assertion criteria provided	VCV000162369	MT	5631	MT	5631	162369	172076	rs786200950	NC_012920.1:5630:G:A
NC_012920.1(MT-CYB):m.5633C>T	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689962	MT	5633	MT	5633	689962	677799	rs879226228	NC_012920.1:5632:C:T
NC_012920.1(MT-CYB):m.5640A>G	MT-TA		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689963	MT	5640	MT	5640	689963	677800	rs1603220065	NC_012920.1:5639:A:G
NC_012920.1(MT-CYB):m.5645G>A	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689964	MT	5645	MT	5645	689964	677801	rs1603220068	NC_012920.1:5644:G:A
m.5650G>A	MT-TA		Myotonic dystrophy-like myopathy	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000009624	MT	5650	MT	5650	9624	24663	rs121434457	NC_012920.1:5649:G:A
NC_012920.1(MT-CYB):m.5654T>C	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689965	MT	5654	MT	5654	689965	677802	rs1603220072	NC_012920.1:5653:T:C
NC_012920.1(MT-CYB):m.5655T>C	MT-TA		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689966	MT	5655	MT	5655	689966	677803	rs1556423019	NC_012920.1:5654:T:C
NC_012920.1(MT-CYB):m.5661A>G	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689967	MT	5661	MT	5661	689967	677804	rs1603220076	NC_012920.1:5660:A:G
NC_012920.1(MT-CYB):m.5662C>T	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689968	MT	5662	MT	5662	689968	677805	rs1603220078	NC_012920.1:5661:C:T
NC_012920.1(MT-CYB):m.5663C>T	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689969	MT	5663	MT	5663	689969	677806	rs1553139251	NC_012920.1:5662:C:T
NC_012920.1(MT-CYB):m.5664A>G	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689970	MT	5664	MT	5664	689970	677807	rs1603220079	NC_012920.1:5663:A:G
NC_012920.1(MT-CYB):m.5665A>G	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689971	MT	5665	MT	5665	689971	677808	rs1603220080	NC_012920.1:5664:A:G
NC_012920.1:m.5667G>A	MT-TN		External ophthalmoplegia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000560167	MT	5667	MT	5667	560167	550883	rs1569484022	NC_012920.1:5666:G:A
NC_012920.1(MT-CYB):m.5669G>A	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689972	MT	5669	MT	5669	689972	677809	rs1603220083	NC_012920.1:5668:G:A
NC_012920.1(MT-CYB):m.5672T>C	MT-TN		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689973	MT	5672	MT	5672	689973	677810	rs1603220085	NC_012920.1:5671:T:C
NC_012920.1(MT-CYB):m.5673T>C	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689974	MT	5673	MT	5673	689974	677811	rs386828975	NC_012920.1:5672:T:C
NC_012920.1(MT-CYB):m.5686A>T	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689975	MT	5686	MT	5686	689975	677812	rs1603220088	NC_012920.1:5685:A:T
m.5692T>C	MT-TN		Ophthalmoplegia, isolated	Pathogenic(Last reviewed: Oct 28, 1994)	no assertion criteria provided	VCV000009621	MT	5692	MT	5692	9621	24660	rs199476131	NC_012920.1:5691:T:C
NC_012920.1(MT-CYB):m.5693T>C	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689976	MT	5693	MT	5693	689976	677813	rs1603220092	NC_012920.1:5692:T:C
NC_012920.1:m.5702A>G	MT-TN		Ptosis|External ophthalmoplegia	Likely pathogenic(Last reviewed: Jan 24, 2020)	no assertion criteria provided	VCV000812543	MT	5702	MT	5702	812543	800785	rs1603220093	NC_012920.1:5701:A:G
m.5703G>A	MT-TN		Ophthalmoplegia, isolated	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000009620	MT	5703	MT	5703	9620	24659	rs199476130	NC_012920.1:5702:G:A
NC_012920.1(MT-CYB):m.5705A>G	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689977	MT	5705	MT	5705	689977	677814	rs1556423024	NC_012920.1:5704:A:G
NC_012920.1(MT-CYB):m.5708C>A	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689978	MT	5708	MT	5708	689978	677815	rs1603220094	NC_012920.1:5707:C:A
NC_012920.1(MT-CYB):m.5711A>G	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689979	MT	5711	MT	5711	689979	677816	rs2854138	NC_012920.1:5710:A:G
NC_012920.1(MT-CYB):m.5715A>G	MT-TN		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689980	MT	5715	MT	5715	689980	677817	rs1603220096	NC_012920.1:5714:A:G
m.5728T>C	MT-TN		MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Cytochrome-c oxidase deficiency disease	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009622	MT	5728	MT	5728	9622	24661	rs199476132	NC_012920.1:5727:T:C
NC_012920.1(MT-CYB):m.5772G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689981	MT	5772	MT	5772	689981	677818	rs1556423031	NC_012920.1:5771:G:A
NC_012920.1(MT-CYB):m.5773G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689982	MT	5773	MT	5773	689982	677819	rs9659239	NC_012920.1:5772:G:A
NC_012920.1(MT-CYB):m.5774T>G	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689984	MT	5774	MT	5774	689984	677821	rs1603220102	NC_012920.1:5773:T:G
NC_012920.1(MT-CYB):m.5774T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689983	MT	5774	MT	5774	689983	677820	rs1603220102	NC_012920.1:5773:T:C
NC_012920.1(MT-CYB):m.5775T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689985	MT	5775	MT	5775	689985	677822	rs1603220105	NC_012920.1:5774:T:C
NC_012920.1(MT-CYB):m.5780G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689986	MT	5780	MT	5780	689986	677823	rs878999194	NC_012920.1:5779:G:A
NC_012920.1(MT-CYB):m.5783G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689987	MT	5783	MT	5783	689987	677825	rs1603220110	NC_012920.1:5782:G:A
NC_012920.1(MT-CYB):m.5785T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689988	MT	5785	MT	5785	689988	677826	rs373493739	NC_012920.1:5784:T:C
NC_012920.1(MT-CYB):m.5786T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689989	MT	5786	MT	5786	689989	677828	rs1603220117	NC_012920.1:5785:T:C
NC_012920.1(MT-CYB):m.5788T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689991	MT	5788	MT	5788	689991	677829	rs1556423033	NC_012920.1:5787:T:C
NC_012920.1(MT-CYB):m.5791G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689992	MT	5791	MT	5791	689992	677831	rs1603220121	NC_012920.1:5790:G:A
NC_012920.1(MT-CYB):m.5793A>G	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689993	MT	5793	MT	5793	689993	677832	rs1603220122	NC_012920.1:5792:A:G
NC_012920.1(MT-CYB):m.5794T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689994	MT	5794	MT	5794	689994	677833	rs1556423035	NC_012920.1:5793:T:C
NC_012920.1(MT-CYB):m.5800A>G	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689995	MT	5800	MT	5800	689995	677834	rs1603220125	NC_012920.1:5799:A:G
NC_012920.1(MT-CYB):m.5802T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689996	MT	5802	MT	5802	689996	677835	rs1603220128	NC_012920.1:5801:T:C
NC_012920.1(MT-CYB):m.5804A>G	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689997	MT	5804	MT	5804	689997	677836	rs1603220130	NC_012920.1:5803:A:G
NC_012920.1(MT-CYB):m.5806T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689998	MT	5806	MT	5806	689998	677837	rs879211572	NC_012920.1:5805:T:C
NC_012920.1(MT-CYB):m.5807A>G	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000689999	MT	5807	MT	5807	689999	677838	rs386828978	NC_012920.1:5806:A:G
NC_012920.1(MT-CYB):m.5809G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690000	MT	5809	MT	5809	690000	677839	rs1603220134	NC_012920.1:5808:G:A
NC_012920.1(MT-CYB):m.5811A>G	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690001	MT	5811	MT	5811	690001	677840	rs1603220136	NC_012920.1:5810:A:G
NC_012920.1(MT-CYB):m.5814T>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690002	MT	5814	MT	5814	690002	677841	rs200077222	NC_012920.1:5813:T:A
m.5814T>C	MT-TC		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000030001	MT	5814	MT	5814	30001	38956	rs200077222	NC_012920.1:5813:T:C
m.5816A>G	MT-TC		Dystonia, mitochondrial	Pathogenic(Last reviewed: Aug 28, 2007)	no assertion criteria provided	VCV000030002	MT	5816	MT	5816	30002	38957	rs387906732	NC_012920.1:5815:A:G
NC_012920.1(MT-CYB):m.5817C>T	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690003	MT	5817	MT	5817	690003	677842	rs1603220138	NC_012920.1:5816:C:T
NC_012920.1(MT-CYB):m.5819T>C	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690004	MT	5819	MT	5819	690004	677843	rs1603220139	NC_012920.1:5818:T:C
NC_012920.1(MT-CYB):m.5821G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690005	MT	5821	MT	5821	690005	677844	rs56133209	NC_012920.1:5820:G:A
NC_012920.1(MT-CYB):m.5822G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690006	MT	5822	MT	5822	690006	677845	rs1556423041	NC_012920.1:5821:G:A
NC_012920.1(MT-CYB):m.5823A>G	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690007	MT	5823	MT	5823	690007	677846	rs878875817	NC_012920.1:5822:A:G
NC_012920.1(MT-CYB):m.5824G>A	MT-TC		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690008	MT	5824	MT	5824	690008	677847	rs879140945	NC_012920.1:5823:G:A
NC_012920.1(MT-CYB):m.5836A>G	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690009	MT	5836	MT	5836	690009	677848	rs386828979	NC_012920.1:5835:A:G
NC_012920.1(MT-CYB):m.5837G>A	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690010	MT	5837	MT	5837	690010	677849	rs1603220147	NC_012920.1:5836:G:A
NC_012920.1(MT-CYB):m.5839C>T	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690011	MT	5839	MT	5839	690011	677850	rs1603220148	NC_012920.1:5838:C:T
NC_012920.1(MT-CYB):m.5840C>T	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690013	MT	5840	MT	5840	690013	677852	rs1603220149	NC_012920.1:5839:C:T
NC_012920.1(MT-CYB):m.5840C>A	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690012	MT	5840	MT	5840	690012	677851	rs1603220149	NC_012920.1:5839:C:A
NC_012920.1(MT-CYB):m.5841T>C	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690014	MT	5841	MT	5841	690014	677853	rs1603220150	NC_012920.1:5840:T:C
m.5843A>G	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Focal segmental glomerulosclerosis and dilated cardiomyopathy	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009553	MT	5843	MT	5843	9553	24592	rs118203894	NC_012920.1:5842:A:G
NC_012920.1(MT-CYB):m.5846C>T	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690015	MT	5846	MT	5846	690015	677854	rs1603220152	NC_012920.1:5845:C:T
NC_012920.1(MT-CYB):m.5852T>C	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690016	MT	5852	MT	5852	690016	677855	rs1603220153	NC_012920.1:5851:T:C
NC_012920.1(MT-CYB):m.5855A>G	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690017	MT	5855	MT	5855	690017	677856	rs1603220155	NC_012920.1:5854:A:G
NC_012920.1(MT-CYB):m.5858T>C	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690018	MT	5858	MT	5858	690018	677857	rs1603220157	NC_012920.1:5857:T:C
NC_012920.1(MT-CYB):m.5864G>A	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690019	MT	5864	MT	5864	690019	677858	rs1603220158	NC_012920.1:5863:G:A
NC_012920.1(MT-CYB):m.5865T>C	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690020	MT	5865	MT	5865	690020	677859	rs1603220159	NC_012920.1:5864:T:C
NC_012920.1(MT-CYB):m.5867C>T	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690021	MT	5867	MT	5867	690021	677860	rs1603220160	NC_012920.1:5866:C:T
m.5874T>C	MT-TY		Exercise intolerance and complex III deficiency, somatic|not provided	Pathogenic(Last reviewed: Oct 24, 2000)	no assertion criteria provided	VCV000009550	MT	5874	MT	5874	9550	24589	rs118203891	NC_012920.1:5873:T:C
NC_012920.1(MT-CYB):m.5875C>T	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690022	MT	5875	MT	5875	690022	677861	rs1603220162	NC_012920.1:5874:C:T
NC_012920.1(MT-CYB):m.5876A>G	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690023	MT	5876	MT	5876	690023	677862	rs1603220163	NC_012920.1:5875:A:G
m.5877C>T	MT-TY		Kearns-Sayre syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000009552	MT	5877	MT	5877	9552	24591	rs118203893	NC_012920.1:5876:C:T
NC_012920.1(MT-CYB):m.5885T>C	MT-TY		See cases|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000690024	MT	5885	MT	5885	690024	677864	rs1603220164	NC_012920.1:5884:T:C
NC_012920.1(MT-CYB):m.5889A>G	MT-TY		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690025	MT	5889	MT	5889	690025	677865	rs1603220167	NC_012920.1:5888:A:G
NC_012920.1:m.5907T>C	MT-CO1	F2L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692598	MT	5907	MT	5907	692598	681134	rs1603220176	NC_012920.1:5906:T:C
NC_012920.1:m.5910G>A	MT-CO1	A3T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692599	MT	5910	MT	5910	692599	681135	rs1603220177	NC_012920.1:5909:G:A
NC_012920.1:m.5911C>T	MT-CO1	A3V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692600	MT	5911	MT	5911	692600	681136	rs879227822	NC_012920.1:5910:C:T
NC_012920.1:m.5913G>A	MT-CO1	D4N	not specified|Leigh syndrome	Benign(Last reviewed: Jul 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000692601	MT	5913	MT	5913	692601	681137	rs201617272	NC_012920.1:5912:G:A
NC_012920.1:m.5918T>C	MT-CO1		not provided	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000805023	MT	5918	MT	5918	805023	793912	rs1556423045	NC_012920.1:5917:T:C
m.5920G>A	MT-CO1	W6*	Myoglobinuria, recurrent	Pathogenic(Last reviewed: Sep 12, 2000)	no assertion criteria provided	VCV000009669	MT	5920	MT	5920	9669	24708	rs199476129	NC_012920.1:5919:G:A
NC_012920.1:m.5951A>G	MT-CO1		not provided	Benign/Likely benign(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235783	MT	5951	MT	5951	235783	237462	rs7340122	NC_012920.1:5950:A:G
NC_012920.1:m.5961C>A	MT-CO1	L20M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692602	MT	5961	MT	5961	692602	681138	rs1603220201	NC_012920.1:5960:C:A
NC_012920.1:m.5973G>A	MT-CO1	A24T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692603	MT	5973	MT	5973	692603	681139	rs1556423059	NC_012920.1:5972:G:A
NC_012920.1:m.5979G>A	MT-CO1	A26T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692604	MT	5979	MT	5979	692604	681140	rs1556423060	NC_012920.1:5978:G:A
NC_012920.1:m.5985G>A	MT-CO1	V28I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692605	MT	5985	MT	5985	692605	681141	rs386828982	NC_012920.1:5984:G:A
NC_012920.1:m.5999T>C	MT-CO1		not specified	Benign(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV000994642	MT	5999	MT	5999	994642	983277	rs879118820	NC_012920.1:5998:T:C
NC_012920.1:m.6012A>G	MT-CO1	I37V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692606	MT	6012	MT	6012	692606	681142	rs1603220222	NC_012920.1:6011:A:G
NC_012920.1:m.6018G>A	MT-CO1	A39T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692607	MT	6018	MT	6018	692607	681143	rs1603220225	NC_012920.1:6017:G:A
NC_012920.1:m.6026G>A	MT-CO1		not provided	Benign(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000805024	MT	6026	MT	6026	805024	793913	rs879112886	NC_012920.1:6025:G:A
NC_012920.1:m.6037G>A	MT-CO1	G45D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692608	MT	6037	MT	6037	692608	681144	rs1603220237	NC_012920.1:6036:G:A
NC_012920.1:m.6040A>G	MT-CO1	N46S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692609	MT	6040	MT	6040	692609	681145	rs1556423072	NC_012920.1:6039:A:G
NC_012920.1:m.6047A>G	MT-CO1		not specified	Benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000994643	MT	6047	MT	6047	994643	983278	rs879104796	NC_012920.1:6046:A:G
NC_012920.1:m.6048G>A	MT-CO1	G49S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692610	MT	6048	MT	6048	692610	681146	rs1603220242	NC_012920.1:6047:G:A
NC_012920.1:m.6052A>G	MT-CO1	N50S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692611	MT	6052	MT	6052	692611	681147	rs1603220245	NC_012920.1:6051:A:G
NC_012920.1:m.6054G>A	MT-CO1	D51N	not provided	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000618721	MT	6054	MT	6054	618721	610275	rs1569484049	NC_012920.1:6053:G:A
NC_012920.1:m.6060A>G	MT-CO1	I53V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692613	MT	6060	MT	6060	692613	681149	rs1603220250	NC_012920.1:6059:A:G
NC_012920.1:m.6060A>C	MT-CO1	I53L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692612	MT	6060	MT	6060	692612	681148	rs1603220250	NC_012920.1:6059:A:C
NC_012920.1:m.6061T>C	MT-CO1	I53T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692614	MT	6061	MT	6061	692614	681150	rs1603220252	NC_012920.1:6060:T:C
NC_012920.1:m.6071T>C	MT-CO1		not provided	Benign/Likely benign(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235696	MT	6071	MT	6071	235696	237376	rs7340086	NC_012920.1:6070:T:C
NC_012920.1:m.6072A>G	MT-CO1	I57V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692615	MT	6072	MT	6072	692615	681151	rs1556423078	NC_012920.1:6071:A:G
NC_012920.1:m.6075G>A	MT-CO1	V58I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692616	MT	6075	MT	6075	692616	681152	rs1603220260	NC_012920.1:6074:G:A
NC_012920.1:m.6081G>T	MT-CO1	A60S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692618	MT	6081	MT	6081	692618	681154	rs1603220261	NC_012920.1:6080:G:T
NC_012920.1:m.6081G>A	MT-CO1	A60T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692617	MT	6081	MT	6081	692617	681153	rs1603220261	NC_012920.1:6080:G:A
NC_012920.1:m.6093G>A	MT-CO1	V64M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692619	MT	6093	MT	6093	692619	681155	rs1603220271	NC_012920.1:6092:G:A
NC_012920.1:m.6109T>C	MT-CO1	M69T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692620	MT	6109	MT	6109	692620	681156	rs1603220275	NC_012920.1:6108:T:C
NC_012920.1(MT-CO1):m.6120A>G	MT-CO1	I73V	Leigh syndrome|not provided	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235378	MT	6120	MT	6120	235378	237064	rs878853023	NC_012920.1:6119:A:G
NC_012920.1:m.6121T>C	MT-CO1	I73T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692621	MT	6121	MT	6121	692621	681157	rs1603220280	NC_012920.1:6120:T:C
NC_012920.1:m.6126A>G	MT-CO1	I75V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692622	MT	6126	MT	6126	692622	681158	rs1556423082	NC_012920.1:6125:A:G
NC_012920.1:m.6132G>A	MT-CO1	G77S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692623	MT	6132	MT	6132	692623	681159	rs1603220289	NC_012920.1:6131:G:A
NC_012920.1:m.6145G>A	MT-CO1	W81*	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692624	MT	6145	MT	6145	692624	681160	rs1603220294	NC_012920.1:6144:G:A
NC_012920.1:m.6150G>A	MT-CO1	V83I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692625	MT	6150	MT	6150	692625	681161	rs879053914	NC_012920.1:6149:G:A
NC_012920.1:m.6174G>A	MT-CO1	D91N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692626	MT	6174	MT	6174	692626	681162	rs1603220303	NC_012920.1:6173:G:A
NC_012920.1:m.6228C>T	MT-CO1	L109F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692627	MT	6228	MT	6228	692627	681163	rs1603220332	NC_012920.1:6227:C:T
NC_012920.1:m.6237C>A	MT-CO1	L112M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692628	MT	6237	MT	6237	692628	681164	rs1603220344	NC_012920.1:6236:C:A
NC_012920.1:m.6249G>A	MT-CO1	A116T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692629	MT	6249	MT	6249	692629	681165	rs1556423095	NC_012920.1:6248:G:A
NC_012920.1:m.6252A>G	MT-CO1	M117V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692630	MT	6252	MT	6252	692630	681166	rs878927119	NC_012920.1:6251:A:G
NC_012920.1:m.6253T>C	MT-CO1	M117T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692631	MT	6253	MT	6253	692631	681167	rs200165736	NC_012920.1:6252:T:C
NC_012920.1:m.6254A>G	MT-CO1		not provided	Likely benign(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV000994644	MT	6254	MT	6254	994644	983279	rs1603220367	NC_012920.1:6253:A:G
NC_012920.1:m.6258G>A	MT-CO1	E119K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692632	MT	6258	MT	6258	692632	681168	rs1603220372	NC_012920.1:6257:G:A
NC_012920.1(MT-CO1):m.6260G>A	MT-CO1		not provided	Benign/Likely benign(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235511	MT	6260	MT	6260	235511	237192	rs201395766	NC_012920.1:6259:G:A
NC_012920.1(MT-CO1):m.6261G>A	MT-CO1	A120T	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235718	MT	6261	MT	6261	235718	237398	rs201262114	NC_012920.1:6260:G:A
m.6264G>A	MT-CO1	G121*	Leigh syndrome|Familial colorectal cancer	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009667	MT	6264	MT	6264	9667	24706	rs267606882	NC_012920.1:6263:G:A
NC_012920.1:m.6267G>A	MT-CO1	A122T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692633	MT	6267	MT	6267	692633	681169	rs202216551	NC_012920.1:6266:G:A
NC_012920.1:m.6273A>G	MT-CO1	T124A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692634	MT	6273	MT	6273	692634	681170	rs1603220381	NC_012920.1:6272:A:G
m.6277G>A	MT-CO1	G125D	Familial colorectal cancer	Pathogenic(Last reviewed: Mar 3, 2009)	no assertion criteria provided	VCV000009672	MT	6277	MT	6277	9672	24711	rs281865417	NC_012920.1:6276:G:A
NC_012920.1:m.6278T>C	MT-CO1		not provided	Likely benign(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000446007	MT	6278	MT	6278	446007	439279	rs1556423104	NC_012920.1:6277:T:C
NC_012920.1:m.6285G>A	MT-CO1	V128I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692635	MT	6285	MT	6285	692635	681171	rs878947044	NC_012920.1:6284:G:A
NC_012920.1:m.6286T>C	MT-CO1	V128A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692636	MT	6286	MT	6286	692636	681172	rs1603220392	NC_012920.1:6285:T:C
NC_012920.1:m.6289A>G	MT-CO1	Y129C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692637	MT	6289	MT	6289	692637	681173	rs1603220395	NC_012920.1:6288:A:G
NC_012920.1:m.6299A>G	MT-CO1		not provided	Uncertain significance(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000377327	MT	6299	MT	6299	377327	364205	rs1057520195	NC_012920.1:6298:A:G
NC_012920.1:m.6307A>G	MT-CO1	N135S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692638	MT	6307	MT	6307	692638	681174	rs1603220406	NC_012920.1:6306:A:G
NC_012920.1:m.6324G>A	MT-CO1	A141T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692639	MT	6324	MT	6324	692639	681175	rs1603220417	NC_012920.1:6323:G:A
m.6328C>T	MT-CO1	S142F	Cytochrome c oxidase i deficiency	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000009671	MT	6328	MT	6328	9671	24710	rs267606883	NC_012920.1:6327:C:T
NC_012920.1:m.6339A>G	MT-CO1	T146A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692640	MT	6339	MT	6339	692640	681176	rs1556423119	NC_012920.1:6338:A:G
NC_012920.1:m.6340C>T	MT-CO1	T146I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692641	MT	6340	MT	6340	692641	681177	rs1603220429	NC_012920.1:6339:C:T
NC_012920.1:m.6345T>C	MT-CO1	F148L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692642	MT	6345	MT	6345	692642	681178	rs1556423121	NC_012920.1:6344:T:C
NC_012920.1:m.6353A>G	MT-CO1		not provided	Benign(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000805025	MT	6353	MT	6353	805025	793914	rs1603220438	NC_012920.1:6352:A:G
NC_012920.1:m.6358T>C	MT-CO1	L152P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692643	MT	6358	MT	6358	692643	681179	rs1603220439	NC_012920.1:6357:T:C
NC_012920.1:m.6366G>C	MT-CO1	V155L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692645	MT	6366	MT	6366	692645	681181	rs370673798	NC_012920.1:6365:G:C
NC_012920.1:m.6366G>A	MT-CO1	V155I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692644	MT	6366	MT	6366	692644	681180	rs370673798	NC_012920.1:6365:G:A
NC_012920.1:m.6367T>C	MT-CO1	V155A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692646	MT	6367	MT	6367	692646	681182	rs1603220442	NC_012920.1:6366:T:C
NC_012920.1:m.6393T>C	MT-CO1	F164L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692647	MT	6393	MT	6393	692647	681183	rs879212050	NC_012920.1:6392:T:C
NC_012920.1:m.6420C>A	MT-CO1	P173T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692648	MT	6420	MT	6420	692648	681184	rs1603220466	NC_012920.1:6419:C:A
NC_012920.1:m.6445C>T	MT-CO1	T181M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692649	MT	6445	MT	6445	692649	681185	rs879164161	NC_012920.1:6444:C:T
NC_012920.1:m.6446G>A	MT-CO1		not provided	Benign(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000805026	MT	6446	MT	6446	805026	793915	rs386420010	NC_012920.1:6445:G:A
NC_012920.1:m.6456G>A	MT-CO1	V185I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692650	MT	6456	MT	6456	692650	681186	rs1603220483	NC_012920.1:6455:G:A
NC_012920.1:m.6465G>A	MT-CO1	V188I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692651	MT	6465	MT	6465	692651	681187	rs28414181	NC_012920.1:6464:G:A
m.6480G>A	MT-CO1	V193I	Leigh syndrome|Cytochrome-c oxidase deficiency disease	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009666	MT	6480	MT	6480	9666	24705	rs199476128	NC_012920.1:6479:G:A
NC_012920.1:m.6481T>C	MT-CO1	V193A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692652	MT	6481	MT	6481	692652	681188	rs28721398	NC_012920.1:6480:T:C
m.6489C>A	MT-CO1	L196I	Cytochrome c oxidase i deficiency|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009670	MT	6489	MT	6489	9670	24709	rs28461189	NC_012920.1:6488:C:A
NC_012920.1:m.6497T>C	MT-CO1		not specified	Benign(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV000994645	MT	6497	MT	6497	994645	983280	rs1556423143	NC_012920.1:6496:T:C
NC_012920.1:m.6504G>A	MT-CO1	V201I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692653	MT	6504	MT	6504	692653	681189	rs1603220512	NC_012920.1:6503:G:A
NC_012920.1:m.6505T>C	MT-CO1	V201A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692654	MT	6505	MT	6505	692654	681190	rs28371932	NC_012920.1:6504:T:C
NC_012920.1:m.6510G>A	MT-CO1	A203T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692655	MT	6510	MT	6510	692655	681191	rs1603220518	NC_012920.1:6509:G:A
NC_012920.1:m.6520T>C	MT-CO1	I206T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692656	MT	6520	MT	6520	692656	681192	rs1603220520	NC_012920.1:6519:T:C
NC_012920.1:m.6526T>C	MT-CO1	M208T	Leigh syndrome	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692657	MT	6526	MT	6526	692657	681193	rs1603220522	NC_012920.1:6525:T:C
NC_012920.1:m.6546C>T	MT-CO1	L215F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692658	MT	6546	MT	6546	692658	681194	rs1603220531	NC_012920.1:6545:C:T
NC_012920.1:m.6550A>G	MT-CO1	N216S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692659	MT	6550	MT	6550	692659	681195	rs1603220532	NC_012920.1:6549:A:G
NC_012920.1:m.6554C>T	MT-CO1		not provided	Uncertain significance(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000235548	MT	6554	MT	6554	235548	237229	rs878853064	NC_012920.1:6553:C:T
NC_012920.1:m.6564G>A	MT-CO1	D221N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692660	MT	6564	MT	6564	692660	681196	rs1603220535	NC_012920.1:6563:G:A
NC_012920.1:m.6570G>T	MT-CO1	A223S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692661	MT	6570	MT	6570	692661	681197	rs386828988	NC_012920.1:6569:G:T
NC_012920.1:m.6626T>C	MT-CO1		not provided	Likely benign(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000805027	MT	6626	MT	6626	805027	793916	rs1556423161	NC_012920.1:6625:T:C
NC_012920.1:m.6642A>G	MT-CO1	I247V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692662	MT	6642	MT	6642	692662	681198	rs1603220559	NC_012920.1:6641:A:G
NC_012920.1:m.6663A>G	MT-CO1	I254V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692663	MT	6663	MT	6663	692663	681199	rs200784106	NC_012920.1:6662:A:G
NC_012920.1:m.6664T>C	MT-CO1	I254T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692664	MT	6664	MT	6664	692664	681200	rs1603220567	NC_012920.1:6663:T:C
NC_012920.1:m.6671T>C	MT-CO1		not provided	Benign(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000805028	MT	6671	MT	6671	805028	793918	rs1978028	NC_012920.1:6670:T:C
NC_012920.1:m.6674T>C	MT-CO1		not provided	Likely benign(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000376859	MT	6674	MT	6674	376859	363737	rs878895466	NC_012920.1:6673:T:C
NC_012920.1:m.6681T>C	MT-CO1	Y260H	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692665	MT	6681	MT	6681	692665	681201	rs879180101	NC_012920.1:6680:T:C
NC_012920.1:m.6709G>A	MT-CO1	G269E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692666	MT	6709	MT	6709	692666	681202	rs1603220583	NC_012920.1:6708:G:A
NC_012920.1:m.6712A>T	MT-CO1	Y270F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692667	MT	6712	MT	6712	692667	681203	rs1603220586	NC_012920.1:6711:A:T
NC_012920.1:m.6713C>T	MT-CO1		not provided	Benign(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000805029	MT	6713	MT	6713	805029	793919	rs1569484102	NC_012920.1:6712:C:T
NC_012920.1:m.6714A>G	MT-CO1	M271V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692668	MT	6714	MT	6714	692668	681204	rs1603220588	NC_012920.1:6713:A:G
NC_012920.1:m.6719T>C	MT-CO1		not provided	Likely benign(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000235489	MT	6719	MT	6719	235489	237171	rs28358872	NC_012920.1:6718:T:C
m.6721T>C	MT-CO1	M273T	Acquired idiopathic sideroblastic anemia	Pathogenic(Last reviewed: Dec 15, 1997)	no assertion criteria provided	VCV000009665	MT	6721	MT	6721	9665	24704	rs199476127	NC_012920.1:6720:T:C
NC_012920.1:m.6723G>A	MT-CO1	V274I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692669	MT	6723	MT	6723	692669	681205	rs1603220595	NC_012920.1:6722:G:A
NC_012920.1(MT-CO1):m.6734G>A	MT-CO1		not provided	Benign(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235522	MT	6734	MT	6734	235522	237203	rs41413745	NC_012920.1:6733:G:A
m.6742T>C	MT-CO1	I280T	Acquired idiopathic sideroblastic anemia	Pathogenic(Last reviewed: Dec 15, 1997)	no assertion criteria provided	VCV000009664	MT	6742	MT	6742	9664	24703	rs199476126	NC_012920.1:6741:T:C
NC_012920.1:m.6747T>C	MT-CO1	F282L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692670	MT	6747	MT	6747	692670	681206	rs1603220609	NC_012920.1:6746:T:C
NC_012920.1:m.6748T>C	MT-CO1	F282S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692671	MT	6748	MT	6748	692671	681207	rs1556423171	NC_012920.1:6747:T:C
NC_012920.1:m.6756T>C	MT-CO1	F285L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692672	MT	6756	MT	6756	692672	681208	rs1603220617	NC_012920.1:6755:T:C
NC_012920.1:m.6776T>C	MT-CO1		not provided	Benign(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000805030	MT	6776	MT	6776	805030	793920	rs41473545	NC_012920.1:6775:T:C
NC_012920.1:m.6781T>C	MT-CO1	F293S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692673	MT	6781	MT	6781	692673	681209	rs1603220626	NC_012920.1:6780:T:C
NC_012920.1:m.6844T>C	MT-CO1	I314T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692674	MT	6844	MT	6844	692674	681210	rs1603220647	NC_012920.1:6843:T:C
NC_012920.1:m.6852G>A	MT-CO1	G317S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692675	MT	6852	MT	6852	692675	681211	rs1603220651	NC_012920.1:6851:G:A
NC_012920.1:m.6855G>A	MT-CO1	V318I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692676	MT	6855	MT	6855	692676	681212	rs1603220653	NC_012920.1:6854:G:A
NC_012920.1:m.6856T>C	MT-CO1	V318A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692677	MT	6856	MT	6856	692677	681213	rs1603220654	NC_012920.1:6855:T:C
NC_012920.1:m.6868G>A	MT-CO1	S322N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692678	MT	6868	MT	6868	692678	681214	rs1603220657	NC_012920.1:6867:G:A
NC_012920.1:m.6876G>A	MT-CO1	A325T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692679	MT	6876	MT	6876	692679	681215	rs1603220659	NC_012920.1:6875:G:A
NC_012920.1:m.6891A>G	MT-CO1	S330G	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692680	MT	6891	MT	6891	692680	681216	rs879091068	NC_012920.1:6890:A:G
NC_012920.1:m.6896T>C	MT-CO1		not provided	Likely benign(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000805031	MT	6896	MT	6896	805031	793921	rs1603220671	NC_012920.1:6895:T:C
NC_012920.1:m.6897A>G	MT-CO1	M332V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692681	MT	6897	MT	6897	692681	681217	rs1603220675	NC_012920.1:6896:A:G
NC_012920.1:m.6899G>C	MT-CO1	M332I	not provided	Uncertain significance(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000805032	MT	6899	MT	6899	805032	793922	rs1556423194	NC_012920.1:6898:G:C
NC_012920.1:m.6909G>A	MT-CO1	A336T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692682	MT	6909	MT	6909	692682	681218	rs1603220684	NC_012920.1:6908:G:A
NC_012920.1:m.6911T>C	MT-CO1		not provided	Benign(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000805033	MT	6911	MT	6911	805033	793923	rs1556423196	NC_012920.1:6910:T:C
NC_012920.1:m.6912G>A	MT-CO1	A337T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692683	MT	6912	MT	6912	692683	681219	rs1603220686	NC_012920.1:6911:G:A
NC_012920.1:m.6915G>A	MT-CO1	V338M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692684	MT	6915	MT	6915	692684	681220	rs1603220687	NC_012920.1:6914:G:A
NC_012920.1:m.6916T>C	MT-CO1	V338A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692685	MT	6916	MT	6916	692685	681221	rs1603220688	NC_012920.1:6915:T:C
NC_012920.1:m.6924G>A	MT-CO1	A341T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692686	MT	6924	MT	6924	692686	681222	rs1603220692	NC_012920.1:6923:G:A
m.6930G>A	MT-CO1	G343*	Cytochrome-c oxidase deficiency disease	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000009668	MT	6930	MT	6930	9668	24707	rs28679680	NC_012920.1:6929:G:A
NC_012920.1:m.6951G>A	MT-CO1	V350M	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000692687	MT	6951	MT	6951	692687	681223	rs1603220711	NC_012920.1:6950:G:A
NC_012920.1:m.6972G>C	MT-CO1	V357L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692688	MT	6972	MT	6972	692688	681224	rs1603220724	NC_012920.1:6971:G:C
NC_012920.1:m.6978G>A	MT-CO1	A359T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692689	MT	6978	MT	6978	692689	681225	rs28451817	NC_012920.1:6977:G:A
NC_012920.1:m.6987T>G	MT-CO1	S362A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692690	MT	6987	MT	6987	692690	681226	rs1603220727	NC_012920.1:6986:T:G
NC_012920.1:m.7013G>A	MT-CO1		not provided	Benign(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000805034	MT	7013	MT	7013	805034	793924	rs1556423218	NC_012920.1:7012:G:A
NC_012920.1:m.7015A>G	MT-CO1	Y371C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692691	MT	7015	MT	7015	692691	681227	rs1603220734	NC_012920.1:7014:A:G
NC_012920.1:m.7020G>A	MT-CO1	V373I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692692	MT	7020	MT	7020	692692	681228	rs1603220735	NC_012920.1:7019:G:A
Single allele	MT-CO1		Mitochondrial disease	Benign(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV001676315	MT	7028	MT	7028	1676315	1667806		NC_012920.1:7027:C:T
NC_012920.1:m.7032T>C	MT-CO1	F377L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692693	MT	7032	MT	7032	692693	681229	rs1603220739	NC_012920.1:7031:T:C
NC_012920.1:m.7041G>A	MT-CO1	V380I	Mitochondrial DNA-related disorder|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000440983	MT	7041	MT	7041	440983	434700	rs1556423220	NC_012920.1:7040:G:A
NC_012920.1:m.7051T>C	MT-CO1	M383T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692694	MT	7051	MT	7051	692694	681230	rs1603220749	NC_012920.1:7050:T:C
NC_012920.1:m.7053G>A	MT-CO1	G384*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692695	MT	7053	MT	7053	692695	681231	rs1603220753	NC_012920.1:7052:G:A
NC_012920.1:m.7077G>A	MT-CO1	G392S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692696	MT	7077	MT	7077	692696	681232	rs1603220764	NC_012920.1:7076:G:A
NC_012920.1:m.7080T>C	MT-CO1	F393L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692697	MT	7080	MT	7080	692697	681233	rs1556423226	NC_012920.1:7079:T:C
NC_012920.1:m.7082C>A	MT-CO1	F393L	External ophthalmoplegia	Likely benign(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000560166	MT	7082	MT	7082	560166	550882	rs1569484134	NC_012920.1:7081:C:A
NC_012920.1:m.7083A>G	MT-CO1	I394V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692698	MT	7083	MT	7083	692698	681234	rs1603220768	NC_012920.1:7082:A:G
NC_012920.1:m.7084T>C	MT-CO1	I394T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692699	MT	7084	MT	7084	692699	681235	rs28445709	NC_012920.1:7083:T:C
F397L	MT-CO1	F397L	Mitochondrial disease	Uncertain significance(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV001328511	MT	7092	MT	7092	1328511	1319160		NC_012920.1:7091:T:C
NC_012920.1:m.7119G>A	MT-CO1	D406N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692700	MT	7119	MT	7119	692700	681236	rs1556423235	NC_012920.1:7118:G:A
NC_012920.1:m.7125A>G	MT-CO1	T408A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692701	MT	7125	MT	7125	692701	681237	rs1603220786	NC_012920.1:7124:A:G
NC_012920.1:m.7129A>G	MT-CO1	Y409C	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692702	MT	7129	MT	7129	692702	681238	rs1603220788	NC_012920.1:7128:A:G
NC_012920.1:m.7138T>C	MT-CO1	I412T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692703	MT	7138	MT	7138	692703	681239	rs1603220794	NC_012920.1:7137:T:C
NC_012920.1:m.7146A>G	MT-CO1	T415A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692704	MT	7146	MT	7146	692704	681240	rs372136420	NC_012920.1:7145:A:G
NC_012920.1:m.7147C>T	MT-CO1	T415I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692706	MT	7147	MT	7147	692706	681242	rs1603220799	NC_012920.1:7146:C:T
NC_012920.1:m.7149A>G	MT-CO1	I416V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692707	MT	7149	MT	7149	692707	681243	rs1603220802	NC_012920.1:7148:A:G
NC_012920.1:m.7150T>C	MT-CO1	I416T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692708	MT	7150	MT	7150	692708	681244	rs1603220803	NC_012920.1:7149:T:C
NC_012920.1:m.7153T>C	MT-CO1	M417T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692709	MT	7153	MT	7153	692709	681245	rs1603220805	NC_012920.1:7152:T:C
NC_012920.1:m.7155T>C	MT-CO1	F418L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692710	MT	7155	MT	7155	692710	681246	rs1603220808	NC_012920.1:7154:T:C
NC_012920.1:m.7158A>C	MT-CO1	I419L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692712	MT	7158	MT	7158	692712	681247	rs878887002	NC_012920.1:7157:A:C
NC_012920.1:m.7158A>G	MT-CO1	I419V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692711	MT	7158	MT	7158	692711	681248	rs878887002	NC_012920.1:7157:A:G
NC_012920.1:m.7159T>C	MT-CO1	I419T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692713	MT	7159	MT	7159	692713	681249	rs3929989	NC_012920.1:7158:T:C
NC_012920.1:m.7168A>G	MT-CO1	N422S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692714	MT	7168	MT	7168	692714	681250	rs1603220812	NC_012920.1:7167:A:G
NC_012920.1(MT-CO1):m.7175T>C	MT-CO1		not provided	Benign(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235418	MT	7175	MT	7175	235418	237103	rs28358874	NC_012920.1:7174:T:C
NC_012920.1:m.7187A>T	MT-CO1	Q428H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692715	MT	7187	MT	7187	692715	681251	rs1603220823	NC_012920.1:7186:A:T
NC_012920.1:m.7191T>C	MT-CO1	F430L	not provided|Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692716	MT	7191	MT	7191	692716	681252	rs1603220824	NC_012920.1:7190:T:C
NC_012920.1:m.7196C>A	MT-CO1		not provided	Benign(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000805035	MT	7196	MT	7196	805035	793925	rs28358875	NC_012920.1:7195:C:A
NC_012920.1:m.7220T>C	MT-CO1		not provided	Likely benign(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000445535	MT	7220	MT	7220	445535	438807	rs1556423250	NC_012920.1:7219:T:C
NC_012920.1:m.7222A>G	MT-CO1	Y440C	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692717	MT	7222	MT	7222	692717	681253	rs1603220834	NC_012920.1:7221:A:G
NC_012920.1:m.7233C>T	MT-CO1	P444S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692718	MT	7233	MT	7233	692718	681254	rs1603220839	NC_012920.1:7232:C:T
NC_012920.1:m.7245A>G	MT-CO1	T448A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692719	MT	7245	MT	7245	692719	681255	rs1556423253	NC_012920.1:7244:A:G
NC_012920.1:m.7249C>T	MT-CO1	T449M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692720	MT	7249	MT	7249	692720	681256	rs1603220851	NC_012920.1:7248:C:T
NC_012920.1:m.7257A>G	MT-CO1	I452V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692721	MT	7257	MT	7257	692721	681257	rs1603220854	NC_012920.1:7256:A:G
NC_012920.1:m.7258T>C	MT-CO1	I452T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692722	MT	7258	MT	7258	692722	681258	rs1556423260	NC_012920.1:7257:T:C
NC_012920.1:m.7269G>A	MT-CO1	V456M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692723	MT	7269	MT	7269	692723	681259	rs386829004	NC_012920.1:7268:G:A
NC_012920.1:m.7270T>C	MT-CO1	V456A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692724	MT	7270	MT	7270	692724	681260	rs879002867	NC_012920.1:7269:T:C
NC_012920.1:m.7272G>A	MT-CO1	G457S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692725	MT	7272	MT	7272	692725	681261	rs28415137	NC_012920.1:7271:G:A
NC_012920.1:m.7274C>T	MT-CO1		not provided	Benign(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000805036	MT	7274	MT	7274	805036	793926	rs879089638	NC_012920.1:7273:C:T
m.7275T>C	MT-CO1	S458P	Familial colorectal cancer	Pathogenic(Last reviewed: Mar 3, 2009)	no assertion criteria provided	VCV000009673	MT	7275	MT	7275	9673	24712	rs267606884	NC_012920.1:7274:T:C
NC_012920.1:m.7278T>C	MT-CO1	F459L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692726	MT	7278	MT	7278	692726	681262	rs1556423264	NC_012920.1:7277:T:C
NC_012920.1:m.7279T>C	MT-CO1	F459S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692727	MT	7279	MT	7279	692727	681263	rs1603220861	NC_012920.1:7278:T:C
NC_012920.1:m.7284T>G	MT-CO1	S461A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692728	MT	7284	MT	7284	692728	681264	rs1603220868	NC_012920.1:7283:T:G
NC_012920.1:m.7290A>G	MT-CO1	T463A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692729	MT	7290	MT	7290	692729	681265	rs1603220870	NC_012920.1:7289:A:G
NC_012920.1:m.7299A>G	MT-CO1	M466V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692730	MT	7299	MT	7299	692730	681266	rs879071265	NC_012920.1:7298:A:G
NC_012920.1:m.7300T>C	MT-CO1	M466T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692731	MT	7300	MT	7300	692731	681267	rs1603220877	NC_012920.1:7299:T:C
NC_012920.1:m.7309T>C	MT-CO1	I469T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692732	MT	7309	MT	7309	692732	681268	rs1556423267	NC_012920.1:7308:T:C
NC_012920.1:m.7332G>A	MT-CO1	A477T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692733	MT	7332	MT	7332	692733	681269	rs1603220889	NC_012920.1:7331:G:A
NC_012920.1:m.7347G>A	MT-CO1	V482I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692734	MT	7347	MT	7347	692734	681270	rs1603220894	NC_012920.1:7346:G:A
NC_012920.1:m.7356G>A	MT-CO1	V485M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692735	MT	7356	MT	7356	692735	681271	rs1556423271	NC_012920.1:7355:G:A
NC_012920.1:m.7357T>C	MT-CO1	V485A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692736	MT	7357	MT	7357	692736	681272	rs1603220914	NC_012920.1:7356:T:C
NC_012920.1:m.7362G>A	MT-CO1	E487K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692737	MT	7362	MT	7362	692737	681273	rs1603220917	NC_012920.1:7361:G:A
NC_012920.1:m.7363A>G	MT-CO1	E487G	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692738	MT	7363	MT	7363	692738	681274	rs1603220918	NC_012920.1:7362:A:G
NC_012920.1:m.7365C>A	MT-CO1	P488T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692739	MT	7365	MT	7365	692739	681275	rs1603220919	NC_012920.1:7364:C:A
NC_012920.1:m.7373A>G	MT-CO1		Optic atrophy	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370048	MT	7373	MT	7373	370048	354301	rs1057516060	NC_012920.1:7372:A:G
NC_012920.1:m.7374A>G	MT-CO1	N491D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692740	MT	7374	MT	7374	692740	681276	rs1603220927	NC_012920.1:7373:A:G
NC_012920.1:m.7389T>C	MT-CO1	Y496H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692741	MT	7389	MT	7389	692741	681277	rs9783095	NC_012920.1:7388:T:C
NC_012920.1:m.7408A>G	MT-CO1	Y502C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692742	MT	7408	MT	7408	692742	681278	rs1603220949	NC_012920.1:7407:A:G
NC_012920.1:m.7419G>A	MT-CO1	E506K	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692743	MT	7419	MT	7419	692743	681279	rs1603220951	NC_012920.1:7418:G:A
NC_012920.1:m.7431T>C	MT-CO1	Y510H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692744	MT	7431	MT	7431	692744	681280	rs1603220957	NC_012920.1:7430:T:C
NC_012920.1:m.7432A>T	MT-CO1	Y510F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692745	MT	7432	MT	7432	692745	681281	rs1603220958	NC_012920.1:7431:A:T
NC_012920.1:m.7440T>G	MT-CO1	S513A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692747	MT	7440	MT	7440	692747	681283	rs1603220962	NC_012920.1:7439:T:G
NC_012920.1:m.7440T>C	MT-CO1	S513P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692746	MT	7440	MT	7440	692746	681282	rs1603220962	NC_012920.1:7439:T:C
NC_012920.1:m.7443A>G	MT-TS1|MT-CO1		Mitochondrial non-syndromic sensorineural hearing loss	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000040158	MT	7443	MT	7443	40158	48657	rs397507452	NC_012920.1:7442:A:G
NC_012920.1:m.7444G>A	MT-CO1|MT-TS1		not provided|Leigh syndrome|Leber optic atrophy|Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000009663	MT	7444	MT	7444	9663	24702	rs199474822	NC_012920.1:7443:G:A
NC_012920.1:m.7445A>T	MT-CO1|MT-TS1		Mitochondrial non-syndromic sensorineural hearing loss	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000631469	MT	7445	MT	7445	631469	619823	rs199474818	NC_012920.1:7444:A:T
m.7445A>C	MT-CO1|MT-TS1		Mitochondrial non-syndromic sensorineural hearing loss	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000009568	MT	7445	MT	7445	9568	24607	rs199474818	NC_012920.1:7444:A:C
NC_012920.1:m.7445A>G	MT-CO1|MT-TS1		Palmoplantar keratoderma-deafness syndrome|Mitochondrial non-syndromic sensorineural hearing loss|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009563	MT	7445	MT	7445	9563	24602	rs199474818	NC_012920.1:7444:A:G
NC_012920.1:m.7453G>A	MT-TS1		neonatal lactic acidosis	Likely pathogenic	criteria provided, single submitter	VCV000869395	MT	7453	MT	7453	869395	857626	rs2068703521	NC_012920.1:7452:G:A
NC_012920.1(MT-CYB):m.7460A>G	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690026	MT	7460	MT	7460	690026	677891	rs1603220969	NC_012920.1:7459:A:G
NC_012920.1:m.7462C>T	MT-TS1		Mitochondrial non-syndromic sensorineural hearing loss	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000631470	MT	7462	MT	7462	631470	619824	rs1569484151	NC_012920.1:7461:C:T
m.7468C>T	MT-TS1		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not specified	Benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042224	MT	7468	MT	7468	42224	51394	rs111033173	NC_012920.1:7467:C:T
NC_012920.1(MT-CYB):m.7469C>T	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690027	MT	7469	MT	7469	690027	677892	rs1603220974	NC_012920.1:7468:C:T
NC_012920.1(MT-CYB):m.7471C>A	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690028	MT	7471	MT	7471	690028	677893	rs397515726	NC_012920.1:7470:C:A
m.7471C>T	MT-TS1		not specified|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign/Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042225	MT	7471	MT	7471	42225	51395	rs397515726	NC_012920.1:7470:C:T
NC_012920.1:m.7472A>T	MT-TS1		not specified|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign/Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505297	MT	7472	MT	7472	505297	497359	rs1556423293	NC_012920.1:7471:A:T
m.7476C>T	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial disease|not specified	Benign(Last reviewed: Jan 10, 2022)	reviewed by expert panel	VCV000042228	MT	7476	MT	7476	42228	51398	rs201950015	NC_012920.1:7475:C:T
NC_012920.1(MT-CYB):m.7478G>A	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690029	MT	7478	MT	7478	690029	677894	rs1603220977	NC_012920.1:7477:G:A
NC_012920.1(MT-CYB):m.7479G>A	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690030	MT	7479	MT	7479	690030	677895	rs1603220980	NC_012920.1:7478:G:A
NC_012920.1:m.7486G>A	MT-TS1		Progressive external ophthalmoplegia	Uncertain significance(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000374215	MT	7486	MT	7486	374215	361118	rs1556423295	NC_012920.1:7485:G:A
NC_012920.1(MT-CYB):m.7487C>T	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690031	MT	7487	MT	7487	690031	677896	rs1603220981	NC_012920.1:7486:C:T
NC_012920.1(MT-CYB):m.7490A>G	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690032	MT	7490	MT	7490	690032	677897	rs1603220984	NC_012920.1:7489:A:G
m.7493C>T	MT-TS1		not specified|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042229	MT	7493	MT	7493	42229	51399	rs397515728	NC_012920.1:7492:C:T
NC_012920.1:m.7496T>C	MT-TS1		Myopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000370049	MT	7496	MT	7496	370049	354302	rs1057516061	NC_012920.1:7495:T:C
m.7497G>A	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Exercise intolerance, muscle pain, and lactic acidemia	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009569	MT	7497	MT	7497	9569	24608	rs387906419	NC_012920.1:7496:G:A
m.7498G>A	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not specified	Benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042230	MT	7498	MT	7498	42230	51400	rs111033324	NC_012920.1:7497:G:A
NC_012920.1(MT-CYB):m.7499C>A	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690033	MT	7499	MT	7499	690033	677898	rs1603220989	NC_012920.1:7498:C:A
NC_012920.1(MT-CYB):m.7501T>C	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690034	MT	7501	MT	7501	690034	677899	rs1556423303	NC_012920.1:7500:T:C
NC_012920.1:m.7502C>T	MT-TS1		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000228859	MT	7502	MT	7502	228859	231301	rs876657868	NC_012920.1:7501:C:T
NC_012920.1:m.7505T>C	MT-TS1		Mitochondrial non-syndromic sensorineural hearing loss	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000040885	MT	7505	MT	7505	40885	49378	rs724159989	NC_012920.1:7504:T:C
m.7510T>C	MT-TS1		Mitochondrial non-syndromic sensorineural hearing loss	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000009565	MT	7510	MT	7510	9565	24604	rs199474820	NC_012920.1:7509:T:C
m.7511T>C	MT-TS1		Mitochondrial non-syndromic sensorineural hearing loss|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009566	MT	7511	MT	7511	9566	24605	rs199474821	NC_012920.1:7510:T:C
m.7512T>C	MT-TS1		MERRF/MELAS overlap syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial cytochrome c oxidase deficiency	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009562	MT	7512	MT	7512	9562	24601	rs199474817	NC_012920.1:7511:T:C
NC_012920.1(MT-CYB):m.7518A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690035	MT	7518	MT	7518	690035	677900	rs1603220992	NC_012920.1:7517:A:G
NC_012920.1(MT-CYB):m.7520G>A	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690036	MT	7520	MT	7520	690036	677901	rs1603220993	NC_012920.1:7519:G:A
NC_012920.1(MT-CYB):m.7521G>A	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690037	MT	7521	MT	7521	690037	677902	rs200336937	NC_012920.1:7520:G:A
NC_012920.1(MT-CYB):m.7525T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690038	MT	7525	MT	7525	690038	677903	rs1603220995	NC_012920.1:7524:T:C
m.7526A>G	MT-TD		Mitochondrial myopathy, isolated	Pathogenic(Last reviewed: Aug 30, 2005)	no assertion criteria provided	VCV000009619	MT	7526	MT	7526	9619	24658	rs121434454	NC_012920.1:7525:A:G
NC_012920.1(MT-CYB):m.7533C>T	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690039	MT	7533	MT	7533	690039	677904	rs1603221000	NC_012920.1:7532:C:T
NC_012920.1(MT-CYB):m.7534C>T	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690040	MT	7534	MT	7534	690040	677905	rs1603221002	NC_012920.1:7533:C:T
NC_012920.1(MT-CYB):m.7538T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690041	MT	7538	MT	7538	690041	677906	rs1603221004	NC_012920.1:7537:T:C
NC_012920.1(MT-CYB):m.7543A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690042	MT	7543	MT	7543	690042	677907	rs1603221006	NC_012920.1:7542:A:G
NC_012920.1(MT-CYB):m.7546T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690043	MT	7546	MT	7546	690043	677908	rs1603221007	NC_012920.1:7545:T:C
NC_012920.1(MT-CYB):m.7547T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690044	MT	7547	MT	7547	690044	677909	rs879076142	NC_012920.1:7546:T:C
NC_012920.1(MT-CYB):m.7552A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690045	MT	7552	MT	7552	690045	677910	rs1603221008	NC_012920.1:7551:A:G
NC_012920.1(MT-CYB):m.7555T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690046	MT	7555	MT	7555	690046	677911	rs1603221010	NC_012920.1:7554:T:C
NC_012920.1(MT-CYB):m.7559A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690047	MT	7559	MT	7559	690047	677912	rs1556423308	NC_012920.1:7558:A:G
NC_012920.1(MT-CYB):m.7561T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690048	MT	7561	MT	7561	690048	677913	rs1603221012	NC_012920.1:7560:T:C
NC_012920.1(MT-CYB):m.7562A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690049	MT	7562	MT	7562	690049	677914	rs1603221015	NC_012920.1:7561:A:G
NC_012920.1(MT-TD):m.7566G>A	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690050	MT	7566	MT	7566	690050	677915	rs1603221016	NC_012920.1:7565:G:A
NC_012920.1(MT-CYB):m.7567C>T	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690051	MT	7567	MT	7567	690051	677916	rs1603221018	NC_012920.1:7566:C:T
NC_012920.1(MT-CYB):m.7568T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690052	MT	7568	MT	7568	690052	677917	rs1603221019	NC_012920.1:7567:T:C
NC_012920.1(MT-CYB):m.7569A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690054	MT	7569	MT	7569	690054	677919	rs1603221021	NC_012920.1:7568:A:G
NC_012920.1(MT-CYB):m.7570A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690055	MT	7570	MT	7570	690055	677920	rs1556423311	NC_012920.1:7569:A:G
NC_012920.1(MT-CYB):m.7572T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690056	MT	7572	MT	7572	690056	677921	rs1603221022	NC_012920.1:7571:T:C
NC_012920.1(MT-CYB):m.7576A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690057	MT	7576	MT	7576	690057	677922	rs1603221023	NC_012920.1:7575:A:G
NC_012920.1(MT-CYB):m.7577T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690058	MT	7577	MT	7577	690058	677923	rs1603221025	NC_012920.1:7576:T:C
NC_012920.1(MT-CYB):m.7581T>C	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690059	MT	7581	MT	7581	690059	677924	rs201582552	NC_012920.1:7580:T:C
NC_012920.1(MT-CYB):m.7582C>T	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690060	MT	7582	MT	7582	690060	677925	rs1603221026	NC_012920.1:7581:C:T
NC_012920.1(MT-CYB):m.7585A>G	MT-TD		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690061	MT	7585	MT	7585	690061	677926	rs1603221028	NC_012920.1:7584:A:G
m.7587T>C	MT-CO2	M1T	Cytochrome-c oxidase deficiency disease	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000009658	MT	7587	MT	7587	9658	24697	rs199474825	NC_012920.1:7586:T:C
NC_012920.1:m.7598G>A	MT-CO2	A5T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692748	MT	7598	MT	7598	692748	681284	rs386420012	NC_012920.1:7597:G:A
NC_012920.1:m.7604G>A	MT-CO2	V7M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692749	MT	7604	MT	7604	692749	681285	rs1603221034	NC_012920.1:7603:G:A
NC_012920.1:m.7606A>G	MT-CO2		not specified	Benign(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000994646	MT	7606	MT	7606	994646	983282	rs2068704310	NC_012920.1:7605:A:G
NC_012920.1:m.7608G>A	MT-CO2	G8D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692750	MT	7608	MT	7608	692750	681286	rs1603221035	NC_012920.1:7607:G:A
NC_012920.1:m.7624T>A	MT-CO2		not provided	Benign(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000805037	MT	7624	MT	7624	805037	793927	rs28358879	NC_012920.1:7623:T:A
NC_012920.1:m.7628C>A	MT-CO2	P15T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692751	MT	7628	MT	7628	692751	681287	rs1603221045	NC_012920.1:7627:C:A
NC_012920.1:m.7632T>C	MT-CO2	I16T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692752	MT	7632	MT	7632	692752	681288	rs1603221049	NC_012920.1:7631:T:C
NC_012920.1(MT-CO2):m.7637G>A	MT-CO2	E18K	not specified|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000439912	MT	7637	MT	7637	439912	433703	rs1556423314	NC_012920.1:7636:G:A
NC_012920.1:m.7645T>C	MT-CO2		not specified	Benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000994647	MT	7645	MT	7645	994647	983283	rs1556423316	NC_012920.1:7644:T:C
NC_012920.1:m.7649A>G	MT-CO2	T22A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692753	MT	7649	MT	7649	692753	681289	rs1603221060	NC_012920.1:7648:A:G
NC_012920.1:m.7650C>T	MT-CO2	T22I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692754	MT	7650	MT	7650	692754	681290	rs1603221063	NC_012920.1:7649:C:T
NC_012920.1:m.7664G>A	MT-CO2	A27T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692756	MT	7664	MT	7664	692756	681291	rs879139393	NC_012920.1:7663:G:A
NC_012920.1:m.7664G>T	MT-CO2	A27S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692755	MT	7664	MT	7664	692755	681292	rs879139393	NC_012920.1:7663:G:T
m.7671T>A	MT-CO2	M29K	Cytochrome-c oxidase deficiency disease	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000009660	MT	7671	MT	7671	9660	24699	rs199474827	NC_012920.1:7670:T:A
NC_012920.1:m.7673A>G	MT-CO2	I30V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692757	MT	7673	MT	7673	692757	681293	rs1569484167	NC_012920.1:7672:A:G
NC_012920.1:m.7674T>C	MT-CO2	I30T	not provided|Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692758	MT	7674	MT	7674	692758	681294	rs1569484168	NC_012920.1:7673:T:C
NC_012920.1:m.7679T>C	MT-CO2	F32L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692759	MT	7679	MT	7679	692759	681295	rs879003775	NC_012920.1:7678:T:C
NC_012920.1:m.7686T>C	MT-CO2	I34T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692760	MT	7686	MT	7686	692760	681296	rs1603221081	NC_012920.1:7685:T:C
NC_012920.1:m.7691T>C	MT-CO2	F36L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692761	MT	7691	MT	7691	692761	681297	rs1603221084	NC_012920.1:7690:T:C
NC_012920.1:m.7697G>A	MT-CO2	V38I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692762	MT	7697	MT	7697	692762	681298	rs879212765	NC_012920.1:7696:G:A
NC_012920.1:m.7698T>C	MT-CO2	V38A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692763	MT	7698	MT	7698	692763	681299	rs1603221090	NC_012920.1:7697:T:C
NC_012920.1:m.7706G>A	MT-CO2	A41T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692764	MT	7706	MT	7706	692764	681300	rs1556423333	NC_012920.1:7705:G:A
NC_012920.1:m.7713T>C	MT-CO2	F43S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692765	MT	7713	MT	7713	692765	681301	rs1603221099	NC_012920.1:7712:T:C
NC_012920.1:m.7718A>G	MT-CO2	T45A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692766	MT	7718	MT	7718	692766	681302	rs1556423337	NC_012920.1:7717:A:G
NC_012920.1:m.7724A>T	MT-CO2	T47S	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000692767	MT	7724	MT	7724	692767	681303	rs1553139599	NC_012920.1:7723:A:T
NC_012920.1:m.7746A>G	MT-CO2	N54S	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000692768	MT	7746	MT	7746	692768	681304	rs1603221113	NC_012920.1:7745:A:G
NC_012920.1:m.7751T>G	MT-CO2	S56A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692769	MT	7751	MT	7751	692769	681305	rs1603221115	NC_012920.1:7750:T:G
NC_012920.1:m.7754G>A	MT-CO2	D57N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692770	MT	7754	MT	7754	692770	681306	rs1556423339	NC_012920.1:7753:G:A
NC_012920.1:m.7757G>A	MT-CO2	A58T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692771	MT	7757	MT	7757	692771	681307	rs1603221120	NC_012920.1:7756:G:A
NC_012920.1:m.7761A>G	MT-CO2	Q59R	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692772	MT	7761	MT	7761	692772	681308	rs1603221122	NC_012920.1:7760:A:G
NC_012920.1:m.7771A>G	MT-CO2		not provided	Benign(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000805038	MT	7771	MT	7771	805038	793928	rs368038563	NC_012920.1:7770:A:G
NC_012920.1:m.7772A>G	MT-CO2	T63A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692773	MT	7772	MT	7772	692773	681309	rs1603221127	NC_012920.1:7771:A:G
NC_012920.1:m.7775G>A	MT-CO2	V64I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692774	MT	7775	MT	7775	692774	681310	rs1556423347	NC_012920.1:7774:G:A
NC_012920.1:m.7784A>G	MT-CO2	I67V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692775	MT	7784	MT	7784	692775	681311	rs1556423348	NC_012920.1:7783:A:G
NC_012920.1:m.7785T>C	MT-CO2	I67T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692776	MT	7785	MT	7785	692776	681312	rs1603221138	NC_012920.1:7784:T:C
NC_012920.1:m.7789G>A	MT-CO2		not provided	Benign(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000376897	MT	7789	MT	7789	376897	363775	rs386829014	NC_012920.1:7788:G:A
NC_012920.1:m.7796A>G	MT-CO2	I71V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692777	MT	7796	MT	7796	692777	681313	rs1603221141	NC_012920.1:7795:A:G
NC_012920.1:m.7797T>C	MT-CO2	I71T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692778	MT	7797	MT	7797	692778	681314	rs1603221143	NC_012920.1:7796:T:C
NC_012920.1:m.7805G>A	MT-CO2	V74I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692779	MT	7805	MT	7805	692779	681315	rs879119797	NC_012920.1:7804:G:A
NC_012920.1:m.7806T>C	MT-CO2	V74A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692780	MT	7806	MT	7806	692780	681316	rs1603221147	NC_012920.1:7805:T:C
NC_012920.1:m.7808C>T	MT-CO2	L75F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692781	MT	7808	MT	7808	692781	681317	rs1603221148	NC_012920.1:7807:C:T
NC_012920.1:m.7811A>G	MT-CO2	I76V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692782	MT	7811	MT	7811	692782	681318	rs1603221152	NC_012920.1:7810:A:G
NC_012920.1:m.7814G>A	MT-CO2	A77T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692783	MT	7814	MT	7814	692783	681319	rs1603221156	NC_012920.1:7813:G:A
NC_012920.1:m.7819C>A	MT-CO2		not provided	Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000235379	MT	7819	MT	7819	235379	237065	rs878853024	NC_012920.1:7818:C:A
NC_012920.1:m.7830G>A	MT-CO2	R82H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692784	MT	7830	MT	7830	692784	681320	rs878897170	NC_012920.1:7829:G:A
NC_012920.1:m.7833T>C	MT-CO2	I83T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692785	MT	7833	MT	7833	692785	681321	rs1603221169	NC_012920.1:7832:T:C
NC_012920.1:m.7844A>G	MT-CO2	T87A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692787	MT	7844	MT	7844	692787	681322	rs1556423353	NC_012920.1:7843:A:G
NC_012920.1:m.7844A>T	MT-CO2	T87S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692786	MT	7844	MT	7844	692786	681323	rs1556423353	NC_012920.1:7843:A:T
NC_012920.1:m.7853G>A	MT-CO2	V90I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692788	MT	7853	MT	7853	692788	681324	rs386420037	NC_012920.1:7852:G:A
NC_012920.1:m.7854T>C	MT-CO2	V90A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692789	MT	7854	MT	7854	692789	681325	rs1603221180	NC_012920.1:7853:T:C
NC_012920.1:m.7859G>A	MT-CO2	D92N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692790	MT	7859	MT	7859	692790	681326	rs373105186	NC_012920.1:7858:G:A
NC_012920.1:m.7861T>C	MT-CO2		not provided	Likely benign(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000235521	MT	7861	MT	7861	235521	237202	rs368623956	NC_012920.1:7860:T:C
NC_012920.1:m.7867C>T	MT-CO2		not provided	Likely benign(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000235282	MT	7867	MT	7867	235282	236969	rs9783079	NC_012920.1:7866:C:T
NC_012920.1:m.7868C>T	MT-CO2	L95F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692791	MT	7868	MT	7868	692791	681327	rs1556423357	NC_012920.1:7867:C:T
NC_012920.1:m.7873C>T	MT-CO2		not provided	Benign(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000805039	MT	7873	MT	7873	805039	793929	rs879161183	NC_012920.1:7872:C:T
NC_012920.1:m.7874A>G	MT-CO2	I97V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692792	MT	7874	MT	7874	692792	681328	rs1603221191	NC_012920.1:7873:A:G
m.7896G>A	MT-CO2	W104*	Cytochrome-c oxidase deficiency disease	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000009662	MT	7896	MT	7896	9662	24701	rs199474829	NC_012920.1:7895:G:A
NC_012920.1:m.7898T>C	MT-CO2	Y105H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692793	MT	7898	MT	7898	692793	681329	rs1603221199	NC_012920.1:7897:T:C
NC_012920.1:m.7904A>G	MT-CO2	T107A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692794	MT	7904	MT	7904	692794	681330	rs1603221201	NC_012920.1:7903:A:G
NC_012920.1:m.7919G>A	MT-CO2	D112N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692795	MT	7919	MT	7919	692795	681331	rs1603221212	NC_012920.1:7918:G:A
NC_012920.1:m.7922T>C	MT-CO2	Y113H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692796	MT	7922	MT	7922	692796	681332	rs1556423362	NC_012920.1:7921:T:C
NC_012920.1:m.7925G>A	MT-CO2	G114S	Decreased activity of mitochondrial complex IV|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000692797	MT	7925	MT	7925	692797	681333	rs1603221215	NC_012920.1:7924:G:A
NC_012920.1:m.7926G>A	MT-CO2	G114D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692798	MT	7926	MT	7926	692798	681334	rs1603221217	NC_012920.1:7925:G:A
NC_012920.1:m.7934A>G	MT-CO2	I117V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692799	MT	7934	MT	7934	692799	681335	rs374261450	NC_012920.1:7933:A:G
NC_012920.1:m.7941A>G	MT-CO2	N119S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692800	MT	7941	MT	7941	692800	681336	rs1603221223	NC_012920.1:7940:A:G
NC_012920.1:m.7943T>C	MT-CO2	S120P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692801	MT	7943	MT	7943	692801	681337	rs1603221224	NC_012920.1:7942:T:C
NC_012920.1:m.7954T>C	MT-CO2		not provided	Benign(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000805040	MT	7954	MT	7954	805040	793930	rs1603221231	NC_012920.1:7953:T:C
NC_012920.1:m.7962T>C	MT-CO2	L126S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692802	MT	7962	MT	7962	692802	681338	rs1603221233	NC_012920.1:7961:T:C
NC_012920.1:m.7964T>C	MT-CO2	F127L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692803	MT	7964	MT	7964	692803	681339	rs1556423367	NC_012920.1:7963:T:C
NC_012920.1:m.7965T>C	MT-CO2	F127S	Cytochrome-c oxidase deficiency disease	Uncertain significance(Last reviewed: Mar 29, 2016)	no assertion criteria provided	VCV000440835	MT	7965	MT	7965	440835	434458	rs1556423369	NC_012920.1:7964:T:C
NC_012920.1:m.7976G>A	MT-CO2	G131S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692804	MT	7976	MT	7976	692804	681340	rs377368526	NC_012920.1:7975:G:A
NC_012920.1:m.7980A>G	MT-CO2	D132G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692805	MT	7980	MT	7980	692805	681341	rs1603221241	NC_012920.1:7979:A:G
NC_012920.1:m.7989T>C	MT-CO2	L135P	Mitochondrial disease	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000430690	MT	7989	MT	7989	430690	424212	rs1131692064	NC_012920.1:7988:T:C
NC_012920.1:m.8001A>G	MT-CO2	D139G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692806	MT	8001	MT	8001	692806	681342	rs1603221247	NC_012920.1:8000:A:G
m.8009G>A	MT-CO2	V142M	Familial colorectal cancer	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000009659	MT	8009	MT	8009	9659	24698	rs199474826	NC_012920.1:8008:G:A
NC_012920.1:m.8010T>C	MT-CO2	V142A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692807	MT	8010	MT	8010	692807	681343	rs1603221254	NC_012920.1:8009:T:C
NC_012920.1:m.8012G>A	MT-CO2	V143M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692808	MT	8012	MT	8012	692808	681344	rs1603221258	NC_012920.1:8011:G:A
NC_012920.1:m.8021A>G	MT-CO2	I146V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692809	MT	8021	MT	8021	692809	681345	rs1603221261	NC_012920.1:8020:A:G
NC_012920.1:m.8022T>C	MT-CO2	I146T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692810	MT	8022	MT	8022	692810	681346	rs1556423376	NC_012920.1:8021:T:C
NC_012920.1:m.8026A>T	MT-CO2	E147D	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692811	MT	8026	MT	8026	692811	681347	rs1603221263	NC_012920.1:8025:A:T
NC_012920.1:m.8027G>A	MT-CO2	A148T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692812	MT	8027	MT	8027	692812	681348	rs1116904	NC_012920.1:8026:G:A
NC_012920.1:m.8030C>T	MT-CO2	P149S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692813	MT	8030	MT	8030	692813	681349	rs1603221266	NC_012920.1:8029:C:T
NC_012920.1:m.8033A>G	MT-CO2	I150V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692814	MT	8033	MT	8033	692814	681350	rs1603221267	NC_012920.1:8032:A:G
NC_012920.1:m.8047T>C	MT-CO2		not provided	Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000235679	MT	8047	MT	8047	235679	237359	rs386829022	NC_012920.1:8046:T:C
NC_012920.1:m.8060G>A	MT-CO2	V159I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692815	MT	8060	MT	8060	692815	681351	rs1603221271	NC_012920.1:8059:G:A
NC_012920.1:m.8069T>C	MT-CO2	S162P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692816	MT	8069	MT	8069	692816	681352	rs1603221275	NC_012920.1:8068:T:C
NC_012920.1:m.8075G>A	MT-CO2	A164T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692817	MT	8075	MT	8075	692817	681353	rs386829024	NC_012920.1:8074:G:A
NC_012920.1:m.8078G>A	MT-CO2	V165I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692818	MT	8078	MT	8078	692818	681354	rs878993263	NC_012920.1:8077:G:A
NC_012920.1:m.8079T>C	MT-CO2	V165A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692819	MT	8079	MT	8079	692819	681355	rs1603221279	NC_012920.1:8078:T:C
NC_012920.1:m.8080C>T	MT-CO2		not provided	Benign(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000805041	MT	8080	MT	8080	805041	793931	rs371628304	NC_012920.1:8079:C:T
NC_012920.1:m.8084A>T	MT-CO2	T167S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692820	MT	8084	MT	8084	692820	681356	rs1057518824	NC_012920.1:8083:A:T
NC_012920.1:m.8084A>G	MT-CO2	T167A	Focal white matter lesions|Ischemic stroke, susceptibility to|Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000373996	MT	8084	MT	8084	373996	361110	rs1057518824	NC_012920.1:8083:A:G
NC_012920.1:m.8108A>G	MT-CO2	I175V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692821	MT	8108	MT	8108	692821	681357	rs1603221288	NC_012920.1:8107:A:G
NC_012920.1:m.8135T>C	MT-CO2	F184L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692822	MT	8135	MT	8135	692822	681358	rs1603221304	NC_012920.1:8134:T:C
NC_012920.1:m.8141G>A	MT-CO2	A186T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692823	MT	8141	MT	8141	692823	681359	rs1603221309	NC_012920.1:8140:G:A
NC_012920.1:m.8156G>C	MT-CO2	V191L	not provided	Uncertain significance(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000618723	MT	8156	MT	8156	618723	610276	rs1569484189	NC_012920.1:8155:G:C
NC_012920.1:m.8187G>A	MT-CO2	G201E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692824	MT	8187	MT	8187	692824	681360	rs1603221319	NC_012920.1:8186:G:A
NC_012920.1:m.8202T>C	MT-CO2	F206S	not provided	Uncertain significance(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000618722	MT	8202	MT	8202	618722	610277	rs1569484193	NC_012920.1:8201:T:C
NC_012920.1:m.8206G>A	MT-CO2		not provided	Benign(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000805042	MT	8206	MT	8206	805042	793933	rs28358883	NC_012920.1:8205:G:A
NC_012920.1:m.8210A>G	MT-CO2	I209V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692825	MT	8210	MT	8210	692825	681361	rs1603221330	NC_012920.1:8209:A:G
NC_012920.1:m.8225A>G	MT-CO2	I214V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692826	MT	8225	MT	8225	692826	681362	rs1603221335	NC_012920.1:8224:A:G
NC_012920.1:m.8237A>G	MT-CO2	I218V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692827	MT	8237	MT	8237	692827	681363	rs1603221342	NC_012920.1:8236:A:G
NC_012920.1:m.8238T>C	MT-CO2	I218T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692828	MT	8238	MT	8238	692828	681364	rs1603221344	NC_012920.1:8237:T:C
NC_012920.1:m.8252C>T	MT-CO2	P223S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692829	MT	8252	MT	8252	692829	681365	rs1603221351	NC_012920.1:8251:C:T
NC_012920.1:m.8256T>C	MT-CO2	V224A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692830	MT	8256	MT	8256	692830	681366	rs1603221354	NC_012920.1:8255:T:C
NC_012920.1:m.8258T>C	MT-CO2	F225L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692831	MT	8258	MT	8258	692831	681367	rs1603221357	NC_012920.1:8257:T:C
NC_012920.1:m.8260T>C	MT-CO2		not provided	Likely benign(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000377045	MT	8260	MT	8260	377045	363923	rs1057520115	NC_012920.1:8259:T:C
NC_012920.1:m.8265T>C	MT-CO2	L227P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692832	MT	8265	MT	8265	692832	681368	rs1603221364	NC_012920.1:8264:T:C
NC_012920.1:m.8269G>A	MT-CO2		not provided	Benign(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000805043	MT	8269	MT	8269	805043	793934	rs1556423413	NC_012920.1:8268:G:A
m.8296A>G	MT-TK		Diabetes-deafness syndrome maternally transmitted|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009584	MT	8296	MT	8296	9584	24623	rs118192102	NC_012920.1:8295:A:G
NC_012920.1(MT-CYB):m.8298T>C	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690062	MT	8298	MT	8298	690062	677927	rs1603221389	NC_012920.1:8297:T:C
NC_012920.1(MT-CYB):m.8299G>A	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690063	MT	8299	MT	8299	690063	677928	rs1603221391	NC_012920.1:8298:G:A
NC_012920.1(MT-CYB):m.8300T>C	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690064	MT	8300	MT	8300	690064	677929	rs1603221393	NC_012920.1:8299:T:C
NC_012920.1(MT-CYB):m.8301A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690065	MT	8301	MT	8301	690065	677930	rs1603221396	NC_012920.1:8300:A:G
NC_012920.1(MT-CYB):m.8308A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690066	MT	8308	MT	8308	690066	677931	rs879081228	NC_012920.1:8307:A:G
NC_012920.1(MT-CYB):m.8311T>A	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690068	MT	8311	MT	8311	690068	677932	rs371589230	NC_012920.1:8310:T:A
NC_012920.1(MT-CYB):m.8311T>C	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690067	MT	8311	MT	8311	690067	677933	rs371589230	NC_012920.1:8310:T:C
m.8313G>A	MT-TK		Mitochondrial DNA depletion syndrome 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000009583	MT	8313	MT	8313	9583	24622	rs118192101	NC_012920.1:8312:G:A
NC_012920.1(MT-CYB):m.8315A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690069	MT	8315	MT	8315	690069	677934	rs1603221400	NC_012920.1:8314:A:G
NC_012920.1(MT-CYB):m.8319A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690070	MT	8319	MT	8319	690070	677935	rs1603221401	NC_012920.1:8318:A:G
NC_012920.1(MT-CYB):m.8331A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690071	MT	8331	MT	8331	690071	677936	rs1603221403	NC_012920.1:8330:A:G
NC_012920.1(MT-CYB):m.8337T>C	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690072	MT	8337	MT	8337	690072	677937	rs1603221405	NC_012920.1:8336:T:C
NC_012920.1(MT-CYB):m.8338A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690073	MT	8338	MT	8338	690073	677938	rs1603221407	NC_012920.1:8337:A:G
m.8342G>A	MT-TK		Progressive external ophthalmoplegia with myoclonus|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2011)	no assertion criteria provided	VCV000009582	MT	8342	MT	8342	9582	24621	rs118192103	NC_012920.1:8341:G:A
NC_012920.1(MT-CYB):m.8343A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690075	MT	8343	MT	8343	690075	677940	rs1603221411	NC_012920.1:8342:A:G
m.8344A>G	MT-TK		MT-TK-related mitochondrial disorder|not provided|Mitochondrial disease|Parkinson disease, mitochondrial|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome	Pathogenic(Last reviewed: Nov 3, 2021)	reviewed by expert panel	VCV000009579	MT	8344	MT	8344	9579	24618	rs118192098	NC_012920.1:8343:A:G
NC_012920.1(MT-CYB):m.8345C>T	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690076	MT	8345	MT	8345	690076	677941	rs1603221413	NC_012920.1:8344:C:T
NC_012920.1(MT-CYB):m.8346C>A	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690077	MT	8346	MT	8346	690077	677942	rs1603221415	NC_012920.1:8345:C:A
NC_012920.1(MT-CYB):m.8347A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690078	MT	8347	MT	8347	690078	677943	rs1603221417	NC_012920.1:8346:A:G
NC_012920.1(MT-CYB):m.8348A>G	MT-TK		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign/Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000690079	MT	8348	MT	8348	690079	677944	rs1556423430	NC_012920.1:8347:A:G
NC_012920.1(MT-CYB):m.8349C>T	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690080	MT	8349	MT	8349	690080	677945	rs1603221418	NC_012920.1:8348:C:T
NC_012920.1(MT-CYB):m.8350A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690081	MT	8350	MT	8350	690081	677946	rs1603221419	NC_012920.1:8349:A:G
m.8356T>C	MT-TK		MERRF syndrome|MERRF/MELAS overlap syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009580	MT	8356	MT	8356	9580	24619	rs118192099	NC_012920.1:8355:T:C
NC_012920.1(MT-CYB):m.8358A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690082	MT	8358	MT	8358	690082	677947	rs1603221421	NC_012920.1:8357:A:G
NC_012920.1(MT-CYB):m.8360A>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690083	MT	8360	MT	8360	690083	677948	rs1603221422	NC_012920.1:8359:A:G
m.8361G>A	MT-TK		MERRF syndrome	Pathogenic(Last reviewed: Jan 5, 2021)	no assertion criteria provided	VCV000009585	MT	8361	MT	8361	9585	24624	rs118192104	NC_012920.1:8360:G:A
NC_012920.1(MT-CYB):m.8362T>G	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690084	MT	8362	MT	8362	690084	677949	rs1603221423	NC_012920.1:8361:T:G
m.8363G>A	MT-TK		Cardiomyopathy and Deafness|MERRF syndrome|Leigh syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009581	MT	8363	MT	8363	9581	24620	rs118192100	NC_012920.1:8362:G:A
NC_012920.1(MT-CYB):m.8364A>T	MT-TK		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690085	MT	8364	MT	8364	690085	677950	rs1603221428	NC_012920.1:8363:A:T
NC_012920.1:m.8369C>T	MT-ATP8	P2S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692833	MT	8369	MT	8369	692833	681369	rs1603221429	NC_012920.1:8368:C:T
NC_012920.1:m.8373A>T	MT-ATP8	Q3L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692835	MT	8373	MT	8373	692835	681371	rs1603221431	NC_012920.1:8372:A:T
NC_012920.1:m.8373A>G	MT-ATP8	Q3R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692834	MT	8373	MT	8373	692834	681370	rs1603221431	NC_012920.1:8372:A:G
NC_012920.1:m.8379A>G	MT-ATP8	N5S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692836	MT	8379	MT	8379	692836	681372	rs1603221434	NC_012920.1:8378:A:G
NC_012920.1:m.8381A>T	MT-ATP8	T6S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692838	MT	8381	MT	8381	692838	681374	rs1603221438	NC_012920.1:8380:A:T
NC_012920.1:m.8381A>G	MT-ATP8	T6A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692837	MT	8381	MT	8381	692837	681373	rs1603221438	NC_012920.1:8380:A:G
NC_012920.1(MT-ATP8):m.8382C>T	MT-ATP8	T6I	not provided|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000445618	MT	8382	MT	8382	445618	438890	rs1556423437	NC_012920.1:8381:C:T
NC_012920.1:m.8387G>A	MT-ATP8	V8M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692839	MT	8387	MT	8387	692839	681375	rs1556423439	NC_012920.1:8386:G:A
NC_012920.1:m.8388T>C	MT-ATP8	V8A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692840	MT	8388	MT	8388	692840	681376	rs879199176	NC_012920.1:8387:T:C
m.8393C>T	MT-ATP8	P10S	Brain pseudoatrophy, reversible, valproate-induced, susceptibility to|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009638	MT	8393	MT	8393	9638	24677	rs1556423442	NC_012920.1:8392:C:T
NC_012920.1:m.8394C>T	MT-ATP8	P10L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692841	MT	8394	MT	8394	692841	681377	rs1603221450	NC_012920.1:8393:C:T
NC_012920.1:m.8396A>G	MT-ATP8	T11A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692842	MT	8396	MT	8396	692842	681378	rs1603221454	NC_012920.1:8395:A:G
NC_012920.1:m.8397C>G	MT-ATP8	T11S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692843	MT	8397	MT	8397	692843	681379	rs1603221456	NC_012920.1:8396:C:G
NC_012920.1:m.8400T>C	MT-ATP8	M12T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692844	MT	8400	MT	8400	692844	681380	rs1603221459	NC_012920.1:8399:T:C
NC_012920.1:m.8403T>C	MT-ATP8	I13T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692845	MT	8403	MT	8403	692845	681381	rs1603221460	NC_012920.1:8402:T:C
NC_012920.1:m.8406C>T	MT-ATP8	T14I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692846	MT	8406	MT	8406	692846	681382	rs1556423448	NC_012920.1:8405:C:T
NC_012920.1:m.8408C>T	MT-ATP8	P15S	See cases	Uncertain significance(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000930945	MT	8408	MT	8408	930945	920080	rs2068708846	NC_012920.1:8407:C:T
NC_012920.1:m.8410C>T	MT-ATP8		not provided	Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000235707	MT	8410	MT	8410	235707	237387	rs200715932	NC_012920.1:8409:C:T
NC_012920.1:m.8411A>G	MT-ATP8	M16V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692848	MT	8411	MT	8411	692848	681384	rs878942289	NC_012920.1:8410:A:G
NC_012920.1:m.8411A>C	MT-ATP8	M16L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692847	MT	8411	MT	8411	692847	681383	rs878942289	NC_012920.1:8410:A:C
NC_012920.1:m.8412T>C	MT-ATP8	M16T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692849	MT	8412	MT	8412	692849	681385	rs1556423451	NC_012920.1:8411:T:C
NC_012920.1:m.8414C>T	MT-ATP8	L17F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692850	MT	8414	MT	8414	692850	681386	rs28358884	NC_012920.1:8413:C:T
NC_012920.1:m.8415T>C	MT-ATP8	L17P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692851	MT	8415	MT	8415	692851	681387	rs1603221470	NC_012920.1:8414:T:C
NC_012920.1:m.8417C>T	MT-ATP8	L18F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692852	MT	8417	MT	8417	692852	681388	rs199616772	NC_012920.1:8416:C:T
NC_012920.1:m.8418T>C	MT-ATP8	L18P	Optic neuropathy	Likely pathogenic(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370050	MT	8418	MT	8418	370050	354303	rs1057516062	NC_012920.1:8417:T:C
NC_012920.1:m.8426T>C	MT-ATP8	F21L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692853	MT	8426	MT	8426	692853	681389	rs1556423461	NC_012920.1:8425:T:C
NC_012920.1:m.8429C>T	MT-ATP8	L22F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692854	MT	8429	MT	8429	692854	681390	rs1603221477	NC_012920.1:8428:C:T
NC_012920.1:m.8430T>C	MT-ATP8	L22P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692855	MT	8430	MT	8430	692855	681391	rs1603221478	NC_012920.1:8429:T:C
NC_012920.1:m.8433T>C	MT-ATP8	I23T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692856	MT	8433	MT	8433	692856	681392	rs1603221480	NC_012920.1:8432:T:C
NC_012920.1:m.8435A>G	MT-ATP8	T24A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692858	MT	8435	MT	8435	692858	681393	rs1603221481	NC_012920.1:8434:A:G
NC_012920.1:m.8435A>T	MT-ATP8	T24S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692857	MT	8435	MT	8435	692857	681394	rs1603221481	NC_012920.1:8434:A:T
NC_012920.1:m.8448T>C	MT-ATP8	M28T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692859	MT	8448	MT	8448	692859	681395	rs879056797	NC_012920.1:8447:T:C
NC_012920.1:m.8453A>G	MT-ATP8	N30D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692860	MT	8453	MT	8453	692860	681396	rs1603221486	NC_012920.1:8452:A:G
NC_012920.1:m.8454A>G	MT-ATP8	N30S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692861	MT	8454	MT	8454	692861	681397	rs1603221488	NC_012920.1:8453:A:G
NC_012920.1:m.8460A>G	MT-ATP8	N32S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692862	MT	8460	MT	8460	692862	681398	rs1116906	NC_012920.1:8459:A:G
NC_012920.1:m.8461C>A	MT-ATP8	N32K	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692863	MT	8461	MT	8461	692863	681399	rs1603221493	NC_012920.1:8460:C:A
NC_012920.1:m.8462T>C	MT-ATP8	Y33H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692864	MT	8462	MT	8462	692864	681400	rs1603221496	NC_012920.1:8461:T:C
NC_012920.1:m.8463A>G	MT-ATP8	Y33C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692865	MT	8463	MT	8463	692865	681401	rs1603221498	NC_012920.1:8462:A:G
NC_012920.1:m.8466A>G	MT-ATP8	H34R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692866	MT	8466	MT	8466	692866	681402	rs1603221500	NC_012920.1:8465:A:G
NC_012920.1:m.8469T>C	MT-ATP8	L35P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692867	MT	8469	MT	8469	692867	681403	rs1603221503	NC_012920.1:8468:T:C
NC_012920.1:m.8471C>T	MT-ATP8	P36S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692868	MT	8471	MT	8471	692868	681404	rs1603221506	NC_012920.1:8470:C:T
NC_012920.1:m.8472C>T	MT-ATP8	P36L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692869	MT	8472	MT	8472	692869	681405	rs879209186	NC_012920.1:8471:C:T
NC_012920.1:m.8474C>T	MT-ATP8	P37S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692870	MT	8474	MT	8474	692870	681406	rs1603221515	NC_012920.1:8473:C:T
NC_012920.1:m.8477T>C	MT-ATP8	S38P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692871	MT	8477	MT	8477	692871	681407	rs1603221517	NC_012920.1:8476:T:C
NC_012920.1:m.8478C>T	MT-ATP8	S38L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692872	MT	8478	MT	8478	692872	681408	rs201902227	NC_012920.1:8477:C:T
NC_012920.1:m.8480C>T	MT-ATP8	P39S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692873	MT	8480	MT	8480	692873	681409	rs1603221520	NC_012920.1:8479:C:T
NC_012920.1:m.8481C>T	MT-ATP8	P39L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692874	MT	8481	MT	8481	692874	681410	rs1603221521	NC_012920.1:8480:C:T
NC_012920.1:m.8489A>G	MT-ATP8	M42V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692875	MT	8489	MT	8489	692875	681411	rs1603221529	NC_012920.1:8488:A:G
NC_012920.1:m.8490T>C	MT-ATP8	M42T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692876	MT	8490	MT	8490	692876	681412	rs1603221530	NC_012920.1:8489:T:C
NC_012920.1:m.8496T>C	MT-ATP8	M44T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692877	MT	8496	MT	8496	692877	681413	rs1603221534	NC_012920.1:8495:T:C
NC_012920.1:m.8502A>T	MT-ATP8	N46I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692879	MT	8502	MT	8502	692879	681415	rs879247004	NC_012920.1:8501:A:T
NC_012920.1:m.8502A>G	MT-ATP8	N46S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692878	MT	8502	MT	8502	692878	681414	rs879247004	NC_012920.1:8501:A:G
NC_012920.1:m.8504T>C	MT-ATP8	Y47H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692880	MT	8504	MT	8504	692880	681416	rs1603221542	NC_012920.1:8503:T:C
NC_012920.1:m.8507A>G	MT-ATP8	N48D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692881	MT	8507	MT	8507	692881	681417	rs1603221546	NC_012920.1:8506:A:G
NC_012920.1:m.8508A>G	MT-ATP8	N48S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692882	MT	8508	MT	8508	692882	681418	rs1603221548	NC_012920.1:8507:A:G
NC_012920.1:m.8514C>T	MT-ATP8	P50L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692883	MT	8514	MT	8514	692883	681419	rs1603221554	NC_012920.1:8513:C:T
NC_012920.1:m.8516T>C	MT-ATP8	W51R	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692884	MT	8516	MT	8516	692884	681420	rs878928585	NC_012920.1:8515:T:C
NC_012920.1(MT-ATP8):m.8519G>A	MT-ATP8	E52K	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235671	MT	8519	MT	8519	235671	237351	rs878853091	NC_012920.1:8518:G:A
NC_012920.1:m.8520A>G	MT-ATP8	E52G	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692885	MT	8520	MT	8520	692885	681421	rs1603221561	NC_012920.1:8519:A:G
NC_012920.1:m.8522C>T	MT-ATP8	P53S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692886	MT	8522	MT	8522	692886	681422	rs1603221562	NC_012920.1:8521:C:T
NC_012920.1:m.8527A>G	MT-ATP8|MT-ATP6	M1V	Leigh syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235294	MT	8527	MT	8527	235294	236981	rs878853003	NC_012920.1:8526:A:G
m.8528T>C	MT-ATP6|MT-ATP8	W55R, M1T	Cardiomyopathy, infantile hypertrophic|Histiocytoid cardiomyopathy	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009640	MT	8528	MT	8528	9640	24679	rs387906422	NC_012920.1:8527:T:C
m.8529G>A	MT-ATP6|MT-ATP8	W55*	Cardiomyopathy, apical hypertrophic, and neuropathy	Pathogenic(Last reviewed: Nov 2, 2016)	no assertion criteria provided	VCV000009639	MT	8529	MT	8529	9639	24678	rs267606881	NC_012920.1:8528:G:A
NC_012920.1:m.8530A>G	MT-ATP6|MT-ATP8	N2D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692887	MT	8530	MT	8530	692887	681423	rs1556423480	NC_012920.1:8529:A:G
NC_012920.1:m.8531A>G	MT-ATP6|MT-ATP8	N2S, T56A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692888	MT	8531	MT	8531	692888	681424	rs1556423481	NC_012920.1:8530:A:G
NC_012920.1:m.8533G>A	MT-ATP6|MT-ATP8	E3K	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692889	MT	8533	MT	8533	692889	681425	rs386829039	NC_012920.1:8532:G:A
NC_012920.1:m.8537A>G	MT-ATP6|MT-ATP8	N4S, I58V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692890	MT	8537	MT	8537	692890	681426	rs1603221571	NC_012920.1:8536:A:G
NC_012920.1:m.8538T>C	MT-ATP8|MT-ATP6	I58T	not provided	Uncertain significance(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	VCV000235326	MT	8538	MT	8538	235326	237013	rs878853010	NC_012920.1:8537:T:C
NC_012920.1:m.8540T>C	MT-ATP8|MT-ATP6	C59R, L5P	not provided|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235227	MT	8540	MT	8540	235227	236915	rs878852987	NC_012920.1:8539:T:C
NC_012920.1:m.8541G>A	MT-ATP6|MT-ATP8	C59Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692891	MT	8541	MT	8541	692891	681427	rs1569484218	NC_012920.1:8540:G:A
NC_012920.1:m.8542T>C	MT-ATP6|MT-ATP8	F6L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692892	MT	8542	MT	8542	692892	681428	rs1603221575	NC_012920.1:8541:T:C
NC_012920.1:m.8545G>A	MT-ATP6|MT-ATP8	A7T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692893	MT	8545	MT	8545	692893	681429	rs1603221578	NC_012920.1:8544:G:A
NC_012920.1:m.8547T>C	MT-ATP6|MT-ATP8	L61P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692894	MT	8547	MT	8547	692894	681430	rs1603221579	NC_012920.1:8546:T:C
NC_012920.1:m.8548T>C	MT-ATP6|MT-ATP8	S8P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692895	MT	8548	MT	8548	692895	681431	rs1603221580	NC_012920.1:8547:T:C
NC_012920.1:m.8550A>G	MT-ATP6|MT-ATP8	H62R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692896	MT	8550	MT	8550	692896	681432	rs1603221581	NC_012920.1:8549:A:G
NC_012920.1:m.8551T>C	MT-ATP6|MT-ATP8	F9L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692897	MT	8551	MT	8551	692897	681433	rs1556423486	NC_012920.1:8550:T:C
NC_012920.1:m.8552T>C	MT-ATP6|MT-ATP8	F9S, S63P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692898	MT	8552	MT	8552	692898	681434	rs1603221582	NC_012920.1:8551:T:C
NC_012920.1:m.8553C>T	MT-ATP6|MT-ATP8	S63L	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000618720	MT	8553	MT	8553	618720	610278	rs1569484219	NC_012920.1:8552:C:T
NC_012920.1:m.8554A>G	MT-ATP6|MT-ATP8	I10V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692899	MT	8554	MT	8554	692899	681435	rs1603221583	NC_012920.1:8553:A:G
NC_012920.1:m.8557G>C	MT-ATP6|MT-ATP8	A11P, L64F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692901	MT	8557	MT	8557	692901	681437	rs386829040	NC_012920.1:8556:G:C
NC_012920.1:m.8557G>A	MT-ATP6|MT-ATP8	A11T	Mitochondrial disease|Leigh syndrome	Benign(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000692900	MT	8557	MT	8557	692900	681436	rs386829040	NC_012920.1:8556:G:A
NC_012920.1:m.8562C>T	MT-ATP6|MT-ATP8	P66L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692902	MT	8562	MT	8562	692902	681438	rs1603221584	NC_012920.1:8561:C:T
NC_012920.1:m.8563A>G	MT-ATP6|MT-ATP8	T13A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692903	MT	8563	MT	8563	692903	681439	rs386829041	NC_012920.1:8562:A:G
NC_012920.1:m.8565A>G	MT-ATP8|MT-ATP6	Q67R	not provided	Uncertain significance(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000235492	MT	8565	MT	8565	235492	237174	rs878853052	NC_012920.1:8564:A:G
NC_012920.1:m.8566A>G	MT-ATP6|MT-ATP8	I14V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692904	MT	8566	MT	8566	692904	681440	rs3020563	NC_012920.1:8565:A:G
NC_012920.1:m.8567T>C	MT-ATP6|MT-ATP8	I14T, S68P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692905	MT	8567	MT	8567	692905	681441	rs1603221586	NC_012920.1:8566:T:C
NC_012920.1:m.8568C>T	MT-ATP6|MT-ATP8	S68F	not provided	not provided	no assertion provided	VCV000918019	MT	8568	MT	8568	918019	906355	rs1603221589	NC_012920.1:8567:C:T
NC_012920.1:m.8568C>A	MT-ATP6|MT-ATP8	I14M, S68Y	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692906	MT	8568	MT	8568	692906	681442	rs1603221589	NC_012920.1:8567:C:A
NC_012920.1:m.8570T>C	MT-ATP6|MT-ATP8	L15P	Acidosis|Failure to thrive|Anemia|Increased serum lactate	Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000869162	MT	8570	MT	8570	869162	857396	rs2068710214	NC_012920.1:8569:T:C
NC_012920.1:m.8572G>A	MT-ATP6|MT-ATP8	G16S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692907	MT	8572	MT	8572	692907	681443	rs28502681	NC_012920.1:8571:G:A
NC_012920.1:m.8573G>A	MT-ATP6	G16D	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692908	MT	8573	MT	8573	692908	681444	rs1603221592	NC_012920.1:8572:G:A
NC_012920.1:m.8576T>C	MT-ATP6	L17P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692909	MT	8576	MT	8576	692909	681445	rs1603221596	NC_012920.1:8575:T:C
NC_012920.1:m.8578C>T	MT-ATP6	P18S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692910	MT	8578	MT	8578	692910	681446	rs1556423492	NC_012920.1:8577:C:T
NC_012920.1:m.8581G>A	MT-ATP6	A19T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692911	MT	8581	MT	8581	692911	681447	rs1603221602	NC_012920.1:8580:G:A
NC_012920.1:m.8582C>T	MT-ATP6	A19V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692912	MT	8582	MT	8582	692912	681448	rs1556423493	NC_012920.1:8581:C:T
NC_012920.1:m.8584G>A	MT-ATP6	A20T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692913	MT	8584	MT	8584	692913	681449	rs3135028	NC_012920.1:8583:G:A
NC_012920.1:m.8588T>C	MT-ATP6	V21A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692914	MT	8588	MT	8588	692914	681450	rs1603221606	NC_012920.1:8587:T:C
NC_012920.1:m.8591T>C	MT-ATP6	L22P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692915	MT	8591	MT	8591	692915	681451	rs1603221609	NC_012920.1:8590:T:C
NC_012920.1:m.8593A>G	MT-ATP6	I23V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692916	MT	8593	MT	8593	692916	681452	rs1603221612	NC_012920.1:8592:A:G
NC_012920.1:m.8596A>G	MT-ATP6	I24V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692917	MT	8596	MT	8596	692917	681453	rs1603221617	NC_012920.1:8595:A:G
NC_012920.1:m.8597T>C	MT-ATP6	I24T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692918	MT	8597	MT	8597	692918	681454	rs1603221620	NC_012920.1:8596:T:C
NC_012920.1:m.8599C>A	MT-ATP6	L25M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692919	MT	8599	MT	8599	692919	681455	rs1603221623	NC_012920.1:8598:C:A
NC_012920.1:m.8602T>C	MT-ATP6	F26L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692920	MT	8602	MT	8602	692920	681456	rs1556423501	NC_012920.1:8601:T:C
NC_012920.1:m.8603T>C	MT-ATP6	F26S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692921	MT	8603	MT	8603	692921	681457	rs1603221627	NC_012920.1:8602:T:C
NC_012920.1:m.8605C>T	MT-ATP6	P27S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692922	MT	8605	MT	8605	692922	681458	rs1603221630	NC_012920.1:8604:C:T
NC_012920.1:m.8609C>T	MT-ATP6	P28L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692923	MT	8609	MT	8609	692923	681459	rs1603221634	NC_012920.1:8608:C:T
NC_012920.1:m.8612T>C	MT-ATP6	L29P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692924	MT	8612	MT	8612	692924	681460	rs1603221635	NC_012920.1:8611:T:C
NC_012920.1:m.8615T>C	MT-ATP6	L30S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692925	MT	8615	MT	8615	692925	681461	rs1603221637	NC_012920.1:8614:T:C
NC_012920.1(MT-ATP6):m.8616G>T	MT-ATP6	L30F	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235626	MT	8616	MT	8616	235626	237307	rs41427749	NC_012920.1:8615:G:T
NC_012920.1:m.8617A>G	MT-ATP6	I31V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692926	MT	8617	MT	8617	692926	681462	rs1603221641	NC_012920.1:8616:A:G
NC_012920.1:m.8618T>C	MT-ATP6	I31T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692927	MT	8618	MT	8618	692927	681463	rs28358885	NC_012920.1:8617:T:C
NC_012920.1:m.8619C>T	MT-ATP6		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235451	MT	8619	MT	8619	235451	237134	rs878853038	NC_012920.1:8618:C:T
NC_012920.1:m.8623A>T	MT-ATP6	T33S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692930	MT	8623	MT	8623	692930	681466	rs1603221645	NC_012920.1:8622:A:T
NC_012920.1:m.8623A>G	MT-ATP6	T33A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692929	MT	8623	MT	8623	692929	681465	rs1603221645	NC_012920.1:8622:A:G
NC_012920.1:m.8623A>C	MT-ATP6	T33P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692928	MT	8623	MT	8623	692928	681464	rs1603221645	NC_012920.1:8622:A:C
NC_012920.1:m.8624C>T	MT-ATP6	T33I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692931	MT	8624	MT	8624	692931	681467	rs1603221647	NC_012920.1:8623:C:T
NC_012920.1:m.8626T>C	MT-ATP6	S34P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692932	MT	8626	MT	8626	692932	681468	rs1603221648	NC_012920.1:8625:T:C
NC_012920.1:m.8632T>C	MT-ATP6	Y36H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692933	MT	8632	MT	8632	692933	681469	rs1603221654	NC_012920.1:8631:T:C
NC_012920.1:m.8635C>T	MT-ATP6	L37F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692934	MT	8635	MT	8635	692934	681470	rs1603221661	NC_012920.1:8634:C:T
NC_012920.1:m.8636T>C	MT-ATP6	L37P	not provided	not provided	no assertion provided	VCV001326905	MT	8636	MT	8636	1326905	1317367		NC_012920.1:8635:T:C
NC_012920.1:m.8638A>G	MT-ATP6	I38V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692935	MT	8638	MT	8638	692935	681471	rs1556423508	NC_012920.1:8637:A:G
NC_012920.1:m.8639T>C	MT-ATP6	I38T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692936	MT	8639	MT	8639	692936	681472	rs200047468	NC_012920.1:8638:T:C
NC_012920.1:m.8641A>G	MT-ATP6	N39D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692937	MT	8641	MT	8641	692937	681473	rs1603221662	NC_012920.1:8640:A:G
NC_012920.1:m.8642A>C	MT-ATP6	N39T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692939	MT	8642	MT	8642	692939	681474	rs1603221663	NC_012920.1:8641:A:C
NC_012920.1:m.8642A>G	MT-ATP6	N39S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692938	MT	8642	MT	8642	692938	681475	rs1603221663	NC_012920.1:8641:A:G
NC_012920.1:m.8648G>A	MT-ATP6	R41Q	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692940	MT	8648	MT	8648	692940	681476	rs28479867	NC_012920.1:8647:G:A
NC_012920.1:m.8651T>C	MT-ATP6	L42P	not provided|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000441129	MT	8651	MT	8651	441129	434782	rs1556423512	NC_012920.1:8650:T:C
NC_012920.1:m.8653A>G	MT-ATP6	I43V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692941	MT	8653	MT	8653	692941	681477	rs1603221669	NC_012920.1:8652:A:G
NC_012920.1:m.8654T>C	MT-ATP6	I43T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692942	MT	8654	MT	8654	692942	681478	rs200811540	NC_012920.1:8653:T:C
NC_012920.1:m.8656A>G	MT-ATP6	T44A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692943	MT	8656	MT	8656	692943	681479	rs1603221673	NC_012920.1:8655:A:G
NC_012920.1:m.8657C>T	MT-ATP6	T44I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692944	MT	8657	MT	8657	692944	681480	rs1603221675	NC_012920.1:8656:C:T
NC_012920.1:m.8659A>G	MT-ATP6	T45A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692945	MT	8659	MT	8659	692945	681481	rs879150284	NC_012920.1:8658:A:G
NC_012920.1:m.8666A>G	MT-ATP6	Q47R	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692946	MT	8666	MT	8666	692946	681482	rs1603221681	NC_012920.1:8665:A:G
NC_012920.1:m.8668T>C	MT-ATP6	W48R	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692947	MT	8668	MT	8668	692947	681483	rs1603221688	NC_012920.1:8667:T:C
NC_012920.1:m.8669G>C	MT-ATP6	W48S	not provided	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000618717	MT	8669	MT	8669	618717	610279	rs1569484228	NC_012920.1:8668:G:C
NC_012920.1:m.8679A>C	MT-ATP6	K51N	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692948	MT	8679	MT	8679	692948	681484	rs386829045	NC_012920.1:8678:A:C
NC_012920.1:m.8681T>C	MT-ATP6	L52P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692949	MT	8681	MT	8681	692949	681485	rs1603221696	NC_012920.1:8680:T:C
NC_012920.1:m.8683A>G	MT-ATP6	T53A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692950	MT	8683	MT	8683	692950	681486	rs1603221698	NC_012920.1:8682:A:G
NC_012920.1:m.8684C>T	MT-ATP6	T53I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692951	MT	8684	MT	8684	692951	681487	rs201336180	NC_012920.1:8683:C:T
NC_012920.1:m.8686T>A	MT-ATP6	S54T	not provided	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000618718	MT	8686	MT	8686	618718	610280	rs1569484231	NC_012920.1:8685:T:A
NC_012920.1:m.8686T>C	MT-ATP6	S54P	Leigh syndrome|Mitochondrial DNA-Associated Leigh Syndrome and NARP|Leber optic atrophy|NARP syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000585120	MT	8686	MT	8686	585120	576199	rs1569484231	NC_012920.1:8685:T:C
NC_012920.1:m.8697G>T	MT-ATP6	M57I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692952	MT	8697	MT	8697	692952	681488	rs879233543	NC_012920.1:8696:G:T
NC_012920.1:m.8699T>C	MT-ATP6	M58T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692953	MT	8699	MT	8699	692953	681489	rs1603221710	NC_012920.1:8698:T:C
NC_012920.1:m.8700A>T	MT-ATP6	M58I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692954	MT	8700	MT	8700	692954	681490	rs1603221711	NC_012920.1:8699:A:T
NC_012920.1:m.8701A>G	MT-ATP6	T59A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692955	MT	8701	MT	8701	692955	681491	rs2000975	NC_012920.1:8700:A:G
NC_012920.1:m.8702C>T	MT-ATP6	T59I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692956	MT	8702	MT	8702	692956	681492	rs1603221713	NC_012920.1:8701:C:T
NC_012920.1(MT-ATP6):m.8704A>G	MT-ATP6	M60V	Leigh syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000235260	MT	8704	MT	8704	235260	236947	rs878852994	NC_012920.1:8703:A:G
NC_012920.1:m.8705T>C	MT-ATP6	M60T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692957	MT	8705	MT	8705	692957	681493	rs878959404	NC_012920.1:8704:T:C
NC_012920.1:m.8711A>G	MT-ATP6	N62S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692958	MT	8711	MT	8711	692958	681494	rs1556423524	NC_012920.1:8710:A:G
NC_012920.1:m.8713A>G	MT-ATP6	T63A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692959	MT	8713	MT	8713	692959	681495	rs1603221721	NC_012920.1:8712:A:G
NC_012920.1:m.8714C>T	MT-ATP6	T63I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692960	MT	8714	MT	8714	692960	681496	rs1603221724	NC_012920.1:8713:C:T
NC_012920.1:m.8719G>A	MT-ATP6	G65*	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692961	MT	8719	MT	8719	692961	681497	rs28624611	NC_012920.1:8718:G:A
NC_012920.1:m.8720G>A	MT-ATP6	G65E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692963	MT	8720	MT	8720	692963	681498	rs1603221728	NC_012920.1:8719:G:A
NC_012920.1:m.8720G>C	MT-ATP6	G65A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692962	MT	8720	MT	8720	692962	681499	rs1603221728	NC_012920.1:8719:G:C
NC_012920.1:m.8722C>T	MT-ATP6	R66W	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692964	MT	8722	MT	8722	692964	681500	rs1603221733	NC_012920.1:8721:C:T
NC_012920.1:m.8723G>A	MT-ATP6	R66Q	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692965	MT	8723	MT	8723	692965	681501	rs1603221734	NC_012920.1:8722:G:A
NC_012920.1:m.8725A>G	MT-ATP6	T67A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692966	MT	8725	MT	8725	692966	681502	rs879216744	NC_012920.1:8724:A:G
NC_012920.1:m.8728T>C	MT-ATP6	W68R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692967	MT	8728	MT	8728	692967	681503	rs1603221742	NC_012920.1:8727:T:C
NC_012920.1:m.8731T>A	MT-ATP6	S69T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692968	MT	8731	MT	8731	692968	681504	rs1603221746	NC_012920.1:8730:T:A
NC_012920.1:m.8735T>C	MT-ATP6	L70P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692969	MT	8735	MT	8735	692969	681505	rs1603221752	NC_012920.1:8734:T:C
NC_012920.1:m.8737A>G	MT-ATP6	M71V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692970	MT	8737	MT	8737	692970	681506	rs1603221754	NC_012920.1:8736:A:G
NC_012920.1:m.8744T>C	MT-ATP6	V73A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692971	MT	8744	MT	8744	692971	681507	rs1603221756	NC_012920.1:8743:T:C
NC_012920.1:m.8746T>C	MT-ATP6	S74P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692972	MT	8746	MT	8746	692972	681508	rs1603221761	NC_012920.1:8745:T:C
NC_012920.1:m.8750T>C	MT-ATP6	L75S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692973	MT	8750	MT	8750	692973	681509	rs1603221765	NC_012920.1:8749:T:C
NC_012920.1:m.8752A>G	MT-ATP6	I76V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692974	MT	8752	MT	8752	692974	681510	rs1603221770	NC_012920.1:8751:A:G
NC_012920.1:m.8756T>C	MT-ATP6	I77T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692975	MT	8756	MT	8756	692975	681511	rs1556423532	NC_012920.1:8755:T:C
NC_012920.1:m.8761A>C	MT-ATP6	I79L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692976	MT	8761	MT	8761	692976	681512	rs1603221776	NC_012920.1:8760:A:C
NC_012920.1:m.8762T>C	MT-ATP6	I79T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692977	MT	8762	MT	8762	692977	681513	rs1603221778	NC_012920.1:8761:T:C
NC_012920.1:m.8764G>A	MT-ATP6	A80T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692978	MT	8764	MT	8764	692978	681514	rs1556423534	NC_012920.1:8763:G:A
NC_012920.1:m.8765C>T	MT-ATP6	A80V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692979	MT	8765	MT	8765	692979	681515	rs1603221781	NC_012920.1:8764:C:T
NC_012920.1:m.8767A>G	MT-ATP6	T81A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692980	MT	8767	MT	8767	692980	681516	rs1603221783	NC_012920.1:8766:A:G
NC_012920.1:m.8768C>T	MT-ATP6	T81M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692981	MT	8768	MT	8768	692981	681517	rs386829048	NC_012920.1:8767:C:T
NC_012920.1:m.8781C>A	MT-ATP6		not provided	Uncertain significance(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	VCV000376869	MT	8781	MT	8781	376869	363747	rs369034118	NC_012920.1:8780:C:A
NC_012920.1:m.8782G>A	MT-ATP6	G86*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692982	MT	8782	MT	8782	692982	681518	rs1603221801	NC_012920.1:8781:G:A
NC_012920.1:m.8783G>A	MT-ATP6	G86E	Leigh syndrome	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692983	MT	8783	MT	8783	692983	681519	rs1603221804	NC_012920.1:8782:G:A
NC_012920.1:m.8785C>G	MT-ATP6	L87V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692985	MT	8785	MT	8785	692985	681520	rs1603221807	NC_012920.1:8784:C:G
NC_012920.1:m.8785C>T	MT-ATP6	L87F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692984	MT	8785	MT	8785	692984	681521	rs1603221807	NC_012920.1:8784:C:T
NC_012920.1:m.8789T>C	MT-ATP6	L88P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692986	MT	8789	MT	8789	692986	681522	rs1603221811	NC_012920.1:8788:T:C
NC_012920.1:m.8790G>A	MT-ATP6		not provided	Likely benign(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000235546	MT	8790	MT	8790	235546	237227	rs878853063	NC_012920.1:8789:G:A
NC_012920.1:m.8794C>T	MT-ATP6	H90Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692987	MT	8794	MT	8794	692987	681523	rs2298007	NC_012920.1:8793:C:T
NC_012920.1:m.8800T>G	MT-ATP6	F92V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692988	MT	8800	MT	8800	692988	681524	rs1569484239	NC_012920.1:8799:T:G
NC_012920.1:m.8800T>C	MT-ATP6	F92L	not provided	Uncertain significance(Last reviewed: May 26, 2018)	criteria provided, single submitter	VCV000618719	MT	8800	MT	8800	618719	610281	rs1569484239	NC_012920.1:8799:T:C
NC_012920.1:m.8803A>G	MT-ATP6	T93A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692989	MT	8803	MT	8803	692989	681525	rs878853020	NC_012920.1:8802:A:G
NC_012920.1(MT-ATP6):m.8803A>T	MT-ATP6	T93S	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000235370	MT	8803	MT	8803	235370	237056	rs878853020	NC_012920.1:8802:A:T
NC_012920.1:m.8806C>T	MT-ATP6	P94S	not provided	not provided	no assertion provided	VCV000972939	MT	8806	MT	8806	972939	961364	rs2068712160	NC_012920.1:8805:C:T
NC_012920.1:m.8812A>T	MT-ATP6	T96S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692991	MT	8812	MT	8812	692991	681527	rs1556423543	NC_012920.1:8811:A:T
NC_012920.1:m.8812A>G	MT-ATP6	T96A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692990	MT	8812	MT	8812	692990	681526	rs1556423543	NC_012920.1:8811:A:G
NC_012920.1:m.8816A>G	MT-ATP6	Q97R	not provided	Uncertain significance(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000376981	MT	8816	MT	8816	376981	363859	rs1057520102	NC_012920.1:8815:A:G
NC_012920.1:m.8818C>T	MT-ATP6		not provided	Likely benign(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000235705	MT	8818	MT	8818	235705	237385	rs878853097	NC_012920.1:8817:C:T
NC_012920.1:m.8821T>A	MT-ATP6	S99T	not provided	not provided	no assertion provided	VCV001326901	MT	8821	MT	8821	1326901	1317363		NC_012920.1:8820:T:A
NC_012920.1:m.8821T>C	MT-ATP6	S99P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692992	MT	8821	MT	8821	692992	681528	rs1603221825	NC_012920.1:8820:T:C
NC_012920.1:m.8824A>G	MT-ATP6	M100V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692993	MT	8824	MT	8824	692993	681529	rs1603221827	NC_012920.1:8823:A:G
NC_012920.1:m.8825T>C	MT-ATP6	M100T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692994	MT	8825	MT	8825	692994	681530	rs1603221830	NC_012920.1:8824:T:C
NC_012920.1:m.8836A>G	MT-ATP6	M104V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692995	MT	8836	MT	8836	692995	681531	rs1603221835	NC_012920.1:8835:A:G
NC_012920.1:m.8839G>A	MT-ATP6	A105T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692996	MT	8839	MT	8839	692996	681532	rs1556423547	NC_012920.1:8838:G:A
NC_012920.1:m.8839G>C	MT-ATP6	A105P	Leigh syndrome|Mitochondrial disease	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000155892	MT	8839	MT	8839	155892	165641	rs1556423547	NC_012920.1:8838:G:C
NC_012920.1:m.8840C>T	MT-ATP6	A105V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692997	MT	8840	MT	8840	692997	681533	rs1603221837	NC_012920.1:8839:C:T
NC_012920.1:m.8842A>G	MT-ATP6	I106V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692999	MT	8842	MT	8842	692999	681535	rs386829052	NC_012920.1:8841:A:G
NC_012920.1:m.8842A>C	MT-ATP6	I106L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000692998	MT	8842	MT	8842	692998	681534	rs386829052	NC_012920.1:8841:A:C
NC_012920.1:m.8843T>C	MT-ATP6	I106T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693000	MT	8843	MT	8843	693000	681536	rs386829053	NC_012920.1:8842:T:C
NC_012920.1:m.8844C>A	MT-ATP6	I106M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693001	MT	8844	MT	8844	693001	681537	rs1603221840	NC_012920.1:8843:C:A
NC_012920.1:m.8851T>C	MT-ATP6	W109R	not provided|Mitochondrial disease|Leber optic atrophy|Striatonigral degeneration, infantile, mitochondrial|Leigh syndrome	Uncertain significance(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000009645	MT	8851	MT	8851	9645	24684	rs199476136	NC_012920.1:8850:T:C
NC_012920.1:m.8854G>A	MT-ATP6	A110T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693002	MT	8854	MT	8854	693002	681538	rs386829055	NC_012920.1:8853:G:A
NC_012920.1:m.8856G>A	MT-ATP6		not provided	Likely benign(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000235606	MT	8856	MT	8856	235606	237287	rs878853078	NC_012920.1:8855:G:A
NC_012920.1:m.8857G>A	MT-ATP6	G111S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693003	MT	8857	MT	8857	693003	681539	rs201017581	NC_012920.1:8856:G:A
NC_012920.1:m.8860A>G	MT-ATP6	T112A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693004	MT	8860	MT	8860	693004	681540	rs2001031	NC_012920.1:8859:A:G
NC_012920.1:m.8863G>A	MT-ATP6	V113M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693005	MT	8863	MT	8863	693005	681541	rs1603221852	NC_012920.1:8862:G:A
NC_012920.1:m.8864T>C	MT-ATP6	V113A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693006	MT	8864	MT	8864	693006	681542	rs1556423555	NC_012920.1:8863:T:C
NC_012920.1:m.8865G>A	MT-ATP6		not provided	Benign(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000235457	MT	8865	MT	8865	235457	237140	rs386829056	NC_012920.1:8864:G:A
NC_012920.1:m.8866A>G	MT-ATP6	I114V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693007	MT	8866	MT	8866	693007	681543	rs1603221856	NC_012920.1:8865:A:G
NC_012920.1:m.8868T>A	MT-ATP6	I114M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693008	MT	8868	MT	8868	693008	681544	rs1556423556	NC_012920.1:8867:T:A
NC_012920.1:m.8869A>G	MT-ATP6	M115V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693009	MT	8869	MT	8869	693009	681545	rs41432347	NC_012920.1:8868:A:G
NC_012920.1:m.8870T>C	MT-ATP6	M115T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693010	MT	8870	MT	8870	693010	681546	rs1556423560	NC_012920.1:8869:T:C
NC_012920.1:m.8873G>C	MT-ATP6	G116A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693011	MT	8873	MT	8873	693011	681547	rs1603221864	NC_012920.1:8872:G:C
NC_012920.1:m.8875T>C	MT-ATP6	F117L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693012	MT	8875	MT	8875	693012	681548	rs201123510	NC_012920.1:8874:T:C
NC_012920.1:m.8878C>T	MT-ATP6	R118C	not provided	not provided	no assertion provided	VCV000918021	MT	8878	MT	8878	918021	906356	rs2068712730	NC_012920.1:8877:C:T
NC_012920.1:m.8879G>A	MT-ATP6	R118H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693013	MT	8879	MT	8879	693013	681549	rs1603221870	NC_012920.1:8878:G:A
NC_012920.1:m.8886G>A	MT-ATP6		not provided	Likely benign(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000376933	MT	8886	MT	8886	376933	363811	rs386829057	NC_012920.1:8885:G:A
NC_012920.1:m.8887A>G	MT-ATP6	I121V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693014	MT	8887	MT	8887	693014	681550	rs1556423565	NC_012920.1:8886:A:G
NC_012920.1:m.8888T>C	MT-ATP6	I121T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693015	MT	8888	MT	8888	693015	681551	rs1603221880	NC_012920.1:8887:T:C
NC_012920.1:m.8895T>A	MT-ATP6	N123K	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693016	MT	8895	MT	8895	693016	681552	rs1603221884	NC_012920.1:8894:T:A
NC_012920.1:m.8896G>A	MT-ATP6	A124T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693017	MT	8896	MT	8896	693017	681553	rs202120082	NC_012920.1:8895:G:A
NC_012920.1:m.8897C>T	MT-ATP6	A124V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693018	MT	8897	MT	8897	693018	681554	rs1603221889	NC_012920.1:8896:C:T
NC_012920.1:m.8906A>C	MT-ATP6	H127P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693019	MT	8906	MT	8906	693019	681555	rs1603221897	NC_012920.1:8905:A:C
NC_012920.1:m.8908T>C	MT-ATP6	F128L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693020	MT	8908	MT	8908	693020	681556	rs1603221898	NC_012920.1:8907:T:C
NC_012920.1:m.8910C>A	MT-ATP6	F128L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693021	MT	8910	MT	8910	693021	681557	rs1603221899	NC_012920.1:8909:C:A
NC_012920.1:m.8920G>A	MT-ATP6	G132S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693022	MT	8920	MT	8920	693022	681558	rs28406348	NC_012920.1:8919:G:A
NC_012920.1:m.8921G>A	MT-ATP6	G132D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693023	MT	8921	MT	8921	693023	681559	rs2298008	NC_012920.1:8920:G:A
NC_012920.1:m.8923A>G	MT-ATP6	T133A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693024	MT	8923	MT	8923	693024	681560	rs200329150	NC_012920.1:8922:A:G
NC_012920.1:m.8930C>T	MT-ATP6	T135M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693025	MT	8930	MT	8930	693025	681561	rs1603221915	NC_012920.1:8929:C:T
NC_012920.1(MT-ATP6):m.8932C>T	MT-ATP6	P136S	Leigh syndrome|not provided|Mitochondrial disease	Benign(Last reviewed: Mar 22, 2021)	reviewed by expert panel	VCV000235343	MT	8932	MT	8932	235343	237030	rs878853013	NC_012920.1:8931:C:T
NC_012920.1:m.8933C>T	MT-ATP6	P136L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693026	MT	8933	MT	8933	693026	681562	rs1603221918	NC_012920.1:8932:C:T
NC_012920.1:m.8935C>T	MT-ATP6	L137F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693027	MT	8935	MT	8935	693027	681563	rs28377547	NC_012920.1:8934:C:T
NC_012920.1:m.8936T>A	MT-ATP6	L137H	Mitochondrial disease	Uncertain significance(Last reviewed: Mar 22, 2021)	reviewed by expert panel	VCV001172526	MT	8936	MT	8936	1172526	1161635		NC_012920.1:8935:T:A
NC_012920.1:m.8936T>C	MT-ATP6	L137P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693028	MT	8936	MT	8936	693028	681564	rs1603221920	NC_012920.1:8935:T:C
NC_012920.1:m.8938A>G	MT-ATP6	I138V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693029	MT	8938	MT	8938	693029	681565	rs1603221923	NC_012920.1:8937:A:G
NC_012920.1:m.8939T>C	MT-ATP6	I138T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693030	MT	8939	MT	8939	693030	681566	rs1603221925	NC_012920.1:8938:T:C
NC_012920.1:m.8941C>T	MT-ATP6	P139S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693031	MT	8941	MT	8941	693031	681567	rs1603221928	NC_012920.1:8940:C:T
NC_012920.1:m.8943C>T	MT-ATP6		not provided	Likely benign(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000377352	MT	8943	MT	8943	377352	364230	rs1057520204	NC_012920.1:8942:C:T
NC_012920.1:m.8944A>G	MT-ATP6	M140V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693032	MT	8944	MT	8944	693032	681568	rs1603221929	NC_012920.1:8943:A:G
NC_012920.1:m.8946A>T	MT-ATP6	M140I	not provided	not provided	no assertion provided	VCV000918025	MT	8946	MT	8946	918025	906357	rs879181854	NC_012920.1:8945:A:T
NC_012920.1:m.8950G>A	MT-ATP6	V142I	Bicuspid aortic valve|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000590268	MT	8950	MT	8950	590268	581210	rs1556423574	NC_012920.1:8949:G:A
NC_012920.1:m.8951T>C	MT-ATP6	V142A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693033	MT	8951	MT	8951	693033	681569	rs1603221934	NC_012920.1:8950:T:C
NC_012920.1:m.8953A>G	MT-ATP6	I143V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693034	MT	8953	MT	8953	693034	681570	rs1603221936	NC_012920.1:8952:A:G
NC_012920.1:m.8954T>C	MT-ATP6	I143T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693035	MT	8954	MT	8954	693035	681571	rs1556423576	NC_012920.1:8953:T:C
NC_012920.1:m.8959G>A	MT-ATP6	E145K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693036	MT	8959	MT	8959	693036	681572	rs1603221944	NC_012920.1:8958:G:A
NC_012920.1:m.8962A>G	MT-ATP6	T146A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693037	MT	8962	MT	8962	693037	681573	rs1603221945	NC_012920.1:8961:A:G
NC_012920.1:m.8966T>C	MT-ATP6	I147T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693038	MT	8966	MT	8966	693038	681574	rs1556423580	NC_012920.1:8965:T:C
NC_012920.1:m.8969G>A	MT-ATP6	S148N	Myopathy, lactic acidosis, and sideroblastic anemia 3|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000191364	MT	8969	MT	8969	191364	189167	rs794726857	NC_012920.1:8968:G:A
NC_012920.1:m.8972T>C	MT-ATP6	L149P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693039	MT	8972	MT	8972	693039	681575	rs1603221948	NC_012920.1:8971:T:C
NC_012920.1:m.8974C>G	MT-ATP6	L150V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693040	MT	8974	MT	8974	693040	681576	rs1603221949	NC_012920.1:8973:C:G
NC_012920.1:m.8975T>C	MT-ATP6	L150P	Mitochondrial DNA-Associated Leigh Syndrome and NARP|Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693041	MT	8975	MT	8975	693041	681577	rs1981459	NC_012920.1:8974:T:C
NC_012920.1:m.8978T>C	MT-ATP6	I151T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693042	MT	8978	MT	8978	693042	681578	rs1603221954	NC_012920.1:8977:T:C
NC_012920.1:m.8980C>A	MT-ATP6	Q152K	not provided	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000931216	MT	8980	MT	8980	931216	920081	rs2068713551	NC_012920.1:8979:C:A
NC_012920.1:m.8981A>G	MT-ATP6	Q152R	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693043	MT	8981	MT	8981	693043	681579	rs1603221955	NC_012920.1:8980:A:G
NC_012920.1:m.8986A>G	MT-ATP6	M154V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693044	MT	8986	MT	8986	693044	681580	rs1603221956	NC_012920.1:8985:A:G
NC_012920.1:m.8987T>C	MT-ATP6	M154T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693045	MT	8987	MT	8987	693045	681581	rs1603221957	NC_012920.1:8986:T:C
NC_012920.1:m.8989G>A	MT-ATP6	A155T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693046	MT	8989	MT	8989	693046	681582	rs587776444	NC_012920.1:8988:G:A
NC_012920.1:m.8989G>C	MT-ATP6	A155P	Leigh syndrome	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000155893	MT	8989	MT	8989	155893	165642	rs587776444	NC_012920.1:8988:G:C
NC_012920.1:m.8993T>C	MT-ATP6	L156P	Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Mitochondrial disease|NARP syndrome|Ataxia and polyneuropathy, adult-onset|Leigh syndrome	Pathogenic(Last reviewed: Feb 17, 2021)	reviewed by expert panel	VCV000009642	MT	8993	MT	8993	9642	24681	rs199476133	NC_012920.1:8992:T:C
NC_012920.1:m.8993T>G	MT-ATP6	L156R	Cerebellar ataxia|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Mitochondrial disease|Leber optic atrophy|NARP syndrome|Leigh syndrome|Rod-cone dystrophy|Camptodactyly of finger|Bilateral cleft lip and palate|Wide intermamillary distance|Low-set ears|Hypertelorism|Postaxial hand polydactyly|Scrotal hypoplasia|Premature birth	Pathogenic(Last reviewed: Mar 22, 2021)	reviewed by expert panel	VCV000009641	MT	8993	MT	8993	9641	24680	rs199476133	NC_012920.1:8992:T:G
NC_012920.1:m.8998G>A	MT-ATP6	V158M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693048	MT	8998	MT	8998	693048	681584	rs376792657	NC_012920.1:8997:G:A
NC_012920.1:m.8999T>C	MT-ATP6	V158A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693049	MT	8999	MT	8999	693049	681585	rs1603221963	NC_012920.1:8998:T:C
NC_012920.1:m.9005T>C	MT-ATP6	L160P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693050	MT	9005	MT	9005	693050	681586	rs1603221971	NC_012920.1:9004:T:C
NC_012920.1:m.9006A>G	MT-ATP6		not provided	Likely benign(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000446022	MT	9006	MT	9006	446022	439294	rs1556423587	NC_012920.1:9005:A:G
NC_012920.1:m.9007A>T	MT-ATP6	T161S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693052	MT	9007	MT	9007	693052	681588	rs1603221973	NC_012920.1:9006:A:T
NC_012920.1:m.9007A>G	MT-ATP6	T161A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693051	MT	9007	MT	9007	693051	681587	rs1603221973	NC_012920.1:9006:A:G
NC_012920.1:m.9010G>A	MT-ATP6	A162T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693053	MT	9010	MT	9010	693053	681589	rs1556423589	NC_012920.1:9009:G:A
NC_012920.1:m.9014A>G	MT-ATP6	N163S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693054	MT	9014	MT	9014	693054	681590	rs1603221980	NC_012920.1:9013:A:G
NC_012920.1:m.9016A>G	MT-ATP6	I164V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693055	MT	9016	MT	9016	693055	681591	rs1556423591	NC_012920.1:9015:A:G
NC_012920.1:m.9019A>G	MT-ATP6	T165A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693056	MT	9019	MT	9019	693056	681592	rs1603221982	NC_012920.1:9018:A:G
NC_012920.1:m.9025G>A	MT-ATP6	G167S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693057	MT	9025	MT	9025	693057	681593	rs28681063	NC_012920.1:9024:G:A
NC_012920.1:m.9026G>A	MT-ATP6	G167D	Mitochondrial disease|Leigh syndrome	Uncertain significance(Last reviewed: Mar 22, 2021)	reviewed by expert panel	VCV000693058	MT	9026	MT	9026	693058	681594	rs1603221987	NC_012920.1:9025:G:A
NC_012920.1:m.9028C>T	MT-ATP6	H168Y	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693059	MT	9028	MT	9028	693059	681595	rs1603221990	NC_012920.1:9027:C:T
NC_012920.1:m.9029A>G	MT-ATP6	H168R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693060	MT	9029	MT	9029	693060	681596	rs1603221991	NC_012920.1:9028:A:G
NC_012920.1:m.9032T>C	MT-ATP6	L169P	Rod-cone dystrophy|Cerebellar atrophy|Tremor|Cerebellar ataxia|Mitochondrial disease|Leigh syndrome	Uncertain significance(Last reviewed: Oct 26, 2021)	reviewed by expert panel	VCV000693061	MT	9032	MT	9032	693061	681597	rs1603221994	NC_012920.1:9031:T:C
NC_012920.1(MT-ATP6):m.9035T>C	MT-ATP6	L170P	Progressive cerebellar ataxia|See cases|Leigh syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000690280	MT	9035	MT	9035	690280	677959	rs1603222000	NC_012920.1:9034:T:C
NC_012920.1:m.9038T>C	MT-ATP6	M171T	See cases|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 2, 2020)	criteria provided, conflicting interpretations	VCV000693062	MT	9038	MT	9038	693062	681598	rs1603222003	NC_012920.1:9037:T:C
NC_012920.1:m.9041A>G	MT-ATP6	H172R	not provided|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000440988	MT	9041	MT	9041	440988	434701	rs879244322	NC_012920.1:9040:A:G
NC_012920.1:m.9047T>C	MT-ATP6	I174T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693063	MT	9047	MT	9047	693063	681599	rs1603222008	NC_012920.1:9046:T:C
NC_012920.1:m.9049G>A	MT-ATP6	G175*	Progressive spastic paraparesis|Abnormal basal ganglia MRI signal intensity|Gonadal dysgenesis|Cerebellar ataxia|Leigh syndrome	Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000693064	MT	9049	MT	9049	693064	681600	rs1603222011	NC_012920.1:9048:G:A
NC_012920.1:m.9052A>G	MT-ATP6	S176G	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693065	MT	9052	MT	9052	693065	681601	rs1556423597	NC_012920.1:9051:A:G
NC_012920.1:m.9053G>A	MT-ATP6	S176N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693066	MT	9053	MT	9053	693066	681602	rs199646902	NC_012920.1:9052:G:A
NC_012920.1:m.9055G>A	MT-ATP6	A177T	Mitochondrial disease|Leigh syndrome	Benign(Last reviewed: Oct 26, 2021)	reviewed by expert panel	VCV000693067	MT	9055	MT	9055	693067	681603	rs193303045	NC_012920.1:9054:G:A
NC_012920.1:m.9056C>T	MT-ATP6	A177V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693068	MT	9056	MT	9056	693068	681604	rs1603222017	NC_012920.1:9055:C:T
NC_012920.1:m.9058A>C	MT-ATP6	T178P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693070	MT	9058	MT	9058	693070	681605	rs1556423599	NC_012920.1:9057:A:C
NC_012920.1:m.9058A>G	MT-ATP6	T178A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693069	MT	9058	MT	9058	693069	681606	rs1556423599	NC_012920.1:9057:A:G
NC_012920.1:m.9064G>A	MT-ATP6	A180T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693071	MT	9064	MT	9064	693071	681607	rs386420013	NC_012920.1:9063:G:A
NC_012920.1:m.9067A>G	MT-ATP6	M181V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693072	MT	9067	MT	9067	693072	681608	rs1603222028	NC_012920.1:9066:A:G
NC_012920.1:m.9070T>G	MT-ATP6	S182A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693074	MT	9070	MT	9070	693074	681610	rs879190502	NC_012920.1:9069:T:G
NC_012920.1:m.9070T>C	MT-ATP6	S182P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693073	MT	9070	MT	9070	693073	681609	rs879190502	NC_012920.1:9069:T:C
NC_012920.1:m.9071C>T	MT-ATP6	S182L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693075	MT	9071	MT	9071	693075	681611	rs1603222032	NC_012920.1:9070:C:T
NC_012920.1:m.9072A>G	MT-ATP6		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235631	MT	9072	MT	9072	235631	237312	rs6650106	NC_012920.1:9071:A:G
NC_012920.1:m.9073A>C	MT-ATP6	T183P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693076	MT	9073	MT	9073	693076	681612	rs1556423603	NC_012920.1:9072:A:C
NC_012920.1:m.9077T>C	MT-ATP6	I184T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693077	MT	9077	MT	9077	693077	681613	rs1603222037	NC_012920.1:9076:T:C
NC_012920.1:m.9079A>G	MT-ATP6	N185D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693078	MT	9079	MT	9079	693078	681614	rs1603222038	NC_012920.1:9078:A:G
NC_012920.1:m.9080A>G	MT-ATP6	N185S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693079	MT	9080	MT	9080	693079	681615	rs1556423607	NC_012920.1:9079:A:G
NC_012920.1:m.9082C>T	MT-ATP6	L186F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693080	MT	9082	MT	9082	693080	681616	rs1603222043	NC_012920.1:9081:C:T
NC_012920.1:m.9083T>C	MT-ATP6	L186P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693081	MT	9083	MT	9083	693081	681617	rs1603222045	NC_012920.1:9082:T:C
NC_012920.1:m.9085C>A	MT-ATP6	P187T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693082	MT	9085	MT	9085	693082	681618	rs1603222048	NC_012920.1:9084:C:A
NC_012920.1:m.9086C>T	MT-ATP6	P187L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693083	MT	9086	MT	9086	693083	681619	rs1603222049	NC_012920.1:9085:C:T
NC_012920.1:m.9088T>C	MT-ATP6	S188P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693084	MT	9088	MT	9088	693084	681620	rs370460521	NC_012920.1:9087:T:C
NC_012920.1(MT-ATP6):m.9091A>G	MT-ATP6	T189A	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000376876	MT	9091	MT	9091	376876	363754	rs1057520079	NC_012920.1:9090:A:G
NC_012920.1:m.9094C>T	MT-ATP6	L190F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693085	MT	9094	MT	9094	693085	681621	rs1603222055	NC_012920.1:9093:C:T
NC_012920.1:m.9095T>C	MT-ATP6	L190P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693086	MT	9095	MT	9095	693086	681622	rs1603222056	NC_012920.1:9094:T:C
NC_012920.1:m.9097A>G	MT-ATP6	I191V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693087	MT	9097	MT	9097	693087	681623	rs1603222059	NC_012920.1:9096:A:G
NC_012920.1:m.9098T>G	MT-ATP6	I191S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693089	MT	9098	MT	9098	693089	681625	rs201559119	NC_012920.1:9097:T:G
NC_012920.1:m.9098T>C	MT-ATP6	I191T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693088	MT	9098	MT	9098	693088	681624	rs201559119	NC_012920.1:9097:T:C
NC_012920.1:m.9099C>A	MT-ATP6	I191M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693090	MT	9099	MT	9099	693090	681626	rs1603222065	NC_012920.1:9098:C:A
NC_012920.1:m.9100A>G	MT-ATP6	I192V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693091	MT	9100	MT	9100	693091	681627	rs1603222068	NC_012920.1:9099:A:G
NC_012920.1:m.9101T>G	MT-ATP6	I192S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693092	MT	9101	MT	9101	693092	681628	rs199476134	NC_012920.1:9100:T:G
m.9101T>C	MT-ATP6	I192T	Leigh syndrome|Leber optic atrophy	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009643	MT	9101	MT	9101	9643	24682	rs199476134	NC_012920.1:9100:T:C
NC_012920.1:m.9103T>C	MT-ATP6	F193L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693093	MT	9103	MT	9103	693093	681629	rs1603222077	NC_012920.1:9102:T:C
NC_012920.1:m.9104T>C	MT-ATP6	F193S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693094	MT	9104	MT	9104	693094	681630	rs1603222079	NC_012920.1:9103:T:C
NC_012920.1:m.9106A>G	MT-ATP6	T194A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693095	MT	9106	MT	9106	693095	681631	rs1603222082	NC_012920.1:9105:A:G
NC_012920.1:m.9110T>C	MT-ATP6	I195T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693096	MT	9110	MT	9110	693096	681632	rs1603222087	NC_012920.1:9109:T:C
NC_012920.1:m.9115A>G	MT-ATP6	I197V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693097	MT	9115	MT	9115	693097	681633	rs1603222091	NC_012920.1:9114:A:G
NC_012920.1:m.9116T>C	MT-ATP6	I197T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693098	MT	9116	MT	9116	693098	681634	rs376203575	NC_012920.1:9115:T:C
NC_012920.1:m.9122T>G	MT-ATP6	L199R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693099	MT	9122	MT	9122	693099	681635	rs1603222104	NC_012920.1:9121:T:G
NC_012920.1:m.9125C>T	MT-ATP6	T200I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693100	MT	9125	MT	9125	693100	681636	rs1603222109	NC_012920.1:9124:C:T
NC_012920.1:m.9127A>G	MT-ATP6	I201V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693101	MT	9127	MT	9127	693101	681637	rs199732761	NC_012920.1:9126:A:G
NC_012920.1:m.9128T>C	MT-ATP6	I201T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693102	MT	9128	MT	9128	693102	681638	rs878867946	NC_012920.1:9127:T:C
NC_012920.1:m.9130C>A	MT-ATP6	L202M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693103	MT	9130	MT	9130	693103	681639	rs1603222113	NC_012920.1:9129:C:A
NC_012920.1:m.9133G>A	MT-ATP6	E203K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693104	MT	9133	MT	9133	693104	681640	rs1603222118	NC_012920.1:9132:G:A
NC_012920.1:m.9134A>G	MT-ATP6	E203G	Leigh syndrome	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693105	MT	9134	MT	9134	693105	681641	rs1603222119	NC_012920.1:9133:A:G
NC_012920.1:m.9137T>C	MT-ATP6	I204T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693106	MT	9137	MT	9137	693106	681642	rs1603222121	NC_012920.1:9136:T:C
NC_012920.1:m.9139G>A	MT-ATP6	A205T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693107	MT	9139	MT	9139	693107	681643	rs879243938	NC_012920.1:9138:G:A
NC_012920.1:m.9140C>T	MT-ATP6	A205V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693108	MT	9140	MT	9140	693108	681644	rs878972895	NC_012920.1:9139:C:T
NC_012920.1:m.9142G>A	MT-ATP6	V206I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693109	MT	9142	MT	9142	693109	681645	rs200660596	NC_012920.1:9141:G:A
NC_012920.1:m.9145G>A	MT-ATP6	A207T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693110	MT	9145	MT	9145	693110	681646	rs1556423622	NC_012920.1:9144:G:A
NC_012920.1:m.9151A>G	MT-ATP6	I209V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693111	MT	9151	MT	9151	693111	681647	rs879206297	NC_012920.1:9150:A:G
NC_012920.1:m.9152T>C	MT-ATP6	I209T	Mitochondrial-DNA disorder|not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000235698	MT	9152	MT	9152	235698	237378	rs878853096	NC_012920.1:9151:T:C
NC_012920.1:m.9157G>A	MT-ATP6	A211T	not provided|Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000441146	MT	9157	MT	9157	441146	434783	rs1556423625	NC_012920.1:9156:G:A
NC_012920.1:m.9160T>C	MT-ATP6	Y212H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693112	MT	9160	MT	9160	693112	681648	rs1603222140	NC_012920.1:9159:T:C
NC_012920.1:m.9163G>A	MT-ATP6	V213I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693113	MT	9163	MT	9163	693113	681649	rs2298010	NC_012920.1:9162:G:A
NC_012920.1:m.9166T>C	MT-ATP6	F214L	Mitochondrial disease|Optic neuropathy|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000370051	MT	9166	MT	9166	370051	354304	rs1057516063	NC_012920.1:9165:T:C
NC_012920.1:m.9167T>C	MT-ATP6	F214S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693114	MT	9167	MT	9167	693114	681650	rs1603222143	NC_012920.1:9166:T:C
NC_012920.1:m.9169A>G	MT-ATP6	T215A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693115	MT	9169	MT	9169	693115	681651	rs1603222145	NC_012920.1:9168:A:G
NC_012920.1:m.9170C>T	MT-ATP6	T215M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693116	MT	9170	MT	9170	693116	681652	rs1603222148	NC_012920.1:9169:C:T
NC_012920.1:m.9176T>G	MT-ATP6	L217R	not provided|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|Mitochondrial disease|Leber optic atrophy|Leigh syndrome	Likely pathogenic(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000009650	MT	9176	MT	9176	9650	24689	rs199476135	NC_012920.1:9175:T:G
NC_012920.1:m.9176T>C	MT-ATP6	L217P	Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leigh syndrome|Leber optic atrophy|Striatonigral degeneration, infantile, mitochondrial	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009644	MT	9176	MT	9176	9644	24683	rs199476135	NC_012920.1:9175:T:C
NC_012920.1:m.9179T>C	MT-ATP6	V218A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693117	MT	9179	MT	9179	693117	681653	rs1603222150	NC_012920.1:9178:T:C
NC_012920.1:m.9181A>G	MT-ATP6	S219G	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693118	MT	9181	MT	9181	693118	681654	rs1556423628	NC_012920.1:9180:A:G
NC_012920.1:m.9182G>A	MT-ATP6	S219N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693119	MT	9182	MT	9182	693119	681655	rs1556423629	NC_012920.1:9181:G:A
NC_012920.1:m.9185T>C	MT-ATP6	L220P	Charcot-Marie-Tooth disease|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Mitochondrial disease|Leber optic atrophy|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000009647	MT	9185	MT	9185	9647	24686	rs199476138	NC_012920.1:9184:T:C
NC_012920.1:m.9188A>G	MT-ATP6	Y221C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693120	MT	9188	MT	9188	693120	681656	rs1603222161	NC_012920.1:9187:A:G
NC_012920.1:m.9191T>C	MT-ATP6	L222P	Mitochondrial disease|Leigh syndrome	Likely pathogenic(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000040153	MT	9191	MT	9191	40153	48652	rs1556423632	NC_012920.1:9190:T:C
NC_012920.1:m.9194A>G	MT-ATP6	H223R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693121	MT	9194	MT	9194	693121	681657	rs1603222162	NC_012920.1:9193:A:G
NC_012920.1:m.9196G>A	MT-ATP6	D224N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693122	MT	9196	MT	9196	693122	681658	rs374870159	NC_012920.1:9195:G:A
NC_012920.1:m.9202A>G	MT-ATP6	T226A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693123	MT	9202	MT	9202	693123	681659	rs1603222169	NC_012920.1:9201:A:G
NC_012920.1:m.9205T>C	MT-ATP6		Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693124	MT	9205	MT	9205	693124	681660	rs1603222171	NC_012920.1:9204:T:C
NC_012920.1:m.9210A>G	MT-CO3	T2A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693125	MT	9210	MT	9210	693125	681661	rs1556423633	NC_012920.1:9209:A:G
NC_012920.1:m.9211C>T	MT-CO3	T2I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693126	MT	9211	MT	9211	693126	681662	rs1603222177	NC_012920.1:9210:C:T
NC_012920.1:m.9214A>G	MT-CO3	H3R	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693127	MT	9214	MT	9214	693127	681663	rs1556423637	NC_012920.1:9213:A:G
NC_012920.1:m.9217A>G	MT-CO3	Q4R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693128	MT	9217	MT	9217	693128	681664	rs1603222182	NC_012920.1:9216:A:G
NC_012920.1:m.9219T>G	MT-CO3	S5A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693129	MT	9219	MT	9219	693129	681665	rs1603222184	NC_012920.1:9218:T:G
NC_012920.1:m.9234A>G	MT-CO3	M10V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693130	MT	9234	MT	9234	693130	681666	rs1603222190	NC_012920.1:9233:A:G
NC_012920.1:m.9237G>A	MT-CO3	V11M	Epilepsy|Mitochondrial encephalopathy|Developmental delay	Likely pathogenic(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370052	MT	9237	MT	9237	370052	354305	rs1057516064	NC_012920.1:9236:G:A
NC_012920.1:m.9247G>A	MT-CO3	S14N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693131	MT	9247	MT	9247	693131	681667	rs1553140066	NC_012920.1:9246:G:A
NC_012920.1:m.9261A>G	MT-CO3	T19A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693132	MT	9261	MT	9261	693132	681668	rs1603222202	NC_012920.1:9260:A:G
NC_012920.1:m.9265G>A	MT-CO3	G20E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693133	MT	9265	MT	9265	693133	681669	rs1556423649	NC_012920.1:9264:G:A
NC_012920.1:m.9267G>A	MT-CO3	A21T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693134	MT	9267	MT	9267	693134	681670	rs1556423650	NC_012920.1:9266:G:A
NC_012920.1:m.9270C>T	MT-CO3	L22F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693135	MT	9270	MT	9270	693135	681671	rs1603222205	NC_012920.1:9269:C:T
NC_012920.1:m.9276G>A	MT-CO3	A24T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693136	MT	9276	MT	9276	693136	681672	rs1603222209	NC_012920.1:9275:G:A
NC_012920.1:m.9281C>T	MT-CO3		not provided	Uncertain significance(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000235461	MT	9281	MT	9281	235461	237144	rs878853042	NC_012920.1:9280:C:T
NC_012920.1:m.9285A>G	MT-CO3	M27V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693137	MT	9285	MT	9285	693137	681673	rs1603222213	NC_012920.1:9284:A:G
NC_012920.1:m.9286T>C	MT-CO3	M27T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693138	MT	9286	MT	9286	693138	681674	rs1603222214	NC_012920.1:9285:T:C
NC_012920.1:m.9288A>G	MT-CO3	T28A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693139	MT	9288	MT	9288	693139	681675	rs1603222218	NC_012920.1:9287:A:G
NC_012920.1:m.9294G>A	MT-CO3	G30S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693140	MT	9294	MT	9294	693140	681676	rs1603222222	NC_012920.1:9293:G:A
NC_012920.1:m.9300G>A	MT-CO3	A32T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693141	MT	9300	MT	9300	693141	681677	rs371745772	NC_012920.1:9299:G:A
NC_012920.1:m.9301C>T	MT-CO3	A32V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693142	MT	9301	MT	9301	693142	681678	rs1603222227	NC_012920.1:9300:C:T
NC_012920.1:m.9304T>C	MT-CO3	M33T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693143	MT	9304	MT	9304	693143	681679	rs1603222232	NC_012920.1:9303:T:C
NC_012920.1:m.9309T>C	MT-CO3	F35L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693144	MT	9309	MT	9309	693144	681680	rs1603222236	NC_012920.1:9308:T:C
NC_012920.1:m.9316T>C	MT-CO3	F37S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693145	MT	9316	MT	9316	693145	681681	rs1603222240	NC_012920.1:9315:T:C
NC_012920.1:m.9318C>T	MT-CO3	H38Y	not provided	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000618214	MT	9318	MT	9318	618214	610282	rs1569484294	NC_012920.1:9317:C:T
NC_012920.1:m.9319A>G	MT-CO3	H38R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693146	MT	9319	MT	9319	693146	681682	rs1603222243	NC_012920.1:9318:A:G
NC_012920.1:m.9324A>G	MT-CO3	M40V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693147	MT	9324	MT	9324	693147	681683	rs1603222245	NC_012920.1:9323:A:G
NC_012920.1:m.9325T>C	MT-CO3	M40T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693148	MT	9325	MT	9325	693148	681684	rs879000531	NC_012920.1:9324:T:C
NC_012920.1:m.9327A>G	MT-CO3	T41A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693150	MT	9327	MT	9327	693150	681686	rs1603222247	NC_012920.1:9326:A:G
NC_012920.1:m.9327A>C	MT-CO3	T41P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693149	MT	9327	MT	9327	693149	681685	rs1603222247	NC_012920.1:9326:A:C
NC_012920.1:m.9331T>C	MT-CO3	L42P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693151	MT	9331	MT	9331	693151	681687	rs1603222252	NC_012920.1:9330:T:C
NC_012920.1:m.9336A>G	MT-CO3	M44V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693152	MT	9336	MT	9336	693152	681688	rs28474779	NC_012920.1:9335:A:G
NC_012920.1:m.9337T>C	MT-CO3	M44T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693153	MT	9337	MT	9337	693153	681689	rs1603222256	NC_012920.1:9336:T:C
NC_012920.1:m.9342G>A	MT-CO3	G46S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693154	MT	9342	MT	9342	693154	681690	rs28672157	NC_012920.1:9341:G:A
NC_012920.1:m.9353C>T	MT-CO3		not provided	Uncertain significance(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000235225	MT	9353	MT	9353	235225	236913	rs878852986	NC_012920.1:9352:C:T
NC_012920.1:m.9355A>G	MT-CO3	N50S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693155	MT	9355	MT	9355	693155	681691	rs1556423663	NC_012920.1:9354:A:G
NC_012920.1:m.9355A>T	MT-CO3	N50I	Subcutaneous lipoma|Nephrolithiasis|Chronic fatigue|Sleep apnea|Abnormal mitochondria in muscle tissue|Moderate sensorineural hearing impairment|Acute liver failure|Exercise intolerance|Oromandibular dystonia|Cerebellar ataxia|Hearing impairment|Short stature|Difficulty walking	Uncertain significance(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523307	MT	9355	MT	9355	523307	514152	rs1556423663	NC_012920.1:9354:A:T
NC_012920.1:m.9357A>G	MT-CO3	T51A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693156	MT	9357	MT	9357	693156	681692	rs1603222269	NC_012920.1:9356:A:G
NC_012920.1:m.9367T>C	MT-CO3	M54T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693157	MT	9367	MT	9367	693157	681693	rs1603222274	NC_012920.1:9366:T:C
NC_012920.1:m.9368A>G	MT-CO3		not provided	Likely benign(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000235541	MT	9368	MT	9368	235541	237222	rs386829076	NC_012920.1:9367:A:G
m.9379G>A	MT-CO3	W58*	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Cytochrome-c oxidase deficiency disease|Mitochondrial disease	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009657	MT	9379	MT	9379	9657	24696	rs267606615	NC_012920.1:9378:G:A
NC_012920.1:m.9387G>A	MT-CO3	V61M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693158	MT	9387	MT	9387	693158	681694	rs1603222285	NC_012920.1:9386:G:A
NC_012920.1:m.9390A>G	MT-CO3	T62A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693159	MT	9390	MT	9390	693159	681695	rs1603222288	NC_012920.1:9389:A:G
NC_012920.1:m.9391C>T	MT-CO3	T62M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693160	MT	9391	MT	9391	693160	681696	rs1556423673	NC_012920.1:9390:C:T
NC_012920.1:m.9405T>C	MT-CO3	Y67H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693161	MT	9405	MT	9405	693161	681697	rs1603222294	NC_012920.1:9404:T:C
m.9438G>A	MT-CO3	G78S	Leigh syndrome|Leber optic atrophy	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009651	MT	9438	MT	9438	9651	24690	rs267606611	NC_012920.1:9437:G:A
NC_012920.1:m.9439G>A	MT-CO3	G78D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693162	MT	9439	MT	9439	693162	681698	rs1603222309	NC_012920.1:9438:G:A
NC_012920.1:m.9445G>A	MT-CO3	R80Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693163	MT	9445	MT	9445	693163	681699	rs1603222311	NC_012920.1:9444:G:A
NC_012920.1:m.9448A>G	MT-CO3	Y81C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693164	MT	9448	MT	9448	693164	681700	rs1603222312	NC_012920.1:9447:A:G
NC_012920.1:m.9456A>C	MT-CO3	I84L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693166	MT	9456	MT	9456	693166	681701	rs1603222315	NC_012920.1:9455:A:C
NC_012920.1:m.9456A>G	MT-CO3	I84V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693165	MT	9456	MT	9456	693165	681702	rs1603222315	NC_012920.1:9455:A:G
NC_012920.1:m.9467T>C	MT-CO3		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235458	MT	9467	MT	9467	235458	237141	rs878853040	NC_012920.1:9466:T:C
NC_012920.1:m.9468A>G	MT-CO3	T88A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693167	MT	9468	MT	9468	693167	681703	rs879015841	NC_012920.1:9467:A:G
NC_012920.1:m.9469C>T	MT-CO3	T88I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693168	MT	9469	MT	9469	693168	681704	rs1603222325	NC_012920.1:9468:C:T
NC_012920.1:m.9477G>C	MT-CO3	V91L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693170	MT	9477	MT	9477	693170	681706	rs2853825	NC_012920.1:9476:G:C
NC_012920.1:m.9477G>A	MT-CO3	V91I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693169	MT	9477	MT	9477	693169	681705	rs2853825	NC_012920.1:9476:G:A
NC_012920.1:m.9478T>G	MT-CO3	V91G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693171	MT	9478	MT	9478	693171	681707	rs587776437	NC_012920.1:9477:T:G
NC_012920.1:m.9478T>C	MT-CO3	V91A	Leigh syndrome	Pathogenic(Last reviewed: Dec 2, 2021)	no assertion criteria provided	VCV000155885	MT	9478	MT	9478	155885	165634	rs587776437	NC_012920.1:9477:T:C
NC_012920.1:m.9480T>C	MT-CO3	F92L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693172	MT	9480	MT	9480	693172	681708	rs1603222335	NC_012920.1:9479:T:C
NC_012920.1:m.9481T>C	MT-CO3	F92S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693173	MT	9481	MT	9481	693173	681709	rs1603222339	NC_012920.1:9480:T:C
NC_012920.1:m.9484T>C	MT-CO3	F93S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693174	MT	9484	MT	9484	693174	681710	rs1603222342	NC_012920.1:9483:T:C
NC_012920.1:m.9489G>A	MT-CO3	A95T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693175	MT	9489	MT	9489	693175	681711	rs1603222343	NC_012920.1:9488:G:A
NC_012920.1:m.9490C>T	MT-CO3	A95V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693176	MT	9490	MT	9490	693176	681712	rs1603222345	NC_012920.1:9489:C:T
NC_012920.1:m.9495T>C	MT-CO3	F97L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693177	MT	9495	MT	9495	693177	681713	rs1556423681	NC_012920.1:9494:T:C
NC_012920.1:m.9508T>A	MT-CO3	F101Y	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693178	MT	9508	MT	9508	693178	681714	rs1603222350	NC_012920.1:9507:T:A
NC_012920.1:m.9509T>C	MT-CO3		not provided	Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000235641	MT	9509	MT	9509	235641	237322	rs375478739	NC_012920.1:9508:T:C
NC_012920.1:m.9525G>A	MT-CO3	A107T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693179	MT	9525	MT	9525	693179	681715	rs878977410	NC_012920.1:9524:G:A
NC_012920.1:m.9531A>G	MT-CO3	T109A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693180	MT	9531	MT	9531	693180	681716	rs386829082	NC_012920.1:9530:A:G
NC_012920.1:m.9545A>G	MT-CO3		not provided	Benign(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000235374	MT	9545	MT	9545	235374	237060	rs878853022	NC_012920.1:9544:A:G
NC_012920.1:m.9549C>T	MT-CO3	H115Y	See cases|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000693181	MT	9549	MT	9549	693181	681717	rs1603222370	NC_012920.1:9548:C:T
NC_012920.1:m.9564G>A	MT-CO3	G120S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693182	MT	9564	MT	9564	693182	681718	rs1603222373	NC_012920.1:9563:G:A
NC_012920.1:m.9568T>C	MT-CO3	I121T	not specified	Uncertain significance(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000439914	MT	9568	MT	9568	439914	433705	rs1556423691	NC_012920.1:9567:T:C
NC_012920.1:m.9571C>T	MT-CO3	T122I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693183	MT	9571	MT	9571	693183	681719	rs1603222374	NC_012920.1:9570:C:T
NC_012920.1:m.9577T>C	MT-CO3	L124P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693184	MT	9577	MT	9577	693184	681720	rs386829086	NC_012920.1:9576:T:C
NC_012920.1:m.9580A>C	MT-CO3	N125T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693185	MT	9580	MT	9580	693185	681721	rs1603222379	NC_012920.1:9579:A:C
NC_012920.1:m.9582C>T	MT-CO3	P126S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693186	MT	9582	MT	9582	693186	681722	rs1603222382	NC_012920.1:9581:C:T
NC_012920.1:m.9588G>A	MT-CO3	E128K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693187	MT	9588	MT	9588	693187	681723	rs1603222385	NC_012920.1:9587:G:A
NC_012920.1:m.9591G>A	MT-CO3	V129I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693188	MT	9591	MT	9591	693188	681724	rs878949273	NC_012920.1:9590:G:A
NC_012920.1:m.9592T>C	MT-CO3	V129A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693189	MT	9592	MT	9592	693189	681725	rs1603222390	NC_012920.1:9591:T:C
NC_012920.1:m.9604A>G	MT-CO3	N133S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693190	MT	9604	MT	9604	693190	681726	rs1556423697	NC_012920.1:9603:A:G
NC_012920.1:m.9612G>A	MT-CO3	V136M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693191	MT	9612	MT	9612	693191	681727	rs1603222398	NC_012920.1:9611:G:A
NC_012920.1:m.9621G>A	MT-CO3	A139T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693192	MT	9621	MT	9621	693192	681728	rs1603222400	NC_012920.1:9620:G:A
NC_012920.1:m.9630G>A	MT-CO3	V142M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693193	MT	9630	MT	9630	693193	681729	rs1603222403	NC_012920.1:9629:G:A
NC_012920.1:m.9631T>C	MT-CO3	V142A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693194	MT	9631	MT	9631	693194	681730	rs1603222406	NC_012920.1:9630:T:C
NC_012920.1:m.9633T>C	MT-CO3	S143P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693195	MT	9633	MT	9633	693195	681731	rs1603222407	NC_012920.1:9632:T:C
NC_012920.1:m.9636A>G	MT-CO3	I144V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693196	MT	9636	MT	9636	693196	681732	rs1603222411	NC_012920.1:9635:A:G
NC_012920.1:m.9637T>C	MT-CO3	I144T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693197	MT	9637	MT	9637	693197	681733	rs1603222412	NC_012920.1:9636:T:C
NC_012920.1:m.9652A>G	MT-CO3	H149R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693198	MT	9652	MT	9652	693198	681734	rs1603222415	NC_012920.1:9651:A:G
NC_012920.1:m.9654A>G	MT-CO3	S150G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693199	MT	9654	MT	9654	693199	681735	rs1603222419	NC_012920.1:9653:A:G
NC_012920.1:m.9660A>G	MT-CO3	M152V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693200	MT	9660	MT	9660	693200	681736	rs1603222423	NC_012920.1:9659:A:G
NC_012920.1:m.9663G>A	MT-CO3	E153K	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693201	MT	9663	MT	9663	693201	681737	rs1603222427	NC_012920.1:9662:G:A
NC_012920.1:m.9664A>G	MT-CO3	E153G	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693202	MT	9664	MT	9664	693202	681738	rs1603222429	NC_012920.1:9663:A:G
NC_012920.1:m.9667A>G	MT-CO3	N154S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693203	MT	9667	MT	9667	693203	681739	rs41482146	NC_012920.1:9666:A:G
NC_012920.1:m.9670A>G	MT-CO3	N155S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693204	MT	9670	MT	9670	693204	681740	rs1556423709	NC_012920.1:9669:A:G
NC_012920.1:m.9682T>C	MT-CO3	M159T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693205	MT	9682	MT	9682	693205	681741	rs199750417	NC_012920.1:9681:T:C
NC_012920.1:m.9685T>C	MT-CO3	I160T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693206	MT	9685	MT	9685	693206	681742	rs1556423710	NC_012920.1:9684:T:C
NC_012920.1:m.9699A>G	MT-CO3	I165V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693207	MT	9699	MT	9699	693207	681743	rs1603222436	NC_012920.1:9698:A:G
NC_012920.1:m.9700T>C	MT-CO3	I165T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693208	MT	9700	MT	9700	693208	681744	rs1603222437	NC_012920.1:9699:T:C
NC_012920.1:m.9705A>G	MT-CO3	I167V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693209	MT	9705	MT	9705	693209	681745	rs1603222440	NC_012920.1:9704:A:G
NC_012920.1:m.9706T>C	MT-CO3	I167T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693210	MT	9706	MT	9706	693210	681746	rs1603222441	NC_012920.1:9705:T:C
NC_012920.1:m.9714G>A	MT-CO3	G170S	not provided	Uncertain significance(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000439913	MT	9714	MT	9714	439913	433704	rs1556423712	NC_012920.1:9713:G:A
NC_012920.1:m.9717C>T	MT-CO3	L171F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693211	MT	9717	MT	9717	693211	681747	rs1603222453	NC_012920.1:9716:C:T
NC_012920.1:m.9727C>T	MT-CO3	T174I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693212	MT	9727	MT	9727	693212	681748	rs1603222461	NC_012920.1:9726:C:T
NC_012920.1:m.9738G>A	MT-CO3	A178T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693213	MT	9738	MT	9738	693213	681749	rs1556423714	NC_012920.1:9737:G:A
NC_012920.1:m.9739C>T	MT-CO3	A178V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693214	MT	9739	MT	9739	693214	681750	rs879159866	NC_012920.1:9738:C:T
NC_012920.1:m.9751T>G	MT-CO3	F182C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693216	MT	9751	MT	9751	693216	681752	rs1603222471	NC_012920.1:9750:T:G
NC_012920.1:m.9751T>C	MT-CO3	F182S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693215	MT	9751	MT	9751	693215	681751	rs1603222471	NC_012920.1:9750:T:C
NC_012920.1:m.9752C>A	MT-CO3	F182L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693217	MT	9752	MT	9752	693217	681753	rs1569484321	NC_012920.1:9751:C:A
NC_012920.1:m.9753G>C	MT-CO3	E183Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693219	MT	9753	MT	9753	693219	681755	rs1569484322	NC_012920.1:9752:G:C
NC_012920.1:m.9753G>A	MT-CO3	E183K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693218	MT	9753	MT	9753	693218	681754	rs1569484322	NC_012920.1:9752:G:A
NC_012920.1:m.9754A>G	MT-CO3	E183G	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693220	MT	9754	MT	9754	693220	681756	rs1603222476	NC_012920.1:9753:A:G
NC_012920.1:m.9756T>G	MT-CO3	S184A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693221	MT	9756	MT	9756	693221	681757	rs1603222480	NC_012920.1:9755:T:G
NC_012920.1:m.9759C>T	MT-CO3	P185S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693222	MT	9759	MT	9759	693222	681758	rs1603222483	NC_012920.1:9758:C:T
NC_012920.1:m.9765A>G	MT-CO3	T187A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693223	MT	9765	MT	9765	693223	681759	rs1603222489	NC_012920.1:9764:A:G
NC_012920.1:m.9769T>C	MT-CO3	I188T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693224	MT	9769	MT	9769	693224	681760	rs1603222494	NC_012920.1:9768:T:C
NC_012920.1:m.9777G>A	MT-CO3	G191S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693225	MT	9777	MT	9777	693225	681761	rs1556423722	NC_012920.1:9776:G:A
NC_012920.1:m.9786G>A	MT-CO3	G194S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693226	MT	9786	MT	9786	693226	681762	rs1603222499	NC_012920.1:9785:G:A
NC_012920.1:m.9801G>A	MT-CO3	V199M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693227	MT	9801	MT	9801	693227	681763	rs1556423726	NC_012920.1:9800:G:A
NC_012920.1:m.9802T>C	MT-CO3	V199A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693228	MT	9802	MT	9802	693228	681764	rs1603222502	NC_012920.1:9801:T:C
NC_012920.1:m.9804G>T	MT-CO3	A200S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693230	MT	9804	MT	9804	693230	681766	rs200613617	NC_012920.1:9803:G:T
NC_012920.1:m.9804G>C	MT-CO3	A200P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693229	MT	9804	MT	9804	693229	681765	rs200613617	NC_012920.1:9803:G:C
m.9804G>A	MT-CO3	A200T	Leigh syndrome|See cases|not provided|Leber optic atrophy	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000009652	MT	9804	MT	9804	9652	24691	rs200613617	NC_012920.1:9803:G:A
NC_012920.1:m.9813T>C	MT-CO3	F203L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693231	MT	9813	MT	9813	693231	681767	rs1556423727	NC_012920.1:9812:T:C
NC_012920.1:m.9813T>A	MT-CO3	F203I	not provided	not provided	no assertion provided	VCV000441131	MT	9813	MT	9813	441131	434784	rs1556423727	NC_012920.1:9812:T:A
NC_012920.1:m.9819G>A	MT-CO3	G205*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693232	MT	9819	MT	9819	693232	681768	rs1603222512	NC_012920.1:9818:G:A
NC_012920.1:m.9820G>A	MT-CO3	G205E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693233	MT	9820	MT	9820	693233	681769	rs1603222513	NC_012920.1:9819:G:A
NC_012920.1:m.9822C>T	MT-CO3	L206F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693234	MT	9822	MT	9822	693234	681770	rs1556423729	NC_012920.1:9821:C:T
NC_012920.1:m.9828G>A	MT-CO3	V208I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693235	MT	9828	MT	9828	693235	681771	rs1603222521	NC_012920.1:9827:G:A
NC_012920.1:m.9837G>A	MT-CO3	G211S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693236	MT	9837	MT	9837	693236	681772	rs1603222528	NC_012920.1:9836:G:A
NC_012920.1:m.9838G>A	MT-CO3	G211D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693237	MT	9838	MT	9838	693237	681773	rs1603222533	NC_012920.1:9837:G:A
NC_012920.1:m.9843A>G	MT-CO3	T213A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693238	MT	9843	MT	9843	693238	681774	rs1603222537	NC_012920.1:9842:A:G
NC_012920.1:m.9844C>T	MT-CO3	T213I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693239	MT	9844	MT	9844	693239	681775	rs1603222540	NC_012920.1:9843:C:T
NC_012920.1:m.9852A>G	MT-CO3	T216A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693240	MT	9852	MT	9852	693240	681776	rs1603222544	NC_012920.1:9851:A:G
NC_012920.1:m.9855A>G	MT-CO3	I217V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693241	MT	9855	MT	9855	693241	681777	rs201552272	NC_012920.1:9854:A:G
NC_012920.1:m.9856T>C	MT-CO3	I217T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693242	MT	9856	MT	9856	693242	681778	rs1603222553	NC_012920.1:9855:T:C
NC_012920.1(MT-CO3):m.9861T>C	MT-CO3	F219L	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235537	MT	9861	MT	9861	235537	237218	rs878853060	NC_012920.1:9860:T:C
NC_012920.1:m.9862T>A	MT-CO3	F219Y	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693243	MT	9862	MT	9862	693243	681779	rs1603222555	NC_012920.1:9861:T:A
NC_012920.1:m.9868G>A	MT-CO3	R221H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693244	MT	9868	MT	9868	693244	681780	rs1603222560	NC_012920.1:9867:G:A
NC_012920.1:m.9903T>C	MT-CO3	F233L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693245	MT	9903	MT	9903	693245	681781	rs199999390	NC_012920.1:9902:T:C
NC_012920.1:m.9909T>C	MT-CO3	F235L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693246	MT	9909	MT	9909	693246	681782	rs28690056	NC_012920.1:9908:T:C
NC_012920.1:m.9911C>A	MT-CO3	F235L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693247	MT	9911	MT	9911	693247	681783	rs28615236	NC_012920.1:9910:C:A
NC_012920.1:m.9921G>A	MT-CO3	A239T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693248	MT	9921	MT	9921	693248	681784	rs1556423740	NC_012920.1:9920:G:A
NC_012920.1:m.9922C>T	MT-CO3	A239V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693249	MT	9922	MT	9922	693249	681785	rs1603222583	NC_012920.1:9921:C:T
NC_012920.1:m.9939G>A	MT-CO3	V245M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693250	MT	9939	MT	9939	693250	681786	rs1603222586	NC_012920.1:9938:G:A
NC_012920.1:m.9947G>A	MT-CO3		not provided	Benign(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000235536	MT	9947	MT	9947	235536	237217	rs370688668	NC_012920.1:9946:G:A
NC_012920.1:m.9948G>A	MT-CO3	V248I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693251	MT	9948	MT	9948	693251	681787	rs1556423747	NC_012920.1:9947:G:A
m.9952G>A	MT-CO3	W249*	Cytochrome-c oxidase deficiency disease	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000009655	MT	9952	MT	9952	9655	24694	rs267606613	NC_012920.1:9951:G:A
NC_012920.1:m.9957T>C	MT-CO3	F251L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693252	MT	9957	MT	9957	693252	681788	rs1556423753	NC_012920.1:9956:T:C
NC_012920.1:m.9966G>C	MT-CO3	V254L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693253	MT	9966	MT	9966	693253	681789	rs200809063	NC_012920.1:9965:G:C
NC_012920.1(MT-CO3):m.9966G>A	MT-CO3	V254I	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377020	MT	9966	MT	9966	377020	363898	rs200809063	NC_012920.1:9965:G:A
NC_012920.1:m.9967T>C	MT-CO3	V254A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693254	MT	9967	MT	9967	693254	681790	rs1603222598	NC_012920.1:9966:T:C
NC_012920.1:m.9972A>G	MT-CO3	I256V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693255	MT	9972	MT	9972	693255	681791	rs1603222600	NC_012920.1:9971:A:G
NC_012920.1:m.9981T>G	MT-CO3	W259G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693256	MT	9981	MT	9981	693256	681792	rs1603222606	NC_012920.1:9980:T:G
NC_012920.1:m.9984G>A	MT-CO3	G260*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693257	MT	9984	MT	9984	693257	681793	rs1603222608	NC_012920.1:9983:G:A
NC_012920.1:m.9987T>C	MT-CO3	S261P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693258	MT	9987	MT	9987	693258	681794	rs1603222609	NC_012920.1:9986:T:C
NC_012920.1(MT-CYB):m.9991A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690086	MT	9991	MT	9991	690086	677951	rs1603222612	NC_012920.1:9990:A:G
NC_012920.1(MT-CYB):m.9993T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690087	MT	9993	MT	9993	690087	677952	rs1603222613	NC_012920.1:9992:T:C
NC_012920.1(MT-CYB):m.9995T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690088	MT	9995	MT	9995	690088	677953	rs1603222616	NC_012920.1:9994:T:C
NC_012920.1(MT-CYB):m.9996T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690089	MT	9996	MT	9996	690089	677954	rs1556423755	NC_012920.1:9995:T:C
NC_012920.1(MT-CYB):m.9997T>A	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690090	MT	9997	MT	9997	690090	677955	rs121434475	NC_012920.1:9996:T:A
m.9997T>C	MT-TG		Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 1, 1994)	no assertion criteria provided	VCV000009611	MT	9997	MT	9997	9611	24650	rs121434475	NC_012920.1:9996:T:C
NC_012920.1(MT-CYB):m.10003T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690091	MT	10003	MT	10003	690091	677483	rs1603222620	NC_012920.1:10002:T:C
NC_012920.1(MT-CYB):m.10005A>T	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690093	MT	10005	MT	10005	690093	677485	rs1603222621	NC_012920.1:10004:A:T
NC_012920.1(MT-CYB):m.10005A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690092	MT	10005	MT	10005	690092	677484	rs1603222621	NC_012920.1:10004:A:G
NC_012920.1(MT-CYB):m.10006A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690094	MT	10006	MT	10006	690094	677486	rs1603222622	NC_012920.1:10005:A:G
NC_012920.1(MT-CYB):m.10007T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690095	MT	10007	MT	10007	690095	677487	rs201906571	NC_012920.1:10006:T:C
NC_012920.1(MT-CYB):m.10008A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690096	MT	10008	MT	10008	690096	677488	rs1603222626	NC_012920.1:10007:A:G
m.10010T>C	MT-TG		Exercise intolerance	Pathogenic(Last reviewed: Apr 23, 2002)	no assertion criteria provided	VCV000009612	MT	10010	MT	10010	9612	24651	rs121434476	NC_012920.1:10009:T:C
NC_012920.1(MT-CYB):m.10013C>T	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690097	MT	10013	MT	10013	690097	677489	rs1603222627	NC_012920.1:10012:C:T
NC_012920.1(MT-CYB):m.10014G>A	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690098	MT	10014	MT	10014	690098	677490	rs1603222629	NC_012920.1:10013:G:A
NC_012920.1(MT-CYB):m.10015T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690099	MT	10015	MT	10015	690099	677491	rs28374827	NC_012920.1:10014:T:C
NC_012920.1:m.10018A>G	MT-TG		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000440974	MT	10018	MT	10018	440974	434696	rs1556423757	NC_012920.1:10017:A:G
NC_012920.1(MT-CYB):m.10020T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690100	MT	10020	MT	10020	690100	677492	rs1603222636	NC_012920.1:10019:T:C
NC_012920.1(MT-CYB):m.10027T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690101	MT	10027	MT	10027	690101	677493	rs1603222638	NC_012920.1:10026:T:C
NC_012920.1(MT-CYB):m.10029A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690102	MT	10029	MT	10029	690102	677494	rs1603222639	NC_012920.1:10028:A:G
NC_012920.1(MT-CYB):m.10031T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690103	MT	10031	MT	10031	690103	677495	rs200048690	NC_012920.1:10030:T:C
NC_012920.1(MT-CYB):m.10034T>C	MT-TG		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000690104	MT	10034	MT	10034	690104	677496	rs41347846	NC_012920.1:10033:T:C
NC_012920.1(MT-CYB):m.10040C>T	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690105	MT	10040	MT	10040	690105	677497	rs1603222642	NC_012920.1:10039:C:T
NC_012920.1(MT-CYB):m.10042A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690106	MT	10042	MT	10042	690106	677498	rs1603222643	NC_012920.1:10041:A:G
m.10044A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Sudden death	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009613	MT	10044	MT	10044	9613	24652	rs41362547	NC_012920.1:10043:A:G
NC_012920.1(MT-CYB):m.10045T>C	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690108	MT	10045	MT	10045	690108	677500	rs1603222648	NC_012920.1:10044:T:C
NC_012920.1:m.10046T>C	MT-TG		not specified|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000235011	MT	10046	MT	10046	235011	236823	rs876661357	NC_012920.1:10045:T:C
NC_012920.1(MT-CYB):m.10048A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690109	MT	10048	MT	10048	690109	677501	rs878957961	NC_012920.1:10047:A:G
NC_012920.1(MT-CYB):m.10055A>G	MT-TG		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690110	MT	10055	MT	10055	690110	677502	rs1603222653	NC_012920.1:10054:A:G
NC_012920.1:m.10083A>G	MT-ND3	I9V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693259	MT	10083	MT	10083	693259	680149	rs1556423760	NC_012920.1:10082:A:G
NC_012920.1(MT-ND3):m.10084T>C	MT-ND3	I9T	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235627	MT	10084	MT	10084	235627	237308	rs41487950	NC_012920.1:10083:T:C
NC_012920.1:m.10086A>G	MT-ND3	N10D	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693260	MT	10086	MT	10086	693260	680150	rs28358274	NC_012920.1:10085:A:G
NC_012920.1:m.10098G>T	MT-ND3	A14S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693261	MT	10098	MT	10098	693261	680151	rs1569484342	NC_012920.1:10097:G:T
NC_012920.1:m.10110A>G	MT-ND3	M18V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693262	MT	10110	MT	10110	693262	680152	rs1603222674	NC_012920.1:10109:A:G
NC_012920.1:m.10111T>C	MT-ND3	M18T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693263	MT	10111	MT	10111	693263	680153	rs1603222676	NC_012920.1:10110:T:C
NC_012920.1:m.10113A>G	MT-ND3	I19V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693264	MT	10113	MT	10113	693264	680154	rs1603222679	NC_012920.1:10112:A:G
NC_012920.1:m.10134C>A	MT-ND3	Q26K	Leigh syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000156375	MT	10134	MT	10134	156375	166157	rs587780529	NC_012920.1:10133:C:A
NC_012920.1:m.10143G>A	MT-ND3	G29S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693265	MT	10143	MT	10143	693265	680155	rs202131419	NC_012920.1:10142:G:A
NC_012920.1:m.10146T>C	MT-ND3	Y30H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693266	MT	10146	MT	10146	693266	680156	rs1603222696	NC_012920.1:10145:T:C
NC_012920.1:m.10158T>A	MT-ND3	S34T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693267	MT	10158	MT	10158	693267	680157	rs199476117	NC_012920.1:10157:T:A
m.10158T>C	MT-ND3	S34P	Mitochondrial complex 1 deficiency, mitochondrial type 1|not provided|Mitochondrial disease|Leigh syndrome	Pathogenic(Last reviewed: Oct 26, 2021)	reviewed by expert panel	VCV000009714	MT	10158	MT	10158	9714	24753	rs199476117	NC_012920.1:10157:T:C
NC_012920.1:m.10159C>A	MT-ND3	S34Y	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693268	MT	10159	MT	10159	693268	680158	rs1603222701	NC_012920.1:10158:C:A
Single allele	MT-ND3		Mitochondrial disease	Likely benign(Last reviewed: Oct 26, 2021)	reviewed by expert panel	VCV001328510	MT	10172	MT	10172	1328510	1319159		NC_012920.1:10171:G:A
NC_012920.1:m.10188A>G	MT-ND3	M44V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693269	MT	10188	MT	10188	693269	680159	rs1603222715	NC_012920.1:10187:A:G
m.10191T>C	MT-ND3	S45P	Mitochondrial complex 1 deficiency, mitochondrial type 1|Leigh syndrome|Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009712	MT	10191	MT	10191	9712	24751	rs267606890	NC_012920.1:10190:T:C
NC_012920.1:m.10192C>T	MT-ND3	S45F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693271	MT	10192	MT	10192	693271	680161	rs1556423776	NC_012920.1:10191:C:T
NC_012920.1:m.10192C>A	MT-ND3	S45Y	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693270	MT	10192	MT	10192	693270	680160	rs1556423776	NC_012920.1:10191:C:A
m.10197G>A	MT-ND3	A47T	Mitochondrial complex 1 deficiency, mitochondrial type 1|not provided|Leber optic atrophy and dystonia|Leigh syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009715	MT	10197	MT	10197	9715	24754	rs267606891	NC_012920.1:10196:G:A
NC_012920.1:m.10203G>A	MT-ND3	V49I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693272	MT	10203	MT	10203	693272	680162	rs1556423781	NC_012920.1:10202:G:A
NC_012920.1:m.10225T>C	MT-ND3	F56S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693273	MT	10225	MT	10225	693273	680163	rs1603222726	NC_012920.1:10224:T:C
NC_012920.1:m.10236A>G	MT-ND3	I60V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693274	MT	10236	MT	10236	693274	680164	rs1603222731	NC_012920.1:10235:A:G
m.10237T>C	MT-ND3	I60T	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065508	MT	10237	MT	10237	65508	76416	rs1556423787	NC_012920.1:10236:T:C
NC_012920.1:m.10254G>A	MT-ND3	D66N	Leigh syndrome	Pathogenic(Last reviewed: Dec 2, 2021)	no assertion criteria provided	VCV000155887	MT	10254	MT	10254	155887	165636	rs587776438	NC_012920.1:10253:G:A
NC_012920.1:m.10266G>A	MT-ND3	A70T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693275	MT	10266	MT	10266	693275	680165	rs1603222746	NC_012920.1:10265:G:A
NC_012920.1:m.10269C>A	MT-ND3	L71I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693276	MT	10269	MT	10269	693276	680166	rs1603222748	NC_012920.1:10268:C:A
NC_012920.1:m.10320G>A	MT-ND3	V88I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693277	MT	10320	MT	10320	693277	680167	rs28358276	NC_012920.1:10319:G:A
NC_012920.1(MT-ND3):m.10321T>C	MT-ND3	V88A	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235782	MT	10321	MT	10321	235782	237461	rs193302928	NC_012920.1:10320:T:C
NC_012920.1:m.10324T>C	MT-ND3	M89T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693278	MT	10324	MT	10324	693278	680168	rs1603222776	NC_012920.1:10323:T:C
NC_012920.1:m.10326T>C	MT-ND3	S90P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693280	MT	10326	MT	10326	693280	680170	rs1603222777	NC_012920.1:10325:T:C
NC_012920.1:m.10326T>A	MT-ND3	S90T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693279	MT	10326	MT	10326	693279	680169	rs1603222777	NC_012920.1:10325:T:A
NC_012920.1:m.10329T>C	MT-ND3	S91P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693281	MT	10329	MT	10329	693281	680171	rs878943163	NC_012920.1:10328:T:C
NC_012920.1:m.10335T>C	MT-ND3		not provided	Likely benign(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000235460	MT	10335	MT	10335	235460	237143	rs878853041	NC_012920.1:10334:T:C
NC_012920.1:m.10345T>C	MT-ND3	I96T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693282	MT	10345	MT	10345	693282	680172	rs201397417	NC_012920.1:10344:T:C
NC_012920.1:m.10348T>C	MT-ND3	I97T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693283	MT	10348	MT	10348	693283	680173	rs1556423803	NC_012920.1:10347:T:C
NC_012920.1:m.10353G>A	MT-ND3	A99T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693284	MT	10353	MT	10353	693284	680174	rs28435660	NC_012920.1:10352:G:A
NC_012920.1:m.10365G>A	MT-ND3	A103T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693285	MT	10365	MT	10365	693285	680175	rs1603222800	NC_012920.1:10364:G:A
NC_012920.1:m.10366C>T	MT-ND3	A103V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693286	MT	10366	MT	10366	693286	680176	rs1603222801	NC_012920.1:10365:C:T
NC_012920.1:m.10371G>A	MT-ND3	E105K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693287	MT	10371	MT	10371	693287	680177	rs1603222803	NC_012920.1:10370:G:A
NC_012920.1:m.10398A>T	MT-ND3	T114S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693288	MT	10398	MT	10398	693288	680178	rs2853826	NC_012920.1:10397:A:T
m.10398A>G	MT-ND3	T114A	Parkinson disease, resistance to|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009713	MT	10398	MT	10398	9713	24752	rs2853826	NC_012920.1:10397:A:G
NC_012920.1:m.10399C>T	MT-ND3	T114I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693289	MT	10399	MT	10399	693289	680179	rs1603222820	NC_012920.1:10398:C:T
NC_012920.1:m.10401G>A	MT-ND3	E115K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693290	MT	10401	MT	10401	693290	680180	rs28719882	NC_012920.1:10400:G:A
NC_012920.1(MT-CYB):m.10405T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690111	MT	10405	MT	10405	690111	677503	rs1603222825	NC_012920.1:10404:T:C
NC_012920.1(MT-CYB):m.10406G>A	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690112	MT	10406	MT	10406	690112	677504	rs1603222826	NC_012920.1:10405:G:A
NC_012920.1(MT-CYB):m.10408T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690113	MT	10408	MT	10408	690113	677505	rs1603222827	NC_012920.1:10407:T:C
NC_012920.1(MT-CYB):m.10410T>A	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690115	MT	10410	MT	10410	690115	677506	rs200478835	NC_012920.1:10409:T:A
NC_012920.1(MT-CYB):m.10410T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690114	MT	10410	MT	10410	690114	677507	rs200478835	NC_012920.1:10409:T:C
NC_012920.1(MT-CYB):m.10411A>G	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690116	MT	10411	MT	10411	690116	677508	rs1603222828	NC_012920.1:10410:A:G
NC_012920.1(MT-CYB):m.10420A>G	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690117	MT	10420	MT	10420	690117	677509	rs1603222829	NC_012920.1:10419:A:G
NC_012920.1(MT-CYB):m.10427G>A	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690118	MT	10427	MT	10427	690118	677510	rs1556423809	NC_012920.1:10426:G:A
m.10438A>G	MT-TR		Mitochondrial encephalomyopathy	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000009623	MT	10438	MT	10438	9623	24662	rs121434456	NC_012920.1:10437:A:G
NC_012920.1(MT-CYB):m.10440T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690119	MT	10440	MT	10440	690119	677511	rs1603222833	NC_012920.1:10439:T:C
NC_012920.1(MT-CYB):m.10446A>G	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690120	MT	10446	MT	10446	690120	677512	rs1603222835	NC_012920.1:10445:A:G
NC_012920.1(MT-CYB):m.10448T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690121	MT	10448	MT	10448	690121	677513	rs1603222836	NC_012920.1:10447:T:C
m.10450A>G	MT-TR		Mitochondrial encephalomyopathy	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000030000	MT	10450	MT	10450	30000	38955	rs387906731	NC_012920.1:10449:A:G
NC_012920.1(MT-CYB):m.10454T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690122	MT	10454	MT	10454	690122	677514	rs878874133	NC_012920.1:10453:T:C
NC_012920.1(MT-CYB):m.10455A>G	MT-TR		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV000690123	MT	10455	MT	10455	690123	677515	rs1603222840	NC_012920.1:10454:A:G
NC_012920.1(MT-CYB):m.10456A>G	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690124	MT	10456	MT	10456	690124	677516	rs1603222842	NC_012920.1:10455:A:G
NC_012920.1(MT-CYB):m.10457T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690125	MT	10457	MT	10457	690125	677517	rs1603222845	NC_012920.1:10456:T:C
NC_012920.1(MT-CYB):m.10460T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690126	MT	10460	MT	10460	690126	677518	rs1603222848	NC_012920.1:10459:T:C
NC_012920.1(MT-CYB):m.10462T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690127	MT	10462	MT	10462	690127	677519	rs1603222850	NC_012920.1:10461:T:C
NC_012920.1(MT-CYB):m.10463T>C	MT-TR		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690128	MT	10463	MT	10463	690128	677520	rs28358279	NC_012920.1:10462:T:C
NC_012920.1:m.10489A>G	MT-ND4L	N7S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693291	MT	10489	MT	10489	693291	680181	rs1603222854	NC_012920.1:10488:A:G
NC_012920.1:m.10491A>G	MT-ND4L	I8V	not provided	not provided	no assertion provided	VCV001339835	MT	10491	MT	10491	1339835	1331045		NC_012920.1:10490:A:G
NC_012920.1:m.10492T>C	MT-ND4L	I8T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693292	MT	10492	MT	10492	693292	680182	rs1603222857	NC_012920.1:10491:T:C
NC_012920.1:m.10499A>G	MT-ND4L		not provided	Benign(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000376866	MT	10499	MT	10499	376866	363744	rs1057520074	NC_012920.1:10498:A:G
NC_012920.1:m.10506A>G	MT-ND4L	T13A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693293	MT	10506	MT	10506	693293	680183	rs199688733	NC_012920.1:10505:A:G
NC_012920.1:m.10507C>T	MT-ND4L	T13I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693294	MT	10507	MT	10507	693294	680184	rs1603222868	NC_012920.1:10506:C:T
NC_012920.1:m.10522G>A	MT-ND4L	G18E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693295	MT	10522	MT	10522	693295	680185	rs1603222873	NC_012920.1:10521:G:A
NC_012920.1:m.10524A>G	MT-ND4L	M19V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693296	MT	10524	MT	10524	693296	680186	rs1603222875	NC_012920.1:10523:A:G
NC_012920.1:m.10530G>A	MT-ND4L	V21M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693297	MT	10530	MT	10530	693297	680187	rs1603222880	NC_012920.1:10529:G:A
m.10563T>C	MT-ND4L	C32R	Familial colorectal cancer	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000009706	MT	10563	MT	10563	9706	24745	rs267606892	NC_012920.1:10562:T:C
NC_012920.1:m.10579T>C	MT-ND4L	M37T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693298	MT	10579	MT	10579	693298	680188	rs1603222900	NC_012920.1:10578:T:C
NC_012920.1:m.10599G>A	MT-ND4L	A44T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693299	MT	10599	MT	10599	693299	680189	rs1603222910	NC_012920.1:10598:G:A
NC_012920.1:m.10600C>T	MT-ND4L	A44V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693300	MT	10600	MT	10600	693300	680190	rs1603222912	NC_012920.1:10599:C:T
NC_012920.1:m.10602A>G	MT-ND4L	T45A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693301	MT	10602	MT	10602	693301	680191	rs1603222913	NC_012920.1:10601:A:G
NC_012920.1:m.10609T>C	MT-ND4L	M47T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693302	MT	10609	MT	10609	693302	680192	rs200487531	NC_012920.1:10608:T:C
NC_012920.1:m.10620A>G	MT-ND4L	T51A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693303	MT	10620	MT	10620	693303	680193	rs1603222915	NC_012920.1:10619:A:G
NC_012920.1:m.10630T>C	MT-ND4L	L54P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693304	MT	10630	MT	10630	693304	680194	rs1603222919	NC_012920.1:10629:T:C
NC_012920.1:m.10632T>C	MT-ND4L		not provided	Likely benign(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000376882	MT	10632	MT	10632	376882	363760	rs878888873	NC_012920.1:10631:T:C
NC_012920.1:m.10635G>A	MT-ND4L	A56T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693305	MT	10635	MT	10635	693305	680195	rs1603222924	NC_012920.1:10634:G:A
NC_012920.1:m.10639A>G	MT-ND4L	N57S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693306	MT	10639	MT	10639	693306	680196	rs1603222927	NC_012920.1:10638:A:G
NC_012920.1(MT-ND4L):m.10644G>A	MT-ND4L	V59M	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000618217	MT	10644	MT	10644	618217	610261	rs1569484385	NC_012920.1:10643:G:A
NC_012920.1:m.10653G>A	MT-ND4L	A62T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693307	MT	10653	MT	10653	693307	680197	rs386829108	NC_012920.1:10652:G:A
NC_012920.1:m.10654C>T	MT-ND4L	A62V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693308	MT	10654	MT	10654	693308	680198	rs1603222934	NC_012920.1:10653:C:T
m.10663T>C	MT-ND4L	V65A	Leber optic atrophy	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009707	MT	10663	MT	10663	9707	24746	rs1556423844	NC_012920.1:10662:T:C
NC_012920.1:m.10677G>A	MT-ND4L	E70K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693309	MT	10677	MT	10677	693309	680199	rs1603222944	NC_012920.1:10676:G:A
NC_012920.1:m.10680G>A	MT-ND4L	A71T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693310	MT	10680	MT	10680	693310	680200	rs1603222945	NC_012920.1:10679:G:A
NC_012920.1:m.10686G>A	MT-ND4L	V73M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693311	MT	10686	MT	10686	693311	680201	rs1603222946	NC_012920.1:10685:G:A
NC_012920.1:m.10704G>A	MT-ND4L	V79I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693312	MT	10704	MT	10704	693312	680202	rs28437034	NC_012920.1:10703:G:A
NC_012920.1:m.10749A>G	MT-ND4L	N94D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693313	MT	10749	MT	10749	693313	680203	rs1603222963	NC_012920.1:10748:A:G
NC_012920.1:m.10750A>G	MT-ND4L	N94S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693314	MT	10750	MT	10750	693314	680204	rs372297272	NC_012920.1:10749:A:G
NC_012920.1:m.10775G>A	MT-ND4	V6I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693315	MT	10775	MT	10775	693315	680205	rs879015842	NC_012920.1:10774:G:A
NC_012920.1:m.10776T>C	MT-ND4	V6A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693316	MT	10776	MT	10776	693316	680206	rs1603222966	NC_012920.1:10775:T:C
NC_012920.1:m.10785T>C	MT-ND4	I9T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693317	MT	10785	MT	10785	693317	680207	rs1603222970	NC_012920.1:10784:T:C
NC_012920.1:m.10791T>C	MT-ND4	L11S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693318	MT	10791	MT	10791	693318	680208	rs1603222973	NC_012920.1:10790:T:C
NC_012920.1:m.10798A>G	MT-ND4		not provided	Likely benign(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000445798	MT	10798	MT	10798	445798	439070	rs1556423866	NC_012920.1:10797:A:G
NC_012920.1:m.10845C>T	MT-ND4	T29I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693319	MT	10845	MT	10845	693319	680209	rs1603222985	NC_012920.1:10844:C:T
NC_012920.1:m.10857T>C	MT-ND4	I33T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693320	MT	10857	MT	10857	693320	680210	rs1603222990	NC_012920.1:10856:T:C
NC_012920.1:m.10863G>A	MT-ND4	S35N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693321	MT	10863	MT	10863	693321	680211	rs1603222992	NC_012920.1:10862:G:A
NC_012920.1(MT-ND4):m.10887A>G	MT-ND4	N43S	Leigh syndrome|not provided	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000684482	MT	10887	MT	10887	684482	672122	rs1603223004	NC_012920.1:10886:A:G
NC_012920.1:m.10895A>G	MT-ND4	N46D	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693322	MT	10895	MT	10895	693322	680212	rs1603223008	NC_012920.1:10894:A:G
NC_012920.1:m.10899A>G	MT-ND4	N47S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693323	MT	10899	MT	10899	693323	680213	rs1603223010	NC_012920.1:10898:A:G
NC_012920.1:m.10907T>C	MT-ND4	F50L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693324	MT	10907	MT	10907	693324	680214	rs879094052	NC_012920.1:10906:T:C
NC_012920.1:m.10911G>A	MT-ND4	S51N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693325	MT	10911	MT	10911	693325	680215	rs1603223016	NC_012920.1:10910:G:A
NC_012920.1:m.10913T>C	MT-ND4	C52R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693326	MT	10913	MT	10913	693326	680216	rs1603223017	NC_012920.1:10912:T:C
NC_012920.1:m.10914G>A	MT-ND4	C52Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693327	MT	10914	MT	10914	693327	680217	rs878931758	NC_012920.1:10913:G:A
NC_012920.1:m.10915T>G	MT-ND4	C52W	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693328	MT	10915	MT	10915	693328	680218	rs2857285	NC_012920.1:10914:T:G
NC_012920.1:m.10920C>T	MT-ND4	P54L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693329	MT	10920	MT	10920	693329	680219	rs1556423876	NC_012920.1:10919:C:T
NC_012920.1:m.10922A>G	MT-ND4	T55A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693330	MT	10922	MT	10922	693330	680220	rs1603223021	NC_012920.1:10921:A:G
NC_012920.1(MT-ND4):m.10931T>C	MT-ND4	S58P	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000618728	MT	10931	MT	10931	618728	610262	rs1569484408	NC_012920.1:10930:T:C
NC_012920.1:m.10932C>T	MT-ND4	S58F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693331	MT	10932	MT	10932	693331	680221	rs1603223028	NC_012920.1:10931:C:T
NC_012920.1:m.11004G>A	MT-ND4	R82H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693332	MT	11004	MT	11004	693332	680222	rs1556423880	NC_012920.1:11003:G:A
NC_012920.1:m.11013C>A	MT-ND4	S85Y	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693333	MT	11013	MT	11013	693333	680223	rs879244441	NC_012920.1:11012:C:A
NC_012920.1:m.11016G>A	MT-ND4	S86N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693334	MT	11016	MT	11016	693334	680224	rs28594904	NC_012920.1:11015:G:A
NC_012920.1:m.11016G>C	MT-ND4	S86T	not provided	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000618729	MT	11016	MT	11016	618729	610263	rs28594904	NC_012920.1:11015:G:C
NC_012920.1:m.11025T>C	MT-ND4	L89P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693335	MT	11025	MT	11025	693335	680225	rs201300253	NC_012920.1:11024:T:C
NC_012920.1:m.11039C>T	MT-ND4	L94F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693336	MT	11039	MT	11039	693336	680226	rs1603223071	NC_012920.1:11038:C:T
NC_012920.1:m.11043A>G	MT-ND4	Y95C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693337	MT	11043	MT	11043	693337	680227	rs1603223072	NC_012920.1:11042:A:G
NC_012920.1:m.11061C>T	MT-ND4	S101F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693338	MT	11061	MT	11061	693338	680228	rs879204439	NC_012920.1:11060:C:T
NC_012920.1:m.11069A>G	MT-ND4	I104V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693339	MT	11069	MT	11069	693339	680229	rs1603223091	NC_012920.1:11068:A:G
m.11084A>G	MT-ND4	T109A	Leigh syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009709	MT	11084	MT	11084	9709	24748	rs199476113	NC_012920.1:11083:A:G
NC_012920.1:m.11087T>C	MT-ND4	F110L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693340	MT	11087	MT	11087	693340	680230	rs28433448	NC_012920.1:11086:T:C
NC_012920.1:m.11090A>G	MT-ND4	T111A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693341	MT	11090	MT	11090	693341	680231	rs1603223101	NC_012920.1:11089:A:G
NC_012920.1:m.11111T>C	MT-ND4	F118L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693342	MT	11111	MT	11111	693342	680232	rs1603223109	NC_012920.1:11110:T:C
NC_012920.1:m.11120T>C	MT-ND4	F121L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693343	MT	11120	MT	11120	693343	680233	rs1603223116	NC_012920.1:11119:T:C
NC_012920.1:m.11129A>G	MT-ND4	T124A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693344	MT	11129	MT	11129	693344	680234	rs1603223122	NC_012920.1:11128:A:G
NC_012920.1:m.11139T>C	MT-ND4	I127T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693345	MT	11139	MT	11139	693345	680235	rs1603223126	NC_012920.1:11138:T:C
NC_012920.1:m.11144A>T	MT-ND4	T129S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693346	MT	11144	MT	11144	693346	680236	rs1603223129	NC_012920.1:11143:A:T
NC_012920.1:m.11150G>A	MT-ND4	A131T	Leigh syndrome|Mitochondrial DNA-Associated Leigh Syndrome and NARP	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693347	MT	11150	MT	11150	693347	680237	rs386829118	NC_012920.1:11149:G:A
NC_012920.1:m.11151C>T	MT-ND4	A131V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693348	MT	11151	MT	11151	693348	680238	rs1556423903	NC_012920.1:11150:C:T
NC_012920.1:m.11157T>C	MT-ND4	I133T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693349	MT	11157	MT	11157	693349	680239	rs1603223138	NC_012920.1:11156:T:C
NC_012920.1:m.11167A>G	MT-ND4		not provided	Likely benign(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	VCV000235673	MT	11167	MT	11167	235673	237353	rs377109096	NC_012920.1:11166:A:G
NC_012920.1:m.11172A>G	MT-ND4	N138S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693350	MT	11172	MT	11172	693350	680240	rs2853489	NC_012920.1:11171:A:G
NC_012920.1:m.11177C>T	MT-ND4	P140S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693351	MT	11177	MT	11177	693351	680241	rs28358284	NC_012920.1:11176:C:T
NC_012920.1:m.11204T>C	MT-ND4	F149L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693352	MT	11204	MT	11204	693352	680242	rs201803443	NC_012920.1:11203:T:C
NC_012920.1:m.11223T>C	MT-ND4	V155A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693353	MT	11223	MT	11223	693353	680243	rs1603223170	NC_012920.1:11222:T:C
NC_012920.1:m.11232T>C	MT-ND4	L158P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693354	MT	11232	MT	11232	693354	680244	rs1603223180	NC_012920.1:11231:T:C
NC_012920.1:m.11246G>A	MT-ND4	A163T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693355	MT	11246	MT	11246	693355	680245	rs1603223192	NC_012920.1:11245:G:A
NC_012920.1:m.11252A>G	MT-ND4	I165V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693356	MT	11252	MT	11252	693356	680246	rs879229170	NC_012920.1:11251:A:G
m.11253T>C	MT-ND4	I165T	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065509	MT	11253	MT	11253	65509	76417	rs200145866	NC_012920.1:11252:T:C
NC_012920.1:m.11255T>C	MT-ND4	Y166H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693357	MT	11255	MT	11255	693357	680247	rs1556423916	NC_012920.1:11254:T:C
NC_012920.1:m.11268C>T	MT-ND4	T170I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693358	MT	11268	MT	11268	693358	680248	rs879011423	NC_012920.1:11267:C:T
NC_012920.1:m.11289T>C	MT-ND4	L177P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693359	MT	11289	MT	11289	693359	680249	rs1603223215	NC_012920.1:11288:T:C
NC_012920.1:m.11301T>C	MT-ND4	L181P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693360	MT	11301	MT	11301	693360	680250	rs1603223221	NC_012920.1:11300:T:C
NC_012920.1:m.11318T>C	MT-ND4	S187P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693361	MT	11318	MT	11318	693361	680251	rs1603223235	NC_012920.1:11317:T:C
NC_012920.1:m.11337A>G	MT-ND4	N193S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693362	MT	11337	MT	11337	693362	680252	rs1603223247	NC_012920.1:11336:A:G
NC_012920.1:m.11360A>G	MT-ND4	M201V	Leber optic atrophy|Seizure|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523304	MT	11360	MT	11360	523304	514149	rs878928689	NC_012920.1:11359:A:G
NC_012920.1:m.11361T>C	MT-ND4	M201T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693363	MT	11361	MT	11361	693363	680253	rs1603223259	NC_012920.1:11360:T:C
NC_012920.1:m.11363G>A	MT-ND4	A202T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693364	MT	11363	MT	11363	693364	680254	rs1603223261	NC_012920.1:11362:G:A
NC_012920.1:m.11393C>T	MT-ND4	L212F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693365	MT	11393	MT	11393	693365	680255	rs1603223277	NC_012920.1:11392:C:T
NC_012920.1:m.11428C>T	MT-ND4		not provided	Likely benign(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000377260	MT	11428	MT	11428	377260	364138	rs1057520176	NC_012920.1:11427:C:T
NC_012920.1:m.11443A>C	MT-ND4		Optic neuropathy|Central scotoma|Optic atrophy|Visual impairment|Optic neuritis	Uncertain significance(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523305	MT	11443	MT	11443	523305	514150	rs1556423952	NC_012920.1:11442:A:C
NC_012920.1:m.11447G>A	MT-ND4	V230M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693366	MT	11447	MT	11447	693366	680256	rs2853492	NC_012920.1:11446:G:A
NC_012920.1:m.11453G>A	MT-ND4	A232T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693367	MT	11453	MT	11453	693367	680257	rs1603223293	NC_012920.1:11452:G:A
NC_012920.1:m.11467A>G	MT-ND4		Mitochondrial disease	Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522716	MT	11467	MT	11467	522716	513402	rs2853493	NC_012920.1:11466:A:G
NC_012920.1:m.11498A>G	MT-ND4	T247A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693368	MT	11498	MT	11498	693368	680258	rs1603223309	NC_012920.1:11497:A:G
NC_012920.1:m.11560A>G	MT-ND4		not provided	Likely benign(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000235733	MT	11560	MT	11560	235733	237413	rs878853103	NC_012920.1:11559:A:G
NC_012920.1:m.11577G>A	MT-ND4	S273N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693369	MT	11577	MT	11577	693369	680259	rs1603223344	NC_012920.1:11576:G:A
NC_012920.1:m.11582A>G	MT-ND4	I275V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693370	MT	11582	MT	11582	693370	680260	rs1603223348	NC_012920.1:11581:A:G
NC_012920.1:m.11583T>C	MT-ND4	I275T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693371	MT	11583	MT	11583	693371	680261	rs1603223350	NC_012920.1:11582:T:C
NC_012920.1:m.11590A>G	MT-ND4		not provided	Uncertain significance(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	VCV000377091	MT	11590	MT	11590	377091	363969	rs370318850	NC_012920.1:11589:A:G
NC_012920.1:m.11615A>G	MT-ND4	I286V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693372	MT	11615	MT	11615	693372	680262	rs1603223360	NC_012920.1:11614:A:G
NC_012920.1:m.11634G>A	MT-ND4	S292N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693374	MT	11634	MT	11634	693374	680264	rs1603223368	NC_012920.1:11633:G:A
NC_012920.1:m.11654A>G	MT-ND4	T299A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693375	MT	11654	MT	11654	693375	680265	rs1603223374	NC_012920.1:11653:A:G
m.11696G>A	MT-ND4	V313I	Leber optic atrophy and dystonia|Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009710	MT	11696	MT	11696	9710	24749	rs200873900	NC_012920.1:11695:G:A
NC_012920.1:m.11708A>G	MT-ND4	I317V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693376	MT	11708	MT	11708	693376	680266	rs386829138	NC_012920.1:11707:A:G
NC_012920.1:m.11711G>A	MT-ND4	A318T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693377	MT	11711	MT	11711	693377	680267	rs1603223391	NC_012920.1:11710:G:A
NC_012920.1:m.11733T>C	MT-ND4	L325S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693378	MT	11733	MT	11733	693378	680268	rs1603223397	NC_012920.1:11732:T:C
m.11777C>A	MT-ND4	R340S	Leber optic atrophy|Leigh syndrome|Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009711	MT	11777	MT	11777	9711	24750	rs28384199	NC_012920.1:11776:C:A
NC_012920.1:m.11778G>A	MT-ND4	R340H	not provided|Leber optic atrophy	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009708	MT	11778	MT	11778	9708	24747	rs199476112	NC_012920.1:11777:G:A
NC_012920.1:m.11781T>C	MT-ND4	I341T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693379	MT	11781	MT	11781	693379	680269	rs1603223410	NC_012920.1:11780:T:C
NC_012920.1:m.11792T>G	MT-ND4	S345A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693380	MT	11792	MT	11792	693380	680270	rs1603223415	NC_012920.1:11791:T:G
NC_012920.1:m.11807A>G	MT-ND4	T350A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693381	MT	11807	MT	11807	693381	680271	rs1603223419	NC_012920.1:11806:A:G
NC_012920.1:m.11815C>G	MT-ND4		Epilepsy|Calcification of extrapyramidal basal ganglia|Developmental delay|Encephalopathy|Dementia|Hypotonia	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370053	MT	11815	MT	11815	370053	354283	rs879025367	NC_012920.1:11814:C:G
NC_012920.1:m.11825G>A	MT-ND4	A356T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693382	MT	11825	MT	11825	693382	680272	rs879083692	NC_012920.1:11824:G:A
NC_012920.1:m.11896C>G	MT-ND4		Hearing impairment|Ataxia|Peripheral neuropathy	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370054	MT	11896	MT	11896	370054	354284	rs1057516065	NC_012920.1:11895:C:G
NC_012920.1:m.11899T>C	MT-ND4		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235318	MT	11899	MT	11899	235318	237005	rs28718242	NC_012920.1:11898:T:C
NC_012920.1:m.11906G>A	MT-ND4	V383M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693383	MT	11906	MT	11906	693383	680273	rs1603223460	NC_012920.1:11905:G:A
NC_012920.1:m.11913C>T	MT-ND4	T385M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693384	MT	11913	MT	11913	693384	680274	rs1603223463	NC_012920.1:11912:C:T
NC_012920.1:m.11928A>G	MT-ND4	N390S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693385	MT	11928	MT	11928	693385	680275	rs1569484466	NC_012920.1:11927:A:G
NC_012920.1:m.11930A>G	MT-ND4	I391V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693386	MT	11930	MT	11930	693386	680276	rs1603223472	NC_012920.1:11929:A:G
NC_012920.1:m.11931T>C	MT-ND4	I391T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693387	MT	11931	MT	11931	693387	680277	rs1603223474	NC_012920.1:11930:T:C
NC_012920.1:m.11946C>T	MT-ND4	T396M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693388	MT	11946	MT	11946	693388	680278	rs1603223482	NC_012920.1:11945:C:T
NC_012920.1:m.11957A>G	MT-ND4	M400V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693389	MT	11957	MT	11957	693389	680279	rs1603223488	NC_012920.1:11956:A:G
NC_012920.1:m.11963G>A	MT-ND4	V402I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693390	MT	11963	MT	11963	693390	680280	rs201803948	NC_012920.1:11962:G:A
NC_012920.1:m.11964T>G	MT-ND4	V402G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693391	MT	11964	MT	11964	693391	680281	rs1603223491	NC_012920.1:11963:T:G
NC_012920.1:m.11969G>A	MT-ND4	A404T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693392	MT	11969	MT	11969	693392	680282	rs28359169	NC_012920.1:11968:G:A
NC_012920.1:m.11978T>A	MT-ND4	S407T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693393	MT	11978	MT	11978	693393	680283	rs1603223502	NC_012920.1:11977:T:A
NC_012920.1:m.11981C>T	MT-ND4	L408F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693394	MT	11981	MT	11981	693394	680284	rs386829143	NC_012920.1:11980:C:T
NC_012920.1:m.11984T>C	MT-ND4	Y409H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000155888	MT	11984	MT	11984	155888	165637	rs200911567	NC_012920.1:11983:T:C
NC_012920.1:m.11990T>C	MT-ND4	F411L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693395	MT	11990	MT	11990	693395	680285	rs1603223505	NC_012920.1:11989:T:C
NC_012920.1:m.12010C>T	MT-ND4		Developmental delay|Dystonic disorder	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370055	MT	12010	MT	12010	370055	354285	rs1057516066	NC_012920.1:12009:C:T
NC_012920.1:m.12011T>C	MT-ND4	S418P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693397	MT	12011	MT	12011	693397	680286	rs386829144	NC_012920.1:12010:T:C
NC_012920.1:m.12011T>G	MT-ND4	S418A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693396	MT	12011	MT	12011	693396	680287	rs386829144	NC_012920.1:12010:T:G
NC_012920.1:m.12013A>G	MT-ND4		Leigh syndrome|Epilepsy|Calcification of extrapyramidal basal ganglia|Developmental delay|Encephalopathy|Dementia|Hypotonia|Congenital cardiomyopathy|Developmental delay|Microcephaly|Hearing impairment|Developmental delay|Macrocephalus|Hearing impairment	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370056	MT	12013	MT	12013	370056	354286	rs1057516067	NC_012920.1:12012:A:G
NC_012920.1:m.12014C>T	MT-ND4	L419F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693398	MT	12014	MT	12014	693398	680288	rs1603223511	NC_012920.1:12013:C:T
NC_012920.1:m.12015T>C	MT-ND4	L419P	Stroke|Seizure	Likely benign(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000805948	MT	12015	MT	12015	805948	794275	rs1603223512	NC_012920.1:12014:T:C
NC_012920.1:m.12017A>G	MT-ND4	T420A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693399	MT	12017	MT	12017	693399	680289	rs879136236	NC_012920.1:12016:A:G
NC_012920.1:m.12018C>G	MT-ND4	T420S	Leigh syndrome|Congenital cardiomyopathy|Developmental delay|Microcephaly|Hearing impairment|Developmental delay|Macrocephalus|Hearing impairment|Epilepsy|Calcification of extrapyramidal basal ganglia|Developmental delay|Encephalopathy|Dementia|Hypotonia	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370057	MT	12018	MT	12018	370057	354287	rs1057516068	NC_012920.1:12017:C:G
NC_012920.1:m.12020C>T	MT-ND4	H421Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693400	MT	12020	MT	12020	693400	680290	rs1603223516	NC_012920.1:12019:C:T
NC_012920.1:m.12026A>G	MT-ND4	I423V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693401	MT	12026	MT	12026	693401	680291	rs202136725	NC_012920.1:12025:A:G
NC_012920.1:m.12030A>G	MT-ND4	N424S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693402	MT	12030	MT	12030	693402	680292	rs1556424041	NC_012920.1:12029:A:G
NC_012920.1:m.12031C>A	MT-ND4	N424K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693403	MT	12031	MT	12031	693403	680293	rs1603223519	NC_012920.1:12030:C:A
NC_012920.1:m.12033A>G	MT-ND4	N425S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693404	MT	12033	MT	12033	693404	680294	rs1603223521	NC_012920.1:12032:A:G
NC_012920.1:m.12040A>T	MT-ND4	K427N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693405	MT	12040	MT	12040	693405	680295	rs1603223523	NC_012920.1:12039:A:T
NC_012920.1:m.12054G>A	MT-ND4	R432Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693406	MT	12054	MT	12054	693406	680296	rs1603223526	NC_012920.1:12053:G:A
NC_012920.1:m.12063C>T	MT-ND4	T435I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693407	MT	12063	MT	12063	693407	680297	rs1603223527	NC_012920.1:12062:C:T
NC_012920.1:m.12074A>C	MT-ND4	M439L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693408	MT	12074	MT	12074	693408	680298	rs1603223534	NC_012920.1:12073:A:C
NC_012920.1:m.12083T>G	MT-ND4	S442A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693409	MT	12083	MT	12083	693409	680299	rs1556424049	NC_012920.1:12082:T:G
NC_012920.1:m.12084C>T	MT-ND4	S442F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693410	MT	12084	MT	12084	693410	680300	rs1556424051	NC_012920.1:12083:C:T
NC_012920.1:m.12092C>T	MT-ND4	L445F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693412	MT	12092	MT	12092	693412	680302	rs1603223542	NC_012920.1:12091:C:T
NC_012920.1:m.12092C>A	MT-ND4	L445I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693411	MT	12092	MT	12092	693411	680301	rs1603223542	NC_012920.1:12091:C:A
NC_012920.1:m.12117T>C	MT-ND4	I453T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693413	MT	12117	MT	12117	693413	680303	rs1603223549	NC_012920.1:12116:T:C
NC_012920.1:m.12122A>G	MT-ND4	T455A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693414	MT	12122	MT	12122	693414	680304	rs1603223553	NC_012920.1:12121:A:G
NC_012920.1:m.12123C>T	MT-ND4	T455I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693415	MT	12123	MT	12123	693415	680305	rs1569484488	NC_012920.1:12122:C:T
NC_012920.1:m.12128T>C	MT-ND4	F457L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693416	MT	12128	MT	12128	693416	680306	rs1603223557	NC_012920.1:12127:T:C
NC_012920.1:m.12134T>C	MT-ND4	S459P	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693417	MT	12134	MT	12134	693417	680307	rs1603223562	NC_012920.1:12133:T:C
NC_012920.1:m.12135C>A	MT-ND4	S459Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693418	MT	12135	MT	12135	693418	680308	rs1556424062	NC_012920.1:12134:C:A
NC_012920.1(MT-CYB):m.12141A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690129	MT	12141	MT	12141	690129	677521	rs1603223565	NC_012920.1:12140:A:G
NC_012920.1(MT-CYB):m.12142A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690130	MT	12142	MT	12142	690130	677522	rs1603223566	NC_012920.1:12141:A:G
NC_012920.1(MT-CYB):m.12143T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690131	MT	12143	MT	12143	690131	677523	rs1603223568	NC_012920.1:12142:T:C
NC_012920.1(MT-CYB):m.12144A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690132	MT	12144	MT	12144	690132	677524	rs1603223569	NC_012920.1:12143:A:G
m.12147G>A	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009610	MT	12147	MT	12147	9610	24649	rs121434474	NC_012920.1:12146:G:A
NC_012920.1(MT-CYB):m.12148T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690133	MT	12148	MT	12148	690133	677525	rs1603223571	NC_012920.1:12147:T:C
NC_012920.1(MT-CYB):m.12150T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690134	MT	12150	MT	12150	690134	677526	rs1603223574	NC_012920.1:12149:T:C
NC_012920.1(MT-CYB):m.12151A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690135	MT	12151	MT	12151	690135	677527	rs1603223576	NC_012920.1:12150:A:G
Single allele	MT-TH		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000376983	MT	12153	MT	12153	376983	363861	rs376606918	NC_012920.1:12152:C:T
NC_012920.1(MT-CYB):m.12160A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690136	MT	12160	MT	12160	690136	677528	rs1603223579	NC_012920.1:12159:A:G
NC_012920.1(MT-CYB):m.12161T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690137	MT	12161	MT	12161	690137	677529	rs386829147	NC_012920.1:12160:T:C
NC_012920.1(MT-CYB):m.12163A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690138	MT	12163	MT	12163	690138	677530	rs1603223581	NC_012920.1:12162:A:G
NC_012920.1(MT-CYB):m.12164G>A	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690139	MT	12164	MT	12164	690139	677531	rs1603223582	NC_012920.1:12163:G:A
NC_012920.1(MT-CYB):m.12166T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690140	MT	12166	MT	12166	690140	677532	rs879126000	NC_012920.1:12165:T:C
NC_012920.1:m.12170G>A	MT-TH		mtDNA-related disorders	not provided	no assertion provided	VCV000441080	MT	12170	MT	12170	441080	434697	rs1556424072	NC_012920.1:12169:G:A
NC_012920.1(MT-CYB):m.12171A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690141	MT	12171	MT	12171	690141	677533	rs1603223589	NC_012920.1:12170:A:G
NC_012920.1(MT-CYB):m.12172A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690142	MT	12172	MT	12172	690142	677534	rs1556424073	NC_012920.1:12171:A:G
NC_012920.1(MT-CYB):m.12173T>A	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690144	MT	12173	MT	12173	690144	677535	rs1556424075	NC_012920.1:12172:T:A
NC_012920.1(MT-CYB):m.12173T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690143	MT	12173	MT	12173	690143	677536	rs1556424075	NC_012920.1:12172:T:C
Single allele	MT-TH		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000376964	MT	12175	MT	12175	376964	363842	rs1057520099	NC_012920.1:12174:T:C
NC_012920.1(MT-CYB):m.12176G>A	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690145	MT	12176	MT	12176	690145	677537	rs1603223594	NC_012920.1:12175:G:A
NC_012920.1:m.12177A>G	MT-TH		not provided	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000618221	MT	12177	MT	12177	618221	610264	rs1569484492	NC_012920.1:12176:A:G
NC_012920.1(MT-CYB):m.12178C>T	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690146	MT	12178	MT	12178	690146	677538	rs1603223596	NC_012920.1:12177:C:T
NC_012920.1(MT-CYB):m.12181C>T	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690147	MT	12181	MT	12181	690147	677539	rs1603223598	NC_012920.1:12180:C:T
m.12183G>A	MT-TH		Pigmentary retinopathy and sensorineural deafness	Pathogenic(Last reviewed: Apr 8, 2003)	no assertion criteria provided	VCV000009609	MT	12183	MT	12183	9609	24648	rs121434473	NC_012920.1:12182:G:A
NC_012920.1(MT-CYB):m.12184A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690148	MT	12184	MT	12184	690148	677540	rs1603223603	NC_012920.1:12183:A:G
NC_012920.1(MT-CYB):m.12185G>A	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690149	MT	12185	MT	12185	690149	677541	rs1603223607	NC_012920.1:12184:G:A
NC_012920.1:m.12187C>T	MT-TH		not provided	not provided	no assertion provided	VCV000918020	MT	12187	MT	12187	918020	906352	rs2068730503	NC_012920.1:12186:C:T
NC_012920.1(MT-CYB):m.12188T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690150	MT	12188	MT	12188	690150	677542	rs879128211	NC_012920.1:12187:T:C
NC_012920.1(MT-CYB):m.12189T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690151	MT	12189	MT	12189	690151	677543	rs28505538	NC_012920.1:12188:T:C
NC_012920.1(MT-CYB):m.12191C>T	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690152	MT	12191	MT	12191	690152	677544	rs1603223610	NC_012920.1:12190:C:T
m.12192G>A	MT-TH		Cardiomyopathy, idiopathic dilated, mitochondrial|Cardiomyopathy, hypertrophic, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009608	MT	12192	MT	12192	9608	24647	rs3134560	NC_012920.1:12191:G:A
NC_012920.1(MT-CYB):m.12193A>G	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690153	MT	12193	MT	12193	690153	677545	rs1603223611	NC_012920.1:12192:A:G
NC_012920.1(MT-CYB):m.12196C>T	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690154	MT	12196	MT	12196	690154	677546	rs1556424080	NC_012920.1:12195:C:T
m.12201T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial non-syndromic sensorineural hearing loss	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000030004	MT	12201	MT	12201	30004	38959	rs387906733	NC_012920.1:12200:T:C
NC_012920.1(MT-CYB):m.12202T>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690155	MT	12202	MT	12202	690155	677547	rs1603223613	NC_012920.1:12201:T:C
NC_012920.1(MT-CYB):m.12204A>C	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690156	MT	12204	MT	12204	690156	677548	rs1603223614	NC_012920.1:12203:A:C
NC_012920.1(MT-CYB):m.12205C>T	MT-TH		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690157	MT	12205	MT	12205	690157	677549	rs1603223615	NC_012920.1:12204:C:T
m.12207G>A	MT-TS2		MERRF/MELAS overlap syndrome	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000009561	MT	12207	MT	12207	9561	24600	rs118203889	NC_012920.1:12206:G:A
NC_012920.1(MT-CYB):m.12213G>A	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690158	MT	12213	MT	12213	690158	677550	rs1603223616	NC_012920.1:12212:G:A
NC_012920.1(MT-CYB):m.12215T>C	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690159	MT	12215	MT	12215	690159	677551	rs1603223617	NC_012920.1:12214:T:C
NC_012920.1(MT-CYB):m.12216C>T	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690160	MT	12216	MT	12216	690160	677552	rs1603223618	NC_012920.1:12215:C:T
NC_012920.1(MT-CYB):m.12217A>G	MT-TS2		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Jul 29, 2020)	criteria provided, conflicting interpretations	VCV000690161	MT	12217	MT	12217	690161	677553	rs1556424082	NC_012920.1:12216:A:G
NC_012920.1(MT-CYB):m.12218C>A	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690162	MT	12218	MT	12218	690162	677554	rs1603223621	NC_012920.1:12217:C:A
NC_012920.1(MT-CYB):m.12223A>G	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690163	MT	12223	MT	12223	690163	677555	rs1603223624	NC_012920.1:12222:A:G
NC_012920.1(MT-CYB):m.12230A>G	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690164	MT	12230	MT	12230	690164	677556	rs1603223625	NC_012920.1:12229:A:G
NC_012920.1(MT-CYB):m.12231C>T	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690165	MT	12231	MT	12231	690165	677557	rs1603223627	NC_012920.1:12230:C:T
NC_012920.1(MT-CYB):m.12234A>G	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690166	MT	12234	MT	12234	690166	677558	rs1603223628	NC_012920.1:12233:A:G
NC_012920.1(MT-CYB):m.12235T>C	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690167	MT	12235	MT	12235	690167	677559	rs1556424083	NC_012920.1:12234:T:C
Single allele	MT-TS2		not specified|not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2019)	criteria provided, conflicting interpretations	VCV000440357	MT	12236	MT	12236	440357	433992	rs28359170	NC_012920.1:12235:G:A
NC_012920.1(MT-CYB):m.12237C>T	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690168	MT	12237	MT	12237	690168	677560	rs1603223632	NC_012920.1:12236:C:T
NC_012920.1(MT-CYB):m.12239C>T	MT-TS2		Mitochondrial disease|not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jan 10, 2022)	reviewed by expert panel	VCV000235361	MT	12239	MT	12239	235361	237048	rs376062400	NC_012920.1:12238:C:T
NC_012920.1(MT-CYB):m.12245T>C	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690171	MT	12245	MT	12245	690171	677563	rs1603223634	NC_012920.1:12244:T:C
NC_012920.1(MT-CYB):m.12246C>T	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690172	MT	12246	MT	12246	690172	677564	rs28508189	NC_012920.1:12245:C:T
NC_012920.1(MT-CYB):m.12247T>C	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690173	MT	12247	MT	12247	690173	677565	rs1603223637	NC_012920.1:12246:T:C
NC_012920.1(MT-CYB):m.12248A>G	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690174	MT	12248	MT	12248	690174	677566	rs202114991	NC_012920.1:12247:A:G
NC_012920.1(MT-CYB):m.12250C>T	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690175	MT	12250	MT	12250	690175	677567	rs1603223639	NC_012920.1:12249:C:T
NC_012920.1(MT-CYB):m.12255T>C	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690176	MT	12255	MT	12255	690176	677568	rs1603223640	NC_012920.1:12254:T:C
NC_012920.1(MT-CYB):m.12258C>T	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690177	MT	12258	MT	12258	690177	677569	rs118203888	NC_012920.1:12257:C:T
m.12258C>A	MT-TS2		Cerebellar ataxia, cataract, and diabetes mellitus|Retinitis pigmentosa-deafness syndrome	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000009560	MT	12258	MT	12258	9560	24599	rs118203888	NC_012920.1:12257:C:A
NC_012920.1(MT-CYB):m.12264C>T	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690178	MT	12264	MT	12264	690178	677570	rs1603223642	NC_012920.1:12263:C:T
NC_012920.1(MT-CYB):m.12265A>G	MT-TS2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690179	MT	12265	MT	12265	690179	677571	rs1603223643	NC_012920.1:12264:A:G
NC_012920.1:m.12271T>C	MT-TL2		Mitochondrial disease	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000430687	MT	12271	MT	12271	430687	424205	rs1131692061	NC_012920.1:12270:T:C
NC_012920.1(MT-CYB):m.12273A>G	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690180	MT	12273	MT	12273	690180	677572	rs1603223644	NC_012920.1:12272:A:G
NC_012920.1(MT-CYB):m.12276G>A	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690181	MT	12276	MT	12276	690181	677573	rs1603223645	NC_012920.1:12275:G:A
NC_012920.1(MT-CYB):m.12278T>C	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690182	MT	12278	MT	12278	690182	677574	rs1603223646	NC_012920.1:12277:T:C
NC_012920.1(MT-CYB):m.12279A>T	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690184	MT	12279	MT	12279	690184	677576	rs1603223647	NC_012920.1:12278:A:T
NC_012920.1(MT-CYB):m.12279A>G	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690183	MT	12279	MT	12279	690183	677575	rs1603223647	NC_012920.1:12278:A:G
NC_012920.1(MT-CYB):m.12280A>G	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690185	MT	12280	MT	12280	690185	677577	rs1603223649	NC_012920.1:12279:A:G
NC_012920.1(MT-CYB):m.12281C>T	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690186	MT	12281	MT	12281	690186	677578	rs1603223651	NC_012920.1:12280:C:T
NC_012920.1:m.12283G>A	MT-TL2		Mitochondrial disease	Pathogenic(Last reviewed: May 22, 2017)	no assertion criteria provided	VCV000430688	MT	12283	MT	12283	430688	424206	rs1131692062	NC_012920.1:12282:G:A
NC_012920.1(MT-CYB):m.12285T>C	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690187	MT	12285	MT	12285	690187	677579	rs386419957	NC_012920.1:12284:T:C
NC_012920.1(MT-CYB):m.12291T>C	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690188	MT	12291	MT	12291	690188	677580	rs1603223653	NC_012920.1:12290:T:C
NC_012920.1(MT-CYB):m.12293G>A	MT-TL2		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690189	MT	12293	MT	12293	690189	677581	rs1603223654	NC_012920.1:12292:G:A
NC_012920.1(MT-CYB):m.12295T>C	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690190	MT	12295	MT	12295	690190	677582	rs1603223656	NC_012920.1:12294:T:C
m.12297T>C	MT-TL2		Cardiomyopathy, mitochondrial|not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009588	MT	12297	MT	12297	9588	24627	rs121434464	NC_012920.1:12296:T:C
NC_012920.1(MT-CYB):m.12302C>T	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690192	MT	12302	MT	12302	690192	677584	rs1603223658	NC_012920.1:12301:C:T
NC_012920.1(MT-CYB):m.12302C>A	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Mar 15, 2020)	criteria provided, single submitter	VCV000690191	MT	12302	MT	12302	690191	677583	rs1603223658	NC_012920.1:12301:C:A
NC_012920.1(MT-CYB):m.12308A>G	MT-TL2		Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jan 10, 2022)	reviewed by expert panel	VCV000690193	MT	12308	MT	12308	690193	677586	rs2853498	NC_012920.1:12307:A:G
NC_012920.1(MT-CYB):m.12311T>C	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690195	MT	12311	MT	12311	690195	677587	rs201754056	NC_012920.1:12310:T:C
m.12315G>A	MT-TL2		Mitochondrial encephalomyopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009586	MT	12315	MT	12315	9586	24625	rs121434462	NC_012920.1:12314:G:A
NC_012920.1(MT-CYB):m.12318G>A	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690196	MT	12318	MT	12318	690196	677588	rs1603223664	NC_012920.1:12317:G:A
m.12320A>G	MT-TL2		Inborn mitochondrial myopathy	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000009587	MT	12320	MT	12320	9587	24626	rs121434463	NC_012920.1:12319:A:G
NC_012920.1(MT-CYB):m.12335T>C	MT-TL2		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690197	MT	12335	MT	12335	690197	677589	rs1603223668	NC_012920.1:12334:T:C
m.12338T>C	MT-ND5	M1T	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000029999	MT	12338	MT	12338	29999	38954	rs201863060	NC_012920.1:12337:T:C
NC_012920.1:m.12340A>G	MT-ND5	T2A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693419	MT	12340	MT	12340	693419	680309	rs28490236	NC_012920.1:12339:A:G
NC_012920.1:m.12341C>T	MT-ND5	T2I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693420	MT	12341	MT	12341	693420	680310	rs1603223671	NC_012920.1:12340:C:T
NC_012920.1:m.12344T>C	MT-ND5	M3T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693421	MT	12344	MT	12344	693421	680311	rs1603223675	NC_012920.1:12343:T:C
NC_012920.1(MT-ND5):m.12346C>T	MT-ND5	H4Y	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000445363	MT	12346	MT	12346	445363	438635	rs200279497	NC_012920.1:12345:C:T
NC_012920.1:m.12349A>G	MT-ND5	T5A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693422	MT	12349	MT	12349	693422	680312	rs1603223678	NC_012920.1:12348:A:G
NC_012920.1:m.12352A>G	MT-ND5	T6A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693423	MT	12352	MT	12352	693423	680313	rs1603223680	NC_012920.1:12351:A:G
NC_012920.1:m.12358A>G	MT-ND5	T8A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693424	MT	12358	MT	12358	693424	680314	rs201027657	NC_012920.1:12357:A:G
NC_012920.1:m.12361A>G	MT-ND5	T9A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693425	MT	12361	MT	12361	693425	680315	rs3134561	NC_012920.1:12360:A:G
NC_012920.1:m.12362C>T	MT-ND5	T9I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693426	MT	12362	MT	12362	693426	680316	rs1603223688	NC_012920.1:12361:C:T
NC_012920.1:m.12367A>G	MT-ND5	T11A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693427	MT	12367	MT	12367	693427	680317	rs1603223696	NC_012920.1:12366:A:G
NC_012920.1:m.12372G>A	MT-ND5		Mitochondrial disease	Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522717	MT	12372	MT	12372	522717	513404	rs2853499	NC_012920.1:12371:G:A
NC_012920.1:m.12373A>G	MT-ND5	T13A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693428	MT	12373	MT	12373	693428	680318	rs1556424095	NC_012920.1:12372:A:G
NC_012920.1:m.12382A>G	MT-ND5	I16V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693429	MT	12382	MT	12382	693429	680319	rs1603223707	NC_012920.1:12381:A:G
NC_012920.1:m.12383T>C	MT-ND5	I16T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693430	MT	12383	MT	12383	693430	680320	rs1603223708	NC_012920.1:12382:T:C
NC_012920.1:m.12386C>T	MT-ND5	P17L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693431	MT	12386	MT	12386	693431	680321	rs1603223709	NC_012920.1:12385:C:T
NC_012920.1:m.12389C>T	MT-ND5	P18L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693432	MT	12389	MT	12389	693432	680322	rs1603223710	NC_012920.1:12388:C:T
m.12397A>G	MT-ND5	T21A	Leigh syndrome|Autosomal recessive early-onset Parkinson disease 6	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009705	MT	12397	MT	12397	9705	24744	rs1556424100	NC_012920.1:12396:A:G
NC_012920.1:m.12400A>G	MT-ND5	T22A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693433	MT	12400	MT	12400	693433	680323	rs201405598	NC_012920.1:12399:A:G
NC_012920.1:m.12401C>T	MT-ND5	T22I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693434	MT	12401	MT	12401	693434	680324	rs1603223721	NC_012920.1:12400:C:T
NC_012920.1:m.12403C>T	MT-ND5	L23F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693435	MT	12403	MT	12403	693435	680325	rs879096684	NC_012920.1:12402:C:T
NC_012920.1:m.12406G>A	MT-ND5	V24I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693436	MT	12406	MT	12406	693436	680326	rs28617389	NC_012920.1:12405:G:A
NC_012920.1:m.12410A>G	MT-ND5	N25S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693437	MT	12410	MT	12410	693437	680327	rs1603223725	NC_012920.1:12409:A:G
NC_012920.1:m.12424A>G	MT-ND5	N30D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693438	MT	12424	MT	12424	693438	680329	rs1603223732	NC_012920.1:12423:A:G
NC_012920.1:m.12425A>G	MT-ND5	N30S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693439	MT	12425	MT	12425	693439	680330	rs1603223735	NC_012920.1:12424:A:G
NC_012920.1:m.12426C>A	MT-ND5	N30K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693441	MT	12426	MT	12426	693441	680331	rs386829158	NC_012920.1:12425:C:A
NC_012920.1:m.12432C>T	MT-ND5		not provided	Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000235471	MT	12432	MT	12432	235471	237154	rs878853046	NC_012920.1:12431:C:T
NC_012920.1:m.12436C>T	MT-ND5	H34Y	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693442	MT	12436	MT	12436	693442	680332	rs1603223738	NC_012920.1:12435:C:T
NC_012920.1:m.12437A>G	MT-ND5	H34R	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693443	MT	12437	MT	12437	693443	680333	rs1603223739	NC_012920.1:12436:A:G
NC_012920.1:m.12448T>C	MT-ND5	S38P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693445	MT	12448	MT	12448	693445	680335	rs1603223748	NC_012920.1:12447:T:C
NC_012920.1:m.12448T>A	MT-ND5	S38T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693444	MT	12448	MT	12448	693444	680334	rs1603223748	NC_012920.1:12447:T:A
NC_012920.1:m.12451A>G	MT-ND5	I39V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693446	MT	12451	MT	12451	693446	680336	rs1603223750	NC_012920.1:12450:A:G
NC_012920.1:m.12454G>A	MT-ND5	V40I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693447	MT	12454	MT	12454	693447	680337	rs200656196	NC_012920.1:12453:G:A
NC_012920.1:m.12457G>A	MT-ND5	A41T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693448	MT	12457	MT	12457	693448	680338	rs1603223754	NC_012920.1:12456:G:A
NC_012920.1:m.12458C>T	MT-ND5	A41V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693449	MT	12458	MT	12458	693449	680339	rs1603223755	NC_012920.1:12457:C:T
NC_012920.1:m.12479T>C	MT-ND5	L48P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693450	MT	12479	MT	12479	693450	680340	rs1603223760	NC_012920.1:12478:T:C
NC_012920.1:m.12481T>A	MT-ND5	F49I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693452	MT	12481	MT	12481	693452	680341	rs1603223762	NC_012920.1:12480:T:A
NC_012920.1:m.12481T>C	MT-ND5	F49L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693451	MT	12481	MT	12481	693451	680342	rs1603223762	NC_012920.1:12480:T:C
NC_012920.1:m.12490A>G	MT-ND5	T52A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693453	MT	12490	MT	12490	693453	680343	rs1603223763	NC_012920.1:12489:A:G
NC_012920.1:m.12493A>G	MT-ND5	M53V	not provided	Uncertain significance(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000446034	MT	12493	MT	12493	446034	439306	rs1556424118	NC_012920.1:12492:A:G
NC_012920.1:m.12499A>G	MT-ND5	M55V	not provided	not provided	no assertion provided	VCV000918027	MT	12499	MT	12499	918027	906353	rs2068732035	NC_012920.1:12498:A:G
NC_012920.1:m.12501G>C	MT-ND5	M55I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693454	MT	12501	MT	12501	693454	680344	rs28397767	NC_012920.1:12500:G:C
NC_012920.1:m.12509A>G	MT-ND5	D58G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693455	MT	12509	MT	12509	693455	680345	rs1603223773	NC_012920.1:12508:A:G
NC_012920.1:m.12512A>T	MT-ND5	Q59L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693456	MT	12512	MT	12512	693456	680346	rs1603223776	NC_012920.1:12511:A:T
NC_012920.1:m.12520A>G	MT-ND5	I62V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693457	MT	12520	MT	12520	693457	680347	rs1603223781	NC_012920.1:12519:A:G
NC_012920.1:m.12530A>G	MT-ND5	N65S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693458	MT	12530	MT	12530	693458	680348	rs1603223785	NC_012920.1:12529:A:G
NC_012920.1:m.12535C>T	MT-ND5	H67Y	Leigh syndrome|not specified	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000235010	MT	12535	MT	12535	235010	236824	rs876661356	NC_012920.1:12534:C:T
NC_012920.1:m.12542C>T	MT-ND5	A69V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693459	MT	12542	MT	12542	693459	680349	rs201922401	NC_012920.1:12541:C:T
NC_012920.1:m.12544A>G	MT-ND5	T70A	Leigh syndrome|Mitochondrial disease	Uncertain significance(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV000693460	MT	12544	MT	12544	693460	680350	rs1603223798	NC_012920.1:12543:A:G
NC_012920.1:m.12545C>T	MT-ND5	T70M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693461	MT	12545	MT	12545	693461	680351	rs1603223799	NC_012920.1:12544:C:T
NC_012920.1:m.12556A>G	MT-ND5	T74A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693462	MT	12556	MT	12556	693462	680352	rs1603223805	NC_012920.1:12555:A:G
NC_012920.1:m.12557C>T	MT-ND5	T74I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693463	MT	12557	MT	12557	693463	680353	rs1556424125	NC_012920.1:12556:C:T
NC_012920.1:m.12560A>G	MT-ND5	Q75R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693464	MT	12560	MT	12560	693464	680354	rs1603223808	NC_012920.1:12559:A:G
NC_012920.1:m.12561G>C	MT-ND5	Q75H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693465	MT	12561	MT	12561	693465	680355	rs28759201	NC_012920.1:12560:G:C
NC_012920.1:m.12587A>G	MT-ND5	Y84C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693466	MT	12587	MT	12587	693466	680356	rs1603223823	NC_012920.1:12586:A:G
NC_012920.1:m.12599T>C	MT-ND5	M88T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693467	MT	12599	MT	12599	693467	680357	rs1556424129	NC_012920.1:12598:T:C
NC_012920.1:m.12601T>C	MT-ND5	F89L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693468	MT	12601	MT	12601	693468	680358	rs1603223830	NC_012920.1:12600:T:C
NC_012920.1:m.12613G>T	MT-ND5	A93S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693469	MT	12613	MT	12613	693469	680359	rs1603223834	NC_012920.1:12612:G:T
NC_012920.1:m.12622G>A	MT-ND5	V96I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693470	MT	12622	MT	12622	693470	680360	rs1603223840	NC_012920.1:12621:G:A
NC_012920.1:m.12631T>C	MT-ND5	S99P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693471	MT	12631	MT	12631	693471	680361	rs1603223847	NC_012920.1:12630:T:C
NC_012920.1:m.12634A>G	MT-ND5	I100V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693472	MT	12634	MT	12634	693472	680362	rs1556424136	NC_012920.1:12633:A:G
NC_012920.1(MT-ND5):m.12661A>T	MT-ND5	N109Y	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693473	MT	12661	MT	12661	693473	680363	rs1603223854	NC_012920.1:12660:A:T
NC_012920.1(MT-ND5):m.12662A>G	MT-ND5	N109S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693474	MT	12662	MT	12662	693474	680364	rs879105366	NC_012920.1:12661:A:G
NC_012920.1(MT-ND5):m.12673A>G	MT-ND5	N113D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693475	MT	12673	MT	12673	693475	680365	rs1556424143	NC_012920.1:12672:A:G
NC_012920.1(MT-ND5):m.12674A>G	MT-ND5	N113S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693476	MT	12674	MT	12674	693476	680366	rs1603223860	NC_012920.1:12673:A:G
NC_012920.1:m.12681T>C	MT-ND5		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235613	MT	12681	MT	12681	235613	237294	rs878853080	NC_012920.1:12680:T:C
m.12706T>C	MT-ND5	F124L	Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009698	MT	12706	MT	12706	9698	24737	rs267606893	NC_012920.1:12705:T:C
NC_012920.1(MT-ND5):m.12713T>C	MT-ND5	I126T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693477	MT	12713	MT	12713	693477	680367	rs1603223871	NC_012920.1:12712:T:C
NC_012920.1(MT-ND5):m.12715A>G	MT-ND5	T127A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693478	MT	12715	MT	12715	693478	680368	rs1603223875	NC_012920.1:12714:A:G
NC_012920.1(MT-ND5):m.12730G>A	MT-ND5	V132I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693479	MT	12730	MT	12730	693479	680369	rs1603223879	NC_012920.1:12729:G:A
NC_012920.1(MT-ND5):m.12743A>G	MT-ND5	N136S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693480	MT	12743	MT	12743	693480	680370	rs1603223885	NC_012920.1:12742:A:G
NC_012920.1:m.12757T>C	MT-ND5	F141L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693481	MT	12757	MT	12757	693481	680371	rs1603223892	NC_012920.1:12756:T:C
m.12770A>G	MT-ND5	E145G	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000009699	MT	12770	MT	12770	9699	24738	rs267606894	NC_012920.1:12769:A:G
NC_012920.1:m.12775G>A	MT-ND5	V147M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693482	MT	12775	MT	12775	693482	680372	rs1603223899	NC_012920.1:12774:G:A
NC_012920.1:m.12797T>C	MT-ND5	L154P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693483	MT	12797	MT	12797	693483	680373	rs1603223906	NC_012920.1:12796:T:C
NC_012920.1:m.12799A>G	MT-ND5	I155V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693484	MT	12799	MT	12799	693484	680374	rs1603223907	NC_012920.1:12798:A:G
NC_012920.1:m.12810A>G	MT-ND5		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235499	MT	12810	MT	12810	235499	237181	rs28359174	NC_012920.1:12809:A:G
m.12811T>C	MT-ND5	Y159H	not provided|Leber optic atrophy|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000065510	MT	12811	MT	12811	65510	76418	rs199974018	NC_012920.1:12810:T:C
NC_012920.1:m.12814G>A	MT-ND5	A160T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693485	MT	12814	MT	12814	693485	680375	rs1603223914	NC_012920.1:12813:G:A
NC_012920.1:m.12820G>A	MT-ND5	A162T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693486	MT	12820	MT	12820	693486	680376	rs200567053	NC_012920.1:12819:G:A
NC_012920.1:m.12835G>A	MT-ND5	A167T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693487	MT	12835	MT	12835	693487	680377	rs1603223923	NC_012920.1:12834:G:A
NC_012920.1:m.12836C>T	MT-ND5	A167V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693488	MT	12836	MT	12836	693488	680378	rs1603223924	NC_012920.1:12835:C:T
NC_012920.1:m.12842T>C	MT-ND5	I169T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693489	MT	12842	MT	12842	693489	680379	rs1603223927	NC_012920.1:12841:T:C
m.12848C>T	MT-ND5	A171V	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009704	MT	12848	MT	12848	9704	24743	rs267606899	NC_012920.1:12847:C:T
NC_012920.1:m.12850A>G	MT-ND5	I172V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693490	MT	12850	MT	12850	693490	680380	rs28705385	NC_012920.1:12849:A:G
NC_012920.1:m.12851T>C	MT-ND5	I172T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693491	MT	12851	MT	12851	693491	680381	rs1603223938	NC_012920.1:12850:T:C
NC_012920.1:m.12858C>A	MT-ND5	Y174*	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693492	MT	12858	MT	12858	693492	680382	rs879012050	NC_012920.1:12857:C:A
NC_012920.1:m.12865A>G	MT-ND5	I177V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693493	MT	12865	MT	12865	693493	680383	rs1603223946	NC_012920.1:12864:A:G
NC_012920.1:m.12868G>A	MT-ND5	G178S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693494	MT	12868	MT	12868	693494	680384	rs1603223947	NC_012920.1:12867:G:A
NC_012920.1:m.12880T>C	MT-ND5	F182L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693495	MT	12880	MT	12880	693495	680385	rs28719001	NC_012920.1:12879:T:C
NC_012920.1:m.12889G>A	MT-ND5	A185T	not provided	Uncertain significance(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000439963	MT	12889	MT	12889	439963	433753	rs1556424185	NC_012920.1:12888:G:A
NC_012920.1:m.12890C>T	MT-ND5	A185V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693496	MT	12890	MT	12890	693496	680386	rs1603223958	NC_012920.1:12889:C:T
NC_012920.1:m.12903T>C	MT-ND5		not provided	Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000235388	MT	12903	MT	12903	235388	237074	rs878853027	NC_012920.1:12902:T:C
NC_012920.1:m.12904A>G	MT-ND5	I190V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693497	MT	12904	MT	12904	693497	680387	rs386829168	NC_012920.1:12903:A:G
NC_012920.1:m.12905T>C	MT-ND5	I190T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693498	MT	12905	MT	12905	693498	680388	rs1603223963	NC_012920.1:12904:T:C
NC_012920.1:m.12906C>A	MT-ND5	I190M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693499	MT	12906	MT	12906	693499	680389	rs28690070	NC_012920.1:12905:C:A
NC_012920.1:m.12923G>T	MT-ND5	W196L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693500	MT	12923	MT	12923	693500	680390	rs1603223971	NC_012920.1:12922:G:T
NC_012920.1:m.12937A>G	MT-ND5	M201V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693501	MT	12937	MT	12937	693501	680391	rs201612920	NC_012920.1:12936:A:G
NC_012920.1:m.12940G>A	MT-ND5	A202T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693502	MT	12940	MT	12940	693502	680392	rs200106331	NC_012920.1:12939:G:A
NC_012920.1:m.12941C>T	MT-ND5	A202V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693503	MT	12941	MT	12941	693503	680393	rs1603223974	NC_012920.1:12940:C:T
NC_012920.1:m.12950A>C	MT-ND5	N205T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693505	MT	12950	MT	12950	693505	680394	rs201361958	NC_012920.1:12949:A:C
NC_012920.1:m.12950A>G	MT-ND5	N205S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693504	MT	12950	MT	12950	693504	680395	rs201361958	NC_012920.1:12949:A:G
NC_012920.1:m.12952G>A	MT-ND5	A206T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693506	MT	12952	MT	12952	693506	680396	rs1603223978	NC_012920.1:12951:G:A
NC_012920.1:m.12961A>G	MT-ND5	S209G	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693507	MT	12961	MT	12961	693507	680397	rs386829171	NC_012920.1:12960:A:G
NC_012920.1:m.12967A>G	MT-ND5	T211A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693508	MT	12967	MT	12967	693508	680398	rs1556424197	NC_012920.1:12966:A:G
NC_012920.1:m.12994G>A	MT-ND5	A220T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693509	MT	12994	MT	12994	693509	680399	rs1603223993	NC_012920.1:12993:G:A
NC_012920.1:m.12997G>A	MT-ND5	A221T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693510	MT	12997	MT	12997	693510	680400	rs1603223994	NC_012920.1:12996:G:A
NC_012920.1:m.13027C>A	MT-ND5	P231T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693511	MT	13027	MT	13027	693511	680401	rs1603224008	NC_012920.1:13026:C:A
m.13042G>A	MT-ND5	A236T	Leigh syndrome due to mitochondrial complex I deficiency|Leber optic atrophy|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009703	MT	13042	MT	13042	9703	24742	rs267606898	NC_012920.1:13041:G:A
m.13045A>C	MT-ND5	M237L	Leigh syndrome due to mitochondrial complex I deficiency|Leber optic atrophy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000009700	MT	13045	MT	13045	9700	24739	rs267606895	NC_012920.1:13044:A:C
NC_012920.1:m.13046T>C	MT-ND5	M237T	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693512	MT	13046	MT	13046	693512	680402	rs1603224015	NC_012920.1:13045:T:C
NC_012920.1:m.13051G>A	MT-ND5	G239S	Mitochondrial disease|Leber optic atrophy	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000430689	MT	13051	MT	13051	430689	424207	rs1131692063	NC_012920.1:13050:G:A
NC_012920.1:m.13063G>A	MT-ND5	V243I	Leigh syndrome	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693513	MT	13063	MT	13063	693513	680403	rs1603224017	NC_012920.1:13062:G:A
NC_012920.1:m.13064T>C	MT-ND5	V243A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693514	MT	13064	MT	13064	693514	680404	rs1603224019	NC_012920.1:13063:T:C
NC_012920.1:m.13073T>A	MT-ND5	L246Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693515	MT	13073	MT	13073	693515	680405	rs1603224023	NC_012920.1:13072:T:A
m.13084A>T	MT-ND5	S250C	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome due to mitochondrial complex I deficiency	Pathogenic(Last reviewed: Jun 10, 2003)	no assertion criteria provided	VCV000009701	MT	13084	MT	13084	9701	24740	rs267606896	NC_012920.1:13083:A:T
NC_012920.1:m.13094T>C	MT-ND5	V253A	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693516	MT	13094	MT	13094	693516	680406	rs1603224029	NC_012920.1:13093:T:C
NC_012920.1:m.13097T>C	MT-ND5	V254A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693517	MT	13097	MT	13097	693517	680407	rs1603224032	NC_012920.1:13096:T:C
NC_012920.1:m.13099G>A	MT-ND5	A255T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693518	MT	13099	MT	13099	693518	680408	rs1603224033	NC_012920.1:13098:G:A
NC_012920.1:m.13105A>G	MT-ND5	I257V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693519	MT	13105	MT	13105	693519	680409	rs2853501	NC_012920.1:13104:A:G
NC_012920.1:m.13106T>C	MT-ND5	I257T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693520	MT	13106	MT	13106	693520	680410	rs1603224035	NC_012920.1:13105:T:C
NC_012920.1:m.13112T>C	MT-ND5	L259S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693521	MT	13112	MT	13112	693521	680411	rs1603224043	NC_012920.1:13111:T:C
NC_012920.1:m.13117A>G	MT-ND5	I261V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693522	MT	13117	MT	13117	693522	680412	rs878966690	NC_012920.1:13116:A:G
NC_012920.1:m.13129C>T	MT-ND5	P265S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693523	MT	13129	MT	13129	693523	680413	rs1603224056	NC_012920.1:13128:C:T
NC_012920.1:m.13135G>A	MT-ND5	A267T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693524	MT	13135	MT	13135	693524	680414	rs200044200	NC_012920.1:13134:G:A
NC_012920.1:m.13145G>A	MT-ND5	S270N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693525	MT	13145	MT	13145	693525	680415	rs386829175	NC_012920.1:13144:G:A
NC_012920.1:m.13147C>T	MT-ND5	P271S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693526	MT	13147	MT	13147	693526	680416	rs1603224061	NC_012920.1:13146:C:T
NC_012920.1:m.13151T>C	MT-ND5	L272P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693527	MT	13151	MT	13151	693527	680417	rs1603224062	NC_012920.1:13150:T:C
NC_012920.1:m.13153A>G	MT-ND5	I273V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693528	MT	13153	MT	13153	693528	680418	rs878957731	NC_012920.1:13152:A:G
NC_012920.1:m.13154T>C	MT-ND5	I273T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693529	MT	13154	MT	13154	693529	680419	rs1603224067	NC_012920.1:13153:T:C
NC_012920.1:m.13159A>G	MT-ND5	T275A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693530	MT	13159	MT	13159	693530	680420	rs1603224070	NC_012920.1:13158:A:G
NC_012920.1:m.13162C>A	MT-ND5	L276M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693531	MT	13162	MT	13162	693531	680421	rs1603224073	NC_012920.1:13161:C:A
NC_012920.1:m.13183A>G	MT-ND5	I283V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693532	MT	13183	MT	13183	693532	680422	rs879155747	NC_012920.1:13182:A:G
NC_012920.1:m.13184T>C	MT-ND5	I283T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693533	MT	13184	MT	13184	693533	680423	rs1603224078	NC_012920.1:13183:T:C
NC_012920.1:m.13198G>A	MT-ND5	A288T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693534	MT	13198	MT	13198	693534	680424	rs1603224086	NC_012920.1:13197:G:A
NC_012920.1:m.13204G>C	MT-ND5	V290L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693536	MT	13204	MT	13204	693536	680426	rs1603224089	NC_012920.1:13203:G:C
NC_012920.1:m.13204G>A	MT-ND5	V290I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693535	MT	13204	MT	13204	693535	680425	rs1603224089	NC_012920.1:13203:G:A
NC_012920.1:m.13212C>T	MT-ND5		not provided	Likely benign(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000445987	MT	13212	MT	13212	445987	439259	rs1556424241	NC_012920.1:13211:C:T
NC_012920.1:m.13225G>A	MT-ND5	D297N	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693537	MT	13225	MT	13225	693537	680427	rs1603224098	NC_012920.1:13224:G:A
NC_012920.1:m.13240G>A	MT-ND5	V302M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693538	MT	13240	MT	13240	693538	680428	rs1603224103	NC_012920.1:13239:G:A
NC_012920.1:m.13246T>C	MT-ND5	F304L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693539	MT	13246	MT	13246	693539	680429	rs1556424250	NC_012920.1:13245:T:C
NC_012920.1:m.13276A>G	MT-ND5	M314V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693540	MT	13276	MT	13276	693540	680430	rs2853502	NC_012920.1:13275:A:G
NC_012920.1:m.13279G>A	MT-ND5	V315I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693541	MT	13279	MT	13279	693541	680431	rs1603224126	NC_012920.1:13278:G:A
NC_012920.1:m.13285A>G	MT-ND5	I317V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693542	MT	13285	MT	13285	693542	680432	rs1603224130	NC_012920.1:13284:A:G
NC_012920.1:m.13288G>A	MT-ND5	G318S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693543	MT	13288	MT	13288	693543	680433	rs1603224132	NC_012920.1:13287:G:A
NC_012920.1:m.13327A>G	MT-ND5	T331A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693544	MT	13327	MT	13327	693544	680434	rs1556424263	NC_012920.1:13326:A:G
NC_012920.1:m.13328C>A	MT-ND5	T331N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693545	MT	13328	MT	13328	693545	680435	rs1603224147	NC_012920.1:13327:C:A
NC_012920.1:m.13336T>C	MT-ND5	F334L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693546	MT	13336	MT	13336	693546	680436	rs1603224150	NC_012920.1:13335:T:C
NC_012920.1:m.13369T>C	MT-ND5	S345P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693547	MT	13369	MT	13369	693547	680437	rs1603224162	NC_012920.1:13368:T:C
NC_012920.1:m.13375A>G	MT-ND5	I347V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693548	MT	13375	MT	13375	693548	680438	rs1603224165	NC_012920.1:13374:A:G
NC_012920.1:m.13376T>C	MT-ND5	I347T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693549	MT	13376	MT	13376	693549	680439	rs1603224166	NC_012920.1:13375:T:C
NC_012920.1:m.13388A>G	MT-ND5	N351S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693550	MT	13388	MT	13388	693550	680440	rs1603224172	NC_012920.1:13387:A:G
NC_012920.1:m.13391A>G	MT-ND5	N352S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693551	MT	13391	MT	13391	693551	680441	rs1603224173	NC_012920.1:13390:A:G
NC_012920.1:m.13406G>A	MT-ND5	R357Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693552	MT	13406	MT	13406	693552	680442	rs1603224178	NC_012920.1:13405:G:A
NC_012920.1:m.13415G>A	MT-ND5	G360E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693553	MT	13415	MT	13415	693553	680443	rs1603224181	NC_012920.1:13414:G:A
NC_012920.1:m.13436C>A	MT-ND5	P367H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693554	MT	13436	MT	13436	693554	680444	rs1603224188	NC_012920.1:13435:C:A
NC_012920.1:m.13438C>A	MT-ND5	L368I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693555	MT	13438	MT	13438	693555	680445	rs1603224189	NC_012920.1:13437:C:A
NC_012920.1:m.13463G>A	MT-ND5	G376D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693556	MT	13463	MT	13463	693556	680446	rs1603224197	NC_012920.1:13462:G:A
NC_012920.1:m.13466G>C	MT-ND5	S377T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693558	MT	13466	MT	13466	693558	680448	rs3902404	NC_012920.1:13465:G:C
NC_012920.1:m.13466G>A	MT-ND5	S377N	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693557	MT	13466	MT	13466	693557	680447	rs3902404	NC_012920.1:13465:G:A
NC_012920.1:m.13468C>A	MT-ND5	L378M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693559	MT	13468	MT	13468	693559	680449	rs28654395	NC_012920.1:13467:C:A
NC_012920.1:m.13471G>A	MT-ND5	A379T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693560	MT	13471	MT	13471	693560	680450	rs1603224200	NC_012920.1:13470:G:A
NC_012920.1:m.13477G>A	MT-ND5	A381T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693561	MT	13477	MT	13477	693561	680451	rs200283691	NC_012920.1:13476:G:A
NC_012920.1:m.13478C>T	MT-ND5	A381V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693562	MT	13478	MT	13478	693562	680452	rs1603224203	NC_012920.1:13477:C:T
NC_012920.1:m.13484T>C	MT-ND5	M383T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693563	MT	13484	MT	13484	693563	680453	rs1603224204	NC_012920.1:13483:T:C
NC_012920.1:m.13485A>G	MT-ND5		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235555	MT	13485	MT	13485	235555	237236	rs28359176	NC_012920.1:13484:A:G
NC_012920.1:m.13488T>C	MT-ND5		not provided	Likely benign(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000235486	MT	13488	MT	13488	235486	237168	rs878853050	NC_012920.1:13487:T:C
NC_012920.1:m.13495A>G	MT-ND5	T387A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693564	MT	13495	MT	13495	693564	680454	rs1603224207	NC_012920.1:13494:A:G
NC_012920.1:m.13507T>C	MT-ND5	S391P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693565	MT	13507	MT	13507	693565	680455	rs1603224215	NC_012920.1:13506:T:C
m.13513G>A	MT-ND5	D393N	Leigh syndrome due to mitochondrial complex I deficiency|not provided|Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome	Pathogenic(Last reviewed: Oct 26, 2021)	reviewed by expert panel	VCV000009702	MT	13513	MT	13513	9702	24741	rs267606897	NC_012920.1:13512:G:A
NC_012920.1:m.13514A>G	MT-ND5	D393G	Leigh syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000155889	MT	13514	MT	13514	155889	165638	rs587776440	NC_012920.1:13513:A:G
NC_012920.1:m.13522A>C	MT-ND5	I396L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693567	MT	13522	MT	13522	693567	680456	rs1603224217	NC_012920.1:13521:A:C
NC_012920.1:m.13522A>G	MT-ND5	I396V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693566	MT	13522	MT	13522	693566	680457	rs1603224217	NC_012920.1:13521:A:G
NC_012920.1:m.13524C>A	MT-ND5	I396M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693568	MT	13524	MT	13524	693568	680458	rs1603224219	NC_012920.1:13523:C:A
NC_012920.1(MT-ND5):m.13528A>G	MT-ND5	T398A	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000618218	MT	13528	MT	13528	618218	610266	rs55882959	NC_012920.1:13527:A:G
NC_012920.1:m.13535A>G	MT-ND5	N400S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693569	MT	13535	MT	13535	693569	680459	rs1603224224	NC_012920.1:13534:A:G
NC_012920.1:m.13543T>C	MT-ND5	Y403H	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693570	MT	13543	MT	13543	693570	680460	rs1603224227	NC_012920.1:13542:T:C
NC_012920.1:m.13547C>T	MT-ND5	T404M	not provided	not provided	no assertion provided	VCV000918033	MT	13547	MT	13547	918033	906354	rs2068736660	NC_012920.1:13546:C:T
NC_012920.1:m.13552G>A	MT-ND5	A406T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693571	MT	13552	MT	13552	693571	680461	rs1603224232	NC_012920.1:13551:G:A
NC_012920.1:m.13565C>T	MT-ND5	S410F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693572	MT	13565	MT	13565	693572	680462	rs56039545	NC_012920.1:13564:C:T
NC_012920.1:m.13568T>C	MT-ND5	I411T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693573	MT	13568	MT	13568	693573	680463	rs1603224237	NC_012920.1:13567:T:C
NC_012920.1:m.13576A>G	MT-ND5	I414V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693574	MT	13576	MT	13576	693574	680464	rs1603224243	NC_012920.1:13575:A:G
NC_012920.1:m.13579G>A	MT-ND5	A415T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693575	MT	13579	MT	13579	693575	680465	rs1603224246	NC_012920.1:13578:G:A
NC_012920.1:m.13583C>T	MT-ND5	T416I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693576	MT	13583	MT	13583	693576	680466	rs1603224248	NC_012920.1:13582:C:T
NC_012920.1:m.13594A>G	MT-ND5	S420G	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693577	MT	13594	MT	13594	693577	680467	rs1603224251	NC_012920.1:13593:A:G
NC_012920.1:m.13606A>G	MT-ND5	T424A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693578	MT	13606	MT	13606	693578	680468	rs1603224258	NC_012920.1:13605:A:G
NC_012920.1:m.13612A>T	MT-ND5	M426L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693579	MT	13612	MT	13612	693579	680469	rs1603224262	NC_012920.1:13611:A:T
NC_012920.1:m.13615A>G	MT-ND5	I427V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693580	MT	13615	MT	13615	693580	680470	rs1603224265	NC_012920.1:13614:A:G
NC_012920.1:m.13616T>C	MT-ND5	I427T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693581	MT	13616	MT	13616	693581	680471	rs1603224267	NC_012920.1:13615:T:C
NC_012920.1:m.13630A>G	MT-ND5	T432A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693582	MT	13630	MT	13630	693582	680472	rs1556424302	NC_012920.1:13629:A:G
NC_012920.1:m.13635T>C	MT-ND5		not provided	Likely benign(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000235598	MT	13635	MT	13635	235598	237279	rs878853075	NC_012920.1:13634:T:C
m.13637A>G	MT-ND5	Q434R	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065511	MT	13637	MT	13637	65511	76419	rs200855215	NC_012920.1:13636:A:G
NC_012920.1:m.13645T>A	MT-ND5	F437I	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693583	MT	13645	MT	13645	693583	680473	rs1603224281	NC_012920.1:13644:T:A
NC_012920.1:m.13649C>T	MT-ND5	P438L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693584	MT	13649	MT	13649	693584	680474	rs1603224283	NC_012920.1:13648:C:T
NC_012920.1:m.13651A>T	MT-ND5	T439S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693587	MT	13651	MT	13651	693587	680477	rs1569484594	NC_012920.1:13650:A:T
NC_012920.1:m.13651A>G	MT-ND5	T439A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693586	MT	13651	MT	13651	693586	680476	rs1569484594	NC_012920.1:13650:A:G
NC_012920.1:m.13651A>C	MT-ND5	T439P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693585	MT	13651	MT	13651	693585	680475	rs1569484594	NC_012920.1:13650:A:C
NC_012920.1:m.13661A>G	MT-ND5	N442S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693588	MT	13661	MT	13661	693588	680478	rs1603224293	NC_012920.1:13660:A:G
NC_012920.1:m.13664T>C	MT-ND5	I443T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693589	MT	13664	MT	13664	693589	680479	rs1603224295	NC_012920.1:13663:T:C
NC_012920.1:m.13676A>G	MT-ND5	N447S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693590	MT	13676	MT	13676	693590	680480	rs1603224300	NC_012920.1:13675:A:G
NC_012920.1:m.13681A>T	MT-ND5	T449S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693592	MT	13681	MT	13681	693592	680482	rs386829187	NC_012920.1:13680:A:T
NC_012920.1:m.13681A>G	MT-ND5	T449A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693591	MT	13681	MT	13681	693591	680481	rs386829187	NC_012920.1:13680:A:G
m.13708G>A	MT-ND5	A458T	Leigh syndrome|Leber optic atrophy	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009696	MT	13708	MT	13708	9696	24735	rs28359178	NC_012920.1:13707:G:A
NC_012920.1:m.13711G>A	MT-ND5	A459T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693593	MT	13711	MT	13711	693593	680483	rs879489195	NC_012920.1:13710:G:A
NC_012920.1:m.13712C>T	MT-ND5	A459V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693594	MT	13712	MT	13712	693594	680484	rs1603224311	NC_012920.1:13711:C:T
NC_012920.1:m.13713C>A	MT-ND5		Hearing impairment|Microcephaly|Developmental delay|Congenital cardiomyopathy	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370058	MT	13713	MT	13713	370058	354288	rs879193643	NC_012920.1:13712:C:A
NC_012920.1:m.13722A>G	MT-ND5		not provided	Benign(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000377244	MT	13722	MT	13722	377244	364122	rs386829190	NC_012920.1:13721:A:G
NC_012920.1:m.13726G>A	MT-ND5	A464T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693595	MT	13726	MT	13726	693595	680485	rs1603224322	NC_012920.1:13725:G:A
m.13730G>A	MT-ND5	G465E	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009697	MT	13730	MT	13730	9697	24736	rs387906425	NC_012920.1:13729:G:A
NC_012920.1:m.13741A>G	MT-ND5	T469A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693596	MT	13741	MT	13741	693596	680486	rs1603224331	NC_012920.1:13740:A:G
NC_012920.1:m.13748A>G	MT-ND5	N471S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693597	MT	13748	MT	13748	693597	680487	rs879029751	NC_012920.1:13747:A:G
NC_012920.1:m.13753T>C	MT-ND5	S473P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693598	MT	13753	MT	13753	693598	680488	rs1603224336	NC_012920.1:13752:T:C
NC_012920.1:m.13754C>T	MT-ND5	S473F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693599	MT	13754	MT	13754	693599	680489	rs1603224337	NC_012920.1:13753:C:T
NC_012920.1:m.13759G>A	MT-ND5	A475T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693600	MT	13759	MT	13759	693600	680490	rs386420024	NC_012920.1:13758:G:A
NC_012920.1:m.13760C>T	MT-ND5	A475V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693601	MT	13760	MT	13760	693601	680491	rs1603224340	NC_012920.1:13759:C:T
NC_012920.1:m.13762T>G	MT-ND5	S476A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693603	MT	13762	MT	13762	693603	680493	rs879154715	NC_012920.1:13761:T:G
NC_012920.1:m.13762T>A	MT-ND5	S476T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693602	MT	13762	MT	13762	693602	680492	rs879154715	NC_012920.1:13761:T:A
NC_012920.1:m.13763C>T	MT-ND5	S476F	Leigh syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial DNA-Associated Leigh Syndrome and NARP|Leber optic atrophy	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693604	MT	13763	MT	13763	693604	680494	rs1603224344	NC_012920.1:13762:C:T
NC_012920.1:m.13768T>C	MT-ND5	F478L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693606	MT	13768	MT	13768	693606	680496	rs1556424325	NC_012920.1:13767:T:C
NC_012920.1:m.13768T>A	MT-ND5	F478I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693605	MT	13768	MT	13768	693605	680495	rs1556424325	NC_012920.1:13767:T:A
NC_012920.1:m.13770C>A	MT-ND5	F478L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693607	MT	13770	MT	13770	693607	680497	rs1603224349	NC_012920.1:13769:C:A
NC_012920.1:m.13780A>G	MT-ND5	I482V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693608	MT	13780	MT	13780	693608	680498	rs41358152	NC_012920.1:13779:A:G
NC_012920.1:m.13781T>C	MT-ND5	I482T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693609	MT	13781	MT	13781	693609	680499	rs386829193	NC_012920.1:13780:T:C
NC_012920.1:m.13789T>C	MT-ND5	Y485H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693610	MT	13789	MT	13789	693610	680500	rs28359179	NC_012920.1:13788:T:C
NC_012920.1:m.13790A>G	MT-ND5	Y485C	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693611	MT	13790	MT	13790	693611	680501	rs1556424326	NC_012920.1:13789:A:G
NC_012920.1:m.13801A>G	MT-ND5	T489A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693612	MT	13801	MT	13801	693612	680502	rs1603224358	NC_012920.1:13800:A:G
NC_012920.1:m.13802C>T	MT-ND5	T489M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693613	MT	13802	MT	13802	693613	680503	rs1556424329	NC_012920.1:13801:C:T
NC_012920.1:m.13810G>A	MT-ND5	A492T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693614	MT	13810	MT	13810	693614	680504	rs1603224361	NC_012920.1:13809:G:A
NC_012920.1:m.13813G>A	MT-ND5	V493I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693615	MT	13813	MT	13813	693615	680505	rs1556424332	NC_012920.1:13812:G:A
NC_012920.1:m.13816A>G	MT-ND5	T494A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693616	MT	13816	MT	13816	693616	680506	rs1603224365	NC_012920.1:13815:A:G
NC_012920.1:m.13819T>C	MT-ND5	F495L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693617	MT	13819	MT	13819	693617	680507	rs371771942	NC_012920.1:13818:T:C
NC_012920.1:m.13820T>C	MT-ND5	F495S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693618	MT	13820	MT	13820	693618	680508	rs1603224368	NC_012920.1:13819:T:C
NC_012920.1:m.13834A>G	MT-ND5	T500A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693619	MT	13834	MT	13834	693619	680509	rs1556424337	NC_012920.1:13833:A:G
NC_012920.1:m.13835C>T	MT-ND5	T500M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693620	MT	13835	MT	13835	693620	680510	rs1603224377	NC_012920.1:13834:C:T
NC_012920.1:m.13862A>G	MT-ND5	N509S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693621	MT	13862	MT	13862	693621	680511	rs1603224389	NC_012920.1:13861:A:G
NC_012920.1:m.13874T>C	MT-ND5	M513T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693622	MT	13874	MT	13874	693622	680512	rs1603224392	NC_012920.1:13873:T:C
NC_012920.1:m.13879T>A	MT-ND5	S515T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693624	MT	13879	MT	13879	693624	680513	rs879087566	NC_012920.1:13878:T:A
NC_012920.1:m.13879T>C	MT-ND5	S515P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693623	MT	13879	MT	13879	693623	680514	rs879087566	NC_012920.1:13878:T:C
NC_012920.1:m.13880C>A	MT-ND5	S515Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693625	MT	13880	MT	13880	693625	680515	rs28359181	NC_012920.1:13879:C:A
NC_012920.1:m.13885C>A	MT-ND5	L517M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693626	MT	13885	MT	13885	693626	680516	rs1603224399	NC_012920.1:13884:C:A
NC_012920.1:m.13886T>C	MT-ND5	L517P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693627	MT	13886	MT	13886	693627	680517	rs28359182	NC_012920.1:13885:T:C
NC_012920.1:m.13888T>C	MT-ND5	C518R	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693628	MT	13888	MT	13888	693628	680518	rs1603224403	NC_012920.1:13887:T:C
NC_012920.1:m.13889G>A	MT-ND5	C518Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693629	MT	13889	MT	13889	693629	680519	rs1556424343	NC_012920.1:13888:G:A
NC_012920.1:m.13907A>G	MT-ND5	N524S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693630	MT	13907	MT	13907	693630	680520	rs1603224408	NC_012920.1:13906:A:G
NC_012920.1:m.13913T>C	MT-ND5	L526P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693631	MT	13913	MT	13913	693631	680521	rs1603224410	NC_012920.1:13912:T:C
NC_012920.1:m.13919T>C	MT-ND5	F528S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693633	MT	13919	MT	13919	693633	680523	rs1603224418	NC_012920.1:13918:T:C
NC_012920.1:m.13919T>A	MT-ND5	F528Y	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693632	MT	13919	MT	13919	693632	680522	rs1603224418	NC_012920.1:13918:T:A
NC_012920.1:m.13924C>T	MT-ND5	P530S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693634	MT	13924	MT	13924	693634	680524	rs200713907	NC_012920.1:13923:C:T
NC_012920.1:m.13926T>C	MT-ND5		not provided	Uncertain significance(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000235477	MT	13926	MT	13926	235477	237159	rs878853047	NC_012920.1:13925:T:C
NC_012920.1:m.13928G>A	MT-ND5	S531N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693636	MT	13928	MT	13928	693636	680525	rs28359184	NC_012920.1:13927:G:A
NC_012920.1:m.13928G>C	MT-ND5	S531T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693635	MT	13928	MT	13928	693635	680526	rs28359184	NC_012920.1:13927:G:C
NC_012920.1:m.13933A>G	MT-ND5	T533A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693637	MT	13933	MT	13933	693637	680527	rs879235634	NC_012920.1:13932:A:G
NC_012920.1:m.13934C>T	MT-ND5	T533M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693638	MT	13934	MT	13934	693638	680528	rs193302971	NC_012920.1:13933:C:T
NC_012920.1:m.13943C>T	MT-ND5	T536M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693639	MT	13943	MT	13943	693639	680529	rs1556424357	NC_012920.1:13942:C:T
NC_012920.1:m.13946T>C	MT-ND5	I537T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693640	MT	13946	MT	13946	693640	680530	rs1603224429	NC_012920.1:13945:T:C
NC_012920.1:m.13948C>T	MT-ND5	P538S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693641	MT	13948	MT	13948	693641	680531	rs878869470	NC_012920.1:13947:C:T
NC_012920.1:m.13958G>C	MT-ND5	G541A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693642	MT	13958	MT	13958	693642	680532	rs202081448	NC_012920.1:13957:G:C
NC_012920.1:m.13966A>G	MT-ND5	T544A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693643	MT	13966	MT	13966	693643	680533	rs41535848	NC_012920.1:13965:A:G
NC_012920.1:m.13967C>T	MT-ND5	T544M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693644	MT	13967	MT	13967	693644	680534	rs386829197	NC_012920.1:13966:C:T
NC_012920.1:m.13973A>T	MT-ND5	Q546L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693645	MT	13973	MT	13973	693645	680535	rs1603224442	NC_012920.1:13972:A:T
NC_012920.1:m.13974A>T	MT-ND5	Q546H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693646	MT	13974	MT	13974	693646	680536	rs1603224443	NC_012920.1:13973:A:T
NC_012920.1:m.13981C>T	MT-ND5	P549S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693647	MT	13981	MT	13981	693647	680537	rs201144988	NC_012920.1:13980:C:T
NC_012920.1(MT-ND5):m.14000T>A	MT-ND5	L555Q	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235700	MT	14000	MT	14000	235700	237380	rs28359185	NC_012920.1:13999:T:A
NC_012920.1(MT-ND5):m.14002A>G	MT-ND5	T556A	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000445967	MT	14002	MT	14002	445967	439239	rs386829198	NC_012920.1:14001:A:G
NC_012920.1:m.14003C>T	MT-ND5	T556I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693648	MT	14003	MT	14003	693648	680538	rs1603224466	NC_012920.1:14002:C:T
NC_012920.1:m.14020T>G	MT-ND5	L562V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693649	MT	14020	MT	14020	693649	680539	rs1556424369	NC_012920.1:14019:T:G
NC_012920.1:m.14022A>G	MT-ND5		not provided	Likely benign(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000235717	MT	14022	MT	14022	235717	237397	rs878853101	NC_012920.1:14021:A:G
NC_012920.1:m.14029A>G	MT-ND5	T565A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693650	MT	14029	MT	14029	693650	680540	rs1603224478	NC_012920.1:14028:A:G
NC_012920.1:m.14035T>G	MT-ND5	S567A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693651	MT	14035	MT	14035	693651	680541	rs1556424374	NC_012920.1:14034:T:G
NC_012920.1:m.14040G>C	MT-ND5	Q568H	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693652	MT	14040	MT	14040	693652	680542	rs57180882	NC_012920.1:14039:G:C
NC_012920.1:m.14040G>A	MT-ND5		not provided	Likely benign(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000445963	MT	14040	MT	14040	445963	439235	rs57180882	NC_012920.1:14039:G:A
NC_012920.1:m.14041C>T	MT-ND5	H569Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693653	MT	14041	MT	14041	693653	680543	rs1603224484	NC_012920.1:14040:C:T
NC_012920.1:m.14042A>T	MT-ND5	H569L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693654	MT	14042	MT	14042	693654	680544	rs1603224485	NC_012920.1:14041:A:T
NC_012920.1:m.14047A>G	MT-ND5	I571V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693655	MT	14047	MT	14047	693655	680545	rs1603224486	NC_012920.1:14046:A:G
NC_012920.1:m.14050T>C	MT-ND5	S572P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693656	MT	14050	MT	14050	693656	680546	rs879112261	NC_012920.1:14049:T:C
NC_012920.1:m.14051C>T	MT-ND5	S572F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693657	MT	14051	MT	14051	693657	680547	rs1603224492	NC_012920.1:14050:C:T
NC_012920.1:m.14053A>C	MT-ND5	T573P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693659	MT	14053	MT	14053	693659	680548	rs200134839	NC_012920.1:14052:A:C
NC_012920.1:m.14053A>G	MT-ND5	T573A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693658	MT	14053	MT	14053	693658	680549	rs200134839	NC_012920.1:14052:A:G
NC_012920.1:m.14059A>G	MT-ND5	I575V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693660	MT	14059	MT	14059	693660	680550	rs878865648	NC_012920.1:14058:A:G
NC_012920.1:m.14060T>C	MT-ND5	I575T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693661	MT	14060	MT	14060	693661	680551	rs1603224503	NC_012920.1:14059:T:C
NC_012920.1:m.14062A>G	MT-ND5	I576V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693662	MT	14062	MT	14062	693662	680552	rs1603224506	NC_012920.1:14061:A:G
NC_012920.1:m.14063T>C	MT-ND5	I576T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693663	MT	14063	MT	14063	693663	680553	rs1556424379	NC_012920.1:14062:T:C
NC_012920.1:m.14071A>G	MT-ND5	T579A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693664	MT	14071	MT	14071	693664	680554	rs1603224512	NC_012920.1:14070:A:G
NC_012920.1:m.14076A>G	MT-ND5		not provided	Likely benign(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000446036	MT	14076	MT	14076	446036	439308	rs1556424380	NC_012920.1:14075:A:G
NC_012920.1:m.14091A>T	MT-ND5	K585N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693665	MT	14091	MT	14091	693665	680555	rs1603224520	NC_012920.1:14090:A:T
NC_012920.1:m.14110T>C	MT-ND5	F592L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693666	MT	14110	MT	14110	693666	680556	rs371451099	NC_012920.1:14109:T:C
NC_012920.1:m.14112C>A	MT-ND5	F592L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693667	MT	14112	MT	14112	693667	680557	rs1603224530	NC_012920.1:14111:C:A
NC_012920.1:m.14113T>C	MT-ND5	F593L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693668	MT	14113	MT	14113	693668	680558	rs1603224531	NC_012920.1:14112:T:C
NC_012920.1:m.14122A>G	MT-ND5	I596V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693669	MT	14122	MT	14122	693669	680559	rs1603224535	NC_012920.1:14121:A:G
NC_012920.1:m.14128A>G	MT-ND5	T598A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693670	MT	14128	MT	14128	693670	680560	rs386829201	NC_012920.1:14127:A:G
NC_012920.1:m.14129C>T	MT-ND5	T598I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693671	MT	14129	MT	14129	693671	680561	rs879039557	NC_012920.1:14128:C:T
NC_012920.1:m.14133A>G	MT-ND5		not provided	Benign(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000377029	MT	14133	MT	14133	377029	363907	rs879100848	NC_012920.1:14132:A:G
NC_012920.1:m.14138T>C	MT-ND5	L601P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693672	MT	14138	MT	14138	693672	680562	rs1603224549	NC_012920.1:14137:T:C
NC_012920.1:m.14140A>G	MT-ND5	I602V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693673	MT	14140	MT	14140	693673	680563	rs1603224551	NC_012920.1:14139:A:G
NC_012920.1:m.14142C>G	MT-ND5	I602M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693675	MT	14142	MT	14142	693675	680565	rs1603224552	NC_012920.1:14141:C:G
NC_012920.1:m.14142C>A	MT-ND5	I602M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693674	MT	14142	MT	14142	693674	680564	rs1603224552	NC_012920.1:14141:C:A
NC_012920.1:m.14143A>G	MT-ND5	T603A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693676	MT	14143	MT	14143	693676	680566	rs1603224556	NC_012920.1:14142:A:G
NC_012920.1:m.14144C>T	MT-ND5	T603M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693677	MT	14144	MT	14144	693677	680567	rs1603224557	NC_012920.1:14143:C:T
NC_012920.1:m.14148A>G	MT-ND5		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235351	MT	14148	MT	14148	235351	237038	rs28357668	NC_012920.1:14147:A:G
NC_012920.1:m.14153T>C	MT-ND6	N174S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693678	MT	14153	MT	14153	693678	680568	rs1603224565	NC_012920.1:14152:T:C
NC_012920.1:m.14154T>G	MT-ND6	N174H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693679	MT	14154	MT	14154	693679	680569	rs1603224566	NC_012920.1:14153:T:G
NC_012920.1:m.14162G>A	MT-ND6	A171V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693680	MT	14162	MT	14162	693680	680570	rs1603224571	NC_012920.1:14161:G:A
NC_012920.1:m.14163C>T	MT-ND6	A171T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693681	MT	14163	MT	14163	693681	680571	rs1603224574	NC_012920.1:14162:C:T
NC_012920.1:m.14178T>C	MT-ND6	I166V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693682	MT	14178	MT	14178	693682	680572	rs28357671	NC_012920.1:14177:T:C
NC_012920.1:m.14180T>C	MT-ND6	Y165C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693684	MT	14180	MT	14180	693684	680573	rs200933339	NC_012920.1:14179:T:C
NC_012920.1:m.14180T>G	MT-ND6	Y165S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693683	MT	14180	MT	14180	693683	680574	rs200933339	NC_012920.1:14179:T:G
NC_012920.1:m.14181A>G	MT-ND6	Y165H	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693685	MT	14181	MT	14181	693685	680575	rs1603224581	NC_012920.1:14180:A:G
NC_012920.1:m.14189A>G	MT-ND6	V162A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693686	MT	14189	MT	14189	693686	680576	rs1603224589	NC_012920.1:14188:A:G
NC_012920.1:m.14193A>G	MT-ND6	F161L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693687	MT	14193	MT	14193	693687	680577	rs1556424397	NC_012920.1:14192:A:G
NC_012920.1:m.14198G>A	MT-ND6	T159M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693688	MT	14198	MT	14198	693688	680578	rs1603224596	NC_012920.1:14197:G:A
NC_012920.1:m.14199T>C	MT-ND6	T159A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693689	MT	14199	MT	14199	693689	680579	rs2857288	NC_012920.1:14198:T:C
NC_012920.1:m.14207G>A	MT-ND6	T156I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693690	MT	14207	MT	14207	693690	680580	rs879217937	NC_012920.1:14206:G:A
NC_012920.1:m.14210A>G	MT-ND6	V155A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693691	MT	14210	MT	14210	693691	680581	rs1603224604	NC_012920.1:14209:A:G
NC_012920.1:m.14211C>T	MT-ND6	V155I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693692	MT	14211	MT	14211	693692	680582	rs1603224605	NC_012920.1:14210:C:T
NC_012920.1:m.14225C>T	MT-ND6	R150H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693693	MT	14225	MT	14225	693693	680583	rs1603224611	NC_012920.1:14224:C:T
NC_012920.1:m.14226G>A	MT-ND6	R150C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693694	MT	14226	MT	14226	693694	680584	rs1603224612	NC_012920.1:14225:G:A
NC_012920.1:m.14231T>C	MT-ND6	Y148C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693695	MT	14231	MT	14231	693695	680585	rs1603224615	NC_012920.1:14230:T:C
NC_012920.1:m.14234T>C	MT-ND6	D147G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693696	MT	14234	MT	14234	693696	680586	rs1603224619	NC_012920.1:14233:T:C
NC_012920.1:m.14249G>A	MT-ND6	A142V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693697	MT	14249	MT	14249	693697	680587	rs1556424407	NC_012920.1:14248:G:A
NC_012920.1:m.14256T>C	MT-ND6	I140V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693698	MT	14256	MT	14256	693698	680588	rs1603224630	NC_012920.1:14255:T:C
NC_012920.1:m.14258G>A	MT-ND6	P139L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693699	MT	14258	MT	14258	693699	680589	rs202227543	NC_012920.1:14257:G:A
NC_012920.1:m.14259G>A	MT-ND6	P139S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693700	MT	14259	MT	14259	693700	680590	rs1603224632	NC_012920.1:14258:G:A
NC_012920.1:m.14276C>T	MT-ND6	G133E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693701	MT	14276	MT	14276	693701	680591	rs1603224645	NC_012920.1:14275:C:T
m.14279G>A	MT-ND6	S132L	Leber optic atrophy|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065516	MT	14279	MT	14279	65516	76424	rs869025187	NC_012920.1:14278:G:A
NC_012920.1:m.14280A>C	MT-ND6	S132A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693703	MT	14280	MT	14280	693703	680592	rs1603224649	NC_012920.1:14279:A:C
NC_012920.1:m.14280A>G	MT-ND6	S132P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693702	MT	14280	MT	14280	693702	680593	rs1603224649	NC_012920.1:14279:A:G
NC_012920.1:m.14297A>G	MT-ND6	I126T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693704	MT	14297	MT	14297	693704	680594	rs1603224655	NC_012920.1:14296:A:G
NC_012920.1:m.14301T>C	MT-ND6	M125V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693705	MT	14301	MT	14301	693705	680595	rs1603224659	NC_012920.1:14300:T:C
NC_012920.1:m.14307T>C	MT-ND6	S123G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693706	MT	14307	MT	14307	693706	680596	rs1603224663	NC_012920.1:14306:T:C
NC_012920.1:m.14312A>G	MT-ND6	V121A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693707	MT	14312	MT	14312	693707	680597	rs1603224665	NC_012920.1:14311:A:G
NC_012920.1:m.14315C>T	MT-ND6	S120N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693708	MT	14315	MT	14315	693708	680598	rs1603224668	NC_012920.1:14314:C:T
NC_012920.1:m.14318T>C	MT-ND6	N119S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693709	MT	14318	MT	14318	693709	680599	rs28357675	NC_012920.1:14317:T:C
m.14319T>C	MT-ND6	N119D	Leigh syndrome|Autosomal recessive early-onset Parkinson disease 6	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009695	MT	14319	MT	14319	9695	24734	rs199476110	NC_012920.1:14318:T:C
m.14325T>C	MT-ND6	N117D	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065512	MT	14325	MT	14325	65512	76420	rs397515505	NC_012920.1:14324:T:C
NC_012920.1:m.14328C>T	MT-ND6	V116M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693710	MT	14328	MT	14328	693710	680600	rs1603224675	NC_012920.1:14327:C:T
NC_012920.1:m.14334C>T	MT-ND6	V114I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693711	MT	14334	MT	14334	693711	680601	rs1603224679	NC_012920.1:14333:C:T
NC_012920.1:m.14339A>G	MT-ND6	V112A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693712	MT	14339	MT	14339	693712	680602	rs1603224682	NC_012920.1:14338:A:G
NC_012920.1:m.14340C>T	MT-ND6	V112M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693713	MT	14340	MT	14340	693713	680603	rs1603224683	NC_012920.1:14339:C:T
NC_012920.1:m.14348T>C	MT-ND6	Y109C	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693714	MT	14348	MT	14348	693714	680604	rs1603224685	NC_012920.1:14347:T:C
NC_012920.1:m.14357A>G	MT-ND6	V106A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693715	MT	14357	MT	14357	693715	680605	rs1603224692	NC_012920.1:14356:A:G
NC_012920.1:m.14372C>A	MT-ND6	G101V	Acute megakaryoblastic leukemia|Mediastinal germ cell tumor	Uncertain significance(Last reviewed: Oct 22, 2015)	no assertion criteria provided	VCV000218344	MT	14372	MT	14372	218344	215055	rs1556424431	NC_012920.1:14371:C:A
NC_012920.1:m.14375A>C	MT-ND6	V100G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693716	MT	14375	MT	14375	693716	680606	rs1603224702	NC_012920.1:14374:A:C
NC_012920.1:m.14382T>G	MT-ND6	M98L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693717	MT	14382	MT	14382	693717	680607	rs1603224704	NC_012920.1:14381:T:G
NC_012920.1:m.14384G>A	MT-ND6	A97V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693718	MT	14384	MT	14384	693718	680608	rs1556424435	NC_012920.1:14383:G:A
NC_012920.1(MT-ND6):m.14393A>G	MT-ND6	V94A	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235743	MT	14393	MT	14393	235743	237423	rs878853104	NC_012920.1:14392:A:G
NC_012920.1:m.14405A>G	MT-ND6	V90A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693719	MT	14405	MT	14405	693719	680609	rs1603224713	NC_012920.1:14404:A:G
NC_012920.1:m.14417A>G	MT-ND6	V86A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693720	MT	14417	MT	14417	693720	680610	rs878905427	NC_012920.1:14416:A:G
NC_012920.1:m.14420C>T	MT-ND6	G85E	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693721	MT	14420	MT	14420	693721	680611	rs1556424442	NC_012920.1:14419:C:T
NC_012920.1:m.14423G>A	MT-ND6	S84L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693722	MT	14423	MT	14423	693722	680612	rs1603224726	NC_012920.1:14422:G:A
NC_012920.1:m.14433C>T	MT-ND6	A81T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693723	MT	14433	MT	14433	693723	680613	rs1556424444	NC_012920.1:14432:C:T
NC_012920.1:m.14444T>C	MT-ND6	E77G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693724	MT	14444	MT	14444	693724	680614	rs1603224732	NC_012920.1:14443:T:C
m.14453G>A	MT-ND6	A74V	Leigh syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009692	MT	14453	MT	14453	9692	24731	rs199476107	NC_012920.1:14452:G:A
m.14459G>A	MT-ND6	A72V	Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial disease|Leigh syndrome|Leber optic atrophy|Leber optic atrophy and dystonia	Pathogenic(Last reviewed: Nov 1, 2021)	reviewed by expert panel	VCV000009689	MT	14459	MT	14459	9689	24728	rs199476105	NC_012920.1:14458:G:A
NC_012920.1:m.14462G>A	MT-ND6	T71M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693725	MT	14462	MT	14462	693725	680615	rs1603224737	NC_012920.1:14461:G:A
NC_012920.1:m.14465G>A	MT-ND6	T70I	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693726	MT	14465	MT	14465	693726	680616	rs1603224738	NC_012920.1:14464:G:A
NC_012920.1:m.14466T>C	MT-ND6	T70A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693727	MT	14466	MT	14466	693727	680617	rs1603224741	NC_012920.1:14465:T:C
NC_012920.1:m.14468T>C	MT-ND6	Y69C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693728	MT	14468	MT	14468	693728	680618	rs1603224744	NC_012920.1:14467:T:C
NC_012920.1:m.14470T>A	MT-ND6		not provided	Likely benign(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000235574	MT	14470	MT	14470	235574	237255	rs3135030	NC_012920.1:14469:T:A
NC_012920.1:m.14476G>A	MT-ND6		not provided	Benign(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000376998	MT	14476	MT	14476	376998	363876	rs1057520103	NC_012920.1:14475:G:A
NC_012920.1:m.14477A>G	MT-ND6	V66A	Constriction of peripheral visual field|Headache|Cognitive impairment|Abnormality of brain morphology|Paresthesia|Muscle spasm|Vertigo	Uncertain significance(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523306	MT	14477	MT	14477	523306	514151	rs1556424448	NC_012920.1:14476:A:G
m.14482C>G	MT-ND6	M64I	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000065513	MT	14482	MT	14482	65513	76421	rs199476108	NC_012920.1:14481:C:G
m.14482C>A	MT-ND6	M64I	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009693	MT	14482	MT	14482	9693	24732	rs199476108	NC_012920.1:14481:C:A
NC_012920.1:m.14484T>G	MT-ND6	M64L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693729	MT	14484	MT	14484	693729	680619	rs199476104	NC_012920.1:14483:T:G
NC_012920.1:m.14484T>C	MT-ND6	M64V	not provided|Leber optic atrophy|Leigh syndrome	Pathogenic(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009688	MT	14484	MT	14484	9688	24727	rs199476104	NC_012920.1:14483:T:C
m.14487T>C	MT-ND6	M63V	Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|Striatal necrosis, bilateral, with dystonia	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009694	MT	14487	MT	14487	9694	24733	rs199476109	NC_012920.1:14486:T:C
m.14495A>G	MT-ND6	L60S	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009691	MT	14495	MT	14495	9691	24730	rs199476106	NC_012920.1:14494:A:G
m.14498T>C	MT-ND6	Y59C	Leber optic atrophy|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065514	MT	14498	MT	14498	65514	76422	rs869025186	NC_012920.1:14497:T:C
NC_012920.1(MT-ND6):m.14502T>C	MT-ND6	I58V	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000690281	MT	14502	MT	14502	690281	677958	rs201327354	NC_012920.1:14501:T:C
NC_012920.1:m.14514T>C	MT-ND6	M54V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693730	MT	14514	MT	14514	693730	680620	rs1603224772	NC_012920.1:14513:T:C
NC_012920.1:m.14523T>C	MT-ND6	M51V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693731	MT	14523	MT	14523	693731	680621	rs1603224780	NC_012920.1:14522:T:C
NC_012920.1:m.14529C>T	MT-ND6	G49S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693732	MT	14529	MT	14529	693732	680622	rs1603224782	NC_012920.1:14528:C:T
NC_012920.1:m.14544G>T	MT-ND6	L44M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693733	MT	14544	MT	14544	693733	680623	rs371485573	NC_012920.1:14543:G:T
NC_012920.1:m.14552A>G	MT-ND6	V41A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693734	MT	14552	MT	14552	693734	680624	rs1556424459	NC_012920.1:14551:A:G
NC_012920.1:m.14553C>T	MT-ND6	V41I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693735	MT	14553	MT	14553	693735	680625	rs1603224787	NC_012920.1:14552:C:T
NC_012920.1:m.14562C>T	MT-ND6	V38I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693736	MT	14562	MT	14562	693736	680626	rs1603224791	NC_012920.1:14561:C:T
NC_012920.1:m.14563C>T	MT-ND6		Mitochondrial cytopathy	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370059	MT	14563	MT	14563	370059	354289	rs1057516069	NC_012920.1:14562:C:T
NC_012920.1:m.14564A>G	MT-ND6	V37A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693737	MT	14564	MT	14564	693737	680627	rs1556424461	NC_012920.1:14563:A:G
m.14568C>T	MT-ND6	G36S	Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000065515	MT	14568	MT	14568	65515	76423	rs397515506	NC_012920.1:14567:C:T
NC_012920.1:m.14571T>A	MT-ND6	S35C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693738	MT	14571	MT	14571	693738	680628	rs1603224793	NC_012920.1:14570:T:A
NC_012920.1:m.14573A>G	MT-ND6	V34A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693739	MT	14573	MT	14573	693739	680629	rs1603224794	NC_012920.1:14572:A:G
NC_012920.1:m.14574C>T	MT-ND6	V34I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693740	MT	14574	MT	14574	693740	680630	rs386829218	NC_012920.1:14573:C:T
NC_012920.1:m.14576A>G	MT-ND6	I33T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693741	MT	14576	MT	14576	693741	680631	rs1603224796	NC_012920.1:14575:A:G
NC_012920.1:m.14577T>C	MT-ND6	I33V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693743	MT	14577	MT	14577	693743	680632	rs386829219	NC_012920.1:14576:T:C
NC_012920.1:m.14577T>G	MT-ND6	I33L	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693742	MT	14577	MT	14577	693742	680633	rs386829219	NC_012920.1:14576:T:G
NC_012920.1:m.14582A>G	MT-ND6	V31A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693744	MT	14582	MT	14582	693744	680634	rs41354845	NC_012920.1:14581:A:G
m.14596A>T	MT-ND6	I26M	Leber optic atrophy and dystonia|Leber optic atrophy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009690	MT	14596	MT	14596	9690	24729	rs387906424	NC_012920.1:14595:A:T
NC_012920.1:m.14597A>G	MT-ND6	I26T	Dystonic disorder|Dysarthria|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000209173	MT	14597	MT	14597	209173	205801	rs797045055	NC_012920.1:14596:A:G
NC_012920.1:m.14598T>C	MT-ND6	I26V	Leigh syndrome|Parkinsonism|Blindness	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000374080	MT	14598	MT	14598	374080	361108	rs1057518882	NC_012920.1:14597:T:C
NC_012920.1:m.14601G>A	MT-ND6	P25S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693745	MT	14601	MT	14601	693745	680635	rs1603224806	NC_012920.1:14600:G:A
NC_012920.1:m.14615G>A	MT-ND6	S20F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693746	MT	14615	MT	14615	693746	680636	rs1603224810	NC_012920.1:14614:G:A
NC_012920.1:m.14619A>G	MT-ND6	F19L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693747	MT	14619	MT	14619	693747	680637	rs1556424471	NC_012920.1:14618:A:G
NC_012920.1:m.14627A>G	MT-ND6	F16S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693748	MT	14627	MT	14627	693748	680638	rs1603224811	NC_012920.1:14626:A:G
NC_012920.1(MT-ND6):m.14633A>G	MT-ND6	M14T	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000618219	MT	14633	MT	14633	618219	610267	rs1569484667	NC_012920.1:14632:A:G
NC_012920.1:m.14634T>C	MT-ND6	M14V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693749	MT	14634	MT	14634	693749	680639	rs1603224816	NC_012920.1:14633:T:C
NC_012920.1:m.14660A>G	MT-ND6	L5S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693750	MT	14660	MT	14660	693750	680640	rs1603224821	NC_012920.1:14659:A:G
NC_012920.1:m.14663G>A	MT-ND6	A4V	Mitochondrial DNA-related disorder	not provided	no assertion provided	VCV000441110	MT	14663	MT	14663	441110	434698	rs1556424474	NC_012920.1:14662:G:A
NC_012920.1:m.14667A>G	MT-ND6	Y3H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693751	MT	14667	MT	14667	693751	680641	rs1603224822	NC_012920.1:14666:A:G
NC_012920.1:m.14668C>T	MT-ND6		Mitochondrial inheritance	Uncertain significance	no assertion criteria provided	VCV001344550	MT	14668	MT	14668	1344550	1336254		NC_012920.1:14667:C:T
NC_012920.1:m.14670T>C	MT-ND6	M2V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693752	MT	14670	MT	14670	693752	680642	rs1603224824	NC_012920.1:14669:T:C
m.14674T>G	MT-TE		Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030003	MT	14674	MT	14674	30003	38958	rs387906421	NC_012920.1:14673:T:G
m.14674T>C	MT-TE		not provided|Mitochondrial disease|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009618	MT	14674	MT	14674	9618	24657	rs387906421	NC_012920.1:14673:T:C
NC_012920.1(MT-CYB):m.14681G>A	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690198	MT	14681	MT	14681	690198	677590	rs1603224827	NC_012920.1:14680:G:A
NC_012920.1(MT-CYB):m.14683A>G	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690199	MT	14683	MT	14683	690199	677591	rs1603224828	NC_012920.1:14682:A:G
NC_012920.1(MT-CYB):m.14684C>T	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690200	MT	14684	MT	14684	690200	677592	rs1603224831	NC_012920.1:14683:C:T
NC_012920.1(MT-CYB):m.14687A>G	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690201	MT	14687	MT	14687	690201	677593	rs200189658	NC_012920.1:14686:A:G
NC_012920.1(MT-CYB):m.14690A>G	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690202	MT	14690	MT	14690	690202	677594	rs1603224834	NC_012920.1:14689:A:G
NC_012920.1(MT-CYB):m.14691C>T	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690203	MT	14691	MT	14691	690203	677595	rs1556424478	NC_012920.1:14690:C:T
NC_012920.1:m.14692A>G	MT-TE		Diabetes-deafness syndrome maternally transmitted	Pathogenic(Last reviewed: Oct 25, 2016)	no assertion criteria provided	VCV000267298	MT	14692	MT	14692	267298	262350	rs879192165	NC_012920.1:14691:A:G
NC_012920.1(MT-CYB):m.14693A>G	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690204	MT	14693	MT	14693	690204	677596	rs386829226	NC_012920.1:14692:A:G
NC_012920.1(MT-CYB):m.14696A>C	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690206	MT	14696	MT	14696	690206	677597	rs1556424481	NC_012920.1:14695:A:C
NC_012920.1(MT-CYB):m.14696A>G	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690205	MT	14696	MT	14696	690205	677598	rs1556424481	NC_012920.1:14695:A:G
NC_012920.1(MT-CYB):m.14701C>T	MT-TE		not provided|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|See cases	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618220	MT	14701	MT	14701	618220	610268	rs1569484669	NC_012920.1:14700:C:T
NC_012920.1:m.14706A>G	MT-TE		Sudden death|Episodic vomiting|Mild liver congestion|Developmental delay|not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000370060	MT	14706	MT	14706	370060	354290	rs1057516070	NC_012920.1:14705:A:G
m.14709T>C	MT-TE		Mitochondrial disease|Diabetes-deafness syndrome maternally transmitted|Myopathy, mitochondrial, with diabetes mellitus|Inborn mitochondrial myopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009617	MT	14709	MT	14709	9617	24656	rs121434453	NC_012920.1:14708:T:C
NC_012920.1(MT-CYB):m.14710G>A	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690207	MT	14710	MT	14710	690207	677599	rs1603224840	NC_012920.1:14709:G:A
NC_012920.1(MT-CYB):m.14716C>T	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690208	MT	14716	MT	14716	690208	677600	rs1603224841	NC_012920.1:14715:C:T
NC_012920.1:m.14724G>A	MT-TE		Cerebellar ataxia|Progressive spastic paraparesis|Abnormal basal ganglia MRI signal intensity|Gonadal dysgenesis	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000805947	MT	14724	MT	14724	805947	794276	rs1603224846	NC_012920.1:14723:G:A
NC_012920.1(MT-CYB):m.14727T>C	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690209	MT	14727	MT	14727	690209	677601	rs1603224847	NC_012920.1:14726:T:C
NC_012920.1(MT-CYB):m.14729T>C	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690210	MT	14729	MT	14729	690210	677602	rs1603224848	NC_012920.1:14728:T:C
NC_012920.1:m.14732A>G	MT-TE		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143918	MT	14732	MT	14732	143918	153641	rs527236202	NC_012920.1:14731:A:G
NC_012920.1(MT-CYB):m.14739G>A	MT-TE		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690211	MT	14739	MT	14739	690211	677603	rs1603224850	NC_012920.1:14738:G:A
NC_012920.1:m.14743A>G			Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143864	MT	14743	MT	14743	143864	153589	rs527236161	NC_012920.1:14742:A:G
NC_012920.1:m.14748T>C	MT-CYB	M1T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693753	MT	14748	MT	14748	693753	680643	rs1603224852	NC_012920.1:14747:T:C
NC_012920.1:m.14750A>T	MT-CYB	T2S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693755	MT	14750	MT	14750	693755	680645	rs1603224853	NC_012920.1:14749:A:T
NC_012920.1:m.14750A>G	MT-CYB	T2A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693754	MT	14750	MT	14750	693754	680644	rs1603224853	NC_012920.1:14749:A:G
NC_012920.1:m.14751C>T	MT-CYB	T2I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693756	MT	14751	MT	14751	693756	680646	rs1603224855	NC_012920.1:14750:C:T
NC_012920.1:m.14753C>T	MT-CYB	P3S	Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143865	MT	14753	MT	14753	143865	153590	rs527236162	NC_012920.1:14752:C:T
NC_012920.1:m.14757T>C	MT-CYB	M4T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693757	MT	14757	MT	14757	693757	680647	rs1603224859	NC_012920.1:14756:T:C
NC_012920.1:m.14760G>A	MT-CYB	R5H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693758	MT	14760	MT	14760	693758	680648	rs1603224860	NC_012920.1:14759:G:A
NC_012920.1:m.14765A>T	MT-CYB	T7S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693759	MT	14765	MT	14765	693759	680649	rs1603224865	NC_012920.1:14764:A:T
m.14766C>T	MT-CYB	T7I	Leigh syndrome|Familial cancer of breast	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000140587	MT	14766	MT	14766	140587	150279	rs193302980	NC_012920.1:14765:C:T
NC_012920.1:m.14768A>G	MT-CYB	N8D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693760	MT	14768	MT	14768	693760	680650	rs1603224870	NC_012920.1:14767:A:G
NC_012920.1:m.14769A>G	MT-CYB	N8S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693761	MT	14769	MT	14769	693761	680651	rs28357679	NC_012920.1:14768:A:G
NC_012920.1:m.14771C>A	MT-CYB	P9T	Autosomal recessive spinocerebellar ataxia 20	Uncertain significance(Last reviewed: Dec 22, 2016)	no assertion criteria provided	VCV000374216	MT	14771	MT	14771	374216	361117	rs1556424489	NC_012920.1:14770:C:A
NC_012920.1:m.14778T>C	MT-CYB	M11T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693762	MT	14778	MT	14778	693762	680652	rs1603224879	NC_012920.1:14777:T:C
m.14783T>C	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000140588	MT	14783	MT	14783	140588	150280	rs193302982	NC_012920.1:14782:T:C
NC_012920.1:m.14784T>C	MT-CYB	L13S	Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143866	MT	14784	MT	14784	143866	153591	rs527236163	NC_012920.1:14783:T:C
NC_012920.1:m.14786A>G	MT-CYB	I14V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693763	MT	14786	MT	14786	693763	680653	rs1603224884	NC_012920.1:14785:A:G
NC_012920.1:m.14790A>G	MT-CYB	N15S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693764	MT	14790	MT	14790	693764	680654	rs1603224887	NC_012920.1:14789:A:G
NC_012920.1:m.14792C>T	MT-CYB	H16Y	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693765	MT	14792	MT	14792	693765	680655	rs1603224892	NC_012920.1:14791:C:T
NC_012920.1:m.14793A>G	MT-CYB	H16R	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693766	MT	14793	MT	14793	693766	680656	rs2853504	NC_012920.1:14792:A:G
NC_012920.1:m.14795T>C	MT-CYB	S17P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693767	MT	14795	MT	14795	693767	680657	rs1603224896	NC_012920.1:14794:T:C
NC_012920.1:m.14798T>C	MT-CYB	F18L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693768	MT	14798	MT	14798	693768	680658	rs28357681	NC_012920.1:14797:T:C
NC_012920.1:m.14800C>T	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143867	MT	14800	MT	14800	143867	153592	rs527236164	NC_012920.1:14799:C:T
NC_012920.1:m.14804G>A	MT-CYB	D20N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693769	MT	14804	MT	14804	693769	680659	rs1603224902	NC_012920.1:14803:G:A
NC_012920.1:m.14813A>T	MT-CYB	T23S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693770	MT	14813	MT	14813	693770	680660	rs1603224906	NC_012920.1:14812:A:T
NC_012920.1:m.14825A>G	MT-CYB	I27V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693771	MT	14825	MT	14825	693771	680661	rs1603224912	NC_012920.1:14824:A:G
NC_012920.1:m.14826T>C	MT-CYB	I27T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693772	MT	14826	MT	14826	693772	680662	rs1603224914	NC_012920.1:14825:T:C
NC_012920.1:m.14831G>C	MT-CYB	A29P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693773	MT	14831	MT	14831	693773	680663	rs199795644	NC_012920.1:14830:G:C
m.14831G>A	MT-CYB	A29T	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000065517	MT	14831	MT	14831	65517	76425	rs199795644	NC_012920.1:14830:G:A
NC_012920.1:m.14832C>T	MT-CYB	A29V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693774	MT	14832	MT	14832	693774	680664	rs1603224915	NC_012920.1:14831:C:T
NC_012920.1:m.14838G>A	MT-CYB	W31*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693775	MT	14838	MT	14838	693775	680665	rs1603224920	NC_012920.1:14837:G:A
NC_012920.1:m.14841A>G	MT-CYB	N32S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693776	MT	14841	MT	14841	693776	680666	rs1556424497	NC_012920.1:14840:A:G
m.14846G>A	MT-CYB	G34S	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Exercise intolerance	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009679	MT	14846	MT	14846	9679	24718	rs207459998	NC_012920.1:14845:G:A
m.14849T>C	MT-CYB	S35P	Exercise intolerance, cardiomyopathy, and septooptic dysplasia|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009685	MT	14849	MT	14849	9685	24724	rs207460004	NC_012920.1:14848:T:C
NC_012920.1:m.14854C>T	MT-CYB		Mitochondrial cytopathy	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370061	MT	14854	MT	14854	370061	354291	rs1057516071	NC_012920.1:14853:C:T
NC_012920.1:m.14858G>A	MT-CYB	G38S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693777	MT	14858	MT	14858	693777	680667	rs1603224930	NC_012920.1:14857:G:A
NC_012920.1:m.14861G>A	MT-CYB	A39T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693778	MT	14861	MT	14861	693778	680668	rs2853505	NC_012920.1:14860:G:A
NC_012920.1:m.14862C>T	MT-CYB	A39V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693779	MT	14862	MT	14862	693779	680669	rs1603224933	NC_012920.1:14861:C:T
NC_012920.1:m.14870A>G	MT-CYB	I42V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693780	MT	14870	MT	14870	693780	680670	rs1603224936	NC_012920.1:14869:A:G
NC_012920.1:m.14871T>C	MT-CYB	I42T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693781	MT	14871	MT	14871	693781	680671	rs28660155	NC_012920.1:14870:T:C
NC_012920.1:m.14873C>T	MT-CYB	L43F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693782	MT	14873	MT	14873	693782	680672	rs879056276	NC_012920.1:14872:C:T
NC_012920.1:m.14879A>T	MT-CYB	I45F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693783	MT	14879	MT	14879	693783	680673	rs1603224945	NC_012920.1:14878:A:T
NC_012920.1:m.14880T>C	MT-CYB	I45T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693784	MT	14880	MT	14880	693784	680674	rs1603224948	NC_012920.1:14879:T:C
NC_012920.1:m.14883C>T	MT-CYB	T46I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693785	MT	14883	MT	14883	693785	680675	rs1603224950	NC_012920.1:14882:C:T
NC_012920.1:m.14888G>A	MT-CYB	G48*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693786	MT	14888	MT	14888	693786	680676	rs1603224952	NC_012920.1:14887:G:A
NC_012920.1:m.14891C>G	MT-CYB	L49V	Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143868	MT	14891	MT	14891	143868	153593	rs386419981	NC_012920.1:14890:C:G
NC_012920.1:m.14895T>C	MT-CYB	F50S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693787	MT	14895	MT	14895	693787	680677	rs1603224957	NC_012920.1:14894:T:C
NC_012920.1:m.14900G>A	MT-CYB	A52T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693788	MT	14900	MT	14900	693788	680678	rs1603224960	NC_012920.1:14899:G:A
NC_012920.1:m.14905G>A	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143919	MT	14905	MT	14905	143919	153642	rs193302983	NC_012920.1:14904:G:A
NC_012920.1:m.14911C>T	MT-CYB		not provided	Likely benign(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000235655	MT	14911	MT	14911	235655	237335	rs28357683	NC_012920.1:14910:C:T
NC_012920.1:m.14921G>A	MT-CYB	A59T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693789	MT	14921	MT	14921	693789	680679	rs1603224964	NC_012920.1:14920:G:A
NC_012920.1:m.14924T>C	MT-CYB	S60P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693790	MT	14924	MT	14924	693790	680680	rs1603224966	NC_012920.1:14923:T:C
NC_012920.1:m.14927A>G	MT-CYB	T61A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693791	MT	14927	MT	14927	693791	680681	rs201551481	NC_012920.1:14926:A:G
NC_012920.1:m.14935T>C	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143920	MT	14935	MT	14935	143920	153643	rs527236204	NC_012920.1:14934:T:C
NC_012920.1:m.14945G>A	MT-CYB	A67T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693792	MT	14945	MT	14945	693792	680682	rs1603224974	NC_012920.1:14944:G:A
NC_012920.1:m.14950C>T	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143869	MT	14950	MT	14950	143869	153594	rs527236166	NC_012920.1:14949:C:T
NC_012920.1:m.14952T>C	MT-CYB	I69T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693793	MT	14952	MT	14952	693793	680683	rs1603224975	NC_012920.1:14951:T:C
NC_012920.1:m.14954A>G	MT-CYB	T70A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693794	MT	14954	MT	14954	693794	680684	rs1603224977	NC_012920.1:14953:A:G
NC_012920.1:m.14958G>A	MT-CYB	R71Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693795	MT	14958	MT	14958	693795	680685	rs1603224979	NC_012920.1:14957:G:A
NC_012920.1:m.14960G>A	MT-CYB	D72N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693796	MT	14960	MT	14960	693796	680686	rs1603224981	NC_012920.1:14959:G:A
NC_012920.1:m.14963G>A	MT-CYB	V73M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693797	MT	14963	MT	14963	693797	680687	rs1603224985	NC_012920.1:14962:G:A
NC_012920.1:m.14968T>C	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143870	MT	14968	MT	14968	143870	153595	rs527236167	NC_012920.1:14967:T:C
NC_012920.1(MT-CYB):m.14969T>C	MT-CYB	Y75H	not provided|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618215	MT	14969	MT	14969	618215	610269	rs1569484685	NC_012920.1:14968:T:C
NC_012920.1:m.14970A>G	MT-CYB	Y75C	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693798	MT	14970	MT	14970	693798	680688	rs1556424510	NC_012920.1:14969:A:G
NC_012920.1:m.14973G>A	MT-CYB	G76D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693799	MT	14973	MT	14973	693799	680689	rs1603224995	NC_012920.1:14972:G:A
NC_012920.1:m.14974C>G	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143871	MT	14974	MT	14974	143871	153596	rs527236168	NC_012920.1:14973:C:G
NC_012920.1:m.14976G>A	MT-CYB	W77*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693800	MT	14976	MT	14976	693800	680690	rs1603224997	NC_012920.1:14975:G:A
NC_012920.1:m.14978A>G	MT-CYB	I78V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693801	MT	14978	MT	14978	693801	680691	rs199997767	NC_012920.1:14977:A:G
NC_012920.1:m.14979T>C	MT-CYB	I78T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693802	MT	14979	MT	14979	693802	680692	rs200786872	NC_012920.1:14978:T:C
NC_012920.1:m.14980C>A	MT-CYB	I78M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693803	MT	14980	MT	14980	693803	680693	rs1603225000	NC_012920.1:14979:C:A
NC_012920.1:m.14982T>C	MT-CYB	I79T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693804	MT	14982	MT	14982	693804	680694	rs1603225002	NC_012920.1:14981:T:C
m.14985G>A	MT-CYB	R80H	Leigh syndrome|Familial colorectal cancer	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009676	MT	14985	MT	14985	9676	24715	rs207459995	NC_012920.1:14984:G:A
NC_012920.1:m.14990C>T	MT-CYB	L82F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693805	MT	14990	MT	14990	693805	680695	rs1603225008	NC_012920.1:14989:C:T
NC_012920.1:m.14996G>A	MT-CYB	A84T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693806	MT	14996	MT	14996	693806	680696	rs1603225010	NC_012920.1:14995:G:A
NC_012920.1:m.15001T>C	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143872	MT	15001	MT	15001	143872	153597	rs527236169	NC_012920.1:15000:T:C
NC_012920.1:m.15002G>A	MT-CYB	G86S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693807	MT	15002	MT	15002	693807	680697	rs370448948	NC_012920.1:15001:G:A
NC_012920.1:m.15003G>A	MT-CYB	G86D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693808	MT	15003	MT	15003	693808	680698	rs1603225014	NC_012920.1:15002:G:A
NC_012920.1:m.15011A>G	MT-CYB	M89V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693809	MT	15011	MT	15011	693809	680699	rs1603225021	NC_012920.1:15010:A:G
NC_012920.1:m.15014T>C	MT-CYB	F90L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693810	MT	15014	MT	15014	693810	680700	rs1603225022	NC_012920.1:15013:T:C
NC_012920.1:m.15016C>A	MT-CYB	F90L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693811	MT	15016	MT	15016	693811	680701	rs1603225024	NC_012920.1:15015:C:A
NC_012920.1:m.15024G>C	MT-CYB	C93S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693812	MT	15024	MT	15024	693812	680702	rs1603225028	NC_012920.1:15023:G:C
NC_012920.1:m.15033T>C	MT-CYB	L96P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693813	MT	15033	MT	15033	693813	680703	rs1603225033	NC_012920.1:15032:T:C
m.15043G>A	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000140589	MT	15043	MT	15043	140589	150281	rs193302985	NC_012920.1:15042:G:A
NC_012920.1:m.15045G>A	MT-CYB	R100Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693814	MT	15045	MT	15045	693814	680704	rs1603225041	NC_012920.1:15044:G:A
NC_012920.1:m.15047G>A	MT-CYB	G101S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693815	MT	15047	MT	15047	693815	680705	rs1603225043	NC_012920.1:15046:G:A
NC_012920.1:m.15048G>C	MT-CYB	G101A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693816	MT	15048	MT	15048	693816	680706	rs1603225045	NC_012920.1:15047:G:C
NC_012920.1:m.15049C>T	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143873	MT	15049	MT	15049	143873	153598	rs527236170	NC_012920.1:15048:C:T
NC_012920.1:m.15058C>T	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143874	MT	15058	MT	15058	143874	153599	rs527236171	NC_012920.1:15057:C:T
NC_012920.1:m.15059G>A	MT-CYB	G105*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693817	MT	15059	MT	15059	693817	680707	rs1603225052	NC_012920.1:15058:G:A
NC_012920.1:m.15060G>A	MT-CYB	G105E	Epilepsy|Bilateral lesions of basal ganglia|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000370062	MT	15060	MT	15060	370062	354292	rs1057516072	NC_012920.1:15059:G:A
NC_012920.1:m.15061A>G	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143921	MT	15061	MT	15061	143921	153644	rs527236205	NC_012920.1:15060:A:G
NC_012920.1:m.15062T>C	MT-CYB	S106P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693818	MT	15062	MT	15062	693818	680708	rs1603225056	NC_012920.1:15061:T:C
NC_012920.1(MT-CYB):m.15071T>C	MT-CYB	Y109H	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000445709	MT	15071	MT	15071	445709	438981	rs199999794	NC_012920.1:15070:T:C
NC_012920.1:m.15074T>C	MT-CYB	S110P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693819	MT	15074	MT	15074	693819	680709	rs201169089	NC_012920.1:15073:T:C
NC_012920.1:m.15077G>A	MT-CYB	E111K	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693820	MT	15077	MT	15077	693820	680710	rs201943501	NC_012920.1:15076:G:A
NC_012920.1:m.15078A>G	MT-CYB	E111G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693821	MT	15078	MT	15078	693821	680711	rs1603225065	NC_012920.1:15077:A:G
NC_012920.1:m.15080A>G	MT-CYB	T112A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693822	MT	15080	MT	15080	693822	680712	rs386829235	NC_012920.1:15079:A:G
NC_012920.1:m.15090T>C	MT-CYB	I115T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693823	MT	15090	MT	15090	693823	680713	rs1603225069	NC_012920.1:15089:T:C
NC_012920.1:m.15096T>C	MT-CYB	I117T	Inborn mitochondrial myopathy	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370063	MT	15096	MT	15096	370063	354293	rs1057516073	NC_012920.1:15095:T:C
NC_012920.1:m.15098A>G	MT-CYB	I118V	Leigh syndrome|Neoplasm of ovary	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143875	MT	15098	MT	15098	143875	153600	rs527236172	NC_012920.1:15097:A:G
NC_012920.1:m.15099T>C	MT-CYB	I118T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693824	MT	15099	MT	15099	693824	680714	rs1603225077	NC_012920.1:15098:T:C
NC_012920.1:m.15100C>A	MT-CYB	I118M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693825	MT	15100	MT	15100	693825	680715	rs1603225079	NC_012920.1:15099:C:A
NC_012920.1:m.15110G>A	MT-CYB	A122T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693826	MT	15110	MT	15110	693826	680716	rs28357685	NC_012920.1:15109:G:A
NC_012920.1:m.15113A>G	MT-CYB	T123A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693827	MT	15113	MT	15113	693827	680717	rs1603225089	NC_012920.1:15112:A:G
NC_012920.1:m.15117T>C	MT-CYB	M124T	Leigh syndrome|Mitochondrial disease	Uncertain significance(Last reviewed: Dec 10, 2021)	reviewed by expert panel	VCV000693828	MT	15117	MT	15117	693828	680718	rs1603225092	NC_012920.1:15116:T:C
NC_012920.1:m.15119G>A	MT-CYB	A125T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693829	MT	15119	MT	15119	693829	680719	rs201194402	NC_012920.1:15118:G:A
NC_012920.1:m.15122A>G	MT-CYB	T126A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693830	MT	15122	MT	15122	693830	680720	rs1556424535	NC_012920.1:15121:A:G
NC_012920.1:m.15127C>T	MT-CYB		Sensorineural hearing loss disorder|Reduced visual acuity|Ataxia|Atrophy of the brain and cerebellum|Parkinsonism-plus	Uncertain significance(Last reviewed: Nov 21, 2016)	no assertion criteria provided	VCV000370064	MT	15127	MT	15127	370064	354294	rs1057516074	NC_012920.1:15126:C:T
NC_012920.1:m.15138A>G	MT-CYB	Y131C	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693831	MT	15138	MT	15138	693831	680721	rs1603225106	NC_012920.1:15137:A:G
NC_012920.1:m.15141T>C	MT-CYB	V132A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693832	MT	15141	MT	15141	693832	680722	rs1603225108	NC_012920.1:15140:T:C
NC_012920.1:m.15148G>A	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143922	MT	15148	MT	15148	143922	153645	rs527236206	NC_012920.1:15147:G:A
m.15150G>A	MT-CYB	W135*	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Exercise intolerance	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009681	MT	15150	MT	15150	9681	24720	rs207460000	NC_012920.1:15149:G:A
NC_012920.1:m.15152G>A	MT-CYB	G136S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693833	MT	15152	MT	15152	693833	680723	rs1603225113	NC_012920.1:15151:G:A
NC_012920.1:m.15153G>A	MT-CYB	G136D	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693834	MT	15153	MT	15153	693834	680724	rs1556424536	NC_012920.1:15152:G:A
NC_012920.1:m.15159T>C	MT-CYB	M138T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693835	MT	15159	MT	15159	693835	680725	rs1603225114	NC_012920.1:15158:T:C
NC_012920.1:m.15164T>C	MT-CYB	F140L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693836	MT	15164	MT	15164	693836	680726	rs1603225118	NC_012920.1:15163:T:C
NC_012920.1:m.15191T>A	MT-CYB	L149M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693837	MT	15191	MT	15191	693837	680727	rs878912989	NC_012920.1:15190:T:A
NC_012920.1:m.15191T>C	MT-CYB		not provided	Likely benign(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000445359	MT	15191	MT	15191	445359	438631	rs878912989	NC_012920.1:15190:T:C
m.15197T>C	MT-CYB	S151P	Exercise intolerance	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000009682	MT	15197	MT	15197	9682	24721	rs207460001	NC_012920.1:15196:T:C
NC_012920.1:m.15200G>A	MT-CYB	A152T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693838	MT	15200	MT	15200	693838	680728	rs1603225142	NC_012920.1:15199:G:A
NC_012920.1:m.15203A>G	MT-CYB	I153V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693839	MT	15203	MT	15203	693839	680729	rs1603225143	NC_012920.1:15202:A:G
NC_012920.1:m.15204T>C	MT-CYB	I153T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693840	MT	15204	MT	15204	693840	680730	rs28357687	NC_012920.1:15203:T:C
NC_012920.1:m.15212A>G	MT-CYB	I156V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693841	MT	15212	MT	15212	693841	680731	rs1603225150	NC_012920.1:15211:A:G
NC_012920.1:m.15213T>C	MT-CYB	I156T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693842	MT	15213	MT	15213	693842	680732	rs1603225151	NC_012920.1:15212:T:C
NC_012920.1:m.15214T>C	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143876	MT	15214	MT	15214	143876	153601	rs527236173	NC_012920.1:15213:T:C
NC_012920.1:m.15217G>A	MT-CYB		not provided	Likely benign(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000235375	MT	15217	MT	15217	235375	237061	rs193302989	NC_012920.1:15216:G:A
NC_012920.1:m.15218A>G	MT-CYB	T158A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693843	MT	15218	MT	15218	693843	680733	rs2853506	NC_012920.1:15217:A:G
NC_012920.1:m.15221G>A	MT-CYB	D159N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693844	MT	15221	MT	15221	693844	680734	rs1603225157	NC_012920.1:15220:G:A
NC_012920.1:m.15222A>G	MT-CYB	D159G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693845	MT	15222	MT	15222	693845	680735	rs1603225158	NC_012920.1:15221:A:G
NC_012920.1:m.15226A>G	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143877	MT	15226	MT	15226	143877	153602	rs527236174	NC_012920.1:15225:A:G
NC_012920.1:m.15228T>C	MT-CYB	V161A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693846	MT	15228	MT	15228	693846	680736	rs1603225161	NC_012920.1:15227:T:C
NC_012920.1:m.15233T>G	MT-CYB	W163G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693848	MT	15233	MT	15233	693848	680738	rs1603225163	NC_012920.1:15232:T:G
NC_012920.1:m.15233T>C	MT-CYB	W163R	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693847	MT	15233	MT	15233	693847	680737	rs1603225163	NC_012920.1:15232:T:C
NC_012920.1:m.15235A>G	MT-CYB		not provided	Benign(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000377041	MT	15235	MT	15235	377041	363919	rs201250154	NC_012920.1:15234:A:G
NC_012920.1:m.15236A>G	MT-CYB	I164V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693849	MT	15236	MT	15236	693849	680739	rs386829239	NC_012920.1:15235:A:G
NC_012920.1:m.15237T>G	MT-CYB	I164S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693850	MT	15237	MT	15237	693850	680740	rs879217377	NC_012920.1:15236:T:G
NC_012920.1:m.15238C>A	MT-CYB	I164M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693851	MT	15238	MT	15238	693851	680741	rs1603225166	NC_012920.1:15237:C:A
m.15242G>A	MT-CYB	G166*	Mitochondrial encephalomyopathy|Leigh syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009680	MT	15242	MT	15242	9680	24719	rs207459999	NC_012920.1:15241:G:A
NC_012920.1:m.15243G>A	MT-CYB	G166E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693852	MT	15243	MT	15243	693852	680742	rs1603225167	NC_012920.1:15242:G:A
NC_012920.1:m.15245G>A	MT-CYB	G167S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693853	MT	15245	MT	15245	693853	680743	rs1603225169	NC_012920.1:15244:G:A
NC_012920.1:m.15246G>A	MT-CYB	G167D	Hearing impairment|Macrocephalus|Developmental delay|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000370065	MT	15246	MT	15246	370065	354295	rs1057516075	NC_012920.1:15245:G:A
m.15257G>A	MT-CYB	D171N	Leber optic atrophy|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009674	MT	15257	MT	15257	9674	24713	rs41518645	NC_012920.1:15256:G:A
NC_012920.1:m.15259C>T	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143923	MT	15259	MT	15259	143923	153646	rs527236207	NC_012920.1:15258:C:T
NC_012920.1:m.15261G>A	MT-CYB	S172N	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693855	MT	15261	MT	15261	693855	680745	rs1556424551	NC_012920.1:15260:G:A
NC_012920.1:m.15262T>C	MT-CYB		not provided	Likely benign(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000376959	MT	15262	MT	15262	376959	363837	rs1057520097	NC_012920.1:15261:T:C
NC_012920.1:m.15263C>T	MT-CYB	P173S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693856	MT	15263	MT	15263	693856	680746	rs200455825	NC_012920.1:15262:C:T
NC_012920.1:m.15266A>G	MT-CYB	T174A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693857	MT	15266	MT	15266	693857	680747	rs1603225185	NC_012920.1:15265:A:G
NC_012920.1:m.15272A>G	MT-CYB	T176A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693858	MT	15272	MT	15272	693858	680748	rs1603225187	NC_012920.1:15271:A:G
NC_012920.1:m.15273C>A	MT-CYB	T176K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693859	MT	15273	MT	15273	693859	680749	rs1603225189	NC_012920.1:15272:C:A
m.15287T>C	MT-CYB	F181L	Leigh syndrome|Familial cancer of breast	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000140590	MT	15287	MT	15287	140590	150282	rs527236044	NC_012920.1:15286:T:C
NC_012920.1:m.15289T>C	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143878	MT	15289	MT	15289	143878	153603	rs527236175	NC_012920.1:15288:T:C
NC_012920.1:m.15294T>C	MT-CYB	F183S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693860	MT	15294	MT	15294	693860	680750	rs1603225203	NC_012920.1:15293:T:C
NC_012920.1:m.15300T>C	MT-CYB	L185S	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693861	MT	15300	MT	15300	693861	680751	rs1556424556	NC_012920.1:15299:T:C
m.15301G>A	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000140591	MT	15301	MT	15301	140591	150283	rs193302991	NC_012920.1:15300:G:A
NC_012920.1:m.15309T>C	MT-CYB	I188T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693862	MT	15309	MT	15309	693862	680752	rs1603225211	NC_012920.1:15308:T:C
NC_012920.1:m.15311A>G	MT-CYB	I189V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693863	MT	15311	MT	15311	693863	680753	rs35070048	NC_012920.1:15310:A:G
NC_012920.1:m.15312T>C	MT-CYB	I189T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693864	MT	15312	MT	15312	693864	680754	rs1603225215	NC_012920.1:15311:T:C
NC_012920.1:m.15314G>A	MT-CYB	A190T	Leigh syndrome|Neoplasm of ovary	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143879	MT	15314	MT	15314	143879	153604	rs527236176	NC_012920.1:15313:G:A
NC_012920.1:m.15315C>T	MT-CYB	A190V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693865	MT	15315	MT	15315	693865	680755	rs879191792	NC_012920.1:15314:C:T
NC_012920.1:m.15317G>A	MT-CYB	A191T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693866	MT	15317	MT	15317	693866	680756	rs2853507	NC_012920.1:15316:G:A
NC_012920.1:m.15323G>A	MT-CYB	A193T	Leigh syndrome|Familial cancer of breast	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143880	MT	15323	MT	15323	143880	153605	rs527236177	NC_012920.1:15322:G:A
m.15326A>G	MT-CYB	T194A	Leigh syndrome|Familial cancer of breast|Mitochondrial disease	Benign(Last reviewed: Mar 24, 2022)	reviewed by expert panel	VCV000140592	MT	15326	MT	15326	140592	150284	rs2853508	NC_012920.1:15325:A:G
NC_012920.1:m.15327C>T	MT-CYB	T194M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693868	MT	15327	MT	15327	693868	680758	rs1603225222	NC_012920.1:15326:C:T
NC_012920.1:m.15328A>G	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143881	MT	15328	MT	15328	143881	153606	rs527236178	NC_012920.1:15327:A:G
NC_012920.1:m.15334C>T	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143882	MT	15334	MT	15334	143882	153607	rs527236179	NC_012920.1:15333:C:T
NC_012920.1:m.15336T>A	MT-CYB	L197H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693869	MT	15336	MT	15336	693869	680759	rs1603225228	NC_012920.1:15335:T:A
NC_012920.1:m.15341T>C	MT-CYB	F199L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693870	MT	15341	MT	15341	693870	680760	rs1603225233	NC_012920.1:15340:T:C
NC_012920.1:m.15346G>A	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143883	MT	15346	MT	15346	143883	153608	rs527236180	NC_012920.1:15345:G:A
NC_012920.1:m.15349C>T	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143885	MT	15349	MT	15349	143885	153610	rs527236201	NC_012920.1:15348:C:T
NC_012920.1:m.15349C>A	MT-CYB	H201Q	Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143884	MT	15349	MT	15349	143884	153609	rs527236201	NC_012920.1:15348:C:A
NC_012920.1:m.15355G>A	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143886	MT	15355	MT	15355	143886	153611	rs527236181	NC_012920.1:15354:G:A
NC_012920.1:m.15357G>A	MT-CYB	G204E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693871	MT	15357	MT	15357	693871	680761	rs1603225244	NC_012920.1:15356:G:A
NC_012920.1:m.15363A>G	MT-CYB	N206S	Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143887	MT	15363	MT	15363	143887	153612	rs527236182	NC_012920.1:15362:A:G
NC_012920.1:m.15377A>G	MT-CYB	I211V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693872	MT	15377	MT	15377	693872	680762	rs1603225248	NC_012920.1:15376:A:G
NC_012920.1:m.15380A>G	MT-CYB	T212A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693873	MT	15380	MT	15380	693873	680763	rs1603225250	NC_012920.1:15379:A:G
NC_012920.1:m.15381C>T	MT-CYB	T212I	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693874	MT	15381	MT	15381	693874	680764	rs199721378	NC_012920.1:15380:C:T
NC_012920.1:m.15383T>C	MT-CYB	S213P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693875	MT	15383	MT	15383	693875	680765	rs1603225252	NC_012920.1:15382:T:C
NC_012920.1:m.15385C>T	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143888	MT	15385	MT	15385	143888	153613	rs527236183	NC_012920.1:15384:C:T
NC_012920.1:m.15386C>T	MT-CYB	H214Y	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693876	MT	15386	MT	15386	693876	680766	rs1556424581	NC_012920.1:15385:C:T
NC_012920.1:m.15401A>G	MT-CYB	T219A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693877	MT	15401	MT	15401	693877	680767	rs200521299	NC_012920.1:15400:A:G
NC_012920.1:m.15402C>T	MT-CYB	T219I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693878	MT	15402	MT	15402	693878	680768	rs879163418	NC_012920.1:15401:C:T
NC_012920.1:m.15404T>C	MT-CYB	F220L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693879	MT	15404	MT	15404	693879	680769	rs1603225259	NC_012920.1:15403:T:C
NC_012920.1:m.15413T>C	MT-CYB	Y223H	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693880	MT	15413	MT	15413	693880	680770	rs1603225265	NC_012920.1:15412:T:C
NC_012920.1:m.15414A>T	MT-CYB	Y223F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693881	MT	15414	MT	15414	693881	680771	rs1603225266	NC_012920.1:15413:A:T
NC_012920.1:m.15428G>A	MT-CYB	D228N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693882	MT	15428	MT	15428	693882	680772	rs1603225270	NC_012920.1:15427:G:A
NC_012920.1:m.15431G>A	MT-CYB	A229T	Neoplasm of ovary|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143924	MT	15431	MT	15431	143924	153647	rs193302993	NC_012920.1:15430:G:A
NC_012920.1:m.15434C>T	MT-CYB	L230F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693883	MT	15434	MT	15434	693883	680773	rs1603225279	NC_012920.1:15433:C:T
NC_012920.1(MT-CYB):m.15437G>A	MT-CYB	G231S	not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leber optic atrophy|Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235525	MT	15437	MT	15437	235525	237206	rs878853058	NC_012920.1:15436:G:A
NC_012920.1:m.15446C>T	MT-CYB	L234F	Focal white matter lesions|Ischemic stroke, susceptibility to	Uncertain significance(Last reviewed: Feb 29, 2016)	no assertion criteria provided	VCV000373995	MT	15446	MT	15446	373995	361109	rs1057518823	NC_012920.1:15445:C:T
NC_012920.1:m.15449T>C	MT-CYB	F235L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693884	MT	15449	MT	15449	693884	680774	rs1603225289	NC_012920.1:15448:T:C
NC_012920.1:m.15450T>C	MT-CYB	F235S	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693885	MT	15450	MT	15450	693885	680775	rs1603225291	NC_012920.1:15449:T:C
NC_012920.1:m.15452C>A	MT-CYB	L236I	Neoplasm of ovary|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143925	MT	15452	MT	15452	143925	153648	rs193302994	NC_012920.1:15451:C:A
NC_012920.1:m.15453T>C	MT-CYB	L236P	Leigh syndrome|Neoplasm of ovary	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143889	MT	15453	MT	15453	143889	153614	rs527236184	NC_012920.1:15452:T:C
NC_012920.1:m.15458T>C	MT-CYB	S238P	Familial cancer of breast|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143890	MT	15458	MT	15458	143890	153615	rs527236185	NC_012920.1:15457:T:C
NC_012920.1:m.15459C>T	MT-CYB	S238F	Leigh syndrome|Neoplasm of ovary	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143891	MT	15459	MT	15459	143891	153616	rs527236186	NC_012920.1:15458:C:T
NC_012920.1:m.15462T>C	MT-CYB	L239S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693887	MT	15462	MT	15462	693887	680777	rs1603225298	NC_012920.1:15461:T:C
NC_012920.1:m.15465T>C	MT-CYB	M240T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693888	MT	15465	MT	15465	693888	680778	rs1603225299	NC_012920.1:15464:T:C
NC_012920.1(MT-CYB):m.15467A>G	MT-CYB	T241A	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000618216	MT	15467	MT	15467	618216	610270	rs1569484723	NC_012920.1:15466:A:G
NC_012920.1:m.15468C>T	MT-CYB	T241M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693889	MT	15468	MT	15468	693889	680779	rs1603225301	NC_012920.1:15467:C:T
NC_012920.1:m.15470T>C	MT-CYB		not provided|Familial cancer of breast	Benign(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000143892	MT	15470	MT	15470	143892	153617	rs527236187	NC_012920.1:15469:T:C
NC_012920.1:m.15479T>C	MT-CYB	F245L	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693890	MT	15479	MT	15479	693890	680780	rs202008188	NC_012920.1:15478:T:C
NC_012920.1:m.15483C>T	MT-CYB	S246L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693891	MT	15483	MT	15483	693891	680781	rs1603225306	NC_012920.1:15482:C:T
NC_012920.1:m.15487A>G	MT-CYB		not provided	Likely benign(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	VCV000377154	MT	15487	MT	15487	377154	364032	rs28357370	NC_012920.1:15486:A:G
NC_012920.1:m.15488G>A	MT-CYB	D248N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693892	MT	15488	MT	15488	693892	680782	rs1603225310	NC_012920.1:15487:G:A
NC_012920.1:m.15492T>C	MT-CYB	L249P	not provided	not provided	no assertion provided	VCV000441132	MT	15492	MT	15492	441132	434775	rs1556424593	NC_012920.1:15491:T:C
m.15497G>A	MT-CYB	G251S	Obesity|Leigh syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009687	MT	15497	MT	15497	9687	24726	rs199951903	NC_012920.1:15496:G:A
m.15498G>A	MT-CYB	G251D	Leigh syndrome|Histiocytoid cardiomyopathy	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009684	MT	15498	MT	15498	9684	24723	rs207460003	NC_012920.1:15497:G:A
NC_012920.1:m.15500G>A	MT-CYB	D252N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693893	MT	15500	MT	15500	693893	680783	rs1603225317	NC_012920.1:15499:G:A
NC_012920.1:m.15501A>G	MT-CYB	D252G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693894	MT	15501	MT	15501	693894	680784	rs1603225319	NC_012920.1:15500:A:G
NC_012920.1:m.15511T>C	MT-CYB		not provided|Neoplasm of ovary	Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000143893	MT	15511	MT	15511	143893	153618	rs527236188	NC_012920.1:15510:T:C
NC_012920.1:m.15512T>C	MT-CYB	Y256H	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693895	MT	15512	MT	15512	693895	680785	rs879031246	NC_012920.1:15511:T:C
NC_012920.1:m.15514T>C	MT-CYB		not provided	Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000235650	MT	15514	MT	15514	235650	237331	rs878853086	NC_012920.1:15513:T:C
NC_012920.1:m.15519T>A	MT-CYB	L258Q	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693897	MT	15519	MT	15519	693897	680786	rs200913192	NC_012920.1:15518:T:A
NC_012920.1:m.15519T>C	MT-CYB	L258P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693896	MT	15519	MT	15519	693896	680787	rs200913192	NC_012920.1:15518:T:C
NC_012920.1:m.15521G>A	MT-CYB	A259T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693898	MT	15521	MT	15521	693898	680788	rs1603225327	NC_012920.1:15520:G:A
NC_012920.1:m.15522C>G	MT-CYB	A259G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693899	MT	15522	MT	15522	693899	680789	rs1603225329	NC_012920.1:15521:C:G
NC_012920.1:m.15524A>G	MT-CYB	N260D	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693900	MT	15524	MT	15524	693900	680790	rs1603225331	NC_012920.1:15523:A:G
NC_012920.1:m.15525A>G	MT-CYB	N260S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693901	MT	15525	MT	15525	693901	680791	rs1603225333	NC_012920.1:15524:A:G
NC_012920.1:m.15531T>C	MT-CYB	L262S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693902	MT	15531	MT	15531	693902	680792	rs1603225336	NC_012920.1:15530:T:C
NC_012920.1:m.15533A>G	MT-CYB	N263D	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693903	MT	15533	MT	15533	693903	680793	rs1556424601	NC_012920.1:15532:A:G
NC_012920.1:m.15534A>G	MT-CYB	N263S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693904	MT	15534	MT	15534	693904	680794	rs1603225337	NC_012920.1:15533:A:G
NC_012920.1:m.15542C>T	MT-CYB	P266S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693905	MT	15542	MT	15542	693905	680795	rs1603225339	NC_012920.1:15541:C:T
NC_012920.1:m.15553G>A	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143894	MT	15553	MT	15553	143894	153619	rs527236189	NC_012920.1:15552:G:A
NC_012920.1:m.15557G>A	MT-CYB	E271K	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693906	MT	15557	MT	15557	693906	680796	rs1603225350	NC_012920.1:15556:G:A
NC_012920.1:m.15567T>C	MT-CYB	F274S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693907	MT	15567	MT	15567	693907	680797	rs1603225354	NC_012920.1:15566:T:C
m.15572T>C	MT-CYB	F276L	Familial colorectal cancer	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000009677	MT	15572	MT	15572	9677	24716	rs207459996	NC_012920.1:15571:T:C
NC_012920.1:m.15575G>A	MT-CYB	A277T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693908	MT	15575	MT	15575	693908	680798	rs1603225356	NC_012920.1:15574:G:A
m.15579A>G	MT-CYB	Y278C	Multisystem disorder|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009683	MT	15579	MT	15579	9683	24722	rs207460002	NC_012920.1:15578:A:G
NC_012920.1:m.15581A>G	MT-CYB	T279A	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693909	MT	15581	MT	15581	693909	680799	rs1603225359	NC_012920.1:15580:A:G
NC_012920.1:m.15584A>G	MT-CYB	I280V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693910	MT	15584	MT	15584	693910	680800	rs1603225361	NC_012920.1:15583:A:G
NC_012920.1:m.15596G>A	MT-CYB	V284I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693911	MT	15596	MT	15596	693911	680801	rs1603225369	NC_012920.1:15595:G:A
NC_012920.1:m.15607A>G	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143926	MT	15607	MT	15607	143926	153649	rs193302996	NC_012920.1:15606:A:G
NC_012920.1:m.15612G>A	MT-CYB	G289E	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693912	MT	15612	MT	15612	693912	680802	rs1603225372	NC_012920.1:15611:G:A
NC_012920.1:m.15614G>A	MT-CYB	G290S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693913	MT	15614	MT	15614	693913	680803	rs1603225376	NC_012920.1:15613:G:A
m.15615G>A	MT-CYB	G290D	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Exercise intolerance	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009678	MT	15615	MT	15615	9678	24717	rs207459997	NC_012920.1:15614:G:A
NC_012920.1:m.15617G>A	MT-CYB	V291I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693915	MT	15617	MT	15617	693915	680804	rs1556424625	NC_012920.1:15616:G:A
NC_012920.1:m.15617G>C	MT-CYB	V291L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693914	MT	15617	MT	15617	693914	680805	rs1556424625	NC_012920.1:15616:G:C
NC_012920.1:m.15623G>A	MT-CYB	A293T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693916	MT	15623	MT	15623	693916	680806	rs1603225385	NC_012920.1:15622:G:A
NC_012920.1:m.15637C>T	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143895	MT	15637	MT	15637	143895	153620	rs527236190	NC_012920.1:15636:C:T
NC_012920.1:m.15638A>G	MT-CYB	I298V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693917	MT	15638	MT	15638	693917	680807	rs1603225395	NC_012920.1:15637:A:G
NC_012920.1:m.15639T>C	MT-CYB	I298T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693918	MT	15639	MT	15639	693918	680808	rs1603225396	NC_012920.1:15638:T:C
NC_012920.1:m.15642T>C	MT-CYB	L299P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693919	MT	15642	MT	15642	693919	680809	rs1603225397	NC_012920.1:15641:T:C
NC_012920.1:m.15644A>G	MT-CYB	I300V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693920	MT	15644	MT	15644	693920	680810	rs1603225400	NC_012920.1:15643:A:G
NC_012920.1:m.15645T>C	MT-CYB	I300T	not provided	not provided	no assertion provided	VCV000973006	MT	15645	MT	15645	973006	961362	rs1603225402	NC_012920.1:15644:T:C
NC_012920.1:m.15649A>G	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143896	MT	15649	MT	15649	143896	153621	rs527236191	NC_012920.1:15648:A:G
NC_012920.1:m.15650G>A	MT-CYB	A302T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693921	MT	15650	MT	15650	693921	680811	rs1556424635	NC_012920.1:15649:G:A
NC_012920.1:m.15651C>T	MT-CYB	A302V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693922	MT	15651	MT	15651	693922	680812	rs1603225405	NC_012920.1:15650:C:T
NC_012920.1:m.15653A>T	MT-CYB	M303L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693924	MT	15653	MT	15653	693924	680814	rs878890251	NC_012920.1:15652:A:T
NC_012920.1:m.15653A>G	MT-CYB	M303V	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693923	MT	15653	MT	15653	693923	680813	rs878890251	NC_012920.1:15652:A:G
NC_012920.1:m.15654T>C	MT-CYB	M303T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693925	MT	15654	MT	15654	693925	680815	rs1556424638	NC_012920.1:15653:T:C
NC_012920.1:m.15657T>C	MT-CYB	I304T	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693926	MT	15657	MT	15657	693926	680816	rs1556424640	NC_012920.1:15656:T:C
NC_012920.1:m.15662A>G	MT-CYB	I306V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693927	MT	15662	MT	15662	693927	680817	rs3094280	NC_012920.1:15661:A:G
NC_012920.1:m.15663T>C	MT-CYB	I306T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693928	MT	15663	MT	15663	693928	680818	rs369851331	NC_012920.1:15662:T:C
NC_012920.1:m.15664C>A	MT-CYB	I306M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693929	MT	15664	MT	15664	693929	680819	rs1603225414	NC_012920.1:15663:C:A
NC_012920.1:m.15670T>C	MT-CYB		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143927	MT	15670	MT	15670	143927	153650	rs193302997	NC_012920.1:15669:T:C
NC_012920.1:m.15672T>C	MT-CYB	M309T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693930	MT	15672	MT	15672	693930	680820	rs199967113	NC_012920.1:15671:T:C
NC_012920.1:m.15674T>C	MT-CYB	S310P	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693931	MT	15674	MT	15674	693931	680821	rs1603225419	NC_012920.1:15673:T:C
NC_012920.1:m.15682A>G	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143897	MT	15682	MT	15682	143897	153622	rs527236192	NC_012920.1:15681:A:G
NC_012920.1:m.15686A>G	MT-CYB	S314G	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693932	MT	15686	MT	15686	693932	680822	rs1603225422	NC_012920.1:15685:A:G
NC_012920.1:m.15690T>C	MT-CYB	M315T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693933	MT	15690	MT	15690	693933	680823	rs1603225423	NC_012920.1:15689:T:C
NC_012920.1:m.15692A>G	MT-CYB	M316V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693934	MT	15692	MT	15692	693934	680824	rs1603225425	NC_012920.1:15691:A:G
NC_012920.1:m.15693T>C	MT-CYB	M316T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693935	MT	15693	MT	15693	693935	680825	rs200975632	NC_012920.1:15692:T:C
NC_012920.1:m.15708G>C	MT-CYB	S321T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693936	MT	15708	MT	15708	693936	680826	rs1556424649	NC_012920.1:15707:G:C
NC_012920.1:m.15708G>A	MT-CYB	S321N	not provided	not provided	no assertion provided	VCV000441130	MT	15708	MT	15708	441130	434776	rs1556424649	NC_012920.1:15707:G:A
NC_012920.1:m.15725C>T	MT-CYB	L327F	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693937	MT	15725	MT	15725	693937	680827	rs1603225438	NC_012920.1:15724:C:T
NC_012920.1:m.15731G>A	MT-CYB	A329T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693938	MT	15731	MT	15731	693938	680828	rs1556424652	NC_012920.1:15730:G:A
NC_012920.1:m.15732C>T	MT-CYB	A329V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693939	MT	15732	MT	15732	693939	680829	rs879129589	NC_012920.1:15731:C:T
NC_012920.1:m.15734G>A	MT-CYB	A330T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693940	MT	15734	MT	15734	693940	680830	rs386829259	NC_012920.1:15733:G:A
NC_012920.1:m.15735C>T	MT-CYB	A330V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693941	MT	15735	MT	15735	693941	680831	rs1603225446	NC_012920.1:15734:C:T
NC_012920.1:m.15737G>A	MT-CYB	D331N	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693942	MT	15737	MT	15737	693942	680832	rs1603225449	NC_012920.1:15736:G:A
NC_012920.1:m.15740C>T	MT-CYB	L332F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693943	MT	15740	MT	15740	693943	680833	rs1603225452	NC_012920.1:15739:C:T
NC_012920.1:m.15743C>T	MT-CYB	L333F	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693944	MT	15743	MT	15743	693944	680834	rs1603225455	NC_012920.1:15742:C:T
NC_012920.1(MT-CYB):m.15746A>G	MT-CYB	I334V	not provided|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235623	MT	15746	MT	15746	235623	237304	rs386829260	NC_012920.1:15745:A:G
NC_012920.1:m.15747T>C	MT-CYB	I334T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693945	MT	15747	MT	15747	693945	680835	rs1603225457	NC_012920.1:15746:T:C
NC_012920.1:m.15758A>G	MT-CYB	I338V	Familial cancer of breast|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143898	MT	15758	MT	15758	143898	153623	rs527236193	NC_012920.1:15757:A:G
NC_012920.1:m.15770C>T	MT-CYB	P342S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693946	MT	15770	MT	15770	693946	680836	rs1603225469	NC_012920.1:15769:C:T
NC_012920.1:m.15773G>A	MT-CYB	V343M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693947	MT	15773	MT	15773	693947	680837	rs386829261	NC_012920.1:15772:G:A
NC_012920.1:m.15774T>C	MT-CYB	V343A	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693948	MT	15774	MT	15774	693948	680838	rs1603225473	NC_012920.1:15773:T:C
NC_012920.1:m.15776A>G	MT-CYB	S344G	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693949	MT	15776	MT	15776	693949	680839	rs1603225477	NC_012920.1:15775:A:G
NC_012920.1:m.15777G>C	MT-CYB	S344T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693950	MT	15777	MT	15777	693950	680840	rs879182710	NC_012920.1:15776:G:C
NC_012920.1(MT-CYB):m.15777G>A	MT-CYB	S344N	not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377195	MT	15777	MT	15777	377195	364073	rs879182710	NC_012920.1:15776:G:A
NC_012920.1:m.15779T>C	MT-CYB	Y345H	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693951	MT	15779	MT	15779	693951	680841	rs1603225480	NC_012920.1:15778:T:C
NC_012920.1:m.15784T>C	MT-CYB		Familial cancer of breast	Likely pathogenic	no assertion criteria provided	VCV000143899	MT	15784	MT	15784	143899	153624	rs527236194	NC_012920.1:15783:T:C
NC_012920.1:m.15785T>C	MT-CYB	F347L	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693952	MT	15785	MT	15785	693952	680842	rs879052837	NC_012920.1:15784:T:C
NC_012920.1:m.15789C>T	MT-CYB	T348I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693953	MT	15789	MT	15789	693953	680843	rs1556424663	NC_012920.1:15788:C:T
NC_012920.1:m.15791A>G	MT-CYB	I349V	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693954	MT	15791	MT	15791	693954	680844	rs1556424666	NC_012920.1:15790:A:G
NC_012920.1:m.15793C>A	MT-CYB	I349M	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693955	MT	15793	MT	15793	693955	680845	rs1603225497	NC_012920.1:15792:C:A
NC_012920.1:m.15803G>A	MT-CYB	V353M	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693956	MT	15803	MT	15803	693956	680846	rs1603225508	NC_012920.1:15802:G:A
NC_012920.1:m.15804T>C	MT-CYB	V353A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693957	MT	15804	MT	15804	693957	680847	rs1556424669	NC_012920.1:15803:T:C
m.15812G>A	MT-CYB	V356M	Leigh syndrome|Leber optic atrophy	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009675	MT	15812	MT	15812	9675	24714	rs200336777	NC_012920.1:15811:G:A
NC_012920.1:m.15813T>C	MT-CYB	V356A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693959	MT	15813	MT	15813	693959	680848	rs1603225521	NC_012920.1:15812:T:C
NC_012920.1:m.15813T>G	MT-CYB	V356G	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693958	MT	15813	MT	15813	693958	680849	rs1603225521	NC_012920.1:15812:T:G
NC_012920.1:m.15824A>G	MT-CYB	T360A	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693960	MT	15824	MT	15824	693960	680850	rs28357376	NC_012920.1:15823:A:G
NC_012920.1:m.15828C>T	MT-CYB	T361M	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693961	MT	15828	MT	15828	693961	680851	rs1603225527	NC_012920.1:15827:C:T
NC_012920.1:m.15831T>C	MT-CYB	I362T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693962	MT	15831	MT	15831	693962	680852	rs1603225529	NC_012920.1:15830:T:C
NC_012920.1:m.15833C>T	MT-CYB		not provided	Likely benign(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000235581	MT	15833	MT	15833	235581	237262	rs41504845	NC_012920.1:15832:C:T
NC_012920.1:m.15834T>C	MT-CYB	L363P	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693963	MT	15834	MT	15834	693963	680853	rs878937787	NC_012920.1:15833:T:C
NC_012920.1:m.15843T>C	MT-CYB	M366T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693964	MT	15843	MT	15843	693964	680854	rs1603225538	NC_012920.1:15842:T:C
NC_012920.1(MT-CYB):m.15848A>G	MT-CYB	T368A	not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2019)	criteria provided, conflicting interpretations	VCV000377369	MT	15848	MT	15848	377369	364247	rs1057520206	NC_012920.1:15847:A:G
NC_012920.1:m.15849C>T	MT-CYB	T368I	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693965	MT	15849	MT	15849	693965	680855	rs202225494	NC_012920.1:15848:C:T
NC_012920.1:m.15851A>G	MT-CYB	I369V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693966	MT	15851	MT	15851	693966	680856	rs3094281	NC_012920.1:15850:A:G
NC_012920.1:m.15852T>G	MT-CYB	I369S	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693968	MT	15852	MT	15852	693968	680858	rs1603225544	NC_012920.1:15851:T:G
NC_012920.1:m.15852T>C	MT-CYB	I369T	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693967	MT	15852	MT	15852	693967	680857	rs1603225544	NC_012920.1:15851:T:C
NC_012920.1:m.15860A>G	MT-CYB	I372V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693970	MT	15860	MT	15860	693970	680859	rs201023973	NC_012920.1:15859:A:G
NC_012920.1:m.15860A>T	MT-CYB	I372F	Leigh syndrome	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693969	MT	15860	MT	15860	693969	680860	rs201023973	NC_012920.1:15859:A:T
NC_012920.1:m.15873T>C	MT-CYB	M376T	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693971	MT	15873	MT	15873	693971	680861	rs1603225557	NC_012920.1:15872:T:C
NC_012920.1:m.15882G>A	MT-CYB	W379*	Leigh syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693972	MT	15882	MT	15882	693972	680862	rs1603225560	NC_012920.1:15881:G:A
NC_012920.1:m.15884G>C	MT-CYB	A380P	not specified|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252455	MT	15884	MT	15884	252455	247210	rs527236195	NC_012920.1:15883:G:C
NC_012920.1:m.15884G>A	MT-CYB	A380T	Neoplasm of ovary|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000143900	MT	15884	MT	15884	143900	153625	rs527236195	NC_012920.1:15883:G:A
NC_012920.1:m.15885C>T	MT-CYB	A380V	Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000693973	MT	15885	MT	15885	693973	680863	rs1603225562	NC_012920.1:15884:C:T
NC_012920.1(MT-CYB):m.15888G>A	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690212	MT	15888	MT	15888	690212	677604	rs1603225568	NC_012920.1:15887:G:A
NC_012920.1(MT-CYB):m.15889T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690213	MT	15889	MT	15889	690213	677605	rs199833246	NC_012920.1:15888:T:C
NC_012920.1(MT-CYB):m.15890C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690214	MT	15890	MT	15890	690214	677606	rs527236196	NC_012920.1:15889:C:T
NC_012920.1:m.15890C>A	MT-TT		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143901	MT	15890	MT	15890	143901	153626	rs527236196	NC_012920.1:15889:C:A
NC_012920.1(MT-CYB):m.15891C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690215	MT	15891	MT	15891	690215	677607	rs1556424681	NC_012920.1:15890:C:T
NC_012920.1(MT-CYB):m.15892T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690216	MT	15892	MT	15892	690216	677608	rs1556424683	NC_012920.1:15891:T:C
NC_012920.1(MT-CYB):m.15893T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690217	MT	15893	MT	15893	690217	677609	rs1603225570	NC_012920.1:15892:T:C
NC_012920.1(MT-CYB):m.15894G>A	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690218	MT	15894	MT	15894	690218	677610	rs1569484752	NC_012920.1:15893:G:A
NC_012920.1(MT-CYB):m.15895T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690219	MT	15895	MT	15895	690219	677611	rs1603225571	NC_012920.1:15894:T:C
NC_012920.1(MT-CYB):m.15897G>A	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690220	MT	15897	MT	15897	690220	677612	rs1603225575	NC_012920.1:15896:G:A
NC_012920.1(MT-CYB):m.15900T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690221	MT	15900	MT	15900	690221	677613	rs878927456	NC_012920.1:15899:T:C
NC_012920.1(MT-CYB):m.15902A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690222	MT	15902	MT	15902	690222	677614	rs1556424685	NC_012920.1:15901:A:G
NC_012920.1(MT-CYB):m.15903A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690223	MT	15903	MT	15903	690223	677615	rs1603225580	NC_012920.1:15902:A:G
NC_012920.1(MT-CYB):m.15904C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690224	MT	15904	MT	15904	690224	677616	rs35788393	NC_012920.1:15903:C:T
NC_012920.1(MT-CYB):m.15905T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690225	MT	15905	MT	15905	690225	677617	rs879126276	NC_012920.1:15904:T:C
NC_012920.1(MT-CYB):m.15907A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690226	MT	15907	MT	15907	690226	677618	rs41383248	NC_012920.1:15906:A:G
NC_012920.1(MT-CYB):m.15908T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690227	MT	15908	MT	15908	690227	677619	rs386829266	NC_012920.1:15907:T:C
NC_012920.1(MT-CYB):m.15909A>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690229	MT	15909	MT	15909	690229	677621	rs1556424690	NC_012920.1:15908:A:T
NC_012920.1(MT-CYB):m.15909A>G	MT-TT		not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690228	MT	15909	MT	15909	690228	677620	rs1556424690	NC_012920.1:15908:A:G
NC_012920.1(MT-CYB):m.15911A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690230	MT	15911	MT	15911	690230	677622	rs1603225583	NC_012920.1:15910:A:G
NC_012920.1(MT-CYB):m.15913C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690231	MT	15913	MT	15913	690231	677623	rs1603225584	NC_012920.1:15912:C:T
NC_012920.1(MT-CYB):m.15914A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690232	MT	15914	MT	15914	690232	677624	rs1603225587	NC_012920.1:15913:A:G
NC_012920.1(MT-CYB):m.15915G>A	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690233	MT	15915	MT	15915	690233	677625	rs1603225588	NC_012920.1:15914:G:A
NC_012920.1(MT-CYB):m.15916T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690234	MT	15916	MT	15916	690234	677626	rs1603225591	NC_012920.1:15915:T:C
NC_012920.1:m.15917C>T	MT-TT		not provided	not provided	no assertion provided	VCV000972986	MT	15917	MT	15917	972986	961363	rs2068749891	NC_012920.1:15916:C:T
NC_012920.1(MT-CYB):m.15921T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690235	MT	15921	MT	15921	690235	677627	rs1603225593	NC_012920.1:15920:T:C
m.15923A>G	MT-TT		Jaundice|Generalized hypotonia|Constipation|Infantile onset|Sudden cardiac death|Neonatal onset|Failure to thrive|Mitochondrial disease|Variant of unknown significance	Conflicting interpretations of pathogenicity(Last reviewed: Mar 13, 2019)	criteria provided, conflicting interpretations	VCV000039575	MT	15923	MT	15923	39575	48174	rs1556424691	NC_012920.1:15922:A:G
NC_012920.1(MT-CYB):m.15924A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690236	MT	15924	MT	15924	690236	677628	rs193303001	NC_012920.1:15923:A:G
NC_012920.1(MT-CYB):m.15925C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690237	MT	15925	MT	15925	690237	677629	rs1603225595	NC_012920.1:15924:C:T
NC_012920.1(MT-CYB):m.15926C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690238	MT	15926	MT	15926	690238	677630	rs1603225597	NC_012920.1:15925:C:T
NC_012920.1:m.15927G>A	MT-TT		Familial cancer of breast|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000143902	MT	15927	MT	15927	143902	153627	rs193303002	NC_012920.1:15926:G:A
NC_012920.1:m.15928G>T	MT-TT		Mitochondrial DNA-related disorder	not provided	no assertion provided	VCV000441111	MT	15928	MT	15928	441111	434699	rs527236198	NC_012920.1:15927:G:T
NC_012920.1:m.15928G>A	MT-TT		Neoplasm of ovary|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000143903	MT	15928	MT	15928	143903	153628	rs527236198	NC_012920.1:15927:G:A
NC_012920.1(MT-CYB):m.15929A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690239	MT	15929	MT	15929	690239	677631	rs878866272	NC_012920.1:15928:A:G
NC_012920.1(MT-CYB):m.15930G>A	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690240	MT	15930	MT	15930	690240	677632	rs41441949	NC_012920.1:15929:G:A
NC_012920.1(MT-CYB):m.15932T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690241	MT	15932	MT	15932	690241	677633	rs527236199	NC_012920.1:15931:T:C
NC_012920.1:m.15932T>G	MT-TT		Neoplasm of ovary	Likely pathogenic	no assertion criteria provided	VCV000143904	MT	15932	MT	15932	143904	153629	rs527236199	NC_012920.1:15931:T:G
NC_012920.1(MT-CYB):m.15935A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690242	MT	15935	MT	15935	690242	677635	rs1556424699	NC_012920.1:15934:A:G
NC_012920.1(MT-CYB):m.15936A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690244	MT	15936	MT	15936	690244	677636	rs1556424701	NC_012920.1:15935:A:G
NC_012920.1(MT-CYB):m.15936A>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690243	MT	15936	MT	15936	690243	677637	rs1556424701	NC_012920.1:15935:A:T
NC_012920.1(MT-CYB):m.15937A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690247	MT	15937	MT	15937	690247	677638	rs1603225605	NC_012920.1:15936:A:G
NC_012920.1(MT-CYB):m.15937A>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690246	MT	15937	MT	15937	690246	677639	rs1603225605	NC_012920.1:15936:A:T
NC_012920.1(MT-CYB):m.15938C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690248	MT	15938	MT	15938	690248	677640	rs200572753	NC_012920.1:15937:C:T
NC_012920.1(MT-CYB):m.15939C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690249	MT	15939	MT	15939	690249	677641	rs878981265	NC_012920.1:15938:C:T
NC_012920.1(MT-CYB):m.15940T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690250	MT	15940	MT	15940	690250	677642	rs879197567	NC_012920.1:15939:T:C
NC_012920.1(MT-CYB):m.15941T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690252	MT	15941	MT	15941	690252	677645	rs193303003	NC_012920.1:15940:T:C
NC_012920.1(MT-CYB):m.15942T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690253	MT	15942	MT	15942	690253	677646	rs28535186	NC_012920.1:15941:T:C
NC_012920.1:m.15943T>C	MT-TT		Neoplasm of ovary|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000143905	MT	15943	MT	15943	143905	153630	rs527236200	NC_012920.1:15942:T:C
NC_012920.1(MT-CYB):m.15944T>C	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690255	MT	15944	MT	15944	690255	677647	rs1603225608	NC_012920.1:15943:T:C
NC_012920.1(MT-CYB):m.15946C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690256	MT	15946	MT	15946	690256	677648	rs202014122	NC_012920.1:15945:C:T
NC_012920.1(MT-CYB):m.15947A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690257	MT	15947	MT	15947	690257	677649	rs1556424708	NC_012920.1:15946:A:G
NC_012920.1(MT-CYB):m.15949G>A	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690258	MT	15949	MT	15949	690258	677650	rs1603225611	NC_012920.1:15948:G:A
m.15950G>A	MT-TT		Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009559	MT	15950	MT	15950	9559	24598	rs118203890	NC_012920.1:15949:G:A
NC_012920.1(MT-CYB):m.15951A>G	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690259	MT	15951	MT	15951	690259	677651	rs199993959	NC_012920.1:15950:A:G
NC_012920.1(MT-CYB):m.15952C>T	MT-TT		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690260	MT	15952	MT	15952	690260	677652	rs1603225613	NC_012920.1:15951:C:T
NC_012920.1:m.15958A>T	MT-TP		Mitochondrial disease	Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000870596	MT	15958	MT	15958	870596	858758	rs2068750239	NC_012920.1:15957:A:T
m.15965A>G	MT-TP		Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009571	MT	15965	MT	15965	9571	24610	rs199474700	NC_012920.1:15964:A:G
m.15967G>A	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERFF syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009572	MT	15967	MT	15967	9572	24611	rs199474701	NC_012920.1:15966:G:A
NC_012920.1(MT-CYB):m.15968T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690261	MT	15968	MT	15968	690261	677653	rs1603225617	NC_012920.1:15967:T:C
NC_012920.1(MT-CYB):m.15970T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690262	MT	15970	MT	15970	690262	677654	rs375213730	NC_012920.1:15969:T:C
NC_012920.1(MT-CYB):m.15976T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690263	MT	15976	MT	15976	690263	677655	rs1603225620	NC_012920.1:15975:T:C
NC_012920.1(MT-CYB):m.15977C>T	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690264	MT	15977	MT	15977	690264	677656	rs1556424716	NC_012920.1:15976:C:T
NC_012920.1(MT-CYB):m.15978C>T	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690265	MT	15978	MT	15978	690265	677657	rs201041059	NC_012920.1:15977:C:T
NC_012920.1(MT-CYB):m.15983T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690266	MT	15983	MT	15983	690266	677658	rs1603225623	NC_012920.1:15982:T:C
NC_012920.1(MT-CYB):m.15984T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690267	MT	15984	MT	15984	690267	677659	rs1603225624	NC_012920.1:15983:T:C
m.15990C>T	MT-TP		Myopathy	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000009570	MT	15990	MT	15990	9570	24609	rs199474699	NC_012920.1:15989:C:T
NC_012920.1(MT-CYB):m.15992A>T	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690268	MT	15992	MT	15992	690268	677660	rs1556424718	NC_012920.1:15991:A:T
NC_012920.1(MT-CYB):m.15994A>G	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690269	MT	15994	MT	15994	690269	677661	rs1603225627	NC_012920.1:15993:A:G
NC_012920.1(MT-CYB):m.15995G>A	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690270	MT	15995	MT	15995	690270	677662	rs1603225630	NC_012920.1:15994:G:A
NC_012920.1(MT-CYB):m.16002T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690271	MT	16002	MT	16002	690271	677663	rs1603225633	NC_012920.1:16001:T:C
NC_012920.1(MT-CYB):m.16003T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690272	MT	16003	MT	16003	690272	677664	rs1603225634	NC_012920.1:16002:T:C
NC_012920.1(MT-CYB):m.16011A>G	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690273	MT	16011	MT	16011	690273	677665	rs1603225635	NC_012920.1:16010:A:G
NC_012920.1(MT-CYB):m.16013A>G	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690274	MT	16013	MT	16013	690274	677666	rs1603225636	NC_012920.1:16012:A:G
NC_012920.1(MT-CYB):m.16017T>C	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690275	MT	16017	MT	16017	690275	677668	rs201864830	NC_012920.1:16016:T:C
NC_012920.1(MT-CYB):m.16021C>T	MT-TP		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000690277	MT	16021	MT	16021	690277	677669	rs1603225641	NC_012920.1:16020:C:T
NC_012920.1:m.16159C>A			Mitochondrial inheritance	Uncertain significance	no assertion criteria provided	VCV001525973	MT	16159	MT	16159	1525973	1517317		NC_012920.1:16158:C:A
NC_012920.1:m.16230A>G			Mitochondrial inheritance	Uncertain significance	no assertion criteria provided	VCV001525975	MT	16230	MT	16230	1525975	1517319		NC_012920.1:16229:A:G
NC_012920.1:m.16274G>A			Mitochondrial inheritance	Uncertain significance	no assertion criteria provided	VCV001525974	MT	16274	MT	16274	1525974	1517318		NC_012920.1:16273:G:A
NC_012920.1:m.16319G>A			Mitochondrial inheritance	Uncertain significance	no assertion criteria provided	VCV001526264	MT	16319	MT	16319	1526264	1517668		NC_012920.1:16318:G:A
